data_1iqt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iqt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.664 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.664 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.5 pp -131.39 171.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.649 ' CD2' ' HB3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -131.5 134.61 46.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.996 -1.065 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 21.9 t -111.09 154.19 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.431 0.634 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.519 ' N ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.888 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.521 ' CG2' HD23 ' A' ' 213' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -61.85 58.22 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.52 1.274 . . . . 0.0 111.664 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -37.28 -66.79 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 111.662 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.4 OUTLIER -47.12 -41.46 17.49 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.014 -177.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -75.92 -27.93 57.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.604 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.1 tp -64.94 -53.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.561 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 12.8 ttt-85 -53.96 -39.51 66.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 5.0 mm-40 -55.2 -41.13 71.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.726 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.469 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.8 t80 -91.67 -71.33 0.64 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.736 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.5 ' CE1' HD12 ' A' ' 184' ' ' ILE . 78.6 m-85 -53.38 -56.83 13.5 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.124 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 208' ' ' VAL . . . -51.34 -24.1 9.9 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -66.45 -45.51 85.0 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.569 ' CZ ' HD13 ' A' ' 239' ' ' ILE . 76.6 m-85 -57.74 -29.71 65.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -1.212 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 177.89 141.64 4.27 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -42.71 141.64 1.02 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.261 . . . . 0.0 110.141 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 230' ' ' PHE . 6.0 t -97.65 146.37 7.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.651 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -87.96 -56.89 3.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.63 163.35 40.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.8 pp -112.66 -171.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.47 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.573 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.3 tp10 -151.48 138.62 19.21 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.031 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.684 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 15.0 mt -112.39 -175.95 0.35 Allowed Pre-proline 0 C--N 1.295 -1.798 0 O-C-N 120.467 -1.396 . . . . 0.0 109.253 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.684 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.303 -1.817 0 O-C-N 123.155 1.081 . . . . 0.0 110.836 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.586 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -146.07 120.08 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 120.803 -1.185 . . . . 0.0 108.662 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.2 m-85 -96.98 -169.56 1.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.39 -1.444 . . . . 0.0 110.379 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.617 ' CG2' ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -165.96 134.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.65 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 7.9 t -109.88 143.9 39.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.187 -1.571 . . . . 0.0 109.62 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.617 ' CE1' ' CG2' ' A' ' 228' ' ' ILE . 22.4 m-85 -111.36 -139.14 0.38 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.121 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -67.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.065 -1.022 . . . . 0.0 112.957 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 1.2 tp10 -70.48 -85.17 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.026 -1.046 . . . . 0.0 113.586 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER 161.21 -27.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 122.192 0.996 . . . . 0.0 108.426 -178.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.584 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.7 OUTLIER -55.77 -53.21 65.4 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -53.16 -43.37 57.77 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.893 0.943 . . . . 0.0 110.561 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.496 HG23 ' CG2' ' A' ' 184' ' ' ILE . 2.1 t -52.78 -46.29 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.1 tttt -47.61 -44.15 26.33 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.106 -1.038 . . . . 0.0 108.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -70.84 -64.22 0.95 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 110.035 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.569 HD13 ' CZ ' ' A' ' 205' ' ' PHE . 0.9 OUTLIER -44.36 -64.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.485 ' CG ' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -44.68 -35.6 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.136 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 7.9 tp10 -65.51 -6.71 11.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.121 -0.987 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.59 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -136.31 51.03 2.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 0.0 109.258 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.6 mtpt -29.21 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -116.44 82.81 1.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.406 -1.434 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.59 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 7.4 m-70 -89.71 -151.82 0.24 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.0 -1.063 . . . . 0.0 110.096 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.7 t30 -143.63 142.83 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.784 . . . . 0.0 109.677 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 249' ' ' LEU . 58.9 t -135.02 116.77 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.064 -1.023 . . . . 0.0 110.474 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 55.06 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.3 OUTLIER -133.51 30.64 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 3.7 m -150.19 153.18 35.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.95 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.8 OUTLIER -119.53 54.43 1.0 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.142 -0.974 . . . . 0.0 110.595 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.537 ' CB ' ' CG1' ' A' ' 186' ' ' VAL . 61.3 m -42.01 167.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.36 -0.838 . . . . 0.0 109.738 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -86.79 170.52 11.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.086 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 243' ' ' LYS . 1.2 mp -147.6 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.284 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.649 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.69 112.4 24.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -38.74 166.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.878 0.847 . . . . 0.0 112.42 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.561 -0.712 . . . . 0.0 110.286 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.65 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.65 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pt -130.32 167.46 25.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.449 -1.3 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -125.89 134.7 51.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 53.1 t -111.78 122.59 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.524 -0.735 . . . . 0.0 110.537 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.549 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.083 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 46.6 p . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.93 49.06 1.51 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.549 1.5 . . . . 0.0 112.533 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -37.2 -66.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.0 -1.063 . . . . 0.0 111.63 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.57 -41.98 22.72 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.849 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 10.1 mttt -74.13 -28.4 61.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.635 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.2 tp -64.46 -54.93 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.585 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 1.1 mpp_? -53.1 -37.44 61.72 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.7 mm-40 -62.97 -36.26 82.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.65 -71.46 0.64 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.544 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.635 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.2 m-85 -57.03 -51.43 69.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.424 -0.911 . . . . 0.0 108.71 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -56.25 -20.72 29.99 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.42 57.63 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.562 ' CD1' HD13 ' A' ' 239' ' ' ILE . 75.3 m-85 -56.15 -36.32 68.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -1.193 . . . . 0.0 108.911 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.58 139.21 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -41.43 141.57 0.71 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -1.15 . . . . 0.0 109.808 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.45 HG21 ' HA2' ' A' ' 203' ' ' GLY . 10.7 t -100.43 151.29 5.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.51 -0.743 . . . . 0.0 110.482 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.451 ' OE1' ' HD2' ' A' ' 231' ' ' LYS . 20.5 tp10 -87.59 -54.46 4.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -153.47 173.66 15.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' A' ' 213' ' ' LEU . 2.4 pp -123.93 -172.02 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 120.556 -1.34 . . . . 0.0 109.554 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.9 tp10 -150.4 122.36 8.2 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 108.882 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.2 mm? -102.54 173.05 3.77 Favored Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 120.324 -1.485 . . . . 0.0 111.16 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.1 Cg_exo . . . . . 0 C--N 1.306 -1.661 0 O-C-N 124.075 1.566 . . . . 0.0 110.871 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 121.976 0.894 . . . . 0.0 111.71 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.662 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.4 p -128.64 118.31 22.69 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -94.37 -166.53 1.5 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.487 -1.383 . . . . 0.0 110.394 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.9 OUTLIER -168.0 138.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.599 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.9 t -115.04 142.74 46.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 119.933 -1.729 . . . . 0.0 110.471 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CD2' ' CB ' ' A' ' 235' ' ' PRO . 39.6 m-85 -104.17 -157.6 0.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.451 ' HD2' ' OE1' ' A' ' 209' ' ' GLU . 4.9 tttm -106.9 -59.97 1.73 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.191 -0.943 . . . . 0.0 111.65 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 11.1 mt-10 -91.61 -70.98 0.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.048 -1.032 . . . . 0.0 111.421 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 165.45 -28.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.163 0.982 . . . . 0.0 109.426 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.68 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 16.9 tt0 -54.88 -44.58 99.54 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.9 Cg_exo -51.74 -33.76 51.27 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 122.774 0.881 . . . . 0.0 110.972 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.54 HG12 ' CG2' ' A' ' 256' ' ' VAL . 61.3 t -78.59 -32.67 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.791 -1.193 . . . . 0.0 108.864 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -47.86 -50.78 25.31 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.017 178.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 1.0 OUTLIER -69.29 -58.53 3.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.045 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.562 HD13 ' CD1' ' A' ' 205' ' ' PHE . 23.0 mm -48.57 -64.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.756 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -44.69 -32.47 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.707 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 9.9 tp10 -71.94 2.66 5.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 3.8 tptt -132.57 51.24 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 108.941 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -25.0 -40.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -117.56 102.36 9.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.523 -1.361 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 25.3 m-70 -89.64 -159.6 0.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -0.94 . . . . 0.0 110.92 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 250' ' ' SER . 1.6 t30 -141.33 125.25 17.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 77.0 t -148.13 126.04 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.45 66.52 2.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.5 mt 46.35 38.69 5.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -1.148 . . . . 0.0 110.504 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 246' ' ' ASN . 1.4 t -146.28 -173.49 4.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.694 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -149.86 51.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.448 179.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.553 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.6 m -34.86 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.835 -0.541 . . . . 0.0 109.737 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.549 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -86.9 170.78 11.34 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.521 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.585 HD11 ' CD2' ' A' ' 245' ' ' HIS . 1.8 mp -149.76 101.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 118.401 -1.32 . . . . 0.0 112.798 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.8 OUTLIER -110.06 111.9 23.56 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -36.65 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.068 0.937 . . . . 0.0 112.805 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.53 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.252 0 O-C-N 121.582 -0.698 . . . . 0.0 110.171 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.667 ' HD3' ' CA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.659 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.2 pp -127.09 169.46 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.235 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.632 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.34 133.22 46.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 110.016 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 39.6 t -109.2 125.8 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.391 -0.818 . . . . 0.0 110.484 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.487 ' HB ' HD11 ' A' ' 213' ' ' LEU . 29.1 p . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.13 46.87 1.2 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.604 1.536 . . . . 0.0 112.359 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.516 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 1.1 mt-10 -36.15 -66.46 0.21 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 0.0 110.977 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 5.4 tt0 -47.49 -41.83 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.874 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 17.8 mttt -75.32 -27.44 59.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.2 tp -64.89 -53.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.569 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.35 -39.27 60.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 37.2 mm-40 -58.53 -39.77 81.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.487 -0.758 . . . . 0.0 110.032 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.3 t80 -91.3 -72.03 0.6 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.42 -1.712 . . . . 0.0 109.712 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.629 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.6 m-85 -54.42 -54.67 37.66 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.409 -0.916 . . . . 0.0 108.691 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -54.96 -22.98 29.61 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -66.73 -46.37 75.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.587 ' CD1' HD13 ' A' ' 239' ' ' ILE . 65.9 m-85 -53.55 -37.69 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -1.203 . . . . 0.0 108.451 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.22 143.69 6.36 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 3.0 pm0 -41.74 141.71 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -1.176 . . . . 0.0 110.009 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.7 t -102.1 154.67 5.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.483 -0.761 . . . . 0.0 110.52 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 231' ' ' LYS . 1.8 tt0 -87.84 -59.28 2.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.38 169.91 21.96 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.511 HD12 ' CD2' ' A' ' 213' ' ' LEU . 8.6 pt -119.16 -170.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.389 -1.324 . . . . 0.0 109.763 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.569 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.6 tp10 -150.6 124.08 9.02 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.1 mm? -101.64 174.18 3.08 Favored Pre-proline 0 C--N 1.293 -1.88 0 O-C-N 120.465 -1.397 . . . . 0.0 110.74 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.306 -1.703 0 O-C-N 123.707 1.372 . . . . 0.0 110.863 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.641 0.734 . . . . 0.0 110.995 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.3 116.45 19.13 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.632 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.26 -170.06 2.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.408 -1.433 . . . . 0.0 110.394 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -166.61 134.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.667 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.4 t -110.42 139.99 45.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.206 -1.559 . . . . 0.0 109.594 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 69.9 m-85 -101.36 -165.65 1.22 Allowed 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 19.2 tttt -92.21 -65.22 1.02 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.555 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -101.56 166.68 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -20.22 65.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.637 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 35.2 tt0 -54.81 -53.61 58.85 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.8 Cg_exo -44.42 -38.72 11.96 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 120.477 0.785 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.498 HG22 ' CG2' ' A' ' 184' ' ' ILE . 55.5 t -74.87 -34.06 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.734 -1.228 . . . . 0.0 109.25 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -46.31 -46.33 18.03 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.333 1.064 . . . . 0.0 108.22 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -62.7 1.29 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.949 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.587 HD13 ' CD1' ' A' ' 205' ' ' PHE . 25.2 mm -46.64 -65.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.485 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 239' ' ' ILE . 12.0 tpt -43.63 -33.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 110.052 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -67.54 -2.84 7.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.116 -0.99 . . . . 0.0 110.828 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.12 50.7 2.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 109.099 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -25.42 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.71 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.6 t80 -114.52 93.71 4.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.463 -1.398 . . . . 0.0 109.454 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 11.3 m-70 -91.19 -157.97 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 111.301 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 12.1 t-20 -141.07 139.8 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.797 -0.564 . . . . 0.0 109.621 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.41 113.32 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.003 -1.061 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 62.66 -87.08 0.05 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 2.2 mt -137.55 27.1 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.187 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.48 170.25 17.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.427 -0.796 . . . . 0.0 109.421 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.71 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -132.95 64.28 1.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.791 -1.193 . . . . 0.0 111.289 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.56 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 67.7 m -39.24 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.55 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.4 OUTLIER -86.51 171.35 11.14 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.048 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.518 ' CD1' ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -150.54 97.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.938 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.0 tttt -103.94 116.17 31.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.2 p -38.38 167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.168 0.985 . . . . 0.0 112.572 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.567 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.231 0 O-C-N 121.634 -0.667 . . . . 0.0 110.207 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.662 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.662 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.8 pt -131.58 172.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.63 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -133.23 132.71 41.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.955 -1.09 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 26.2 t -105.95 127.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.424 -0.797 . . . . 0.0 110.395 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.079 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 9.5 p . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.679 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -73.47 113.75 3.86 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.513 1.475 . . . . 0.0 111.646 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.528 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -97.73 -70.56 0.72 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.01 0.909 . . . . 0.0 109.556 177.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -50.79 -47.5 59.79 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -63.82 -26.95 68.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -68.06 -60.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.62 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 1.4 tmm_? -50.34 -31.87 15.7 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -63.26 -41.05 98.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.708 178.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' GLY . 0.9 OUTLIER -90.89 -70.4 0.68 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.813 179.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 184' ' ' ILE . 70.8 m-85 -54.07 -55.61 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.726 -0.79 . . . . 0.0 108.947 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -55.08 -22.64 29.27 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -67.33 -46.74 68.19 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.575 ' CD1' HD12 ' A' ' 239' ' ' ILE . 82.6 m-85 -56.3 -31.04 63.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.031 -1.276 . . . . 0.0 108.494 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.68 142.73 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.4 pm0 -42.87 143.81 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.048 -1.266 . . . . 0.0 109.824 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.615 ' CG2' ' CE2' ' A' ' 230' ' ' PHE . 11.8 t -105.12 154.26 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.396 -0.815 . . . . 0.0 110.874 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -88.33 -57.74 2.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.467 ' O ' HG21 ' A' ' 229' ' ' THR . 0.4 OUTLIER -153.4 170.24 21.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 42.6 pt -118.57 -169.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 118.549 -1.26 . . . . 0.0 110.021 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.562 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.0 tt0 -151.12 121.8 7.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -98.64 173.7 3.68 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.405 -1.434 . . . . 0.0 110.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.7 Cg_exo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.753 1.396 . . . . 0.0 110.746 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 121.467 0.651 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.635 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -131.57 118.19 19.77 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -96.21 -171.75 2.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.46 -1.4 . . . . 0.0 110.159 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.4 mt -163.91 137.52 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.598 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 7.0 t -113.17 146.3 39.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.079 -1.638 . . . . 0.0 110.253 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 235' ' ' PRO . 44.0 m-85 -109.8 -164.86 0.96 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.583 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 232' ' ' GLU . 31.1 tttt -110.49 -65.78 1.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.477 0.656 . . . . 0.0 110.911 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 6.6 mt-10 -66.05 -67.68 0.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 110.842 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.9 OUTLIER 147.72 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-O 122.807 1.289 . . . . 0.0 107.666 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt-10 -54.74 -45.21 99.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -50.9 -21.5 8.61 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.496 0.735 . . . . 0.0 110.451 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.564 HG11 ' CG2' ' A' ' 256' ' ' VAL . 57.6 t -91.31 -35.33 6.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -48.21 -48.38 34.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -73.54 -61.58 1.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.962 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.575 HD12 ' CD1' ' A' ' 205' ' ' PHE . 15.4 mm -43.56 -66.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.463 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.09 -44.49 4.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 110.386 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -59.17 -13.52 7.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.137 -0.977 . . . . 0.0 110.438 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -124.4 45.21 2.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' ILE . 4.6 ttmt -25.43 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.64 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -115.25 95.02 4.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.428 -1.42 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.594 ' NE2' ' O ' ' A' ' 242' ' ' LYS . 1.6 m-70 -102.36 -145.91 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.997 -1.065 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 3.6 m-20 -145.09 145.32 31.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.0 109.538 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.55 108.3 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 110.415 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 249' ' ' LEU . . . 65.62 -86.01 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 248' ' ' GLY . 0.8 OUTLIER -142.62 28.92 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.102 . . . . 0.0 110.008 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.52 132.7 23.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.64 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -90.2 46.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.608 -179.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.537 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 29.1 p -35.57 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.575 -0.703 . . . . 0.0 109.783 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.529 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -87.43 173.14 9.3 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.419 -1.312 . . . . 0.0 108.668 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 1.2 mp -150.26 94.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.406 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.608 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 17.7 ttmt -100.08 113.0 25.3 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.3 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.071 0.939 . . . . 0.0 112.686 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.541 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.487 0.661 . . . . 0.0 110.04 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.635 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.635 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.6 pp -132.2 -178.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.731 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.86 148.4 50.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 110.041 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 24.1 t -120.55 124.94 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.079 -1.013 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.522 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.495 2.574 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.598 ' HB ' ' CG ' ' A' ' 213' ' ' LEU . 4.4 m . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.05 76.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 198' ' ' ILE . 1.8 mt-10 -36.45 -40.5 0.24 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.482 -0.761 . . . . 0.0 110.128 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.1 -53.31 39.64 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 117.937 -1.505 . . . . 0.0 108.519 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 12.3 ttmt -69.78 -28.63 65.91 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.578 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.18 -51.2 71.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.542 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -54.38 -33.25 58.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -61.61 -40.51 95.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.502 ' CE2' ' HB3' ' A' ' 245' ' ' HIS . 3.3 t80 -91.02 -68.8 0.77 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.529 -1.669 . . . . 0.0 109.449 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 198' ' ' ILE . 77.9 m-85 -58.33 -52.34 66.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -57.25 -25.63 54.74 Favored Glycine 0 N--CA 1.481 1.678 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -59.5 -44.82 96.41 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.564 ' CD2' HD12 ' A' ' 239' ' ' ILE . 78.9 m-85 -61.34 -40.08 92.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.167 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.46 140.22 6.15 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.7 OUTLIER -42.63 143.12 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.251 . . . . 0.0 110.122 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.628 ' CG2' ' CE2' ' A' ' 230' ' ' PHE . 14.2 t -110.24 152.54 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 110.728 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 1.1 tp10 -88.32 -58.51 2.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 229' ' ' THR . 1.7 m -153.14 163.58 39.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 198' ' ' ILE . 2.2 pp -111.59 -171.27 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.176 -1.409 . . . . 0.0 110.351 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.534 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 22.7 tt0 -152.69 139.65 19.13 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.452 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 4.0 mt -99.28 -177.93 0.64 Allowed Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.5 Cg_exo . . . . . 0 C--N 1.308 -1.588 0 O-C-N 122.627 0.804 . . . . 0.0 110.145 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.7 p90 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 10.3 p -138.19 129.62 27.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -95.62 -175.56 3.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.569 -1.332 . . . . 0.0 109.203 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.7 mt -161.58 133.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 7.7 t -110.49 143.66 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.166 -1.584 . . . . 0.0 110.299 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.628 ' CE2' ' CG2' ' A' ' 208' ' ' VAL . 63.5 m-85 -104.68 -126.41 0.23 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.61 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -139.92 -56.09 0.55 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.654 -1.279 . . . . 0.0 111.182 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 2.1 tt0 -92.8 -69.75 0.73 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.018 -1.051 . . . . 0.0 110.145 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 2.0 pt-20 165.88 -31.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.238 1.018 . . . . 0.0 108.914 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -48.58 -48.91 67.41 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -51.03 -36.18 53.27 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 122.667 0.825 . . . . 0.0 110.522 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.544 HG23 ' CG2' ' A' ' 184' ' ' ILE . 3.6 t -67.62 -41.96 86.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 108.333 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.58 -46.08 9.8 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.278 1.037 . . . . 0.0 108.741 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -71.82 -63.33 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.916 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.564 HD12 ' CD2' ' A' ' 205' ' ' PHE . 31.4 mm -44.23 -64.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.393 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -46.18 -34.15 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.958 . . . . 0.0 109.476 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 15.0 tt0 -80.05 10.17 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 110.522 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.584 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.5 mmtt -131.28 49.03 2.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 108.987 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 242' ' ' LYS . 1.4 tmmm? -26.55 -39.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.686 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -123.56 104.59 9.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.624 -1.298 . . . . 0.0 109.616 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 36.5 m-70 -89.6 -174.6 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.951 . . . . 0.0 110.663 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 250' ' ' SER . 3.8 m120 -133.92 119.19 18.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.523 -0.736 . . . . 0.0 109.494 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 250' ' ' SER . 54.5 t -145.59 131.56 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.997 -1.064 . . . . 0.0 110.57 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.04 65.3 2.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp 48.24 28.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -1.159 . . . . 0.0 110.937 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 69.8 m -136.3 171.57 14.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.048 -1.032 . . . . 0.0 109.762 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.686 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -150.47 53.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 111.313 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 24.0 p -39.05 161.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 109.405 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.522 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -86.52 168.57 13.59 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.043 -1.463 . . . . 0.0 108.01 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 245' ' ' HIS . 2.5 mp -150.26 109.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 117.942 -1.503 . . . . 0.0 113.548 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.528 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tttp -99.18 -154.67 0.47 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 7.0 p -122.64 168.41 15.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.309 -1.495 . . . . 0.0 110.448 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.515 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.878 . . . . 0.0 110.654 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.661 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.8 pt -130.22 176.99 7.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 118.317 -1.353 . . . . 0.0 110.48 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.634 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.72 117.82 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.775 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 22.3 t -89.62 119.08 36.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.527 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.417 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.6 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 94.8 m . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.543 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.6 Cg_endo -68.06 71.98 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.756 1.398 . . . . 0.0 112.158 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.72 -64.55 0.34 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.479 -0.763 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 1.8 tt0 -46.28 -43.67 15.88 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.083 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 2.5 tttt -74.64 -29.06 61.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.589 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.3 tp -62.24 -53.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.575 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 12.5 mtt180 -52.43 -37.48 56.89 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 2.4 mm-40 -59.59 -38.39 81.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.909 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.55 -70.86 0.67 Allowed 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.589 ' CD2' HG13 ' A' ' 198' ' ' ILE . 91.2 m-85 -56.6 -53.24 59.9 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.893 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -55.44 -21.5 27.53 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.46 70.73 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.574 ' CD2' HD13 ' A' ' 239' ' ' ILE . 77.8 m-85 -56.72 -40.84 76.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -1.209 . . . . 0.0 108.896 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.32 138.03 4.95 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 206' ' ' GLY . 1.1 pm0 -41.83 142.36 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -1.185 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 229' ' ' THR . 18.5 t -102.98 152.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.419 -0.8 . . . . 0.0 110.951 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.1 tt0 -88.12 -55.89 3.56 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.474 ' O ' HG23 ' A' ' 229' ' ' THR . 3.4 m -153.59 169.0 24.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 2.4 pt -118.63 -171.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.528 -1.357 . . . . 0.0 110.137 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.571 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 11.5 tp10 -151.51 130.82 12.83 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.106 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.807 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.4 mm? -101.87 176.99 1.61 Allowed Pre-proline 0 C--N 1.295 -1.762 0 O-C-N 120.528 -1.357 . . . . 0.0 109.829 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.807 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.327 1.172 . . . . 0.0 110.457 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.555 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.4 p90 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.616 0.722 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.534 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -165.07 117.37 1.19 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.82 . . . . 0.0 108.83 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.82 -174.8 3.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.476 -1.39 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.2 mt -164.03 133.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.627 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.0 t -106.18 141.97 36.65 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.221 -1.549 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 20.8 m-85 -100.65 -142.68 0.34 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.198 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -123.23 -58.56 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.837 -1.165 . . . . 0.0 111.674 -178.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 8.8 mt-10 -92.24 -70.08 0.71 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 110.725 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 163.76 -27.61 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.461 1.124 . . . . 0.0 108.895 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 tt0 -57.93 -42.6 96.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -52.74 -31.44 50.93 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.496 0.735 . . . . 0.0 110.304 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.547 HG11 ' CG2' ' A' ' 256' ' ' VAL . 37.2 t -76.74 -36.82 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.741 -1.224 . . . . 0.0 108.121 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -44.5 -46.75 9.93 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.468 1.128 . . . . 0.0 108.25 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.84 -61.26 1.85 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.892 0.853 . . . . 0.0 109.869 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.574 HD13 ' CD2' ' A' ' 205' ' ' PHE . 15.4 mm -45.63 -65.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.482 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -48.21 -31.15 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.55 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 70.8 tt0 -66.41 -5.26 10.29 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.932 -1.105 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.607 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.26 52.88 1.45 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 0.0 109.355 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 33.6 ttpt -26.32 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.623 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -107.59 90.74 3.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.334 -1.479 . . . . 0.0 110.456 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.607 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 11.9 m-70 -95.11 -164.09 1.12 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.254 -0.904 . . . . 0.0 110.703 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 13.2 m120 -137.1 143.99 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.639 -0.663 . . . . 0.0 109.629 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.45 99.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.07 . . . . 0.0 110.323 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 67.28 -83.61 0.13 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.17 24.41 2.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -1.145 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 4.1 m -143.95 134.52 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.623 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.79 56.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.063 . . . . 0.0 110.895 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.555 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 33.9 m -41.34 162.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.287 -0.883 . . . . 0.0 109.065 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.527 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 2.2 pt-20 -88.1 175.7 7.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.575 -1.328 . . . . 0.0 108.293 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 1.2 mp -149.2 108.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.426 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 1.2 tttt -114.6 110.56 19.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.3 p -37.55 167.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.114 0.959 . . . . 0.0 112.918 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.315 0 O-C-N 121.764 -0.585 . . . . 0.0 109.762 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.626 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.626 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.1 pt -128.78 178.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 117.593 -1.643 . . . . 0.0 110.734 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.616 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -147.35 119.24 8.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.951 -1.093 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 225' ' ' PHE . 95.0 t -89.2 121.7 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.573 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . . . . . . 0 N--CA 1.497 2.732 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.949 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.539 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 44.9 p . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.653 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.89 47.18 1.19 Allowed 'Trans proline' 0 C--O 1.204 -1.224 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.537 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -37.33 -71.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.959 -1.088 . . . . 0.0 112.315 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -47.25 -40.49 16.67 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.299 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 13.2 mmtt -75.84 -26.58 57.29 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.1 tp -67.37 -55.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.584 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 42.7 ttt-85 -56.94 -34.68 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.9 mm-40 -57.97 -46.78 84.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 110.182 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.45 -71.05 0.64 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 117.377 -1.729 . . . . 0.0 109.657 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.631 ' CD2' HG13 ' A' ' 198' ' ' ILE . 11.4 m-30 -51.29 -51.33 55.19 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.177 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.537 ' HA2' HG21 ' A' ' 208' ' ' VAL . . . -55.62 -21.18 27.49 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.24 -45.73 29.83 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 239' ' ' ILE . 73.6 m-85 -54.35 -28.1 40.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -1.187 . . . . 0.0 108.361 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.91 129.45 1.3 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.0 OUTLIER -39.84 141.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -1.098 . . . . 0.0 110.199 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.591 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -91.17 140.46 15.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.587 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -87.53 -47.02 9.06 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 176.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.53 ' HB2' ' CG2' ' A' ' 229' ' ' THR . 35.2 m -153.19 161.31 42.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.537 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 4.4 pt -118.58 -166.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.037 -1.465 . . . . 0.0 110.638 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.96 130.52 12.24 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.972 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.671 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 3.0 mm? -111.78 172.7 3.34 Favored Pre-proline 0 C--N 1.292 -1.92 0 O-C-N 120.614 -1.304 . . . . 0.0 108.595 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.299 -2.039 0 O-C-N 123.366 1.193 . . . . 0.0 110.938 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 3.6 p90 . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.4 0.619 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.508 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 14.8 p -139.26 131.07 27.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.318 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.65 ' HB2' ' HB3' ' A' ' 212' ' ' GLU . 2.3 m-85 -97.25 -173.33 2.64 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.114 -1.616 . . . . 0.0 108.875 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.541 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -163.34 132.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.621 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 13.3 t -111.2 150.49 29.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.423 -1.423 . . . . 0.0 110.253 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 208' ' ' VAL . 66.9 m-85 -118.93 -116.04 0.32 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.048 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -47.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.815 -1.178 . . . . 0.0 111.654 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -83.75 -101.18 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.916 -1.115 . . . . 0.0 111.366 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 176.05 -27.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 109.844 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.612 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.8 mt-10 -59.49 -49.56 91.69 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 112.6 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -53.25 -22.68 20.81 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 122.923 0.959 . . . . 0.0 111.563 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.531 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.1 t -79.37 -48.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.83 -41.29 10.92 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.191 0.996 . . . . 0.0 108.653 178.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 1.1 tttm -71.22 -64.62 0.88 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.856 0.836 . . . . 0.0 110.332 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.572 HD12 ' CE1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -50.96 -62.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.825 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 239' ' ' ILE . 3.5 tmm? -44.3 -32.79 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 110.333 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -65.3 -5.89 8.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.019 -1.051 . . . . 0.0 110.599 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.587 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -137.69 51.7 1.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.134 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 254' ' ' ILE . 3.0 ttmt -25.02 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.654 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -106.75 91.94 3.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.478 -1.388 . . . . 0.0 109.567 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 3.4 m-70 -89.64 -159.61 0.6 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.07 -1.018 . . . . 0.0 110.83 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 247' ' ' VAL . 9.4 t-20 -136.59 128.57 29.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 248' ' ' GLY . 44.4 t -146.36 136.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.925 -1.109 . . . . 0.0 110.634 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 42.55 70.93 0.43 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.3 OUTLIER 42.51 35.75 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -144.87 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.654 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -137.19 46.87 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.005 . . . . 0.0 110.583 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.591 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 63.6 m -40.07 157.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 1.9 pt-20 -87.92 165.51 15.19 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 117.618 -1.633 . . . . 0.0 107.568 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.576 ' CG2' ' NE2' ' A' ' 245' ' ' HIS . 2.5 mp -150.37 110.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.168 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.603 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 8.5 tttt -100.98 113.82 27.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.531 HG21 ' CG1' ' A' ' 236' ' ' VAL . 2.3 p -40.6 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 111.912 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.658 -0.651 . . . . 0.0 109.848 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.689 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.689 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pp -138.22 169.53 18.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.035 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.607 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -115.39 155.33 27.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.931 -1.105 . . . . 0.0 109.573 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 61.7 t -134.82 136.35 52.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.198 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.47 ' OG1' ' CD1' ' A' ' 213' ' ' LEU . 62.9 p . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -66.92 43.23 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.467 1.444 . . . . 0.0 113.255 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.555 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -37.94 -66.68 0.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.886 -1.134 . . . . 0.0 111.523 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.6 mm-40 -47.59 -43.44 25.58 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.182 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 5.7 mttt -73.97 -25.45 59.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.592 ' CG2' ' N ' ' A' ' 199' ' ' ARG . 0.6 OUTLIER -65.76 -56.61 14.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.592 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -51.17 -37.33 45.84 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.4 mm-40 -60.53 -40.05 90.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.675 . . . . 0.0 109.905 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.21 -72.27 0.59 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.497 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 198' ' ' ILE . 79.4 m-85 -53.53 -53.37 52.61 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.472 -0.891 . . . . 0.0 108.982 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 208' ' ' VAL . . . -55.68 -21.97 30.97 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -70.01 -45.7 55.49 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.533 ' CE1' HD12 ' A' ' 239' ' ' ILE . 82.0 m-85 -57.06 -34.75 68.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -1.222 . . . . 0.0 108.886 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.83 139.41 4.63 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.5 OUTLIER -41.31 142.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -1.104 . . . . 0.0 109.983 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.511 HG23 ' CE1' ' A' ' 230' ' ' PHE . 7.6 t -101.76 148.52 7.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 44.1 tt0 -87.95 -53.27 4.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 229' ' ' THR . 3.7 m -153.54 168.67 25.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 12.0 pt -121.54 -170.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.538 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 227' ' ' PHE . 8.7 tt0 -150.8 130.51 13.15 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.712 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 13.4 mt -106.78 178.75 1.02 Allowed Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 120.786 -1.196 . . . . 0.0 109.591 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.0 Cg_exo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 123.212 1.112 . . . . 0.0 111.1 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.577 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.2 p -142.26 116.6 9.57 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 120.96 -1.087 . . . . 0.0 108.632 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.607 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.5 m-85 -92.79 -165.78 1.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.647 -1.283 . . . . 0.0 109.642 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.567 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.1 mt -168.25 139.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 8.1 t -113.25 145.62 40.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.065 -1.647 . . . . 0.0 110.118 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 22.9 m-30 -109.56 -125.02 0.26 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.738 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 209' ' ' GLU . 7.5 tttt -174.7 -50.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.104 -0.997 . . . . 0.0 109.866 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.9 mt-10 -71.48 -26.44 62.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -0.801 . . . . 0.0 109.117 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 88.52 -27.12 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 122.843 1.306 . . . . 0.0 108.377 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.64 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 8.4 mt-10 -65.06 -39.32 35.86 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.767 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.1 Cg_exo -54.83 -24.83 40.23 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 N-CA-C 109.618 -0.955 . . . . 0.0 109.618 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.55 HG13 ' CG2' ' A' ' 256' ' ' VAL . 16.2 t -81.12 -41.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 236' ' ' VAL . 1.8 tptt -42.85 -45.77 5.03 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.423 1.106 . . . . 0.0 108.348 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.9 OUTLIER -72.31 -62.2 1.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.856 0.836 . . . . 0.0 109.722 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.533 HD12 ' CE1' ' A' ' 205' ' ' PHE . 8.2 mm -43.94 -65.44 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.329 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.461 ' HG3' HG12 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -43.63 -37.85 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 5.2 tt0 -63.3 -8.95 9.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.129 -0.982 . . . . 0.0 110.644 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.22 51.52 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.503 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 10.1 ttmt -26.96 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.628 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.27 100.78 8.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.442 . . . . 0.0 110.015 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 4.2 m-70 -102.35 -158.32 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.156 -0.965 . . . . 0.0 110.773 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -139.19 149.14 44.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.519 -0.738 . . . . 0.0 109.958 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 249' ' ' LEU . 37.9 t -143.67 123.15 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.41 -93.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -131.71 32.78 4.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 110.088 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.9 m -149.98 155.74 40.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.96 56.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 111.072 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 30.3 p -37.19 156.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.724 . . . . 0.0 109.835 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 2.0 pm0 -88.34 172.42 9.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.624 -1.231 . . . . 0.0 108.973 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.535 ' O ' ' CD ' ' A' ' 255' ' ' LYS . 1.0 OUTLIER -146.25 129.42 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.509 -1.276 . . . . 0.0 112.155 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -137.42 104.92 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.9 p -34.48 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.094 0.949 . . . . 0.0 113.171 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.558 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.676 -0.64 . . . . 0.0 109.651 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.678 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.678 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pt -133.35 179.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.92 130.46 35.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.987 -1.071 . . . . 0.0 110.236 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 59.3 t -102.62 122.23 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 110.304 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.515 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.453 ' HB ' ' CD2' ' A' ' 213' ' ' LEU . 43.8 p . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.645 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -71.73 103.65 1.49 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.411 1.407 . . . . 0.0 111.399 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.606 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -94.44 -66.72 0.9 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.882 0.849 . . . . 0.0 110.201 178.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.14 -46.03 53.63 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.657 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -67.49 -26.12 66.2 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -66.35 -58.94 4.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 50.2 ttt180 -53.05 -34.64 57.39 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 15.2 mm-40 -59.88 -41.94 92.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.34 -69.96 0.71 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.43 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -54.47 -53.99 46.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -55.52 -21.59 28.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.92 -46.1 54.08 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.579 ' CZ ' HD13 ' A' ' 239' ' ' ILE . 80.8 m-85 -55.98 -38.01 69.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.951 -1.323 . . . . 0.0 108.847 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -173.31 142.04 6.43 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' OE2' ' CD ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -42.39 142.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -1.198 . . . . 0.0 110.095 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.4 HG21 ' CE1' ' A' ' 230' ' ' PHE . 13.3 t -103.06 151.9 6.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 110.689 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 29.2 tp10 -87.8 -61.05 1.8 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 229' ' ' THR . 4.0 m -153.72 161.1 42.41 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 16.6 pt -106.46 -168.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.236 -1.386 . . . . 0.0 109.714 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.55 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.2 tt0 -150.91 131.41 13.82 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.745 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.648 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 11.2 mt -102.7 177.53 1.44 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.309 1.163 . . . . 0.0 111.039 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 121.496 0.665 . . . . 0.0 110.815 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.577 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -127.61 119.74 26.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -91.78 -169.34 2.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 110.147 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.5 mt -164.34 133.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.616 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.8 t -109.7 141.56 42.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 119.834 -1.791 . . . . 0.0 109.879 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 20.2 m-30 -98.28 -140.3 0.3 Allowed 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' CD ' ' OE2' ' A' ' 207' ' ' GLU . 74.4 tttt -126.83 -54.85 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.936 -1.103 . . . . 0.0 111.41 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.6 mt-10 -97.4 -68.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.013 -1.054 . . . . 0.0 110.481 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 162.35 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.173 0.987 . . . . 0.0 108.997 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.658 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -56.43 -43.5 99.33 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.65 -32.24 53.72 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 122.663 0.822 . . . . 0.0 110.649 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.556 HG12 ' CG2' ' A' ' 256' ' ' VAL . 40.6 t -77.67 -34.5 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.262 . . . . 0.0 108.226 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -44.88 -48.15 11.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.281 1.038 . . . . 0.0 108.454 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -61.27 1.83 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.868 0.842 . . . . 0.0 109.731 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.579 HD13 ' CZ ' ' A' ' 205' ' ' PHE . 14.7 mm -44.93 -66.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.464 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -41.23 -42.24 2.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.483 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -58.03 -14.0 5.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.095 -1.003 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -132.26 48.25 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.8 ttmt -26.95 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.4 t80 -112.13 96.58 6.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.533 -1.354 . . . . 0.0 110.081 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 1.6 m-70 -103.34 -150.81 0.42 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.07 -1.019 . . . . 0.0 110.569 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -130.0 141.48 50.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.555 -0.716 . . . . 0.0 109.648 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 250' ' ' SER . 40.7 t -150.28 118.69 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 0.0 110.816 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 39.76 76.71 0.08 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 4.6 mt 44.95 24.0 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -1.206 . . . . 0.0 110.85 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 247' ' ' VAL . 17.4 m -143.6 122.17 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.101 -0.999 . . . . 0.0 109.216 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.612 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.4 pttt -89.61 52.47 2.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.089 -1.007 . . . . 0.0 110.958 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 22.0 p -38.81 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 1.2 pt-20 -87.59 168.78 12.73 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.847 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.536 HG22 ' CG2' ' A' ' 239' ' ' ILE . 1.3 mp -142.74 95.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.025 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.594 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.33 110.14 22.77 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.1 p -39.85 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.879 -1.138 . . . . 0.0 112.045 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.545 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.554 -0.716 . . . . 0.0 110.441 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.673 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.673 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.4 pt -125.93 162.3 29.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.891 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.659 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.66 135.82 50.75 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.027 -1.045 . . . . 0.0 110.723 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 17.6 t -109.44 137.81 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.553 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.019 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.563 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 98.1 m . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.62 64.41 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.335 1.357 . . . . 0.0 112.105 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.58 -69.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.444 -0.785 . . . . 0.0 112.002 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 25.4 tt0 -45.92 -41.25 11.28 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.281 -176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -75.71 -30.05 59.17 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.0 OUTLIER -62.94 -51.8 67.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.548 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -56.28 -38.49 71.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -55.98 -40.08 72.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.88 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -70.59 0.68 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.563 -1.655 . . . . 0.0 110.006 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 184' ' ' ILE . 39.3 m-85 -57.19 -53.03 62.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.53 -0.731 . . . . 0.0 109.649 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 208' ' ' VAL . . . -52.67 -23.02 12.9 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.56 55.89 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 239' ' ' ILE . 86.1 m-85 -57.02 -27.89 62.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.952 -1.323 . . . . 0.0 108.711 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' HA3' ' HG3' ' A' ' 235' ' ' PRO . . . -179.13 133.7 2.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 15.1 pt-20 -40.98 142.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.559 HG23 ' CD1' ' A' ' 230' ' ' PHE . 10.7 t -97.32 145.53 9.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.449 -0.782 . . . . 0.0 110.847 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -87.81 -53.31 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.485 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.74 167.72 28.66 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 176.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 38.5 pt -112.38 -168.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 118.357 -1.337 . . . . 0.0 109.835 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -151.48 125.62 9.28 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 2.5 mm? -108.32 174.53 2.41 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.343 -1.473 . . . . 0.0 110.348 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.9 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 O-C-N 123.675 1.355 . . . . 0.0 111.212 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 121.147 0.498 . . . . 0.0 110.206 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.583 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -126.18 119.25 27.02 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.659 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.9 m-85 -96.22 -165.36 1.27 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.497 -1.377 . . . . 0.0 110.757 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.575 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -169.71 134.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.659 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.5 t -112.31 143.64 43.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.849 -1.782 . . . . 0.0 109.627 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 228' ' ' ILE . 21.1 m-85 -108.9 -134.33 0.34 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.156 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 232' ' ' GLU . 2.7 tptt -128.2 -69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.06 -1.025 . . . . 0.0 113.276 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.9 mt-10 -73.82 -80.5 0.07 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.87 -1.144 . . . . 0.0 113.535 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.2 OUTLIER 161.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 122.111 0.958 . . . . 0.0 109.087 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.56 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 15.1 mm-40 -56.4 -55.99 36.53 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -51.62 -40.68 63.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.86 0.926 . . . . 0.0 110.682 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -55.21 -48.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.6 -1.313 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.87 -42.37 7.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -70.17 -62.68 1.29 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.868 0.842 . . . . 0.0 109.724 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.584 HD13 ' CD2' ' A' ' 205' ' ' PHE . 14.1 mm -45.6 -64.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.121 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -43.06 -37.17 1.87 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 110.191 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -9.02 11.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.114 -0.991 . . . . 0.0 110.658 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.1 mmtt -132.55 47.58 2.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.335 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 254' ' ' ILE . 12.0 ttmt -29.62 -32.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.6 t80 -117.57 86.99 2.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.27 -1.518 . . . . 0.0 110.39 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 2.6 m-70 -93.03 -144.78 0.22 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.967 -1.083 . . . . 0.0 110.061 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.0 OUTLIER -143.04 135.37 27.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.761 . . . . 0.0 109.384 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 246' ' ' ASN . 60.1 t -147.53 133.32 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.908 -1.12 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 250' ' ' SER . . . 41.86 62.5 1.97 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.43 24.62 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -1.209 . . . . 0.0 110.546 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 248' ' ' GLY . 0.7 OUTLIER -137.26 128.43 27.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.1 -1.0 . . . . 0.0 109.594 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.637 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.26 44.42 1.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 0.0 110.552 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 26.7 p -37.27 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.604 -0.685 . . . . 0.0 109.44 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.553 ' HG2' ' CA ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -86.86 172.05 10.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.226 -1.389 . . . . 0.0 108.458 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 243' ' ' LYS . 1.3 mp -149.24 91.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.836 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.2 tttt -98.86 113.99 26.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -36.87 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.837 0.827 . . . . 0.0 112.122 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.504 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.141 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.672 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.672 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.8 pp -124.64 172.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.328 -1.349 . . . . 0.0 110.653 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.645 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.33 124.14 18.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.308 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 17.3 t -96.84 108.3 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.543 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 50.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.497 0.189 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -71.24 83.94 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.819 1.431 . . . . 0.0 111.237 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.491 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -36.55 -63.18 0.42 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.593 -0.692 . . . . 0.0 111.145 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -47.58 -44.11 26.01 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.108 -177.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 18.4 tttm -75.53 -27.16 58.59 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.598 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.3 tp -64.56 -52.06 59.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.8 OUTLIER -54.13 -38.35 65.35 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.7 mt-10 -56.34 -41.34 75.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.95 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 3.7 t80 -90.94 -69.9 0.71 Allowed 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.479 -1.689 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.598 ' CD2' HG13 ' A' ' 198' ' ' ILE . 74.4 m-85 -57.74 -54.11 50.56 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.373 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' CA ' HG22 ' A' ' 208' ' ' VAL . . . -52.1 -24.9 16.34 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -63.23 -45.86 94.33 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.47 ' CD2' HG12 ' A' ' 239' ' ' ILE . 70.3 m-85 -57.0 -33.51 67.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -1.135 . . . . 0.0 108.68 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.58 140.26 4.69 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 2.6 pt-20 -42.45 142.19 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -1.176 . . . . 0.0 110.091 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.587 HG23 ' CD1' ' A' ' 230' ' ' PHE . 8.3 t -99.92 146.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.519 -0.738 . . . . 0.0 111.131 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -88.71 -55.7 3.6 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG22 ' A' ' 229' ' ' THR . 4.8 m -153.34 161.89 41.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 4.8 pt -114.43 -170.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.209 -1.396 . . . . 0.0 110.253 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.572 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.6 tp10 -151.21 138.95 19.77 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.165 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.776 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -110.49 172.32 3.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.699 -1.251 . . . . 0.0 110.187 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.776 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.2 Cg_exo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.503 1.265 . . . . 0.0 111.103 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.591 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.709 0.766 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.529 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 3.1 p -146.45 127.44 14.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.645 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -99.01 -173.67 2.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.112 -1.617 . . . . 0.0 109.555 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.566 HG23 ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -163.69 131.87 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.636 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.7 t -107.54 139.68 41.69 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 119.918 -1.739 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.587 ' CD1' HG23 ' A' ' 208' ' ' VAL . 23.8 m-85 -105.94 -131.48 0.3 Allowed 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.623 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 -64.71 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.846 -1.159 . . . . 0.0 112.874 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.42 -80.47 0.1 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.994 -1.066 . . . . 0.0 113.483 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 5.1 pt-20 162.97 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.948 0.88 . . . . 0.0 108.748 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 235' ' ' PRO . 1.3 mt-10 -55.47 -61.99 5.21 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 234' ' ' GLU . 5.2 Cg_exo -47.19 -39.9 26.89 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 122.988 0.994 . . . . 0.0 110.659 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 256' ' ' VAL . 2.1 t -57.41 -48.25 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -45.51 -40.69 8.81 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.07 0.938 . . . . 0.0 108.536 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 8.6 tttt -72.23 -64.0 1.03 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.925 0.869 . . . . 0.0 109.55 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.564 HD12 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -45.16 -65.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.523 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.2 tmm? -43.15 -39.16 2.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.192 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 39.3 tt0 -61.92 -15.67 44.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.617 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.53 47.33 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.708 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.3 mtpt -30.87 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.615 ' CE1' ' HD3' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -99.88 85.25 3.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.414 -1.429 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 7.5 m-70 -89.5 -148.72 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.975 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.564 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.9 OUTLIER -140.65 129.64 23.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.658 -0.651 . . . . 0.0 109.524 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 250' ' ' SER . 24.5 t -150.19 129.26 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.592 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 41.15 69.32 0.53 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.9 25.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 247' ' ' VAL . 18.9 m -139.11 118.96 13.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.546 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.615 ' HD3' ' CE1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.06 44.36 1.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.879 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.568 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 30.7 p -29.07 148.3 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.184 -0.322 . . . . 0.0 110.502 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 1.4 pt-20 -86.49 161.68 18.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.974 -1.49 . . . . 0.0 107.871 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.551 ' N ' ' O ' ' A' ' 243' ' ' LYS . 2.5 mp -146.32 105.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.807 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.606 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 13.8 tttt -99.21 115.48 29.19 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 3.5 p -37.6 162.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.473 ' HB2' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.542 -0.723 . . . . 0.0 110.607 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.683 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.683 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.9 pp -127.27 165.74 25.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.433 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.76 139.27 52.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.861 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.567 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 43.6 t -114.03 130.28 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 110.459 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.528 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 213' ' ' LEU . 62.1 m . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.8 72.47 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.415 1.41 . . . . 0.0 112.293 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.8 -67.14 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.369 -0.832 . . . . 0.0 111.596 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.6 OUTLIER -47.03 -43.62 19.8 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.147 -177.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.558 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.0 OUTLIER -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.608 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.4 -54.28 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.576 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 5.9 mtp180 -51.78 -38.22 54.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 4.6 mm-40 -56.57 -40.52 75.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.394 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.36 -71.77 0.62 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.608 ' CD2' HG13 ' A' ' 198' ' ' ILE . 83.6 m-85 -54.3 -54.94 33.48 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.947 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.21 -22.8 23.01 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.269 -2.332 . . . . 0.0 107.269 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.1 -44.93 86.3 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -57.97 -36.55 72.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -1.199 . . . . 0.0 108.93 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.14 141.99 6.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 206' ' ' GLY . 9.4 pt-20 -42.48 142.04 0.89 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -1.174 . . . . 0.0 109.86 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 229' ' ' THR . 12.6 t -104.36 150.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.518 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -88.01 -57.64 2.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.34 173.08 16.07 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pt -120.07 -170.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.895 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.589 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 3.0 tp10 -151.17 129.59 12.09 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.687 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 14.0 mt -105.82 175.12 2.24 Favored Pre-proline 0 C--N 1.295 -1.79 0 O-C-N 120.608 -1.308 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--N 1.303 -1.846 0 O-C-N 123.586 1.309 . . . . 0.0 110.984 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.151 0 CA-C-O 121.378 0.608 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.612 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.1 118.88 23.2 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.205 -0.935 . . . . 0.0 109.072 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.83 -171.44 2.35 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.275 -1.516 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.1 mt -165.78 132.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.64 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.0 t -106.22 137.72 43.66 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.03 -1.669 . . . . 0.0 109.041 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 73.8 m-85 -96.79 -162.38 0.95 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.742 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.11 -46.26 6.23 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.478 -0.764 . . . . 0.0 109.197 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.482 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 42.2 mt-10 -121.79 167.22 13.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.559 -0.713 . . . . 0.0 109.371 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -15.79 63.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.985 -1.072 . . . . 0.0 109.341 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.628 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -57.39 -58.78 15.75 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.665 -0.647 . . . . 0.0 112.702 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -45.25 -24.91 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.226 1.119 . . . . 0.0 111.176 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 184' ' ' ILE . 6.5 t -83.34 -41.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.008 -1.058 . . . . 0.0 108.842 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -45.51 -44.84 12.91 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.136 0.97 . . . . 0.0 108.536 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -71.63 -63.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.982 0.896 . . . . 0.0 109.738 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm -44.54 -64.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.373 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 2.6 ttm -45.17 -36.19 3.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 1.5 tp10 -62.73 -9.55 9.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 0.0 110.483 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.624 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.03 52.26 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.156 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 254' ' ' ILE . 11.7 mtmt -31.86 -25.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.624 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -121.68 87.24 2.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.084 -1.635 . . . . 0.0 110.803 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 6.0 m-70 -89.61 -149.66 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.867 -1.146 . . . . 0.0 110.375 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 5.4 p-10 -145.19 145.19 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 249' ' ' LEU . 53.5 t -140.97 126.65 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.856 -1.152 . . . . 0.0 110.242 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 249' ' ' LEU . . . 46.13 -94.83 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 247' ' ' VAL . 19.2 mt -131.55 34.17 3.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 110.026 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.9 m -150.45 135.47 17.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.624 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.5 pttt -103.76 52.07 0.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.051 -1.03 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.567 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 84.5 m -36.77 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.774 -0.579 . . . . 0.0 109.818 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.528 ' HG2' ' CA ' ' A' ' 187' ' ' GLY . 1.8 pm0 -87.65 172.39 9.75 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.286 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 243' ' ' LYS . 2.5 mp -150.89 96.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 118.294 -1.362 . . . . 0.0 112.897 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 8.8 mttm -100.64 115.89 31.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -38.43 166.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.024 0.916 . . . . 0.0 112.546 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.522 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.627 -0.67 . . . . 0.0 110.04 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.691 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.691 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 29.3 pt -133.1 -176.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.531 -1.268 . . . . 0.0 111.018 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.38 141.23 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.247 -0.908 . . . . 0.0 110.506 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.581 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 46.3 t -110.39 128.69 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 55.4 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -64.58 60.88 0.27 Allowed 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 121.313 1.342 . . . . 0.0 112.474 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 mm-40 -37.98 -65.31 0.34 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 111.414 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 24.4 tt0 -47.59 -42.45 23.96 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.692 -1.203 . . . . 0.0 108.705 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.01 -28.13 62.18 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.593 ' CG2' ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -65.99 -56.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.593 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.15 -36.96 32.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -61.09 -36.68 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.554 -0.716 . . . . 0.0 109.768 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.3 t80 -91.25 -72.04 0.6 Allowed 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 117.571 -1.652 . . . . 0.0 109.864 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.543 ' CD2' HG13 ' A' ' 198' ' ' ILE . 23.0 m-85 -58.64 -50.18 74.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -56.15 -20.75 29.41 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.51 -46.25 41.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.569 ' CE2' HD12 ' A' ' 239' ' ' ILE . 74.1 m-85 -53.78 -37.75 63.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.049 -1.265 . . . . 0.0 108.633 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.13 132.44 2.51 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.4 OUTLIER -39.76 142.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -1.106 . . . . 0.0 109.905 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.521 HG13 ' CG2' ' A' ' 211' ' ' ILE . 6.4 t -97.48 146.18 8.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.549 -0.719 . . . . 0.0 110.653 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -87.48 -47.61 8.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.469 ' O ' HG21 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.31 169.88 22.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 213' ' ' LEU . 2.2 pp -128.66 -173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.646 -1.284 . . . . 0.0 110.304 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.577 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 33.6 tp10 -152.14 135.6 16.04 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.327 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.708 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.3 mm? -106.02 172.2 4.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.484 -1.385 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.708 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.307 -1.618 0 O-C-N 123.806 1.424 . . . . 0.0 110.801 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 4.8 p90 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.532 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 8.2 p -170.35 125.44 0.75 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -99.46 -176.94 3.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.264 -1.522 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -163.89 134.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 6.8 t -107.1 140.11 40.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.157 -1.589 . . . . 0.0 109.896 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 18.9 m-30 -100.13 -141.63 0.33 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -63.47 1.44 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.238 -0.914 . . . . 0.0 110.935 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 5.4 mt-10 -102.8 -69.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 0.0 111.037 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 7.0 pt-20 174.03 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.697 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.594 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -38.68 -55.29 2.72 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.2 Cg_exo -52.4 -37.6 72.33 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.093 1.049 . . . . 0.0 110.94 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 230' ' ' PHE . 2.1 t -67.38 -43.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.04 . . . . 0.0 108.92 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.32 -47.01 13.22 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.175 0.988 . . . . 0.0 108.597 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -68.51 -58.5 4.22 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.528 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 205' ' ' PHE . 3.7 mm -48.62 -63.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.688 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 1.6 tmm? -44.45 -35.4 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.942 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -65.45 -7.63 15.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.175 -0.953 . . . . 0.0 110.497 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -136.97 49.61 2.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 35.1 mtpt -29.09 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.649 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.06 89.9 3.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.515 -1.366 . . . . 0.0 110.012 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.551 ' NE2' ' O ' ' A' ' 242' ' ' LYS . 2.9 m-70 -95.8 -149.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.135 -0.978 . . . . 0.0 110.786 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -133.46 137.61 45.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.698 -0.626 . . . . 0.0 109.534 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.65 125.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.017 -1.052 . . . . 0.0 110.211 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 47.19 75.2 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.1 OUTLIER 41.85 34.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -1.095 . . . . 0.0 110.529 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.6 t -146.72 166.4 26.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.649 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 4.3 ptpp? -124.38 45.98 2.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.572 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 28.7 p -40.05 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.53 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -88.08 171.36 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.629 -1.228 . . . . 0.0 109.141 179.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 1.0 OUTLIER -144.75 103.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.484 -178.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.35 107.65 19.05 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -43.97 167.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.21 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.509 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.934 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.645 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.645 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 22.4 mt -131.72 177.62 6.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 C-N-CA 117.3 -1.76 . . . . 0.0 110.639 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.16 117.6 6.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.962 -1.086 . . . . 0.0 110.801 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 58.0 t -89.62 126.77 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.899 -1.126 . . . . 0.0 109.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.517 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.628 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 213' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.7 Cg_endo -67.92 52.34 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.406 1.404 . . . . 0.0 112.525 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -36.66 -66.51 0.22 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.192 -0.943 . . . . 0.0 111.286 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.41 -40.65 18.36 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.814 -177.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 11.0 mttt -74.32 -28.66 61.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.592 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -66.36 -55.91 16.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.592 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -52.2 -36.39 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -61.07 -39.19 88.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 110.376 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.437 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.16 -70.91 0.66 Allowed 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 117.361 -1.735 . . . . 0.0 109.421 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.581 ' CD2' HG13 ' A' ' 198' ' ' ILE . 22.4 m-85 -57.19 -51.81 67.85 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.137 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.492 ' HA2' HG21 ' A' ' 208' ' ' VAL . . . -56.42 -20.63 30.8 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.5 -45.22 60.78 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.571 ' CD1' HD11 ' A' ' 239' ' ' ILE . 81.2 m-85 -58.36 -33.23 69.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -1.232 . . . . 0.0 108.962 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.58 130.36 1.98 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' GLY . 12.2 pt-20 -41.6 141.79 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -1.216 . . . . 0.0 110.079 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.4 t -92.11 144.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.566 0.698 . . . . 0.0 111.222 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -88.12 -48.75 7.49 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 229' ' ' THR . 69.5 m -153.58 158.39 41.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.54 ' CG2' HG13 ' A' ' 208' ' ' VAL . 9.0 pt -114.93 -170.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.781 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 24.8 tp10 -151.3 137.26 18.18 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.321 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.693 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 5.3 mt -107.04 172.61 3.69 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 120.545 -1.347 . . . . 0.0 110.748 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.693 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.308 -1.598 0 O-C-N 124.098 1.578 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 1.8 p90 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.755 0.788 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.527 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 0.6 OUTLIER -170.73 129.11 0.8 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -101.55 -173.69 2.42 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.243 -1.536 . . . . 0.0 108.918 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.592 ' CD1' ' CG2' ' A' ' 198' ' ' ILE . 1.2 mt -164.91 136.32 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.613 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 14.3 t -113.8 149.6 34.71 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.237 -1.539 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 208' ' ' VAL . 70.2 m-85 -117.82 -115.7 0.33 Allowed 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.472 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.481 ' HE2' ' N ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER -163.77 -39.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 53.7 tt0 -87.83 -96.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.796 -1.19 . . . . 0.0 111.302 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.4 OUTLIER 169.61 -24.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.199 -0.938 . . . . 0.0 109.912 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.584 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.1 tm-20 -63.44 -52.06 62.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.277 -0.889 . . . . 0.0 112.967 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.4 Cg_exo -52.38 -21.28 13.3 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 122.815 0.903 . . . . 0.0 111.349 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.546 ' CG1' HG23 ' A' ' 256' ' ' VAL . 2.0 t -80.74 -51.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 240' ' ' MET . 0.0 OUTLIER -41.76 -42.04 2.5 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.312 1.053 . . . . 0.0 108.886 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -59.15 3.26 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.412 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 205' ' ' PHE . 17.3 mm -51.69 -62.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.528 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.518 ' HG3' ' N ' ' A' ' 241' ' ' GLU . 1.4 ppp? -44.75 -33.2 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.493 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.518 ' N ' ' HG3' ' A' ' 240' ' ' MET . 1.8 tt0 -70.74 -8.48 52.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.596 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -131.19 47.66 2.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.978 -1.076 . . . . 0.0 109.107 179.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -28.12 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -111.76 83.14 1.73 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.508 -1.37 . . . . 0.0 110.34 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 3.5 m-70 -92.79 -147.14 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.983 -1.073 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -144.1 120.24 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 249' ' ' LEU . 4.4 t -112.04 112.01 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.954 -1.091 . . . . 0.0 110.635 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 64.01 -68.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -154.24 23.08 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 110.482 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.2 t -145.45 148.0 32.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.033 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -102.06 50.54 0.84 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.755 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.0 m -43.84 169.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.549 -0.719 . . . . 0.0 109.376 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.4 OUTLIER -87.14 165.0 16.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.496 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -142.36 98.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.266 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.61 ' CB ' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.4 108.17 20.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.546 HG23 ' CG1' ' A' ' 236' ' ' VAL . 2.0 p -43.62 166.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.917 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.521 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.406 -0.809 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.678 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.678 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 7.2 pt -130.14 175.33 11.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.429 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -137.35 135.44 37.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.189 -0.945 . . . . 0.0 110.213 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 55.4 t -111.55 128.38 68.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.902 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.473 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.544 ' CG2' HD13 ' A' ' 213' ' ' LEU . 18.8 m . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -70.61 80.23 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.741 1.39 . . . . 0.0 112.072 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -37.03 -61.67 0.54 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.452 -0.78 . . . . 0.0 111.038 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.2 mt-10 -49.22 -45.34 44.33 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.031 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -74.62 -26.42 59.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.0 OUTLIER -64.53 -50.11 77.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.514 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -57.01 -35.28 69.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.5 mt-10 -59.75 -38.82 82.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.46 -70.49 0.68 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.509 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -57.95 -52.19 66.54 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -55.36 -21.77 27.95 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.44 -45.61 67.51 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.447 ' CD1' HD12 ' A' ' 239' ' ' ILE . 90.6 m-85 -59.52 -34.29 72.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -1.232 . . . . 0.0 109.207 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 235' ' ' PRO . . . -172.42 135.09 3.22 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -41.51 141.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.978 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 230' ' ' PHE . 12.7 t -104.2 145.91 12.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.541 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.0 -49.69 6.89 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 177.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.6 174.33 14.6 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 5.1 pt -127.54 -171.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.092 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.526 ' O ' ' O ' ' A' ' 227' ' ' PHE . 3.2 tt0 -150.82 128.5 11.57 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.917 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.5 mm? -104.88 171.38 5.02 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 120.578 -1.326 . . . . 0.0 111.004 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.4 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.15 1.605 . . . . 0.0 110.574 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.695 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -119.76 117.93 29.5 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.642 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -97.25 -169.45 1.86 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.503 -1.373 . . . . 0.0 109.986 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -166.54 138.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 8.1 t -111.79 144.4 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 119.816 -1.802 . . . . 0.0 110.413 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 22.2 m-30 -103.44 -136.01 0.34 Allowed 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.073 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -154.27 -48.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.488 -178.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 83.9 tt0 -79.26 -56.48 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.975 . . . . 0.0 109.236 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.634 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 131.06 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.626 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -57.01 -45.65 99.94 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.366 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 3.9 Cg_exo -54.58 -27.48 50.83 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 109.709 -0.92 . . . . 0.0 109.709 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.552 HG22 ' CG2' ' A' ' 184' ' ' ILE . 2.3 t -74.16 -43.96 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.43 -48.28 9.92 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 108.836 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -61.28 1.84 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.015 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 235' ' ' PRO . 11.4 mm -44.79 -64.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.64 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.512 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.0 tmm? -46.65 -33.26 4.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.372 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 3.9 tt0 -73.08 2.45 7.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.92 51.01 1.72 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.014 -1.054 . . . . 0.0 109.444 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 4.1 ttmm -26.45 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.631 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -120.28 94.48 4.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.297 -1.502 . . . . 0.0 110.258 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 242' ' ' LYS . 4.3 m-70 -97.79 -148.88 0.33 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.009 -1.057 . . . . 0.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.57 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 7.6 m-80 -145.35 139.83 27.27 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 249' ' ' LEU . 25.8 t -133.29 120.43 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.99 -1.069 . . . . 0.0 110.174 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.22 -90.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -135.56 32.81 3.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -1.111 . . . . 0.0 109.824 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.58 145.39 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.631 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.0 pttt -113.41 54.91 0.72 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.97 -1.081 . . . . 0.0 110.934 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.578 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 62.1 m -40.47 162.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.38 -0.825 . . . . 0.0 108.94 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 254' ' ' ILE . 2.1 pm0 -87.7 177.42 7.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.722 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 0.9 OUTLIER -150.04 147.38 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.329 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 5.1 tttp -156.03 105.4 2.34 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.5 p -35.08 161.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.94 0.876 . . . . 0.0 112.94 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.484 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.685 -0.635 . . . . 0.0 110.164 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.654 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.654 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.4 pp -132.47 171.36 18.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.09 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -132.37 135.65 46.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 110.412 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.593 ' CG1' ' CB ' ' A' ' 252' ' ' CYS . 16.4 t -108.35 131.76 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.67 -0.644 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.549 ' CG2' HD23 ' A' ' 213' ' ' LEU . 3.6 m . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.27 55.31 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.238 1.292 . . . . 0.0 112.155 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.5 OUTLIER -37.46 -60.28 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.427 -0.796 . . . . 0.0 110.26 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 200' ' ' GLU . 10.6 tt0 -49.07 -45.17 42.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.471 -1.291 . . . . 0.0 108.854 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -74.39 -23.94 59.05 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -68.06 -51.59 47.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.543 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 22.6 ttm180 -55.72 -36.05 66.78 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.533 ' CA ' ' OE1' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -57.48 -42.88 83.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.622 -0.674 . . . . 0.0 109.537 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -91.25 -73.69 0.53 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 117.582 -1.647 . . . . 0.0 110.05 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -51.09 -50.28 59.05 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.229 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -54.98 -21.21 23.22 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -75.39 -43.97 23.32 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.579 ' CD1' HD11 ' A' ' 239' ' ' ILE . 83.5 m-85 -58.01 -28.26 64.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -1.212 . . . . 0.0 108.941 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 179.72 132.73 1.85 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' GLY . 6.9 pt-20 -41.12 142.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.137 . . . . 0.0 110.263 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.641 ' CG2' ' CE2' ' A' ' 230' ' ' PHE . 10.7 t -102.64 147.48 9.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -54.81 4.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG21 ' A' ' 229' ' ' THR . 53.9 m -154.05 158.23 40.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pp -105.2 -168.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.305 -1.358 . . . . 0.0 109.418 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.561 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.8 tp10 -151.27 134.33 15.91 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.743 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 19.6 mt -109.52 178.13 1.09 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 120.794 -1.191 . . . . 0.0 109.7 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.0 Cg_exo . . . . . 0 C--N 1.302 -1.896 0 O-C-N 123.389 1.205 . . . . 0.0 110.754 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.411 0.624 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.559 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -130.68 120.79 24.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.115 -0.991 . . . . 0.0 109.015 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -98.27 -168.7 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.407 -1.433 . . . . 0.0 110.428 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.3 mt -164.81 134.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 10.5 t -116.15 146.47 42.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.072 -1.642 . . . . 0.0 110.225 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CE2' ' CG2' ' A' ' 208' ' ' VAL . 58.0 m-85 -114.44 -127.83 0.29 Allowed 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -145.04 -44.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.673 -1.267 . . . . 0.0 113.377 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 7.5 mt-10 -82.74 -82.8 0.14 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.614 -1.304 . . . . 0.0 112.883 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.73 -28.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.6 tt0 -62.8 -53.29 57.44 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.315 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.3 Cg_exo -48.49 -32.71 21.42 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.992 0.996 . . . . 0.0 110.323 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 183' ' ' LYS . 2.1 t -68.71 -47.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.844 -1.16 . . . . 0.0 107.907 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.19 -43.66 7.3 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.215 1.007 . . . . 0.0 108.8 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -60.43 2.36 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.539 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.579 HD11 ' CD1' ' A' ' 205' ' ' PHE . 12.4 mm -49.08 -63.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.259 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.481 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -47.86 -28.37 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.637 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -77.13 7.02 5.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 111.059 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.98 54.42 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 109.047 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.3 OUTLIER -25.46 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.653 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.3 t80 -120.27 96.27 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.378 -1.451 . . . . 0.0 110.215 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 15.0 m-70 -93.58 -165.34 1.31 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.086 -1.009 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 57.0 m-80 -135.92 133.74 37.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 250' ' ' SER . 55.7 t -149.48 131.68 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.111 -0.993 . . . . 0.0 110.477 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 42.74 62.96 2.08 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 1.9 tp 48.22 22.37 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.152 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 50.3 m -132.34 118.06 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.653 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.2 pttt -97.94 53.74 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 110.693 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.593 ' CB ' ' CG1' ' A' ' 186' ' ' VAL . 58.8 m -41.67 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.459 -0.776 . . . . 0.0 109.011 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.55 ' HG2' ' CA ' ' A' ' 187' ' ' GLY . 1.7 pm0 -86.94 173.88 9.07 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.388 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 1.2 mp -150.43 129.28 3.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.015 -1.474 . . . . 0.0 112.873 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 9.1 mttm -134.46 107.57 7.64 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -37.1 163.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.026 0.917 . . . . 0.0 112.575 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.695 -0.628 . . . . 0.0 109.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.693 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.693 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.3 mt -138.82 174.74 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.095 -1.003 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.08 139.79 50.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.143 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.574 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 62.9 t -114.62 131.38 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.55 -0.719 . . . . 0.0 109.862 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.527 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.464 ' HB ' HD13 ' A' ' 213' ' ' LEU . 76.5 p . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -69.25 45.17 0.39 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.436 1.424 . . . . 0.0 112.872 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.66 -69.41 0.11 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.048 -1.033 . . . . 0.0 111.679 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 3.8 tt0 -47.82 -39.88 19.61 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.577 -1.249 . . . . 0.0 109.034 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 194' ' ' PRO . 26.0 mmmt -75.7 -27.04 58.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.626 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.2 tp -66.99 -54.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.572 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 3.3 ttp85 -54.48 -38.28 66.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -59.32 -40.38 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.477 -0.765 . . . . 0.0 110.158 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 204' ' ' GLY . 2.0 t80 -91.02 -71.87 0.61 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.395 -1.722 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.0 m-85 -54.41 -54.06 45.72 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.564 -0.855 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.474 ' HA2' HG21 ' A' ' 208' ' ' VAL . . . -55.17 -22.1 27.83 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.93 -46.99 57.61 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 239' ' ' ILE . 85.6 m-85 -56.13 -31.22 63.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.269 . . . . 0.0 108.698 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.39 138.82 4.04 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.1 OUTLIER -43.56 143.14 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.016 -1.285 . . . . 0.0 109.577 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.474 HG21 ' HA2' ' A' ' 203' ' ' GLY . 10.4 t -101.19 152.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.754 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 3.2 tt0 -87.83 -56.19 3.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 229' ' ' THR . 30.8 m -153.47 160.35 42.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 46.2 pt -110.66 -169.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.009 -1.476 . . . . 0.0 109.584 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.549 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 4.6 tp10 -152.11 129.36 11.24 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.669 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.0 mm? -102.22 178.23 1.27 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.706 -1.246 . . . . 0.0 108.71 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.304 -1.806 0 O-C-N 123.101 1.053 . . . . 0.0 110.844 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.29 0 CA-C-O 121.488 0.661 . . . . 0.0 110.645 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.584 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -130.29 120.7 24.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.18 -173.8 3.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.451 -1.406 . . . . 0.0 109.984 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.535 HD11 ' CG1' ' A' ' 198' ' ' ILE . 2.0 mt -161.51 134.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 2.5 t -107.68 138.46 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.863 -1.773 . . . . 0.0 110.21 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CD2' ' CG ' ' A' ' 235' ' ' PRO . 35.1 m-85 -99.47 -112.75 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.298 -1.361 . . . . 0.0 111.922 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 28.6 tttp 175.32 -53.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.636 -1.29 . . . . 0.0 109.892 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.602 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 2.3 mt-10 -75.51 -22.98 56.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.144 -0.972 . . . . 0.0 108.682 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 2.2 pt-20 87.7 -21.35 0.17 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.361 1.077 . . . . 0.0 108.751 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.7 mt-10 -61.11 -45.65 96.02 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -54.06 -25.29 36.24 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 109.675 -0.933 . . . . 0.0 109.675 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.568 HG23 ' CG1' ' A' ' 184' ' ' ILE . 2.2 t -76.89 -47.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -44.16 -46.52 8.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.306 1.051 . . . . 0.0 108.895 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.61 -61.95 1.59 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.883 0.849 . . . . 0.0 109.751 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 254' ' ' ILE . 21.5 mm -43.12 -65.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.5 ' CG ' HG23 ' A' ' 256' ' ' VAL . 0.4 OUTLIER -46.55 -34.08 4.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -61.14 -11.58 9.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 110.68 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.605 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.06 52.98 1.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.161 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.5 ttpp -27.87 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.1 t80 -115.43 92.85 4.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.325 -1.484 . . . . 0.0 110.061 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 2.7 m-70 -97.96 -154.85 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 110.778 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 10.2 p30 -136.26 143.35 44.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.306 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 24.4 t -139.5 131.01 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.421 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.18 -93.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -133.19 34.22 3.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -1.181 . . . . 0.0 110.197 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.23 168.25 24.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.597 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.54 48.38 1.61 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 110.49 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 26.7 p -34.08 152.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.866 -0.522 . . . . 0.0 109.922 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.527 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 1.4 pt-20 -87.66 170.9 10.87 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.79 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.533 HG22 ' CG2' ' A' ' 239' ' ' ILE . 1.1 mp -145.26 113.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.293 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.602 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -119.71 106.82 12.51 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 18.4 t -38.32 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.14 -0.975 . . . . 0.0 112.404 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.599 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.637 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.637 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pp -130.01 -175.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 117.663 -1.615 . . . . 0.0 110.912 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.13 124.14 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 111.454 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 92.6 t -93.34 128.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 109.278 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.534 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.688 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.577 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 1.3 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.36 58.67 0.68 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.269 1.313 . . . . 0.0 111.915 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.601 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -36.98 -67.9 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.258 -0.901 . . . . 0.0 111.739 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -47.91 -38.3 16.16 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.864 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.474 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.3 OUTLIER -77.21 -27.97 53.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.618 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.2 tp -66.57 -55.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.562 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 4.8 mtt180 -56.29 -38.3 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.49 -49.02 65.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.65 -0.656 . . . . 0.0 110.464 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.6 -71.18 0.64 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 117.249 -1.78 . . . . 0.0 109.752 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.618 ' CD2' HG13 ' A' ' 198' ' ' ILE . 7.7 m-30 -50.4 -55.01 17.63 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.669 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -54.39 -22.06 21.97 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.18 -46.29 28.03 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.588 ' CZ ' HD13 ' A' ' 239' ' ' ILE . 77.7 m-85 -53.05 -36.0 60.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.318 . . . . 0.0 108.628 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.22 135.04 3.02 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.2 pt-20 -40.5 141.55 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.059 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.8 t -95.25 144.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 110.52 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 49.4 tp10 -87.65 -50.8 6.26 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 229' ' ' THR . 51.9 m -153.0 171.73 17.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.601 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 27.4 pt -125.17 -170.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.654 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.61 138.57 19.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.7 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.0 mm? -110.53 170.2 5.55 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 120.264 -1.523 . . . . 0.0 111.576 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.8 Cg_exo . . . . . 0 C--N 1.31 -1.485 0 O-C-N 124.051 1.553 . . . . 0.0 111.287 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 2.1 p90 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.511 0.672 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 0.5 OUTLIER -168.52 128.63 1.21 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.275 -0.891 . . . . 0.0 108.848 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.7 m-85 -101.01 -176.61 3.21 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.695 -1.253 . . . . 0.0 109.021 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.9 OUTLIER -165.61 136.13 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 5.2 t -107.39 139.54 41.72 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.295 -1.503 . . . . 0.0 109.784 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 15.0 m-85 -97.1 -131.64 0.2 Allowed 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.811 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -136.09 -52.67 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.761 -1.212 . . . . 0.0 110.92 -178.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 4.1 mt-10 -96.48 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.98 -26.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.227 1.013 . . . . 0.0 108.991 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.658 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -56.89 -43.58 99.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.93 -34.8 68.25 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 122.601 0.79 . . . . 0.0 110.803 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.523 HG12 ' CG2' ' A' ' 256' ' ' VAL . 54.6 t -75.67 -34.93 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.768 -1.208 . . . . 0.0 108.455 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -45.64 -44.16 13.02 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.3 1.047 . . . . 0.0 108.34 178.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -62.93 1.29 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.829 0.823 . . . . 0.0 110.458 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.588 HD13 ' CZ ' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -50.04 -60.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.693 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.517 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -50.48 -33.62 21.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.089 -1.007 . . . . 0.0 110.817 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.8 -6.69 8.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.855 -1.153 . . . . 0.0 110.973 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.606 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -133.89 53.1 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 108.743 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 254' ' ' ILE . 5.5 mtpt -26.64 -34.86 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.606 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.7 OUTLIER -115.11 90.05 3.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.466 -1.396 . . . . 0.0 109.666 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.606 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 36.2 m-70 -89.87 -157.61 0.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.125 -0.985 . . . . 0.0 111.371 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 6.1 t30 -144.67 120.01 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.2 122.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 57.44 53.95 40.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.18 22.78 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -1.082 . . . . 0.0 109.957 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 7.6 m -132.87 117.84 18.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.69 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.606 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -93.42 51.63 1.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 110.591 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 62.2 m -41.86 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.497 -0.752 . . . . 0.0 109.409 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.9 OUTLIER -88.01 164.44 15.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.591 -1.318 . . . . 0.0 109.753 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.527 HG22 ' NE2' ' A' ' 245' ' ' HIS . 1.4 mp -139.0 117.1 12.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.716 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.605 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tmtt? -126.64 112.34 15.36 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.544 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.5 p -39.72 166.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 112.132 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.575 -0.703 . . . . 0.0 110.423 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.654 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.654 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.6 pt -129.24 -179.2 2.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.361 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.605 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -150.15 125.89 10.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 60.8 t -94.65 132.26 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.119 -0.988 . . . . 0.0 110.339 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.589 ' CG2' ' CD2' ' A' ' 213' ' ' LEU . 61.1 m . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -65.51 54.92 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.165 1.243 . . . . 0.0 112.133 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.532 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.01 -66.16 0.22 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.52 -0.737 . . . . 0.0 110.762 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.46 -37.85 12.54 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.85 -177.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -78.22 -28.82 48.04 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.42 -53.79 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.574 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -56.48 -36.08 68.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.6 mm-40 -60.12 -41.21 92.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.267 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.477 ' CZ ' ' O ' ' A' ' 246' ' ' ASN . 2.6 t80 -90.99 -70.99 0.65 Allowed 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.36 -1.736 . . . . 0.0 108.967 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.642 ' CD2' HG13 ' A' ' 198' ' ' ILE . 14.6 m-30 -53.81 -55.73 23.92 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.919 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -53.89 -22.91 20.85 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.92 -47.64 53.47 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -51.06 -33.94 27.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.059 -1.259 . . . . 0.0 108.352 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.75 136.93 3.2 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 206' ' ' GLY . 4.4 pt-20 -42.21 141.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -1.185 . . . . 0.0 109.809 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 211' ' ' ILE . 4.8 t -95.06 150.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.522 -0.736 . . . . 0.0 110.654 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -87.65 -51.92 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 229' ' ' THR . 0.0 OUTLIER -152.79 165.62 34.81 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.53 ' CG2' HG13 ' A' ' 208' ' ' VAL . 5.8 pt -126.29 -173.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 118.199 -1.4 . . . . 0.0 110.158 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.58 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.9 tp10 -151.3 132.11 14.11 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.845 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.589 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 6.6 mt -104.37 169.9 6.69 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 120.338 -1.476 . . . . 0.0 110.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.3 Cg_exo . . . . . 0 C--N 1.304 -1.772 0 O-C-N 123.871 1.459 . . . . 0.0 110.772 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 4.2 p90 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.2 0.524 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.543 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 13.7 p -122.68 126.91 48.54 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -96.85 -177.28 3.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.281 -1.512 . . . . 0.0 109.275 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.541 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -164.77 134.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.627 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 5.5 t -109.07 138.47 45.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.14 -1.6 . . . . 0.0 109.193 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.514 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 37.1 m-85 -101.52 -166.91 1.35 Allowed 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.877 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -90.5 -49.73 6.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 3.0 mt-10 -119.09 174.44 6.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.02 -18.86 60.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 0.0 109.886 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.667 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 30.9 mt-10 -49.35 -53.15 42.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.6 Cg_exo -47.16 -43.39 25.61 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.727 0.951 . . . . 0.0 111.73 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.495 HG11 ' CG2' ' A' ' 256' ' ' VAL . 76.9 t -72.21 -32.05 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.631 -1.293 . . . . 0.0 109.671 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -49.74 -45.59 49.56 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.645 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -64.54 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.161 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -47.56 -64.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.976 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 8.0 ttp -41.33 -40.17 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 110.695 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 2.1 tp10 -56.11 -16.18 4.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.582 ' O ' ' ND1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.3 50.96 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 34.4 ttpt -25.52 -37.84 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.664 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.8 t80 -103.23 91.04 3.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.363 -1.46 . . . . 0.0 108.658 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.582 ' ND1' ' O ' ' A' ' 242' ' ' LYS . 3.0 m-70 -89.37 -166.42 1.59 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.043 -1.036 . . . . 0.0 110.884 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' A' ' 201' ' ' TYR . 4.1 m120 -137.71 115.36 11.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 250' ' ' SER . 38.2 t -130.23 124.73 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 0.0 110.543 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 249' ' ' LEU . . . 52.97 51.41 46.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 248' ' ' GLY . 0.5 OUTLIER 60.25 25.7 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 110.067 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 17.6 m -138.57 122.08 17.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.664 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.01 56.03 0.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.945 . . . . 0.0 111.181 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.511 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 60.2 m -45.43 169.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.957 . . . . 0.0 109.109 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.7 OUTLIER -88.04 167.89 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.275 -1.37 . . . . 0.0 107.86 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.541 HD11 ' CD2' ' A' ' 245' ' ' HIS . 3.5 mp -151.32 102.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.293 -1.363 . . . . 0.0 112.449 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -98.72 117.22 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.2 p -40.74 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 112.095 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.557 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.708 -0.62 . . . . 0.0 110.076 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.642 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.642 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 4.1 pt -129.91 173.21 14.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.118 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -132.66 136.11 46.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.018 -1.051 . . . . 0.0 110.609 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 98.3 t -109.12 136.81 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.698 -0.626 . . . . 0.0 110.621 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.543 HG21 ' CD ' ' A' ' 214' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.617 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.3 124.08 9.67 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.553 1.502 . . . . 0.0 111.904 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.543 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -95.63 -65.25 0.99 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -49.82 -50.91 43.39 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.534 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -62.61 -26.0 68.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 194' ' ' PRO . 0.7 OUTLIER -68.81 -61.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -54.72 -31.44 58.24 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 8.1 tp10 -61.28 -42.78 99.23 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.75 -69.89 0.72 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 117.653 -1.619 . . . . 0.0 109.369 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' HD13 ' A' ' 184' ' ' ILE . 58.8 m-85 -54.93 -50.95 67.57 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.542 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -55.36 -21.43 26.67 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.28 47.61 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.54 ' CD1' HD13 ' A' ' 239' ' ' ILE . 76.7 m-85 -55.94 -31.1 62.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -1.2 . . . . 0.0 108.86 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.14 138.82 3.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 5.6 pt-20 -41.73 141.62 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.427 HG23 ' CD1' ' A' ' 230' ' ' PHE . 5.4 t -100.55 150.14 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.799 . . . . 0.0 110.55 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -87.8 -54.53 4.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 229' ' ' THR . 21.1 m -153.51 173.42 15.73 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 14.8 pt -124.23 -171.27 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.125 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.569 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 15.3 tt0 -150.97 128.7 11.57 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.167 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 8.4 mt -103.49 174.46 2.78 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 120.591 -1.318 . . . . 0.0 110.0 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 123.654 1.344 . . . . 0.0 111.117 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.164 0 CA-C-O 121.526 0.679 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.626 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -127.82 119.88 26.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 109.295 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -95.74 -170.36 2.12 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.38 -1.45 . . . . 0.0 110.058 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -165.27 137.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 7.5 t -110.39 144.38 39.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.121 -1.612 . . . . 0.0 110.096 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 23.0 m-30 -103.71 -149.89 0.41 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.328 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -69.12 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 111.88 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.8 mm-40 -86.09 -68.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 111.116 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 1.4 pt-20 164.24 -27.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.221 1.01 . . . . 0.0 109.152 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 mt-10 -55.32 -45.05 99.92 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -53.24 -28.77 43.84 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.689 0.836 . . . . 0.0 110.586 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 230' ' ' PHE . 34.2 t -80.99 -35.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.826 -1.171 . . . . 0.0 108.433 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.7 ttpt -45.2 -46.79 12.44 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.394 1.092 . . . . 0.0 108.287 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -61.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.54 HD13 ' CD1' ' A' ' 205' ' ' PHE . 10.1 mm -43.5 -66.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.314 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.493 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -45.36 -37.38 4.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 110.013 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -59.58 -13.77 10.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -130.7 48.55 2.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -26.59 -33.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.663 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -116.37 91.2 3.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.338 -1.476 . . . . 0.0 110.274 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 2.3 m-70 -98.5 -145.82 0.32 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 16.2 p30 -142.59 139.62 31.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 50.1 t -150.4 125.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.93 62.68 5.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 83.4 mt 50.09 23.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -1.175 . . . . 0.0 110.523 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.8 t -132.67 151.5 51.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.139 -0.975 . . . . 0.0 109.704 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.663 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 2.3 ptpt -107.41 44.55 1.07 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.866 -1.146 . . . . 0.0 110.505 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.53 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 30.8 p -35.98 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.808 -0.558 . . . . 0.0 109.719 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.53 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 1.4 pt-20 -87.62 171.09 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.418 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 1.3 mp -147.66 91.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.983 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.556 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 25.0 mttt -100.08 114.92 28.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -38.3 166.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.03 0.919 . . . . 0.0 112.346 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.529 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.666 -0.646 . . . . 0.0 109.845 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.664 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.664 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.5 pp -131.39 171.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.649 ' CD2' ' HB3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -131.5 134.61 46.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.996 -1.065 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 21.9 t -111.09 154.19 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.431 0.634 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.519 ' N ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.45 32.85 7.02 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 189' ' ' LEU . . . -76.28 -35.68 42.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.604 ' CD2' ' O ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER 26.74 40.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.672 0.749 . . . . 0.0 111.593 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 188' ' ' GLY . 0.5 OUTLIER -70.89 168.58 19.48 Favored Pre-proline 0 C--N 1.295 -1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.689 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -55.83 -28.97 70.17 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.61 1.321 . . . . 0.0 110.342 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 192' ' ' ASP . 25.2 p-10 -150.57 107.0 3.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.942 . . . . 0.0 110.294 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.521 ' CG2' HD23 ' A' ' 213' ' ' LEU . 7.8 m -54.78 110.97 2.48 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -61.85 58.22 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.52 1.274 . . . . 0.0 111.664 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -37.28 -66.79 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 111.662 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.4 OUTLIER -47.12 -41.46 17.49 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.014 -177.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -75.92 -27.93 57.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.604 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.1 tp -64.94 -53.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.561 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 12.8 ttt-85 -53.96 -39.51 66.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 5.0 mm-40 -55.2 -41.13 71.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.726 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.469 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.8 t80 -91.67 -71.33 0.64 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.736 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.5 ' CE1' HD12 ' A' ' 184' ' ' ILE . 78.6 m-85 -53.38 -56.83 13.5 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.124 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 208' ' ' VAL . . . -51.34 -24.1 9.9 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -66.45 -45.51 85.0 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.569 ' CZ ' HD13 ' A' ' 239' ' ' ILE . 76.6 m-85 -57.74 -29.71 65.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -1.212 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 177.89 141.64 4.27 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -42.71 141.64 1.02 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.261 . . . . 0.0 110.141 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 230' ' ' PHE . 6.0 t -97.65 146.37 7.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.651 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -87.96 -56.89 3.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.63 163.35 40.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.8 pp -112.66 -171.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.47 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.573 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.3 tp10 -151.48 138.62 19.21 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.031 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.684 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 15.0 mt -112.39 -175.95 0.35 Allowed Pre-proline 0 C--N 1.295 -1.798 0 O-C-N 120.467 -1.396 . . . . 0.0 109.253 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.684 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -64.03 164.85 20.81 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.155 1.081 . . . . 0.0 110.836 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.02 178.96 2.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 218' ' ' LYS . 3.1 t70 -97.16 -155.18 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.389 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 4.3 m120 58.23 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.426 -0.797 . . . . 0.0 110.328 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.4 OUTLIER 66.67 51.19 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.81 51.62 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.2 -86.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.483 -0.761 . . . . 0.0 110.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 168.45 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 110.183 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -77.76 80.06 4.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 70.18 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.232 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.604 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . -120.63 126.76 6.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.586 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -151.36 -162.41 1.53 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.304 -1.116 . . . . 0.0 108.478 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -146.07 120.08 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 120.803 -1.185 . . . . 0.0 108.662 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.2 m-85 -96.98 -169.56 1.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.39 -1.444 . . . . 0.0 110.379 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.617 ' CG2' ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -165.96 134.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.65 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 7.9 t -109.88 143.9 39.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.187 -1.571 . . . . 0.0 109.62 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.617 ' CE1' ' CG2' ' A' ' 228' ' ' ILE . 22.4 m-85 -111.36 -139.14 0.38 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.121 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -67.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.065 -1.022 . . . . 0.0 112.957 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 1.2 tp10 -70.48 -85.17 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.026 -1.046 . . . . 0.0 113.586 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER 161.21 -27.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 122.192 0.996 . . . . 0.0 108.426 -178.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.584 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.7 OUTLIER -55.77 -53.21 65.4 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -53.16 -43.37 57.77 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.893 0.943 . . . . 0.0 110.561 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.496 HG23 ' CG2' ' A' ' 184' ' ' ILE . 2.1 t -52.78 -46.29 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.1 tttt -47.61 -44.15 26.33 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.106 -1.038 . . . . 0.0 108.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -70.84 -64.22 0.95 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 110.035 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.569 HD13 ' CZ ' ' A' ' 205' ' ' PHE . 0.9 OUTLIER -44.36 -64.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.485 ' CG ' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -44.68 -35.6 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.136 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 7.9 tp10 -65.51 -6.71 11.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.121 -0.987 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.59 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -136.31 51.03 2.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 0.0 109.258 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.6 mtpt -29.21 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -116.44 82.81 1.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.406 -1.434 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.59 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 7.4 m-70 -89.71 -151.82 0.24 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.0 -1.063 . . . . 0.0 110.096 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.7 t30 -143.63 142.83 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.784 . . . . 0.0 109.677 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 249' ' ' LEU . 58.9 t -135.02 116.77 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.064 -1.023 . . . . 0.0 110.474 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 55.06 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.3 OUTLIER -133.51 30.64 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 3.7 m -150.19 153.18 35.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.95 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.8 OUTLIER -119.53 54.43 1.0 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.142 -0.974 . . . . 0.0 110.595 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.537 ' CB ' ' CG1' ' A' ' 186' ' ' VAL . 61.3 m -42.01 167.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.36 -0.838 . . . . 0.0 109.738 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -86.79 170.52 11.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.086 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 243' ' ' LYS . 1.2 mp -147.6 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.284 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.649 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.69 112.4 24.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -38.74 166.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.878 0.847 . . . . 0.0 112.42 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.561 -0.712 . . . . 0.0 110.286 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.65 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.65 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pt -130.32 167.46 25.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.449 -1.3 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -125.89 134.7 51.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 53.1 t -111.78 122.59 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.524 -0.735 . . . . 0.0 110.537 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.549 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -95.57 49.49 1.84 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.553 ' C ' ' CD1' ' A' ' 189' ' ' LEU . . . -122.17 -14.58 4.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.553 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER 16.45 54.39 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -41.34 166.4 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -58.57 -19.43 44.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.547 1.288 . . . . 0.0 111.435 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 2.4 p30 -149.84 99.1 2.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.948 -1.095 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 46.6 p -39.28 96.08 0.11 Allowed Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.634 -0.666 . . . . 0.0 109.997 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.93 49.06 1.51 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.549 1.5 . . . . 0.0 112.533 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -37.2 -66.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.0 -1.063 . . . . 0.0 111.63 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.57 -41.98 22.72 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.849 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 10.1 mttt -74.13 -28.4 61.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.635 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.2 tp -64.46 -54.93 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.585 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 1.1 mpp_? -53.1 -37.44 61.72 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.7 mm-40 -62.97 -36.26 82.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.65 -71.46 0.64 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.544 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.635 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.2 m-85 -57.03 -51.43 69.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.424 -0.911 . . . . 0.0 108.71 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -56.25 -20.72 29.99 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.42 57.63 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.562 ' CD1' HD13 ' A' ' 239' ' ' ILE . 75.3 m-85 -56.15 -36.32 68.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -1.193 . . . . 0.0 108.911 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.58 139.21 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -41.43 141.57 0.71 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -1.15 . . . . 0.0 109.808 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.45 HG21 ' HA2' ' A' ' 203' ' ' GLY . 10.7 t -100.43 151.29 5.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.51 -0.743 . . . . 0.0 110.482 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.451 ' OE1' ' HD2' ' A' ' 231' ' ' LYS . 20.5 tp10 -87.59 -54.46 4.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -153.47 173.66 15.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' A' ' 213' ' ' LEU . 2.4 pp -123.93 -172.02 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 120.556 -1.34 . . . . 0.0 109.554 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.9 tp10 -150.4 122.36 8.2 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 108.882 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.2 mm? -102.54 173.05 3.77 Favored Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 120.324 -1.485 . . . . 0.0 111.16 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.1 Cg_exo -70.82 57.54 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.075 1.566 . . . . 0.0 110.871 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 52.66 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.991 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 218' ' ' LYS . 36.3 t0 -83.7 -12.29 56.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.471 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 3.6 m-20 -84.87 -43.27 14.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 216' ' ' ASP . 1.0 OUTLIER 63.4 45.52 4.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 110.226 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 15.2 t -150.6 39.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.738 0.78 . . . . 0.0 109.996 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 22.5 p-10 -150.92 -42.3 0.12 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.692 . . . . 0.0 109.76 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -149.4 -170.34 3.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.572 -0.705 . . . . 0.0 109.825 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 223' ' ' ARG . 40.6 ttt180 -91.78 99.52 12.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -51.65 -174.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.944 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.543 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . 165.52 -87.78 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.046 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -88.82 177.67 6.65 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.441 -1.035 . . . . 0.0 111.71 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.662 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.4 p -128.64 118.31 22.69 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -94.37 -166.53 1.5 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.487 -1.383 . . . . 0.0 110.394 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.9 OUTLIER -168.0 138.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.599 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.9 t -115.04 142.74 46.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 119.933 -1.729 . . . . 0.0 110.471 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CD2' ' CB ' ' A' ' 235' ' ' PRO . 39.6 m-85 -104.17 -157.6 0.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.451 ' HD2' ' OE1' ' A' ' 209' ' ' GLU . 4.9 tttm -106.9 -59.97 1.73 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.191 -0.943 . . . . 0.0 111.65 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 11.1 mt-10 -91.61 -70.98 0.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.048 -1.032 . . . . 0.0 111.421 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 165.45 -28.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.163 0.982 . . . . 0.0 109.426 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.68 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 16.9 tt0 -54.88 -44.58 99.54 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.9 Cg_exo -51.74 -33.76 51.27 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 122.774 0.881 . . . . 0.0 110.972 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.54 HG12 ' CG2' ' A' ' 256' ' ' VAL . 61.3 t -78.59 -32.67 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.791 -1.193 . . . . 0.0 108.864 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -47.86 -50.78 25.31 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.017 178.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 1.0 OUTLIER -69.29 -58.53 3.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.045 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.562 HD13 ' CD1' ' A' ' 205' ' ' PHE . 23.0 mm -48.57 -64.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.756 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -44.69 -32.47 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.707 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 9.9 tp10 -71.94 2.66 5.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 3.8 tptt -132.57 51.24 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 108.941 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -25.0 -40.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -117.56 102.36 9.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.523 -1.361 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 25.3 m-70 -89.64 -159.6 0.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -0.94 . . . . 0.0 110.92 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 250' ' ' SER . 1.6 t30 -141.33 125.25 17.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 77.0 t -148.13 126.04 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.45 66.52 2.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.5 mt 46.35 38.69 5.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -1.148 . . . . 0.0 110.504 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 246' ' ' ASN . 1.4 t -146.28 -173.49 4.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.694 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -149.86 51.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.448 179.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.553 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.6 m -34.86 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.835 -0.541 . . . . 0.0 109.737 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.549 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -86.9 170.78 11.34 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.521 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.585 HD11 ' CD2' ' A' ' 245' ' ' HIS . 1.8 mp -149.76 101.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 118.401 -1.32 . . . . 0.0 112.798 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.8 OUTLIER -110.06 111.9 23.56 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -36.65 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.068 0.937 . . . . 0.0 112.805 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.53 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.252 0 O-C-N 121.582 -0.698 . . . . 0.0 110.171 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.667 ' HD3' ' CA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.659 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.2 pp -127.09 169.46 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.235 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.632 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.34 133.22 46.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 110.016 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 39.6 t -109.2 125.8 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.391 -0.818 . . . . 0.0 110.484 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -98.83 45.99 1.54 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.567 ' HA3' ' CB ' ' A' ' 252' ' ' CYS . . . -131.17 2.67 5.5 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER 0.02 68.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -41.0 165.94 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 110.24 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -55.75 -30.75 77.48 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.446 1.235 . . . . 0.0 111.199 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -140.0 104.44 4.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.086 -1.008 . . . . 0.0 110.356 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.487 ' HB ' HD11 ' A' ' 213' ' ' LEU . 29.1 p -38.88 95.38 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.13 46.87 1.2 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.604 1.536 . . . . 0.0 112.359 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.516 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 1.1 mt-10 -36.15 -66.46 0.21 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 0.0 110.977 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 5.4 tt0 -47.49 -41.83 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.874 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 17.8 mttt -75.32 -27.44 59.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.2 tp -64.89 -53.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.569 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.35 -39.27 60.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 37.2 mm-40 -58.53 -39.77 81.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.487 -0.758 . . . . 0.0 110.032 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.3 t80 -91.3 -72.03 0.6 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.42 -1.712 . . . . 0.0 109.712 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.629 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.6 m-85 -54.42 -54.67 37.66 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.409 -0.916 . . . . 0.0 108.691 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -54.96 -22.98 29.61 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -66.73 -46.37 75.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.587 ' CD1' HD13 ' A' ' 239' ' ' ILE . 65.9 m-85 -53.55 -37.69 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -1.203 . . . . 0.0 108.451 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.22 143.69 6.36 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 3.0 pm0 -41.74 141.71 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -1.176 . . . . 0.0 110.009 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.7 t -102.1 154.67 5.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.483 -0.761 . . . . 0.0 110.52 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 231' ' ' LYS . 1.8 tt0 -87.84 -59.28 2.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.38 169.91 21.96 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.511 HD12 ' CD2' ' A' ' 213' ' ' LEU . 8.6 pt -119.16 -170.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.389 -1.324 . . . . 0.0 109.763 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.569 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.6 tp10 -150.6 124.08 9.02 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.62 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.1 mm? -101.64 174.18 3.08 Favored Pre-proline 0 C--N 1.293 -1.88 0 O-C-N 120.465 -1.397 . . . . 0.0 110.74 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -69.11 89.37 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.707 1.372 . . . . 0.0 110.863 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -161.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.487 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.477 ' HA ' ' NZ ' ' A' ' 218' ' ' LYS . 3.0 t70 -79.51 -138.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.43 ' C ' ' HG3' ' A' ' 218' ' ' LYS . 1.7 t-20 60.46 94.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.477 ' NZ ' ' HA ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -136.79 47.73 2.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.96 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -125.68 41.32 3.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.752 0.786 . . . . 0.0 109.964 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 8.8 p-10 -150.78 -41.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.621 -0.674 . . . . 0.0 110.094 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.401 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -147.83 -170.41 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.539 ' O ' ' CZ ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -55.5 162.26 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.012 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -130.89 140.29 50.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.324 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . 118.68 50.93 0.31 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.539 ' CZ ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -151.71 177.41 10.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.243 . . . . 0.0 110.995 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.3 116.45 19.13 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.632 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.26 -170.06 2.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.408 -1.433 . . . . 0.0 110.394 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -166.61 134.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.667 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.4 t -110.42 139.99 45.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.206 -1.559 . . . . 0.0 109.594 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 69.9 m-85 -101.36 -165.65 1.22 Allowed 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 19.2 tttt -92.21 -65.22 1.02 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.555 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -101.56 166.68 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -20.22 65.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.637 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 35.2 tt0 -54.81 -53.61 58.85 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.8 Cg_exo -44.42 -38.72 11.96 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 120.477 0.785 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.498 HG22 ' CG2' ' A' ' 184' ' ' ILE . 55.5 t -74.87 -34.06 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.734 -1.228 . . . . 0.0 109.25 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -46.31 -46.33 18.03 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.333 1.064 . . . . 0.0 108.22 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -62.7 1.29 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.949 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.587 HD13 ' CD1' ' A' ' 205' ' ' PHE . 25.2 mm -46.64 -65.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.485 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 239' ' ' ILE . 12.0 tpt -43.63 -33.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 110.052 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -67.54 -2.84 7.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.116 -0.99 . . . . 0.0 110.828 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.12 50.7 2.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 109.099 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.0 OUTLIER -25.42 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.71 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.6 t80 -114.52 93.71 4.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.463 -1.398 . . . . 0.0 109.454 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 11.3 m-70 -91.19 -157.97 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 111.301 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 12.1 t-20 -141.07 139.8 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.797 -0.564 . . . . 0.0 109.621 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.41 113.32 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.003 -1.061 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 62.66 -87.08 0.05 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 2.2 mt -137.55 27.1 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.187 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.48 170.25 17.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.427 -0.796 . . . . 0.0 109.421 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.71 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -132.95 64.28 1.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.791 -1.193 . . . . 0.0 111.289 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.567 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 67.7 m -39.24 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.55 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.4 OUTLIER -86.51 171.35 11.14 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.048 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.518 ' CD1' ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -150.54 97.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.938 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.0 tttt -103.94 116.17 31.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.2 p -38.38 167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.168 0.985 . . . . 0.0 112.572 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.567 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.231 0 O-C-N 121.634 -0.667 . . . . 0.0 110.207 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.662 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.662 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.8 pt -131.58 172.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.63 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -133.23 132.71 41.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.955 -1.09 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 26.2 t -105.95 127.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.424 -0.797 . . . . 0.0 110.395 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -102.5 48.88 1.02 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 252' ' ' CYS . . . -125.66 -10.64 4.36 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.548 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 12.89 56.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -42.12 166.84 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.208 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -59.62 -13.65 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.653 1.343 . . . . 0.0 111.018 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 65.5 m-20 -142.92 92.09 2.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 9.5 p -38.92 95.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.727 -0.608 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.679 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -73.47 113.75 3.86 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.513 1.475 . . . . 0.0 111.646 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.528 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -97.73 -70.56 0.72 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.01 0.909 . . . . 0.0 109.556 177.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -50.79 -47.5 59.79 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -63.82 -26.95 68.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.679 ' HB ' ' O ' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -68.06 -60.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.62 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 1.4 tmm_? -50.34 -31.87 15.7 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -63.26 -41.05 98.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.708 178.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' GLY . 0.9 OUTLIER -90.89 -70.4 0.68 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.813 179.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 184' ' ' ILE . 70.8 m-85 -54.07 -55.61 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.726 -0.79 . . . . 0.0 108.947 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -55.08 -22.64 29.27 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -67.33 -46.74 68.19 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.575 ' CD1' HD12 ' A' ' 239' ' ' ILE . 82.6 m-85 -56.3 -31.04 63.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.031 -1.276 . . . . 0.0 108.494 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.68 142.73 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.4 pm0 -42.87 143.81 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.048 -1.266 . . . . 0.0 109.824 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.615 ' CG2' ' CE2' ' A' ' 230' ' ' PHE . 11.8 t -105.12 154.26 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.396 -0.815 . . . . 0.0 110.874 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -88.33 -57.74 2.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.467 ' O ' HG21 ' A' ' 229' ' ' THR . 0.4 OUTLIER -153.4 170.24 21.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 42.6 pt -118.57 -169.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 118.549 -1.26 . . . . 0.0 110.021 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.562 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.0 tt0 -151.12 121.8 7.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -98.64 173.7 3.68 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.405 -1.434 . . . . 0.0 110.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.7 Cg_exo -66.41 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.753 1.396 . . . . 0.0 110.746 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.6 mtt -100.9 176.23 5.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.421 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 218' ' ' LYS . 25.3 t0 -89.29 160.42 16.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 21.6 m-20 64.18 -69.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER 65.84 50.98 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 0.0 109.769 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.0 t -144.59 50.06 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.225 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -150.2 -38.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 0.0 109.97 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 -173.41 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.444 -0.785 . . . . 0.0 110.145 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 223' ' ' ARG . 2.8 mtp85 -45.78 163.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.2 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -47.46 177.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . -121.87 125.51 6.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -90.76 -179.53 5.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.454 -1.027 . . . . 0.0 110.389 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.635 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -131.57 118.19 19.77 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -96.21 -171.75 2.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.46 -1.4 . . . . 0.0 110.159 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.4 mt -163.91 137.52 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.598 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 7.0 t -113.17 146.3 39.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.079 -1.638 . . . . 0.0 110.253 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 235' ' ' PRO . 44.0 m-85 -109.8 -164.86 0.96 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.583 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 232' ' ' GLU . 31.1 tttt -110.49 -65.78 1.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.477 0.656 . . . . 0.0 110.911 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 6.6 mt-10 -66.05 -67.68 0.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 110.842 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.9 OUTLIER 147.72 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-O 122.807 1.289 . . . . 0.0 107.666 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt-10 -54.74 -45.21 99.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -50.9 -21.5 8.61 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.496 0.735 . . . . 0.0 110.451 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.564 HG11 ' CG2' ' A' ' 256' ' ' VAL . 57.6 t -91.31 -35.33 6.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -48.21 -48.38 34.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -73.54 -61.58 1.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.962 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.575 HD12 ' CD1' ' A' ' 205' ' ' PHE . 15.4 mm -43.56 -66.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.463 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.09 -44.49 4.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 110.386 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -59.17 -13.52 7.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.137 -0.977 . . . . 0.0 110.438 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -124.4 45.21 2.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' ILE . 4.6 ttmt -25.43 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.64 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -115.25 95.02 4.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.428 -1.42 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.594 ' NE2' ' O ' ' A' ' 242' ' ' LYS . 1.6 m-70 -102.36 -145.91 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.997 -1.065 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 3.6 m-20 -145.09 145.32 31.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.0 109.538 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.55 108.3 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 110.415 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 249' ' ' LEU . . . 65.62 -86.01 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 248' ' ' GLY . 0.8 OUTLIER -142.62 28.92 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.102 . . . . 0.0 110.008 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.52 132.7 23.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.64 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -90.2 46.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.608 -179.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.551 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 29.1 p -35.57 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.575 -0.703 . . . . 0.0 109.783 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.529 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -87.43 173.14 9.3 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.419 -1.312 . . . . 0.0 108.668 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 1.2 mp -150.26 94.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.406 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.608 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 17.7 ttmt -100.08 113.0 25.3 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.3 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.071 0.939 . . . . 0.0 112.686 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.541 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.487 0.661 . . . . 0.0 110.04 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.635 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.635 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.6 pp -132.2 -178.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.731 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.86 148.4 50.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 110.041 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 24.1 t -120.55 124.94 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.079 -1.013 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.522 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -97.69 32.69 6.52 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 252' ' ' CYS . . . -156.01 16.77 0.45 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.697 ' N ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -34.41 156.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.775 -0.838 . . . . 0.0 111.983 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 2.8 p -89.03 -175.25 0.53 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.1 Cg_exo -66.07 -25.16 51.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.293 1.154 . . . . 0.0 110.486 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.521 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 1.8 t70 -148.75 83.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.324 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.598 ' HB ' ' CG ' ' A' ' 213' ' ' LEU . 4.4 m -38.64 95.02 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.691 -0.631 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.05 76.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 198' ' ' ILE . 1.8 mt-10 -36.45 -40.5 0.24 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.482 -0.761 . . . . 0.0 110.128 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.1 -53.31 39.64 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 117.937 -1.505 . . . . 0.0 108.519 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 12.3 ttmt -69.78 -28.63 65.91 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.578 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.18 -51.2 71.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.542 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -54.38 -33.25 58.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -61.61 -40.51 95.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.502 ' CE2' ' HB3' ' A' ' 245' ' ' HIS . 3.3 t80 -91.02 -68.8 0.77 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.529 -1.669 . . . . 0.0 109.449 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CD2' HG13 ' A' ' 198' ' ' ILE . 77.9 m-85 -58.33 -52.34 66.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -57.25 -25.63 54.74 Favored Glycine 0 N--CA 1.481 1.678 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -59.5 -44.82 96.41 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.564 ' CD2' HD12 ' A' ' 239' ' ' ILE . 78.9 m-85 -61.34 -40.08 92.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.167 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.46 140.22 6.15 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.7 OUTLIER -42.63 143.12 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.251 . . . . 0.0 110.122 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.628 ' CG2' ' CE2' ' A' ' 230' ' ' PHE . 14.2 t -110.24 152.54 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 110.728 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 1.1 tp10 -88.32 -58.51 2.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 229' ' ' THR . 1.7 m -153.14 163.58 39.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.524 ' CG2' HG21 ' A' ' 198' ' ' ILE . 2.2 pp -111.59 -171.27 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.176 -1.409 . . . . 0.0 110.351 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.534 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 22.7 tt0 -152.69 139.65 19.13 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.452 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.661 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 4.0 mt -99.28 -177.93 0.64 Allowed Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.5 Cg_exo -58.8 -78.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 122.627 0.804 . . . . 0.0 110.145 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 216' ' ' ASP . 0.1 OUTLIER 40.45 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.621 -0.675 . . . . 0.0 111.458 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 214' ' ' PRO . 11.6 t70 -40.96 166.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 110.75 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 1.3 m-20 67.82 83.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.294 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HG3' ' C ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -133.35 45.72 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.3 52.29 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 110.198 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.47 -99.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -144.65 -169.43 3.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.97 -1.081 . . . . 0.0 110.276 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 221' ' ' LYS . 30.3 ttt-85 -40.94 118.3 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.727 . . . . 0.0 110.195 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.83 177.02 4.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.981 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 163.02 68.47 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.7 p90 -147.07 165.52 29.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.226 -1.161 . . . . 0.0 110.433 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 10.3 p -138.19 129.62 27.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -95.62 -175.56 3.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.569 -1.332 . . . . 0.0 109.203 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.7 mt -161.58 133.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 7.7 t -110.49 143.66 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.166 -1.584 . . . . 0.0 110.299 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.628 ' CE2' ' CG2' ' A' ' 208' ' ' VAL . 63.5 m-85 -104.68 -126.41 0.23 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.61 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 232' ' ' GLU . 0.1 OUTLIER -139.92 -56.09 0.55 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.654 -1.279 . . . . 0.0 111.182 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 2.1 tt0 -92.8 -69.75 0.73 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.018 -1.051 . . . . 0.0 110.145 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 2.0 pt-20 165.88 -31.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.238 1.018 . . . . 0.0 108.914 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -48.58 -48.91 67.41 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -51.03 -36.18 53.27 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 122.667 0.825 . . . . 0.0 110.522 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.544 HG23 ' CG2' ' A' ' 184' ' ' ILE . 3.6 t -67.62 -41.96 86.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 108.333 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.58 -46.08 9.8 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.278 1.037 . . . . 0.0 108.741 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -71.82 -63.33 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.916 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.564 HD12 ' CD2' ' A' ' 205' ' ' PHE . 31.4 mm -44.23 -64.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.393 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -46.18 -34.15 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.958 . . . . 0.0 109.476 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 15.0 tt0 -80.05 10.17 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 110.522 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.584 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.5 mmtt -131.28 49.03 2.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 108.987 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 242' ' ' LYS . 1.4 tmmm? -26.55 -39.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.686 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -123.56 104.59 9.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.624 -1.298 . . . . 0.0 109.616 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 36.5 m-70 -89.6 -174.6 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.951 . . . . 0.0 110.663 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 250' ' ' SER . 3.8 m120 -133.92 119.19 18.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.523 -0.736 . . . . 0.0 109.494 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 250' ' ' SER . 54.5 t -145.59 131.56 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.997 -1.064 . . . . 0.0 110.57 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.04 65.3 2.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 6.8 mp 48.24 28.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -1.159 . . . . 0.0 110.937 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 69.8 m -136.3 171.57 14.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.048 -1.032 . . . . 0.0 109.762 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.686 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -150.47 53.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 111.313 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 24.0 p -39.05 161.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 109.405 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.522 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -86.52 168.57 13.59 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.043 -1.463 . . . . 0.0 108.01 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 245' ' ' HIS . 2.5 mp -150.26 109.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 117.942 -1.503 . . . . 0.0 113.548 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.528 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tttp -99.18 -154.67 0.47 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 7.0 p -122.64 168.41 15.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.309 -1.495 . . . . 0.0 110.448 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.515 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.878 . . . . 0.0 110.654 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.661 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.8 pt -130.22 176.99 7.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 118.317 -1.353 . . . . 0.0 110.48 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.634 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.72 117.82 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.775 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 22.3 t -89.62 119.08 36.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.527 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -95.55 41.02 2.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 252' ' ' CYS . . . -147.62 13.09 1.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.693 ' N ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -24.83 145.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.145 0.974 . . . . 0.0 112.826 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.4 p -92.21 -174.47 0.42 Allowed Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -62.31 -25.01 76.28 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 122.924 0.96 . . . . 0.0 109.833 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 2.7 m-20 -150.91 85.76 1.36 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.009 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.6 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 94.8 m -40.41 99.92 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.306 -0.871 . . . . 0.0 110.361 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.543 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.6 Cg_endo -68.06 71.98 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.756 1.398 . . . . 0.0 112.158 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.72 -64.55 0.34 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.479 -0.763 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 1.8 tt0 -46.28 -43.67 15.88 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.083 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 2.5 tttt -74.64 -29.06 61.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.589 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.3 tp -62.24 -53.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.575 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 12.5 mtt180 -52.43 -37.48 56.89 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 2.4 mm-40 -59.59 -38.39 81.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.909 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.55 -70.86 0.67 Allowed 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.589 ' CD2' HG13 ' A' ' 198' ' ' ILE . 91.2 m-85 -56.6 -53.24 59.9 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.893 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -55.44 -21.5 27.53 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.46 70.73 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.574 ' CD2' HD13 ' A' ' 239' ' ' ILE . 77.8 m-85 -56.72 -40.84 76.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -1.209 . . . . 0.0 108.896 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.32 138.03 4.95 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 206' ' ' GLY . 1.1 pm0 -41.83 142.36 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -1.185 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 229' ' ' THR . 18.5 t -102.98 152.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.419 -0.8 . . . . 0.0 110.951 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.1 tt0 -88.12 -55.89 3.56 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.474 ' O ' HG23 ' A' ' 229' ' ' THR . 3.4 m -153.59 169.0 24.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 2.4 pt -118.63 -171.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.528 -1.357 . . . . 0.0 110.137 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.571 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 11.5 tp10 -151.51 130.82 12.83 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.106 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.807 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.4 mm? -101.87 176.99 1.61 Allowed Pre-proline 0 C--N 1.295 -1.762 0 O-C-N 120.528 -1.357 . . . . 0.0 109.829 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.807 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo -59.92 105.87 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.327 1.172 . . . . 0.0 110.457 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.45 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -121.45 -158.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.468 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 215' ' ' MET . 19.9 t0 66.18 26.26 10.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 217' ' ' ASN . 3.4 p-10 -96.72 44.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.995 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.596 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -146.86 48.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.834 . . . . 0.0 109.729 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 218' ' ' LYS . 45.1 p -148.65 -81.64 0.12 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.611 1.196 . . . . 0.0 110.21 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.3 -33.33 0.4 Allowed 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.391 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.49 -172.71 3.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 110.301 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.38 -169.64 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -112.57 130.64 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.17 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' A' ' 189' ' ' LEU . . . -156.17 24.89 0.54 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.555 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.4 p90 -150.51 -166.87 2.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -1.187 . . . . 0.0 110.648 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.534 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -165.07 117.37 1.19 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.82 . . . . 0.0 108.83 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.82 -174.8 3.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.476 -1.39 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.2 mt -164.03 133.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.627 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.0 t -106.18 141.97 36.65 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.221 -1.549 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 20.8 m-85 -100.65 -142.68 0.34 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.198 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -123.23 -58.56 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.837 -1.165 . . . . 0.0 111.674 -178.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 8.8 mt-10 -92.24 -70.08 0.71 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 110.725 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 163.76 -27.61 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.461 1.124 . . . . 0.0 108.895 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 tt0 -57.93 -42.6 96.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -52.74 -31.44 50.93 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.496 0.735 . . . . 0.0 110.304 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.547 HG11 ' CG2' ' A' ' 256' ' ' VAL . 37.2 t -76.74 -36.82 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.741 -1.224 . . . . 0.0 108.121 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -44.5 -46.75 9.93 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.468 1.128 . . . . 0.0 108.25 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.84 -61.26 1.85 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.892 0.853 . . . . 0.0 109.869 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.574 HD13 ' CD2' ' A' ' 205' ' ' PHE . 15.4 mm -45.63 -65.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.482 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -48.21 -31.15 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.55 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 70.8 tt0 -66.41 -5.26 10.29 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.932 -1.105 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.607 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.26 52.88 1.45 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 0.0 109.355 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 33.6 ttpt -26.32 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.623 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -107.59 90.74 3.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.334 -1.479 . . . . 0.0 110.456 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.607 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 11.9 m-70 -95.11 -164.09 1.12 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.254 -0.904 . . . . 0.0 110.703 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 13.2 m120 -137.1 143.99 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.639 -0.663 . . . . 0.0 109.629 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.45 99.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.07 . . . . 0.0 110.323 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 67.28 -83.61 0.13 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.17 24.41 2.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -1.145 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 4.1 m -143.95 134.52 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.623 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.79 56.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.063 . . . . 0.0 110.895 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.555 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 33.9 m -41.34 162.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.287 -0.883 . . . . 0.0 109.065 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.527 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 2.2 pt-20 -88.1 175.7 7.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.575 -1.328 . . . . 0.0 108.293 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 1.2 mp -149.2 108.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.426 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 1.2 tttt -114.6 110.56 19.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.3 p -37.55 167.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.114 0.959 . . . . 0.0 112.918 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.315 0 O-C-N 121.764 -0.585 . . . . 0.0 109.762 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.626 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.626 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.1 pt -128.78 178.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 117.593 -1.643 . . . . 0.0 110.734 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.616 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -147.35 119.24 8.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.951 -1.093 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.616 ' O ' ' CB ' ' A' ' 225' ' ' PHE . 95.0 t -89.2 121.7 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.573 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -77.0 -59.31 3.19 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.949 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 189' ' ' LEU . . . -72.52 -59.35 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.569 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 0.4 OUTLIER 69.43 151.66 0.09 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.71 -0.877 . . . . 0.0 110.811 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.56 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 2.7 p -72.29 -174.35 0.3 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 109.231 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.0 Cg_exo -66.67 -15.92 48.93 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.352 1.185 . . . . 0.0 111.208 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 3.9 p30 -150.04 123.44 9.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.973 -1.079 . . . . 0.0 110.771 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.539 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 44.9 p -39.59 96.62 0.12 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.653 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.89 47.18 1.19 Allowed 'Trans proline' 0 C--O 1.204 -1.224 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.537 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -37.33 -71.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.959 -1.088 . . . . 0.0 112.315 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -47.25 -40.49 16.67 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.299 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 13.2 mmtt -75.84 -26.58 57.29 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.1 tp -67.37 -55.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.584 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 42.7 ttt-85 -56.94 -34.68 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.9 mm-40 -57.97 -46.78 84.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 110.182 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.45 -71.05 0.64 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 117.377 -1.729 . . . . 0.0 109.657 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.631 ' CD2' HG13 ' A' ' 198' ' ' ILE . 11.4 m-30 -51.29 -51.33 55.19 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.177 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.537 ' HA2' HG21 ' A' ' 208' ' ' VAL . . . -55.62 -21.18 27.49 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.24 -45.73 29.83 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 239' ' ' ILE . 73.6 m-85 -54.35 -28.1 40.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -1.187 . . . . 0.0 108.361 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.91 129.45 1.3 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.0 OUTLIER -39.84 141.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -1.098 . . . . 0.0 110.199 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.591 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.6 t -91.17 140.46 15.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.587 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -87.53 -47.02 9.06 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 176.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.53 ' HB2' ' CG2' ' A' ' 229' ' ' THR . 35.2 m -153.19 161.31 42.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.537 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 4.4 pt -118.58 -166.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.037 -1.465 . . . . 0.0 110.638 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.96 130.52 12.24 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.972 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.671 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 3.0 mm? -111.78 172.7 3.34 Favored Pre-proline 0 C--N 1.292 -1.92 0 O-C-N 120.614 -1.304 . . . . 0.0 108.595 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -61.2 101.86 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.366 1.193 . . . . 0.0 110.938 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 8.5 ttt -132.81 -80.77 0.49 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.324 -0.86 . . . . 0.0 110.533 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 217' ' ' ASN . 2.4 t70 -98.8 -160.87 0.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.673 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 1.6 t-20 70.96 83.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.476 ' CD ' ' C ' ' A' ' 217' ' ' ASN . 1.3 mmtt -118.63 40.77 3.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.88 47.75 1.92 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.486 0.66 . . . . 0.0 110.153 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.42 ' ND2' ' OD1' ' A' ' 217' ' ' ASN . 1.5 p30 -150.24 -73.78 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 110.258 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.42 -176.65 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.15 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -175.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -94.28 116.13 28.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.184 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 148.82 46.18 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.109 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 3.6 p90 -127.06 162.01 27.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.059 -1.26 . . . . 0.0 110.256 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 189' ' ' LEU . 14.8 p -139.26 131.07 27.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.318 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.65 ' HB2' ' HB3' ' A' ' 212' ' ' GLU . 2.3 m-85 -97.25 -173.33 2.64 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.114 -1.616 . . . . 0.0 108.875 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.541 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -163.34 132.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.621 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 13.3 t -111.2 150.49 29.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.423 -1.423 . . . . 0.0 110.253 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 208' ' ' VAL . 66.9 m-85 -118.93 -116.04 0.32 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.048 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -47.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.815 -1.178 . . . . 0.0 111.654 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -83.75 -101.18 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.916 -1.115 . . . . 0.0 111.366 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 176.05 -27.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 109.844 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.612 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.8 mt-10 -59.49 -49.56 91.69 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 112.6 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -53.25 -22.68 20.81 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 122.923 0.959 . . . . 0.0 111.563 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.531 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.1 t -79.37 -48.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.83 -41.29 10.92 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.191 0.996 . . . . 0.0 108.653 178.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 1.1 tttm -71.22 -64.62 0.88 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.856 0.836 . . . . 0.0 110.332 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.572 HD12 ' CE1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -50.96 -62.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.825 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 239' ' ' ILE . 3.5 tmm? -44.3 -32.79 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 110.333 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -65.3 -5.89 8.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.019 -1.051 . . . . 0.0 110.599 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.587 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -137.69 51.7 1.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.134 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 254' ' ' ILE . 3.0 ttmt -25.02 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.654 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -106.75 91.94 3.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.478 -1.388 . . . . 0.0 109.567 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 3.4 m-70 -89.64 -159.61 0.6 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.07 -1.018 . . . . 0.0 110.83 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 247' ' ' VAL . 9.4 t-20 -136.59 128.57 29.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 248' ' ' GLY . 44.4 t -146.36 136.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.925 -1.109 . . . . 0.0 110.634 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 42.55 70.93 0.43 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.3 OUTLIER 42.51 35.75 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -144.87 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.654 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -137.19 46.87 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.005 . . . . 0.0 110.583 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.591 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 63.6 m -40.07 157.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 1.9 pt-20 -87.92 165.51 15.19 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 117.618 -1.633 . . . . 0.0 107.568 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.576 ' CG2' ' NE2' ' A' ' 245' ' ' HIS . 2.5 mp -150.37 110.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.168 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.603 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 8.5 tttt -100.98 113.82 27.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.531 HG21 ' CG1' ' A' ' 236' ' ' VAL . 2.3 p -40.6 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 111.912 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.658 -0.651 . . . . 0.0 109.848 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.689 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.689 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pp -138.22 169.53 18.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.035 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.607 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -115.39 155.33 27.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.931 -1.105 . . . . 0.0 109.573 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 61.7 t -134.82 136.35 52.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.198 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 253' ' ' GLU . . . -97.83 39.04 2.88 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 189' ' ' LEU . . . -84.89 -38.07 9.68 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 224' ' ' GLY . 0.3 OUTLIER 24.25 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 188' ' ' GLY . 0.8 OUTLIER -67.87 169.02 10.57 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 110.267 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -60.79 -23.09 75.71 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.612 1.322 . . . . 0.0 110.676 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 193' ' ' THR . 12.5 t0 -141.22 95.77 2.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.791 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.47 ' OG1' ' CD1' ' A' ' 213' ' ' LEU . 62.9 p -41.58 103.92 0.32 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.848 . . . . 0.0 109.633 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -66.92 43.23 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.467 1.444 . . . . 0.0 113.255 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.555 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -37.94 -66.68 0.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.886 -1.134 . . . . 0.0 111.523 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.6 mm-40 -47.59 -43.44 25.58 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.182 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 5.7 mttt -73.97 -25.45 59.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.592 ' CG2' ' N ' ' A' ' 199' ' ' ARG . 0.6 OUTLIER -65.76 -56.61 14.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.592 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -51.17 -37.33 45.84 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.4 mm-40 -60.53 -40.05 90.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.675 . . . . 0.0 109.905 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.21 -72.27 0.59 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.497 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 198' ' ' ILE . 79.4 m-85 -53.53 -53.37 52.61 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.472 -0.891 . . . . 0.0 108.982 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 208' ' ' VAL . . . -55.68 -21.97 30.97 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -70.01 -45.7 55.49 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.533 ' CE1' HD12 ' A' ' 239' ' ' ILE . 82.0 m-85 -57.06 -34.75 68.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -1.222 . . . . 0.0 108.886 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.83 139.41 4.63 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.5 OUTLIER -41.31 142.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -1.104 . . . . 0.0 109.983 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.511 HG23 ' CE1' ' A' ' 230' ' ' PHE . 7.6 t -101.76 148.52 7.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 44.1 tt0 -87.95 -53.27 4.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 229' ' ' THR . 3.7 m -153.54 168.67 25.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 12.0 pt -121.54 -170.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.538 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 227' ' ' PHE . 8.7 tt0 -150.8 130.51 13.15 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.712 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 13.4 mt -106.78 178.75 1.02 Allowed Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 120.786 -1.196 . . . . 0.0 109.591 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.0 Cg_exo -64.75 -174.57 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.212 1.112 . . . . 0.0 111.1 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.42 163.79 12.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 110.534 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 217' ' ' ASN . 3.6 t0 -72.07 -163.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.466 ' O ' ' OD1' ' A' ' 217' ' ' ASN . 9.1 p30 36.61 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.737 -0.602 . . . . 0.0 110.629 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -164.48 55.9 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 110.268 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 38.8 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 5.5 p30 -151.26 -45.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.696 0.76 . . . . 0.0 109.763 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -105.74 -161.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.744 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 221' ' ' LYS . 0.8 OUTLIER -48.76 -179.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.54 -0.725 . . . . 0.0 110.284 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.479 ' HG3' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -117.62 48.77 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 110.771 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.613 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . 35.69 -143.21 0.11 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -150.97 -165.61 2.31 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.663 -0.904 . . . . 0.0 108.941 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.577 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.2 p -142.26 116.6 9.57 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 120.96 -1.087 . . . . 0.0 108.632 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.607 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.5 m-85 -92.79 -165.78 1.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.647 -1.283 . . . . 0.0 109.642 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.567 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.1 mt -168.25 139.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 8.1 t -113.25 145.62 40.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.065 -1.647 . . . . 0.0 110.118 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 22.9 m-30 -109.56 -125.02 0.26 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.738 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 209' ' ' GLU . 7.5 tttt -174.7 -50.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.104 -0.997 . . . . 0.0 109.866 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.9 mt-10 -71.48 -26.44 62.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -0.801 . . . . 0.0 109.117 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 88.52 -27.12 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 122.843 1.306 . . . . 0.0 108.377 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.64 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 8.4 mt-10 -65.06 -39.32 35.86 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.767 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.1 Cg_exo -54.83 -24.83 40.23 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 N-CA-C 109.618 -0.955 . . . . 0.0 109.618 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.55 HG13 ' CG2' ' A' ' 256' ' ' VAL . 16.2 t -81.12 -41.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 236' ' ' VAL . 1.8 tptt -42.85 -45.77 5.03 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.423 1.106 . . . . 0.0 108.348 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.9 OUTLIER -72.31 -62.2 1.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.856 0.836 . . . . 0.0 109.722 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.533 HD12 ' CE1' ' A' ' 205' ' ' PHE . 8.2 mm -43.94 -65.44 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.329 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.461 ' HG3' HG12 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -43.63 -37.85 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 5.2 tt0 -63.3 -8.95 9.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.129 -0.982 . . . . 0.0 110.644 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.22 51.52 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.503 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 10.1 ttmt -26.96 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.628 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.27 100.78 8.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.442 . . . . 0.0 110.015 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 4.2 m-70 -102.35 -158.32 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.156 -0.965 . . . . 0.0 110.773 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -139.19 149.14 44.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.519 -0.738 . . . . 0.0 109.958 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 249' ' ' LEU . 37.9 t -143.67 123.15 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.41 -93.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -131.71 32.78 4.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 110.088 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.9 m -149.98 155.74 40.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.96 56.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 111.072 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 30.3 p -37.19 156.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.724 . . . . 0.0 109.835 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 2.0 pm0 -88.34 172.42 9.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.624 -1.231 . . . . 0.0 108.973 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.535 ' O ' ' CD ' ' A' ' 255' ' ' LYS . 1.0 OUTLIER -146.25 129.42 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.509 -1.276 . . . . 0.0 112.155 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -137.42 104.92 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.9 p -34.48 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.094 0.949 . . . . 0.0 113.171 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.558 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.676 -0.64 . . . . 0.0 109.651 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.678 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.678 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pt -133.35 179.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.92 130.46 35.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.987 -1.071 . . . . 0.0 110.236 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 59.3 t -102.62 122.23 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 110.304 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.515 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -96.11 41.46 2.42 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 190' ' ' SER . . . -119.46 -16.3 5.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.678 ' N ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER 1.46 56.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.2 p -44.8 170.97 0.05 OUTLIER Pre-proline 0 C--N 1.277 -2.571 0 O-C-N 121.869 -0.519 . . . . 0.0 109.845 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -60.73 -10.74 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.537 1.283 . . . . 0.0 110.877 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 5.1 t70 -138.5 91.96 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.509 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.453 ' HB ' ' CD2' ' A' ' 213' ' ' LEU . 43.8 p -39.09 97.05 0.12 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.65 -0.657 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.645 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -71.73 103.65 1.49 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.411 1.407 . . . . 0.0 111.399 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.606 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -94.44 -66.72 0.9 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.882 0.849 . . . . 0.0 110.201 178.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.14 -46.03 53.63 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.657 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -67.49 -26.12 66.2 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -66.35 -58.94 4.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 50.2 ttt180 -53.05 -34.64 57.39 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 15.2 mm-40 -59.88 -41.94 92.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.34 -69.96 0.71 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.43 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -54.47 -53.99 46.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -55.52 -21.59 28.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.92 -46.1 54.08 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.579 ' CZ ' HD13 ' A' ' 239' ' ' ILE . 80.8 m-85 -55.98 -38.01 69.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.951 -1.323 . . . . 0.0 108.847 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -173.31 142.04 6.43 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' OE2' ' CD ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -42.39 142.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -1.198 . . . . 0.0 110.095 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.4 HG21 ' CE1' ' A' ' 230' ' ' PHE . 13.3 t -103.06 151.9 6.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 110.689 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 29.2 tp10 -87.8 -61.05 1.8 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 229' ' ' THR . 4.0 m -153.72 161.1 42.41 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 16.6 pt -106.46 -168.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.236 -1.386 . . . . 0.0 109.714 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.55 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.2 tt0 -150.91 131.41 13.82 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.745 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.648 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 11.2 mt -102.7 177.53 1.44 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.648 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo -67.66 166.76 23.02 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.309 1.163 . . . . 0.0 111.039 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 215' ' ' MET . 7.1 ttp -92.03 25.39 2.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.913 . . . . 0.0 110.361 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 217' ' ' ASN . 9.0 t0 44.2 -145.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 109.9 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 216' ' ' ASP . 6.2 t-20 41.47 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 0.0 110.113 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 44.34 2.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.303 -0.873 . . . . 0.0 109.931 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.7 p -121.16 40.16 3.64 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.81 0.814 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -150.23 -41.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.383 0.611 . . . . 0.0 110.121 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.83 -175.06 4.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 110.146 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -90.0 100.19 13.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.74 131.74 4.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 189' ' ' LEU . . . 176.36 36.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -88.68 174.86 7.79 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.471 -1.017 . . . . 0.0 110.815 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.577 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -127.61 119.74 26.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -91.78 -169.34 2.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 110.147 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.5 mt -164.34 133.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.616 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.8 t -109.7 141.56 42.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 119.834 -1.791 . . . . 0.0 109.879 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 20.2 m-30 -98.28 -140.3 0.3 Allowed 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' CD ' ' OE2' ' A' ' 207' ' ' GLU . 74.4 tttt -126.83 -54.85 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.936 -1.103 . . . . 0.0 111.41 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.6 mt-10 -97.4 -68.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.013 -1.054 . . . . 0.0 110.481 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 162.35 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.173 0.987 . . . . 0.0 108.997 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.658 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -56.43 -43.5 99.33 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.65 -32.24 53.72 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 122.663 0.822 . . . . 0.0 110.649 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.556 HG12 ' CG2' ' A' ' 256' ' ' VAL . 40.6 t -77.67 -34.5 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.262 . . . . 0.0 108.226 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -44.88 -48.15 11.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.281 1.038 . . . . 0.0 108.454 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -61.27 1.83 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.868 0.842 . . . . 0.0 109.731 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.579 HD13 ' CZ ' ' A' ' 205' ' ' PHE . 14.7 mm -44.93 -66.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.464 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -41.23 -42.24 2.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.483 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -58.03 -14.0 5.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.095 -1.003 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -132.26 48.25 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.8 ttmt -26.95 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.4 t80 -112.13 96.58 6.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.533 -1.354 . . . . 0.0 110.081 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 1.6 m-70 -103.34 -150.81 0.42 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.07 -1.019 . . . . 0.0 110.569 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -130.0 141.48 50.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.555 -0.716 . . . . 0.0 109.648 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 250' ' ' SER . 40.7 t -150.28 118.69 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 0.0 110.816 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 39.76 76.71 0.08 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 4.6 mt 44.95 24.0 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -1.206 . . . . 0.0 110.85 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 247' ' ' VAL . 17.4 m -143.6 122.17 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.101 -0.999 . . . . 0.0 109.216 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.612 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.4 pttt -89.61 52.47 2.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.089 -1.007 . . . . 0.0 110.958 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 22.0 p -38.81 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 1.2 pt-20 -87.59 168.78 12.73 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.847 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.536 HG22 ' CG2' ' A' ' 239' ' ' ILE . 1.3 mp -142.74 95.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.025 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.594 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.33 110.14 22.77 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.1 p -39.85 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.879 -1.138 . . . . 0.0 112.045 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.545 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.554 -0.716 . . . . 0.0 110.441 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.673 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.673 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.4 pt -125.93 162.3 29.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.891 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.659 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.66 135.82 50.75 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.027 -1.045 . . . . 0.0 110.723 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 17.6 t -109.44 137.81 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.553 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -106.96 46.18 1.2 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.559 ' C ' ' CD1' ' A' ' 189' ' ' LEU . . . -112.82 -17.11 8.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.559 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.1 OUTLIER 22.4 43.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 121.476 0.655 . . . . 0.0 112.268 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 188' ' ' GLY . 2.8 p -47.42 175.64 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -58.16 -36.05 98.19 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.198 1.104 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 30.1 t0 -150.8 99.64 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.421 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.563 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 98.1 m -42.69 101.9 0.26 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.602 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.62 64.41 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.335 1.357 . . . . 0.0 112.105 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.58 -69.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.444 -0.785 . . . . 0.0 112.002 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 25.4 tt0 -45.92 -41.25 11.28 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.281 -176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -75.71 -30.05 59.17 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.0 OUTLIER -62.94 -51.8 67.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.548 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -56.28 -38.49 71.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -55.98 -40.08 72.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.88 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -70.59 0.68 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.563 -1.655 . . . . 0.0 110.006 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 184' ' ' ILE . 39.3 m-85 -57.19 -53.03 62.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.53 -0.731 . . . . 0.0 109.649 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.496 ' CA ' HG22 ' A' ' 208' ' ' VAL . . . -52.67 -23.02 12.9 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.56 55.89 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 239' ' ' ILE . 86.1 m-85 -57.02 -27.89 62.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.952 -1.323 . . . . 0.0 108.711 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' HA3' ' HG3' ' A' ' 235' ' ' PRO . . . -179.13 133.7 2.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 15.1 pt-20 -40.98 142.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.559 HG23 ' CD1' ' A' ' 230' ' ' PHE . 10.7 t -97.32 145.53 9.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.449 -0.782 . . . . 0.0 110.847 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -87.81 -53.31 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.485 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.74 167.72 28.66 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 176.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 38.5 pt -112.38 -168.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 118.357 -1.337 . . . . 0.0 109.835 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -151.48 125.62 9.28 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 213' ' ' LEU . 2.5 mm? -108.32 174.53 2.41 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.343 -1.473 . . . . 0.0 110.348 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.9 Cg_endo -72.28 66.87 3.52 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.675 1.355 . . . . 0.0 111.212 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -138.06 28.44 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 59.5 t0 -152.98 36.3 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.847 . . . . 0.0 110.099 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 6.5 t-20 -83.3 -56.32 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.681 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 70.25 53.34 0.34 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.8 p -111.82 -83.59 0.58 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.492 1.139 . . . . 0.0 110.281 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.54 -105.85 0.1 Allowed 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 222' ' ' ARG . 1.5 mmtt -114.5 -175.6 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.841 -1.162 . . . . 0.0 110.239 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER 60.23 130.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.159 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 171.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.867 . . . . 0.0 110.349 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . -110.36 -131.13 5.96 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -109.04 -179.14 3.77 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.279 -1.13 . . . . 0.0 110.206 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.583 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -126.18 119.25 27.02 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.659 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.9 m-85 -96.22 -165.36 1.27 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.497 -1.377 . . . . 0.0 110.757 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.575 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -169.71 134.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.659 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.5 t -112.31 143.64 43.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.849 -1.782 . . . . 0.0 109.627 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 228' ' ' ILE . 21.1 m-85 -108.9 -134.33 0.34 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.156 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 232' ' ' GLU . 2.7 tptt -128.2 -69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.06 -1.025 . . . . 0.0 113.276 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.9 mt-10 -73.82 -80.5 0.07 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.87 -1.144 . . . . 0.0 113.535 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.2 OUTLIER 161.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 122.111 0.958 . . . . 0.0 109.087 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.56 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 15.1 mm-40 -56.4 -55.99 36.53 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -51.62 -40.68 63.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.86 0.926 . . . . 0.0 110.682 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -55.21 -48.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.6 -1.313 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.87 -42.37 7.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -70.17 -62.68 1.29 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.868 0.842 . . . . 0.0 109.724 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.584 HD13 ' CD2' ' A' ' 205' ' ' PHE . 14.1 mm -45.6 -64.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.121 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -43.06 -37.17 1.87 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 110.191 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -9.02 11.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.114 -0.991 . . . . 0.0 110.658 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.1 mmtt -132.55 47.58 2.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.335 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 254' ' ' ILE . 12.0 ttmt -29.62 -32.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.6 t80 -117.57 86.99 2.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.27 -1.518 . . . . 0.0 110.39 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 2.6 m-70 -93.03 -144.78 0.22 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.967 -1.083 . . . . 0.0 110.061 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.0 OUTLIER -143.04 135.37 27.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.761 . . . . 0.0 109.384 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 246' ' ' ASN . 60.1 t -147.53 133.32 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.908 -1.12 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 250' ' ' SER . . . 41.86 62.5 1.97 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.43 24.62 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -1.209 . . . . 0.0 110.546 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 248' ' ' GLY . 0.7 OUTLIER -137.26 128.43 27.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.1 -1.0 . . . . 0.0 109.594 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.637 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.26 44.42 1.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 0.0 110.552 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 26.7 p -37.27 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.604 -0.685 . . . . 0.0 109.44 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.553 ' HG2' ' CA ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -86.86 172.05 10.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.226 -1.389 . . . . 0.0 108.458 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 243' ' ' LYS . 1.3 mp -149.24 91.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.836 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.2 tttt -98.86 113.99 26.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -36.87 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.837 0.827 . . . . 0.0 112.122 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.504 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.141 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.672 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.672 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.8 pp -124.64 172.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.328 -1.349 . . . . 0.0 110.653 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.645 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.33 124.14 18.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.308 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 17.3 t -96.84 108.3 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -71.76 -32.38 64.08 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 189' ' ' LEU . . . -96.74 29.58 10.25 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 2.7 pt? -38.67 172.16 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.06 0.933 . . . . 0.0 111.507 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 4.8 p -93.09 168.35 12.39 Favored Pre-proline 0 C--N 1.296 -1.743 0 O-C-N 121.533 -0.729 . . . . 0.0 110.136 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.0 Cg_endo -62.7 -29.55 77.55 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.631 1.332 . . . . 0.0 108.831 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.508 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 3.6 t70 -146.9 76.99 1.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.543 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 50.0 m -38.01 96.82 0.12 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.656 -0.652 . . . . 0.0 111.014 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -71.24 83.94 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.819 1.431 . . . . 0.0 111.237 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.491 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -36.55 -63.18 0.42 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.593 -0.692 . . . . 0.0 111.145 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -47.58 -44.11 26.01 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.108 -177.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 18.4 tttm -75.53 -27.16 58.59 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.598 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.3 tp -64.56 -52.06 59.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.8 OUTLIER -54.13 -38.35 65.35 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.7 mt-10 -56.34 -41.34 75.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.95 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 3.7 t80 -90.94 -69.9 0.71 Allowed 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.479 -1.689 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.598 ' CD2' HG13 ' A' ' 198' ' ' ILE . 74.4 m-85 -57.74 -54.11 50.56 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.373 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' CA ' HG22 ' A' ' 208' ' ' VAL . . . -52.1 -24.9 16.34 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -63.23 -45.86 94.33 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.47 ' CD2' HG12 ' A' ' 239' ' ' ILE . 70.3 m-85 -57.0 -33.51 67.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -1.135 . . . . 0.0 108.68 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.58 140.26 4.69 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 2.6 pt-20 -42.45 142.19 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -1.176 . . . . 0.0 110.091 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.587 HG23 ' CD1' ' A' ' 230' ' ' PHE . 8.3 t -99.92 146.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.519 -0.738 . . . . 0.0 111.131 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -88.71 -55.7 3.6 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG22 ' A' ' 229' ' ' THR . 4.8 m -153.34 161.89 41.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 4.8 pt -114.43 -170.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.209 -1.396 . . . . 0.0 110.253 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.572 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.6 tp10 -151.21 138.95 19.77 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.165 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.776 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -110.49 172.32 3.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.699 -1.251 . . . . 0.0 110.187 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.776 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.2 Cg_exo -50.06 -79.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.503 1.265 . . . . 0.0 111.103 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.57 -70.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.005 -1.06 . . . . 0.0 110.473 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 217' ' ' ASN . 4.1 t70 -177.93 168.84 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 0.9 OUTLIER 45.48 82.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.784 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HG3' ' C ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -130.46 45.19 2.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.48 44.66 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.662 0.744 . . . . 0.0 109.853 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.43 -100.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 110.136 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -176.41 3.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.97 -1.081 . . . . 0.0 110.288 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 45.32 80.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -85.61 158.71 20.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . -114.77 -125.41 4.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.591 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -152.25 -166.32 2.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.385 -1.068 . . . . 0.0 110.584 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.529 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 3.1 p -146.45 127.44 14.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.645 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -99.01 -173.67 2.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.112 -1.617 . . . . 0.0 109.555 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.566 HG23 ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -163.69 131.87 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.636 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.7 t -107.54 139.68 41.69 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 119.918 -1.739 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.587 ' CD1' HG23 ' A' ' 208' ' ' VAL . 23.8 m-85 -105.94 -131.48 0.3 Allowed 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.623 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 -64.71 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.846 -1.159 . . . . 0.0 112.874 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.42 -80.47 0.1 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.994 -1.066 . . . . 0.0 113.483 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 5.1 pt-20 162.97 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.948 0.88 . . . . 0.0 108.748 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 235' ' ' PRO . 1.3 mt-10 -55.47 -61.99 5.21 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 234' ' ' GLU . 5.2 Cg_exo -47.19 -39.9 26.89 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 122.988 0.994 . . . . 0.0 110.659 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 256' ' ' VAL . 2.1 t -57.41 -48.25 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -45.51 -40.69 8.81 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.07 0.938 . . . . 0.0 108.536 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 8.6 tttt -72.23 -64.0 1.03 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.925 0.869 . . . . 0.0 109.55 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.564 HD12 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -45.16 -65.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.523 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.2 tmm? -43.15 -39.16 2.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.192 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 39.3 tt0 -61.92 -15.67 44.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.617 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.53 47.33 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.708 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.3 mtpt -30.87 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.615 ' CE1' ' HD3' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -99.88 85.25 3.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.414 -1.429 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 7.5 m-70 -89.5 -148.72 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.975 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.564 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.9 OUTLIER -140.65 129.64 23.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.658 -0.651 . . . . 0.0 109.524 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 250' ' ' SER . 24.5 t -150.19 129.26 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.592 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 41.15 69.32 0.53 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.9 25.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 247' ' ' VAL . 18.9 m -139.11 118.96 13.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.546 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.615 ' HD3' ' CE1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.06 44.36 1.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.879 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.568 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 30.7 p -29.07 148.3 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.184 -0.322 . . . . 0.0 110.502 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 1.4 pt-20 -86.49 161.68 18.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.974 -1.49 . . . . 0.0 107.871 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.551 ' N ' ' O ' ' A' ' 243' ' ' LYS . 2.5 mp -146.32 105.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.807 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.606 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 13.8 tttt -99.21 115.48 29.19 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 3.5 p -37.6 162.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.473 ' HB2' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.542 -0.723 . . . . 0.0 110.607 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.683 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.683 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.9 pp -127.27 165.74 25.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.433 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.76 139.27 52.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.861 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.567 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 43.6 t -114.03 130.28 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 110.459 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.528 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -100.18 42.41 1.97 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.576 ' HA3' ' CB ' ' A' ' 252' ' ' CYS . . . -122.31 -7.95 7.38 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.565 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 13.61 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 26.5 p -42.42 164.51 0.11 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.213 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.7 Cg_exo -53.91 -31.38 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.271 1.143 . . . . 0.0 110.933 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 1.7 t70 -150.66 85.66 1.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.053 . . . . 0.0 110.488 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 213' ' ' LEU . 62.1 m -40.21 99.03 0.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.844 . . . . 0.0 109.841 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.8 72.47 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.415 1.41 . . . . 0.0 112.293 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.8 -67.14 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.369 -0.832 . . . . 0.0 111.596 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.6 OUTLIER -47.03 -43.62 19.8 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.147 -177.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.558 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.0 OUTLIER -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.608 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.4 -54.28 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.576 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 5.9 mtp180 -51.78 -38.22 54.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 4.6 mm-40 -56.57 -40.52 75.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.394 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.36 -71.77 0.62 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.608 ' CD2' HG13 ' A' ' 198' ' ' ILE . 83.6 m-85 -54.3 -54.94 33.48 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.947 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.21 -22.8 23.01 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.269 -2.332 . . . . 0.0 107.269 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.1 -44.93 86.3 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -57.97 -36.55 72.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -1.199 . . . . 0.0 108.93 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.14 141.99 6.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 206' ' ' GLY . 9.4 pt-20 -42.48 142.04 0.89 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -1.174 . . . . 0.0 109.86 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 229' ' ' THR . 12.6 t -104.36 150.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.518 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -88.01 -57.64 2.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.34 173.08 16.07 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pt -120.07 -170.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.895 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.589 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 3.0 tp10 -151.17 129.59 12.09 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.687 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 14.0 mt -105.82 175.12 2.24 Favored Pre-proline 0 C--N 1.295 -1.79 0 O-C-N 120.608 -1.308 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo -70.1 -152.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.586 1.309 . . . . 0.0 110.984 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.436 ' O ' ' NZ ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -113.59 -147.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 218' ' ' LYS . 36.1 t70 -137.58 174.76 10.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 2.0 t-20 68.76 78.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.286 -0.884 . . . . 0.0 109.045 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -155.7 56.58 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.497 -0.752 . . . . 0.0 109.912 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.5 t -112.4 38.57 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 4.5 p-10 -148.66 -43.39 0.15 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.486 0.66 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.41 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 1.9 mmtt -133.62 -175.36 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 110.051 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 223' ' ' ARG . 3.5 mtt180 -109.65 129.37 55.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.287 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' A' ' 222' ' ' ARG . 4.7 ptm180 175.51 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.172 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' A' ' 189' ' ' LEU . . . -163.64 89.49 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -89.81 -178.92 5.62 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.513 -0.992 . . . . 0.0 110.708 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.612 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.1 118.88 23.2 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.205 -0.935 . . . . 0.0 109.072 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.83 -171.44 2.35 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.275 -1.516 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.1 mt -165.78 132.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.64 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.0 t -106.22 137.72 43.66 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.03 -1.669 . . . . 0.0 109.041 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 73.8 m-85 -96.79 -162.38 0.95 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.742 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.11 -46.26 6.23 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.478 -0.764 . . . . 0.0 109.197 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.482 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 42.2 mt-10 -121.79 167.22 13.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.559 -0.713 . . . . 0.0 109.371 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -15.79 63.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.985 -1.072 . . . . 0.0 109.341 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.628 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -57.39 -58.78 15.75 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.665 -0.647 . . . . 0.0 112.702 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -45.25 -24.91 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.226 1.119 . . . . 0.0 111.176 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 184' ' ' ILE . 6.5 t -83.34 -41.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.008 -1.058 . . . . 0.0 108.842 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -45.51 -44.84 12.91 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.136 0.97 . . . . 0.0 108.536 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -71.63 -63.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.982 0.896 . . . . 0.0 109.738 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm -44.54 -64.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.373 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 2.6 ttm -45.17 -36.19 3.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 1.5 tp10 -62.73 -9.55 9.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 0.0 110.483 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.624 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.03 52.26 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.156 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 254' ' ' ILE . 11.7 mtmt -31.86 -25.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.624 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -121.68 87.24 2.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.084 -1.635 . . . . 0.0 110.803 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 6.0 m-70 -89.61 -149.66 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.867 -1.146 . . . . 0.0 110.375 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 5.4 p-10 -145.19 145.19 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 249' ' ' LEU . 53.5 t -140.97 126.65 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.856 -1.152 . . . . 0.0 110.242 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 249' ' ' LEU . . . 46.13 -94.83 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 247' ' ' VAL . 19.2 mt -131.55 34.17 3.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 110.026 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.9 m -150.45 135.47 17.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.624 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.5 pttt -103.76 52.07 0.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.051 -1.03 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.576 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 84.5 m -36.77 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.774 -0.579 . . . . 0.0 109.818 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.528 ' HG2' ' CA ' ' A' ' 187' ' ' GLY . 1.8 pm0 -87.65 172.39 9.75 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.286 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 243' ' ' LYS . 2.5 mp -150.89 96.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 118.294 -1.362 . . . . 0.0 112.897 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 8.8 mttm -100.64 115.89 31.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -38.43 166.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.024 0.916 . . . . 0.0 112.546 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.522 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.627 -0.67 . . . . 0.0 110.04 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.691 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.691 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 29.3 pt -133.1 -176.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.531 -1.268 . . . . 0.0 111.018 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.38 141.23 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.247 -0.908 . . . . 0.0 110.506 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.581 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 46.3 t -110.39 128.69 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.35 59.18 0.44 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 179.22 69.23 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 226' ' ' CYS . 2.5 mm? -106.96 153.83 21.99 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.487 -1.008 . . . . 0.0 111.562 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.604 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 2.9 p -88.91 -166.52 0.11 Allowed Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.5 Cg_exo -62.84 -11.46 24.32 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 122.762 0.875 . . . . 0.0 110.266 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 62.7 t0 -150.74 133.29 15.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.167 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 55.4 m -87.73 113.78 56.03 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.048 -1.032 . . . . 0.0 110.032 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -64.58 60.88 0.27 Allowed 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 121.313 1.342 . . . . 0.0 112.474 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 mm-40 -37.98 -65.31 0.34 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 111.414 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 24.4 tt0 -47.59 -42.45 23.96 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.692 -1.203 . . . . 0.0 108.705 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.01 -28.13 62.18 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.593 ' CG2' ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -65.99 -56.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.593 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.15 -36.96 32.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -61.09 -36.68 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.554 -0.716 . . . . 0.0 109.768 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.3 t80 -91.25 -72.04 0.6 Allowed 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 117.571 -1.652 . . . . 0.0 109.864 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.543 ' CD2' HG13 ' A' ' 198' ' ' ILE . 23.0 m-85 -58.64 -50.18 74.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -56.15 -20.75 29.41 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.51 -46.25 41.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.569 ' CE2' HD12 ' A' ' 239' ' ' ILE . 74.1 m-85 -53.78 -37.75 63.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.049 -1.265 . . . . 0.0 108.633 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.13 132.44 2.51 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.4 OUTLIER -39.76 142.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -1.106 . . . . 0.0 109.905 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.521 HG13 ' CG2' ' A' ' 211' ' ' ILE . 6.4 t -97.48 146.18 8.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.549 -0.719 . . . . 0.0 110.653 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -87.48 -47.61 8.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.469 ' O ' HG21 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.31 169.88 22.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 213' ' ' LEU . 2.2 pp -128.66 -173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.646 -1.284 . . . . 0.0 110.304 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.577 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 33.6 tp10 -152.14 135.6 16.04 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.327 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.708 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.3 mm? -106.02 172.2 4.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.484 -1.385 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.708 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -52.05 -37.03 67.64 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.806 1.424 . . . . 0.0 110.801 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.25 -163.22 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.603 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.467 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 35.8 t70 -98.14 16.06 22.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.528 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 30.0 t30 -83.24 102.59 12.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.528 ' HD3' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 176.52 67.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.275 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.6 p -136.25 46.44 2.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.882 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 221' ' ' LYS . 2.1 p30 -150.62 -43.19 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.579 -0.7 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -149.62 -167.78 2.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 110.015 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 221' ' ' LYS . 22.8 ttt180 -41.44 157.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.387 -0.82 . . . . 0.0 110.167 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.87 -167.82 2.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.598 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.45 77.58 1.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 4.8 p90 -149.88 -166.4 2.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -1.218 . . . . 0.0 110.959 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.532 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 8.2 p -170.35 125.44 0.75 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -99.46 -176.94 3.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.264 -1.522 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -163.89 134.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 6.8 t -107.1 140.11 40.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.157 -1.589 . . . . 0.0 109.896 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 18.9 m-30 -100.13 -141.63 0.33 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -63.47 1.44 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.238 -0.914 . . . . 0.0 110.935 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 5.4 mt-10 -102.8 -69.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 0.0 111.037 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 7.0 pt-20 174.03 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.697 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.594 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -38.68 -55.29 2.72 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.2 Cg_exo -52.4 -37.6 72.33 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.093 1.049 . . . . 0.0 110.94 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 230' ' ' PHE . 2.1 t -67.38 -43.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.04 . . . . 0.0 108.92 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.32 -47.01 13.22 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.175 0.988 . . . . 0.0 108.597 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -68.51 -58.5 4.22 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.528 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 205' ' ' PHE . 3.7 mm -48.62 -63.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.688 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 1.6 tmm? -44.45 -35.4 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.942 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -65.45 -7.63 15.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.175 -0.953 . . . . 0.0 110.497 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -136.97 49.61 2.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 35.1 mtpt -29.09 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.649 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.06 89.9 3.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.515 -1.366 . . . . 0.0 110.012 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.551 ' NE2' ' O ' ' A' ' 242' ' ' LYS . 2.9 m-70 -95.8 -149.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.135 -0.978 . . . . 0.0 110.786 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.6 OUTLIER -133.46 137.61 45.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.698 -0.626 . . . . 0.0 109.534 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.65 125.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.017 -1.052 . . . . 0.0 110.211 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 47.19 75.2 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.1 OUTLIER 41.85 34.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -1.095 . . . . 0.0 110.529 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.6 t -146.72 166.4 26.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.649 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 4.3 ptpp? -124.38 45.98 2.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.572 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 28.7 p -40.05 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.53 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -88.08 171.36 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.629 -1.228 . . . . 0.0 109.141 179.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 1.0 OUTLIER -144.75 103.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.484 -178.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.35 107.65 19.05 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -43.97 167.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.21 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.509 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.934 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.645 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.645 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 22.4 mt -131.72 177.62 6.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 C-N-CA 117.3 -1.76 . . . . 0.0 110.639 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.16 117.6 6.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.962 -1.086 . . . . 0.0 110.801 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 58.0 t -89.62 126.77 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.899 -1.126 . . . . 0.0 109.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -103.44 59.21 0.51 Allowed Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.475 ' O ' HD22 ' A' ' 189' ' ' LEU . . . -178.93 62.84 0.08 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 186' ' ' VAL . 67.3 mt -135.55 162.45 32.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -1.205 . . . . 0.0 111.573 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 0.4 OUTLIER -90.01 172.4 7.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.8 Cg_exo -53.23 -17.23 8.13 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.331 1.174 . . . . 0.0 110.541 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -109.97 101.6 10.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 213' ' ' LEU . 2.6 m -86.56 129.32 53.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.165 -0.96 . . . . 0.0 110.399 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.7 Cg_endo -67.92 52.34 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.406 1.404 . . . . 0.0 112.525 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -36.66 -66.51 0.22 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.192 -0.943 . . . . 0.0 111.286 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.41 -40.65 18.36 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.814 -177.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 11.0 mttt -74.32 -28.66 61.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.592 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -66.36 -55.91 16.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.592 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -52.2 -36.39 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -61.07 -39.19 88.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 110.376 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.437 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.16 -70.91 0.66 Allowed 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 117.361 -1.735 . . . . 0.0 109.421 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.581 ' CD2' HG13 ' A' ' 198' ' ' ILE . 22.4 m-85 -57.19 -51.81 67.85 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.137 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.492 ' HA2' HG21 ' A' ' 208' ' ' VAL . . . -56.42 -20.63 30.8 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.5 -45.22 60.78 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.571 ' CD1' HD11 ' A' ' 239' ' ' ILE . 81.2 m-85 -58.36 -33.23 69.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -1.232 . . . . 0.0 108.962 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.58 130.36 1.98 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' GLY . 12.2 pt-20 -41.6 141.79 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -1.216 . . . . 0.0 110.079 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 230' ' ' PHE . 2.4 t -92.11 144.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.566 0.698 . . . . 0.0 111.222 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -88.12 -48.75 7.49 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 229' ' ' THR . 69.5 m -153.58 158.39 41.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.54 ' CG2' HG13 ' A' ' 208' ' ' VAL . 9.0 pt -114.93 -170.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.781 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 24.8 tp10 -151.3 137.26 18.18 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.321 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.693 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 5.3 mt -107.04 172.61 3.69 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 120.545 -1.347 . . . . 0.0 110.748 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.693 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -50.57 83.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.098 1.578 . . . . 0.0 111.168 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 213' ' ' LEU . 1.4 mtt 37.49 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.619 -0.676 . . . . 0.0 110.682 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 214' ' ' PRO . 4.5 t70 -175.39 -178.51 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.04 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 1.7 m-20 62.36 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.079 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER 63.83 50.87 2.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 109.754 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.0 t -142.71 49.94 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 110.132 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -142.1 -39.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.35 -169.59 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.486 ' C ' ' HG2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -114.44 -176.46 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.477 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 223' ' ' ARG . 20.0 ptp180 30.68 61.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.414 0.625 . . . . 0.0 111.376 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 189' ' ' LEU . . . -63.97 -146.45 0.03 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 1.8 p90 -148.4 -166.86 2.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -1.111 . . . . 0.0 110.704 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.543 ' SG ' ' CD1' ' A' ' 189' ' ' LEU . 0.6 OUTLIER -170.73 129.11 0.8 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -101.55 -173.69 2.42 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.243 -1.536 . . . . 0.0 108.918 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.592 ' CD1' ' CG2' ' A' ' 198' ' ' ILE . 1.2 mt -164.91 136.32 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.613 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 14.3 t -113.8 149.6 34.71 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.237 -1.539 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 208' ' ' VAL . 70.2 m-85 -117.82 -115.7 0.33 Allowed 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.472 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.481 ' HE2' ' N ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER -163.77 -39.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 53.7 tt0 -87.83 -96.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.796 -1.19 . . . . 0.0 111.302 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.4 OUTLIER 169.61 -24.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.199 -0.938 . . . . 0.0 109.912 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.584 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.1 tm-20 -63.44 -52.06 62.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.277 -0.889 . . . . 0.0 112.967 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.4 Cg_exo -52.38 -21.28 13.3 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 122.815 0.903 . . . . 0.0 111.349 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.546 ' CG1' HG23 ' A' ' 256' ' ' VAL . 2.0 t -80.74 -51.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 240' ' ' MET . 0.0 OUTLIER -41.76 -42.04 2.5 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.312 1.053 . . . . 0.0 108.886 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -59.15 3.26 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.412 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 205' ' ' PHE . 17.3 mm -51.69 -62.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.528 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.518 ' HG3' ' N ' ' A' ' 241' ' ' GLU . 1.4 ppp? -44.75 -33.2 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.493 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.518 ' N ' ' HG3' ' A' ' 240' ' ' MET . 1.8 tt0 -70.74 -8.48 52.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.596 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -131.19 47.66 2.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.978 -1.076 . . . . 0.0 109.107 179.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -28.12 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -111.76 83.14 1.73 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.508 -1.37 . . . . 0.0 110.34 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 3.5 m-70 -92.79 -147.14 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.983 -1.073 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -144.1 120.24 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 249' ' ' LEU . 4.4 t -112.04 112.01 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.954 -1.091 . . . . 0.0 110.635 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 64.01 -68.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -154.24 23.08 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 110.482 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.2 t -145.45 148.0 32.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.033 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -102.06 50.54 0.84 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.755 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.0 m -43.84 169.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.549 -0.719 . . . . 0.0 109.376 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.4 OUTLIER -87.14 165.0 16.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.496 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -142.36 98.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.266 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.61 ' CB ' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.4 108.17 20.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.546 HG23 ' CG1' ' A' ' 236' ' ' VAL . 2.0 p -43.62 166.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.917 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.521 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.406 -0.809 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.678 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.678 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 7.2 pt -130.14 175.33 11.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.429 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -137.35 135.44 37.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.189 -0.945 . . . . 0.0 110.213 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 55.4 t -111.55 128.38 68.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.902 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.473 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -99.71 44.5 1.64 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.559 ' HA3' ' CB ' ' A' ' 252' ' ' CYS . . . -132.2 2.94 5.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.557 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 3.56 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 178.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.2 p -43.75 170.07 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.551 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.6 Cg_exo -55.54 -35.11 91.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.275 1.145 . . . . 0.0 111.374 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 4.7 p-10 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.865 -1.147 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.544 ' CG2' HD13 ' A' ' 213' ' ' LEU . 18.8 m -39.69 97.09 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.585 -0.697 . . . . 0.0 109.958 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -70.61 80.23 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.741 1.39 . . . . 0.0 112.072 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -37.03 -61.67 0.54 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.452 -0.78 . . . . 0.0 111.038 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.2 mt-10 -49.22 -45.34 44.33 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.031 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -74.62 -26.42 59.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.0 OUTLIER -64.53 -50.11 77.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.514 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -57.01 -35.28 69.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.5 mt-10 -59.75 -38.82 82.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.46 -70.49 0.68 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.509 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -57.95 -52.19 66.54 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -55.36 -21.77 27.95 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.44 -45.61 67.51 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.447 ' CD1' HD12 ' A' ' 239' ' ' ILE . 90.6 m-85 -59.52 -34.29 72.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -1.232 . . . . 0.0 109.207 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 235' ' ' PRO . . . -172.42 135.09 3.22 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -41.51 141.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.978 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.434 HG23 ' CE1' ' A' ' 230' ' ' PHE . 12.7 t -104.2 145.91 12.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.541 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.0 -49.69 6.89 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 177.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.6 174.33 14.6 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 5.1 pt -127.54 -171.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.092 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.526 ' O ' ' O ' ' A' ' 227' ' ' PHE . 3.2 tt0 -150.82 128.5 11.57 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.917 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.5 mm? -104.88 171.38 5.02 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 120.578 -1.326 . . . . 0.0 111.004 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.4 Cg_endo -75.5 0.17 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.15 1.605 . . . . 0.0 110.574 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 1.1 tpt 71.36 -162.61 0.13 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 22.7 t70 -155.83 26.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.519 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 0.9 OUTLIER -88.83 -52.18 5.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.693 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 64.48 50.29 2.25 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.256 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.47 50.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 110.207 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 19.6 p-10 -149.92 -48.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.466 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -150.75 -171.68 3.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.432 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -58.92 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.258 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 222' ' ' ARG . 18.3 ptt180 -39.72 161.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.462 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . -117.76 -162.37 12.4 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.181 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -151.9 173.97 14.17 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -1.025 . . . . 0.0 109.757 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.695 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -119.76 117.93 29.5 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.642 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -97.25 -169.45 1.86 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.503 -1.373 . . . . 0.0 109.986 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -166.54 138.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.6 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 8.1 t -111.79 144.4 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 119.816 -1.802 . . . . 0.0 110.413 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 22.2 m-30 -103.44 -136.01 0.34 Allowed 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.073 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -154.27 -48.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.488 -178.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 83.9 tt0 -79.26 -56.48 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.975 . . . . 0.0 109.236 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.634 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 131.06 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.626 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -57.01 -45.65 99.94 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.366 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 3.9 Cg_exo -54.58 -27.48 50.83 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 109.709 -0.92 . . . . 0.0 109.709 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.552 HG22 ' CG2' ' A' ' 184' ' ' ILE . 2.3 t -74.16 -43.96 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.43 -48.28 9.92 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 108.836 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -61.28 1.84 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.015 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 235' ' ' PRO . 11.4 mm -44.79 -64.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.64 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.512 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.0 tmm? -46.65 -33.26 4.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.372 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 3.9 tt0 -73.08 2.45 7.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.92 51.01 1.72 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.014 -1.054 . . . . 0.0 109.444 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 4.1 ttmm -26.45 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.631 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -120.28 94.48 4.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.297 -1.502 . . . . 0.0 110.258 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 242' ' ' LYS . 4.3 m-70 -97.79 -148.88 0.33 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.009 -1.057 . . . . 0.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.57 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 7.6 m-80 -145.35 139.83 27.27 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 249' ' ' LEU . 25.8 t -133.29 120.43 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.99 -1.069 . . . . 0.0 110.174 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.22 -90.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -135.56 32.81 3.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -1.111 . . . . 0.0 109.824 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.58 145.39 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.631 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.0 pttt -113.41 54.91 0.72 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.97 -1.081 . . . . 0.0 110.934 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.578 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 62.1 m -40.47 162.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.38 -0.825 . . . . 0.0 108.94 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 254' ' ' ILE . 2.1 pm0 -87.7 177.42 7.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.722 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 0.9 OUTLIER -150.04 147.38 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.329 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 5.1 tttp -156.03 105.4 2.34 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.5 p -35.08 161.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.94 0.876 . . . . 0.0 112.94 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.484 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.685 -0.635 . . . . 0.0 110.164 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.654 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.654 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.4 pp -132.47 171.36 18.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.09 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -132.37 135.65 46.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 110.412 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.593 ' CG1' ' CB ' ' A' ' 252' ' ' CYS . 16.4 t -108.35 131.76 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.67 -0.644 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -95.64 47.98 1.87 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.623 ' O ' ' N ' ' A' ' 190' ' ' SER . . . -119.01 -29.83 1.73 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER 21.84 39.83 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.869 0.842 . . . . 0.0 112.805 179.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.623 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.3 p -41.39 167.12 0.06 OUTLIER Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -56.13 -18.71 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.409 1.215 . . . . 0.0 110.841 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 17.6 m-20 -150.49 87.31 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 110.501 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.549 ' CG2' HD23 ' A' ' 213' ' ' LEU . 3.6 m -48.25 106.31 0.59 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.526 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.27 55.31 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.238 1.292 . . . . 0.0 112.155 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.5 OUTLIER -37.46 -60.28 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.427 -0.796 . . . . 0.0 110.26 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 200' ' ' GLU . 10.6 tt0 -49.07 -45.17 42.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.471 -1.291 . . . . 0.0 108.854 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -74.39 -23.94 59.05 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -68.06 -51.59 47.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.543 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 22.6 ttm180 -55.72 -36.05 66.78 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.533 ' CA ' ' OE1' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -57.48 -42.88 83.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.622 -0.674 . . . . 0.0 109.537 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -91.25 -73.69 0.53 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 117.582 -1.647 . . . . 0.0 110.05 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -51.09 -50.28 59.05 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.229 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -54.98 -21.21 23.22 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -75.39 -43.97 23.32 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.579 ' CD1' HD11 ' A' ' 239' ' ' ILE . 83.5 m-85 -58.01 -28.26 64.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -1.212 . . . . 0.0 108.941 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 179.72 132.73 1.85 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' GLY . 6.9 pt-20 -41.12 142.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.137 . . . . 0.0 110.263 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.641 ' CG2' ' CE2' ' A' ' 230' ' ' PHE . 10.7 t -102.64 147.48 9.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -54.81 4.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.484 ' O ' HG21 ' A' ' 229' ' ' THR . 53.9 m -154.05 158.23 40.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pp -105.2 -168.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.305 -1.358 . . . . 0.0 109.418 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.561 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.8 tp10 -151.27 134.33 15.91 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.743 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 19.6 mt -109.52 178.13 1.09 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 120.794 -1.191 . . . . 0.0 109.7 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.0 Cg_exo -69.85 -172.36 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.389 1.205 . . . . 0.0 110.754 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -170.2 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.072 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 5.0 t70 -108.62 -7.53 15.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.253 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.472 ' C ' ' CD ' ' A' ' 218' ' ' LYS . 35.4 m-80 -77.23 111.03 12.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' A' ' 217' ' ' ASN . 0.3 OUTLIER -134.96 46.55 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.1 m -144.87 49.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.493 -0.755 . . . . 0.0 110.321 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 6.5 p-10 -150.45 -46.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.28 -174.41 4.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 109.962 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.22 53.16 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 110.115 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -117.02 166.35 12.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 109.994 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . 140.56 137.67 3.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -151.87 -178.35 6.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -1.128 . . . . 0.0 110.265 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.559 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -130.68 120.79 24.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.115 -0.991 . . . . 0.0 109.015 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -98.27 -168.7 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.407 -1.433 . . . . 0.0 110.428 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.3 mt -164.81 134.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 10.5 t -116.15 146.47 42.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.072 -1.642 . . . . 0.0 110.225 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CE2' ' CG2' ' A' ' 208' ' ' VAL . 58.0 m-85 -114.44 -127.83 0.29 Allowed 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -145.04 -44.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.673 -1.267 . . . . 0.0 113.377 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 7.5 mt-10 -82.74 -82.8 0.14 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.614 -1.304 . . . . 0.0 112.883 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.73 -28.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.6 tt0 -62.8 -53.29 57.44 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.315 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.3 Cg_exo -48.49 -32.71 21.42 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.992 0.996 . . . . 0.0 110.323 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.51 HG22 ' N ' ' A' ' 183' ' ' LYS . 2.1 t -68.71 -47.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.844 -1.16 . . . . 0.0 107.907 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.19 -43.66 7.3 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.215 1.007 . . . . 0.0 108.8 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -60.43 2.36 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.539 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.579 HD11 ' CD1' ' A' ' 205' ' ' PHE . 12.4 mm -49.08 -63.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.259 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.481 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -47.86 -28.37 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.637 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -77.13 7.02 5.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 111.059 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.98 54.42 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 109.047 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.3 OUTLIER -25.46 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.653 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.3 t80 -120.27 96.27 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.378 -1.451 . . . . 0.0 110.215 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 15.0 m-70 -93.58 -165.34 1.31 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.086 -1.009 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 57.0 m-80 -135.92 133.74 37.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 250' ' ' SER . 55.7 t -149.48 131.68 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.111 -0.993 . . . . 0.0 110.477 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 42.74 62.96 2.08 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 1.9 tp 48.22 22.37 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.152 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 50.3 m -132.34 118.06 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.653 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.2 pttt -97.94 53.74 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 110.693 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.593 ' CB ' ' CG1' ' A' ' 186' ' ' VAL . 58.8 m -41.67 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.459 -0.776 . . . . 0.0 109.011 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.55 ' HG2' ' CA ' ' A' ' 187' ' ' GLY . 1.7 pm0 -86.94 173.88 9.07 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.388 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 253' ' ' GLU . 1.2 mp -150.43 129.28 3.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.015 -1.474 . . . . 0.0 112.873 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 9.1 mttm -134.46 107.57 7.64 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -37.1 163.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.026 0.917 . . . . 0.0 112.575 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.695 -0.628 . . . . 0.0 109.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.693 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.693 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.3 mt -138.82 174.74 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.095 -1.003 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.08 139.79 50.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.143 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.574 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 62.9 t -114.62 131.38 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.55 -0.719 . . . . 0.0 109.862 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.527 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -104.97 43.6 1.64 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.552 ' C ' ' CD1' ' A' ' 189' ' ' LEU . . . -117.38 -15.46 6.49 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.552 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 10.35 58.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 188' ' ' GLY . 1.3 p -44.77 168.49 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.244 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -58.04 -11.93 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.416 1.219 . . . . 0.0 110.914 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 8.4 t0 -150.24 105.26 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.965 -1.085 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.464 ' HB ' HD13 ' A' ' 213' ' ' LEU . 76.5 p -40.21 98.99 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.373 -0.829 . . . . 0.0 109.822 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -69.25 45.17 0.39 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.436 1.424 . . . . 0.0 112.872 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.66 -69.41 0.11 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.048 -1.033 . . . . 0.0 111.679 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 3.8 tt0 -47.82 -39.88 19.61 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.577 -1.249 . . . . 0.0 109.034 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 194' ' ' PRO . 26.0 mmmt -75.7 -27.04 58.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.626 ' N ' ' O ' ' A' ' 194' ' ' PRO . 1.2 tp -66.99 -54.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.572 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 3.3 ttp85 -54.48 -38.28 66.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -59.32 -40.38 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.477 -0.765 . . . . 0.0 110.158 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 204' ' ' GLY . 2.0 t80 -91.02 -71.87 0.61 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.395 -1.722 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.622 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.0 m-85 -54.41 -54.06 45.72 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.564 -0.855 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.474 ' HA2' HG21 ' A' ' 208' ' ' VAL . . . -55.17 -22.1 27.83 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.93 -46.99 57.61 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 239' ' ' ILE . 85.6 m-85 -56.13 -31.22 63.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.269 . . . . 0.0 108.698 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.39 138.82 4.04 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.1 OUTLIER -43.56 143.14 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.016 -1.285 . . . . 0.0 109.577 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.474 HG21 ' HA2' ' A' ' 203' ' ' GLY . 10.4 t -101.19 152.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.754 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 3.2 tt0 -87.83 -56.19 3.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 229' ' ' THR . 30.8 m -153.47 160.35 42.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 46.2 pt -110.66 -169.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.009 -1.476 . . . . 0.0 109.584 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.549 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 4.6 tp10 -152.11 129.36 11.24 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.669 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.0 mm? -102.22 178.23 1.27 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.706 -1.246 . . . . 0.0 108.71 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -65.6 -165.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.101 1.053 . . . . 0.0 110.844 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.6 mtt -119.13 -176.25 3.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.1 -1.0 . . . . 0.0 110.563 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -77.56 -162.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.263 -0.898 . . . . 0.0 110.281 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 56.14 85.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.443 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -124.87 41.82 3.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.764 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.2 t -145.43 47.49 1.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.503 0.668 . . . . 0.0 109.827 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 220' ' ' ASN . 2.7 p-10 -150.51 -45.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.522 -0.736 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 -170.99 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 110.237 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.476 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -103.03 65.86 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -128.66 76.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 189' ' ' LEU . . . -140.68 58.1 0.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -89.44 177.69 6.51 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.574 -0.956 . . . . 0.0 110.645 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.584 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -130.29 120.7 24.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.18 -173.8 3.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.451 -1.406 . . . . 0.0 109.984 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.535 HD11 ' CG1' ' A' ' 198' ' ' ILE . 2.0 mt -161.51 134.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 2.5 t -107.68 138.46 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.863 -1.773 . . . . 0.0 110.21 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CD2' ' CG ' ' A' ' 235' ' ' PRO . 35.1 m-85 -99.47 -112.75 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.298 -1.361 . . . . 0.0 111.922 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 28.6 tttp 175.32 -53.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.636 -1.29 . . . . 0.0 109.892 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.602 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 2.3 mt-10 -75.51 -22.98 56.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.144 -0.972 . . . . 0.0 108.682 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 2.2 pt-20 87.7 -21.35 0.17 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.361 1.077 . . . . 0.0 108.751 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.7 mt-10 -61.11 -45.65 96.02 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -54.06 -25.29 36.24 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 109.675 -0.933 . . . . 0.0 109.675 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.568 HG23 ' CG1' ' A' ' 184' ' ' ILE . 2.2 t -76.89 -47.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -44.16 -46.52 8.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.306 1.051 . . . . 0.0 108.895 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.61 -61.95 1.59 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.883 0.849 . . . . 0.0 109.751 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 254' ' ' ILE . 21.5 mm -43.12 -65.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.5 ' CG ' HG23 ' A' ' 256' ' ' VAL . 0.4 OUTLIER -46.55 -34.08 4.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -61.14 -11.58 9.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 110.68 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.605 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.06 52.98 1.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.161 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.5 ttpp -27.87 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.1 t80 -115.43 92.85 4.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.325 -1.484 . . . . 0.0 110.061 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 2.7 m-70 -97.96 -154.85 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 110.778 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 10.2 p30 -136.26 143.35 44.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.306 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 24.4 t -139.5 131.01 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.421 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.18 -93.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -133.19 34.22 3.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -1.181 . . . . 0.0 110.197 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.23 168.25 24.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.597 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.54 48.38 1.61 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 110.49 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 26.7 p -34.08 152.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.866 -0.522 . . . . 0.0 109.922 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.527 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 1.4 pt-20 -87.66 170.9 10.87 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.79 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.533 HG22 ' CG2' ' A' ' 239' ' ' ILE . 1.1 mp -145.26 113.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.293 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.602 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -119.71 106.82 12.51 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 18.4 t -38.32 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.14 -0.975 . . . . 0.0 112.404 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.599 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.637 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.637 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.2 pp -130.01 -175.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 117.663 -1.615 . . . . 0.0 110.912 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.13 124.14 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 111.454 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 189' ' ' LEU . 92.6 t -93.34 128.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 109.278 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -105.25 58.96 0.45 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.688 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 179.58 67.67 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.551 ' CD1' ' SG ' ' A' ' 226' ' ' CYS . 40.9 mt -139.87 163.52 32.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -1.192 . . . . 0.0 111.644 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -79.74 171.43 12.47 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.7 Cg_exo -55.25 -16.4 13.06 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.38 1.2 . . . . 0.0 110.555 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.57 117.49 31.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.577 ' CG2' ' CD1' ' A' ' 213' ' ' LEU . 1.3 m -84.09 125.54 72.31 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.36 58.67 0.68 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.269 1.313 . . . . 0.0 111.915 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.601 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -36.98 -67.9 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.258 -0.901 . . . . 0.0 111.739 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -47.91 -38.3 16.16 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.864 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.474 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.3 OUTLIER -77.21 -27.97 53.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.618 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.2 tp -66.57 -55.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.562 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 4.8 mtt180 -56.29 -38.3 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.49 -49.02 65.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.65 -0.656 . . . . 0.0 110.464 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.6 -71.18 0.64 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 117.249 -1.78 . . . . 0.0 109.752 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.618 ' CD2' HG13 ' A' ' 198' ' ' ILE . 7.7 m-30 -50.4 -55.01 17.63 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.669 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -54.39 -22.06 21.97 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.18 -46.29 28.03 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.588 ' CZ ' HD13 ' A' ' 239' ' ' ILE . 77.7 m-85 -53.05 -36.0 60.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.318 . . . . 0.0 108.628 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.22 135.04 3.02 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.2 pt-20 -40.5 141.55 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.059 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.8 t -95.25 144.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 110.52 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 49.4 tp10 -87.65 -50.8 6.26 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 229' ' ' THR . 51.9 m -153.0 171.73 17.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.601 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 27.4 pt -125.17 -170.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.654 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.61 138.57 19.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.7 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.0 mm? -110.53 170.2 5.55 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 120.264 -1.523 . . . . 0.0 111.576 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.8 Cg_exo -49.71 88.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 124.051 1.553 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER 41.75 -141.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.428 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 218' ' ' LYS . 15.5 t70 -120.38 167.67 12.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.872 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 216' ' ' ASP . 11.8 t-20 63.77 -67.78 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.479 -0.763 . . . . 0.0 110.206 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER 63.98 46.81 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.972 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.2 m -150.76 53.38 0.88 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.665 . . . . 0.0 109.898 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -131.68 -37.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.829 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -132.78 -171.66 2.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 110.789 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -55.36 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 110.72 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 222' ' ' ARG . 32.6 ptt180 -43.73 169.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.702 . . . . 0.0 110.165 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -134.11 -148.9 5.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 2.1 p90 -131.15 -163.73 1.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.398 -1.06 . . . . 0.0 110.215 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.551 ' SG ' ' CD1' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -168.52 128.63 1.21 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.275 -0.891 . . . . 0.0 108.848 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.7 m-85 -101.01 -176.61 3.21 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.695 -1.253 . . . . 0.0 109.021 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.9 OUTLIER -165.61 136.13 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 5.2 t -107.39 139.54 41.72 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.295 -1.503 . . . . 0.0 109.784 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 15.0 m-85 -97.1 -131.64 0.2 Allowed 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.811 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -136.09 -52.67 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.761 -1.212 . . . . 0.0 110.92 -178.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 4.1 mt-10 -96.48 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.98 -26.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.227 1.013 . . . . 0.0 108.991 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.658 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -56.89 -43.58 99.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.93 -34.8 68.25 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 122.601 0.79 . . . . 0.0 110.803 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.523 HG12 ' CG2' ' A' ' 256' ' ' VAL . 54.6 t -75.67 -34.93 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.768 -1.208 . . . . 0.0 108.455 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -45.64 -44.16 13.02 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.3 1.047 . . . . 0.0 108.34 178.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -62.93 1.29 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.829 0.823 . . . . 0.0 110.458 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.588 HD13 ' CZ ' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -50.04 -60.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.693 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.517 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -50.48 -33.62 21.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.089 -1.007 . . . . 0.0 110.817 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.8 -6.69 8.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.855 -1.153 . . . . 0.0 110.973 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.606 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -133.89 53.1 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 108.743 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 254' ' ' ILE . 5.5 mtpt -26.64 -34.86 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.606 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.7 OUTLIER -115.11 90.05 3.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.466 -1.396 . . . . 0.0 109.666 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.606 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 36.2 m-70 -89.87 -157.61 0.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.125 -0.985 . . . . 0.0 111.371 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 6.1 t30 -144.67 120.01 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.2 122.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 57.44 53.95 40.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.18 22.78 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -1.082 . . . . 0.0 109.957 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 7.6 m -132.87 117.84 18.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.69 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.606 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -93.42 51.63 1.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 110.591 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 62.2 m -41.86 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.497 -0.752 . . . . 0.0 109.409 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.9 OUTLIER -88.01 164.44 15.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.591 -1.318 . . . . 0.0 109.753 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.527 HG22 ' NE2' ' A' ' 245' ' ' HIS . 1.4 mp -139.0 117.1 12.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.716 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.605 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tmtt? -126.64 112.34 15.36 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.544 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.5 p -39.72 166.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 112.132 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.575 -0.703 . . . . 0.0 110.423 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.654 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.654 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.6 pt -129.24 -179.2 2.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.361 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.605 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -150.15 125.89 10.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 60.8 t -94.65 132.26 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.119 -0.988 . . . . 0.0 110.339 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -105.56 56.82 0.51 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -178.64 64.56 0.08 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.529 HD22 ' CG1' ' A' ' 186' ' ' VAL . 2.0 mm? -105.23 152.26 23.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.508 -0.995 . . . . 0.0 111.484 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 3.0 p -90.12 -167.92 0.16 Allowed Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.3 Cg_exo -65.15 -6.52 13.25 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.047 1.025 . . . . 0.0 110.632 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.7 120.18 6.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.357 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.589 ' CG2' ' CD2' ' A' ' 213' ' ' LEU . 61.1 m -79.71 120.29 79.61 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.964 -1.085 . . . . 0.0 109.937 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -65.51 54.92 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.165 1.243 . . . . 0.0 112.133 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.532 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.01 -66.16 0.22 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.52 -0.737 . . . . 0.0 110.762 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.46 -37.85 12.54 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.85 -177.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -78.22 -28.82 48.04 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.42 -53.79 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.574 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -56.48 -36.08 68.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.6 mm-40 -60.12 -41.21 92.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.267 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.477 ' CZ ' ' O ' ' A' ' 246' ' ' ASN . 2.6 t80 -90.99 -70.99 0.65 Allowed 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.36 -1.736 . . . . 0.0 108.967 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.642 ' CD2' HG13 ' A' ' 198' ' ' ILE . 14.6 m-30 -53.81 -55.73 23.92 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.919 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 199' ' ' ARG . . . -53.89 -22.91 20.85 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.92 -47.64 53.47 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -51.06 -33.94 27.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.059 -1.259 . . . . 0.0 108.352 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.75 136.93 3.2 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 206' ' ' GLY . 4.4 pt-20 -42.21 141.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -1.185 . . . . 0.0 109.809 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 211' ' ' ILE . 4.8 t -95.06 150.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.522 -0.736 . . . . 0.0 110.654 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -87.65 -51.92 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 229' ' ' THR . 0.0 OUTLIER -152.79 165.62 34.81 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.53 ' CG2' HG13 ' A' ' 208' ' ' VAL . 5.8 pt -126.29 -173.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 118.199 -1.4 . . . . 0.0 110.158 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.58 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.9 tp10 -151.3 132.11 14.11 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.845 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.589 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 6.6 mt -104.37 169.9 6.69 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 120.338 -1.476 . . . . 0.0 110.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.3 Cg_exo -62.57 85.88 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.871 1.459 . . . . 0.0 110.772 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.2 ptp -165.88 146.86 6.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 110.361 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.524 ' O ' ' CE ' ' A' ' 218' ' ' LYS . 5.7 t0 -172.05 -65.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.713 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.462 ' HB3' ' CG2' ' A' ' 219' ' ' THR . 11.1 m-20 -67.53 -28.79 68.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.419 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 216' ' ' ASP . 8.8 mttt 59.58 40.56 20.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 217' ' ' ASN . 5.0 t -151.29 43.61 0.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.567 -0.708 . . . . 0.0 110.129 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -151.06 -98.43 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.462 -0.774 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -147.49 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 110.268 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 191' ' ' PRO . 45.4 mtm180 -98.77 68.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -165.98 169.09 15.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 131.18 -95.58 0.32 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 4.2 p90 -143.97 153.66 42.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.273 -1.134 . . . . 0.0 110.074 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.543 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 13.7 p -122.68 126.91 48.54 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -96.85 -177.28 3.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.281 -1.512 . . . . 0.0 109.275 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.541 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -164.77 134.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.627 ' HA ' ' HB2' ' A' ' 183' ' ' LYS . 5.5 t -109.07 138.47 45.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.14 -1.6 . . . . 0.0 109.193 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.514 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 37.1 m-85 -101.52 -166.91 1.35 Allowed 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.877 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -90.5 -49.73 6.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 3.0 mt-10 -119.09 174.44 6.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.02 -18.86 60.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 0.0 109.886 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.667 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 30.9 mt-10 -49.35 -53.15 42.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.6 Cg_exo -47.16 -43.39 25.61 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.727 0.951 . . . . 0.0 111.73 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.495 HG11 ' CG2' ' A' ' 256' ' ' VAL . 76.9 t -72.21 -32.05 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.631 -1.293 . . . . 0.0 109.671 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -49.74 -45.59 49.56 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.645 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -64.54 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.161 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -47.56 -64.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.976 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 236' ' ' VAL . 8.0 ttp -41.33 -40.17 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 110.695 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 2.1 tp10 -56.11 -16.18 4.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.582 ' O ' ' ND1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.3 50.96 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.519 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 34.4 ttpt -25.52 -37.84 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.664 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.8 t80 -103.23 91.04 3.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.363 -1.46 . . . . 0.0 108.658 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.582 ' ND1' ' O ' ' A' ' 242' ' ' LYS . 3.0 m-70 -89.37 -166.42 1.59 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.043 -1.036 . . . . 0.0 110.884 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' A' ' 201' ' ' TYR . 4.1 m120 -137.71 115.36 11.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 250' ' ' SER . 38.2 t -130.23 124.73 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 0.0 110.543 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 249' ' ' LEU . . . 52.97 51.41 46.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 248' ' ' GLY . 0.5 OUTLIER 60.25 25.7 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 110.067 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 17.6 m -138.57 122.08 17.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.664 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.01 56.03 0.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.945 . . . . 0.0 111.181 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.511 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 60.2 m -45.43 169.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.957 . . . . 0.0 109.109 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 186' ' ' VAL . 0.7 OUTLIER -88.04 167.89 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.275 -1.37 . . . . 0.0 107.86 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.541 HD11 ' CD2' ' A' ' 245' ' ' HIS . 3.5 mp -151.32 102.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.293 -1.363 . . . . 0.0 112.449 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -98.72 117.22 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 257' ' ' ALA . 2.2 p -40.74 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 112.095 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.557 ' N ' ' CG2' ' A' ' 256' ' ' VAL . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.708 -0.62 . . . . 0.0 110.076 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.642 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.642 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 4.1 pt -129.91 173.21 14.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.118 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -132.66 136.11 46.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.018 -1.051 . . . . 0.0 110.609 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 98.3 t -109.12 136.81 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.698 -0.626 . . . . 0.0 110.621 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -110.34 47.79 1.01 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.562 ' C ' ' CD1' ' A' ' 189' ' ' LEU . . . -120.0 -15.64 5.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.562 ' CD1' ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 13.53 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.368 0.604 . . . . 0.0 112.57 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.0 p -45.03 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 109.92 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -59.47 -12.97 18.79 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.446 1.235 . . . . 0.0 110.977 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 1.8 t70 -150.08 87.25 1.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 110.253 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.543 HG21 ' CD ' ' A' ' 214' ' ' PRO . 0.6 OUTLIER -39.13 96.8 0.12 Allowed Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.613 -0.679 . . . . 0.0 110.362 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.617 ' O ' ' HB ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.3 124.08 9.67 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.553 1.502 . . . . 0.0 111.904 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.543 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -95.63 -65.25 0.99 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -49.82 -50.91 43.39 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.534 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -62.61 -26.0 68.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 194' ' ' PRO . 0.7 OUTLIER -68.81 -61.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -54.72 -31.44 58.24 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 197' ' ' LYS . 8.1 tp10 -61.28 -42.78 99.23 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.75 -69.89 0.72 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 117.653 -1.619 . . . . 0.0 109.369 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.441 ' CD1' HD13 ' A' ' 184' ' ' ILE . 58.8 m-85 -54.93 -50.95 67.57 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.542 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -55.36 -21.43 26.67 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.28 47.61 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.54 ' CD1' HD13 ' A' ' 239' ' ' ILE . 76.7 m-85 -55.94 -31.1 62.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -1.2 . . . . 0.0 108.86 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.14 138.82 3.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 5.6 pt-20 -41.73 141.62 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.427 HG23 ' CD1' ' A' ' 230' ' ' PHE . 5.4 t -100.55 150.14 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.799 . . . . 0.0 110.55 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -87.8 -54.53 4.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 229' ' ' THR . 21.1 m -153.51 173.42 15.73 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 14.8 pt -124.23 -171.27 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.125 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.569 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 15.3 tt0 -150.97 128.7 11.57 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.167 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 8.4 mt -103.49 174.46 2.78 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 120.591 -1.318 . . . . 0.0 110.0 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo -69.43 -4.92 14.78 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.654 1.344 . . . . 0.0 111.117 -178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.423 ' O ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -53.54 -177.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 110.156 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 215' ' ' MET . 5.2 t0 60.36 150.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.138 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.435 ' C ' ' HG3' ' A' ' 218' ' ' LYS . 1.0 OUTLIER 52.73 97.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.107 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 179.32 48.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.217 -0.927 . . . . 0.0 110.481 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 36.9 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.94 0.876 . . . . 0.0 109.472 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.43 -37.4 0.14 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.407 0.622 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.522 ' HD3' ' CG ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.44 -166.49 1.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 110.321 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -137.59 64.25 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 110.219 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.522 ' CG ' ' HD3' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 175.74 141.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.351 -0.843 . . . . 0.0 109.957 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 189' ' ' LEU . . . -160.93 173.71 37.44 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.12 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -91.44 177.75 6.14 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.473 -1.016 . . . . 0.0 110.758 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.626 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -127.82 119.88 26.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 109.295 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -95.74 -170.36 2.12 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.38 -1.45 . . . . 0.0 110.058 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 227' ' ' PHE . 1.0 OUTLIER -165.27 137.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 7.5 t -110.39 144.38 39.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.121 -1.612 . . . . 0.0 110.096 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 23.0 m-30 -103.71 -149.89 0.41 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.328 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -69.12 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 111.88 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.8 mm-40 -86.09 -68.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 111.116 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 1.4 pt-20 164.24 -27.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.221 1.01 . . . . 0.0 109.152 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 mt-10 -55.32 -45.05 99.92 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -53.24 -28.77 43.84 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.689 0.836 . . . . 0.0 110.586 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 230' ' ' PHE . 34.2 t -80.99 -35.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.826 -1.171 . . . . 0.0 108.433 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.7 ttpt -45.2 -46.79 12.44 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.394 1.092 . . . . 0.0 108.287 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -61.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.54 HD13 ' CD1' ' A' ' 205' ' ' PHE . 10.1 mm -43.5 -66.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.314 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.493 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -45.36 -37.38 4.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 110.013 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -59.58 -13.77 10.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -130.7 48.55 2.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -26.59 -33.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.663 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -116.37 91.2 3.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.338 -1.476 . . . . 0.0 110.274 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 242' ' ' LYS . 2.3 m-70 -98.5 -145.82 0.32 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 16.2 p30 -142.59 139.62 31.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 50.1 t -150.4 125.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.93 62.68 5.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 83.4 mt 50.09 23.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -1.175 . . . . 0.0 110.523 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.8 t -132.67 151.5 51.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.139 -0.975 . . . . 0.0 109.704 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.663 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 2.3 ptpt -107.41 44.55 1.07 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.866 -1.146 . . . . 0.0 110.505 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.542 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 30.8 p -35.98 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.808 -0.558 . . . . 0.0 109.719 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.53 ' HG3' ' CA ' ' A' ' 187' ' ' GLY . 1.4 pt-20 -87.62 171.09 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.418 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 1.3 mp -147.66 91.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.983 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.556 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 25.0 mttt -100.08 114.92 28.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -38.3 166.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.03 0.919 . . . . 0.0 112.346 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.529 ' N ' ' HA ' ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.666 -0.646 . . . . 0.0 109.845 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.685 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.676 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.5 pp -131.39 171.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.674 ' CD2' ' HB3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -131.5 134.61 46.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.996 -1.065 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 252' ' ' CYS . 21.9 t -111.09 154.19 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.431 0.634 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.535 ' N ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.888 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.769 ' CB ' HD22 ' A' ' 213' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -61.85 58.22 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.52 1.274 . . . . 0.0 111.664 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -37.28 -66.79 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 111.662 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.4 OUTLIER -47.12 -41.46 17.49 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.014 -177.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -75.92 -27.93 57.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.94 -53.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.8 ttt-85 -53.96 -39.51 66.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 5.0 mm-40 -55.2 -41.13 71.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.726 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.469 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.8 t80 -91.67 -71.33 0.64 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.736 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.6 m-85 -53.38 -56.83 13.5 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.124 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.751 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -51.34 -24.1 9.9 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -66.45 -45.51 85.0 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 239' ' ' ILE . 76.6 m-85 -57.74 -29.71 65.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -1.212 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 177.89 141.64 4.27 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -42.71 141.64 1.02 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.261 . . . . 0.0 110.141 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.876 HG22 ' CE1' ' A' ' 230' ' ' PHE . 6.0 t -97.65 146.37 7.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.651 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -87.96 -56.89 3.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.63 163.35 40.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.617 ' CD1' HD21 ' A' ' 213' ' ' LEU . 1.8 pp -112.66 -171.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.47 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.614 ' O ' HD23 ' A' ' 213' ' ' LEU . 8.3 tp10 -151.48 138.62 19.21 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.031 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.769 HD22 ' CB ' ' A' ' 193' ' ' THR . 15.0 mt -112.39 -175.95 0.35 Allowed Pre-proline 0 C--N 1.295 -1.798 0 O-C-N 120.467 -1.396 . . . . 0.0 109.253 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.303 -1.817 0 O-C-N 123.155 1.081 . . . . 0.0 110.836 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.586 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.509 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -146.07 120.08 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 120.803 -1.185 . . . . 0.0 108.662 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.2 m-85 -96.98 -169.56 1.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.39 -1.444 . . . . 0.0 110.379 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -165.96 134.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 210' ' ' SER . 7.9 t -109.88 143.9 39.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.187 -1.571 . . . . 0.0 109.62 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.876 ' CE1' HG22 ' A' ' 208' ' ' VAL . 22.4 m-85 -111.36 -139.14 0.38 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.121 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -67.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.065 -1.022 . . . . 0.0 112.957 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 1.2 tp10 -70.48 -85.17 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.026 -1.046 . . . . 0.0 113.586 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER 161.21 -27.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 122.192 0.996 . . . . 0.0 108.426 -178.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.607 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.7 OUTLIER -55.77 -53.21 65.4 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -53.16 -43.37 57.77 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.893 0.943 . . . . 0.0 110.561 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 184' ' ' ILE . 2.1 t -52.78 -46.29 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.1 tttt -47.61 -44.15 26.33 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.106 -1.038 . . . . 0.0 108.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -70.84 -64.22 0.95 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 110.035 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.657 HG21 HG21 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -44.36 -64.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.579 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -44.68 -35.6 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.136 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 7.9 tp10 -65.51 -6.71 11.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.121 -0.987 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.741 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -136.31 51.03 2.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 0.0 109.258 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.6 mtpt -29.21 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.616 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -116.44 82.81 1.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.406 -1.434 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.912 ' CE1' HG21 ' A' ' 254' ' ' ILE . 6.6 m80 -89.71 -151.82 0.24 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.0 -1.063 . . . . 0.0 110.096 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.469 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 16.2 t-20 -143.63 142.83 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.784 . . . . 0.0 109.677 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 249' ' ' LEU . 58.9 t -135.02 116.77 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.064 -1.023 . . . . 0.0 110.474 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 55.06 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.3 OUTLIER -133.51 30.64 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 3.7 m -150.19 153.18 35.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.95 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.616 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.8 OUTLIER -119.53 54.43 1.0 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.142 -0.974 . . . . 0.0 110.595 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 186' ' ' VAL . 61.3 m -42.01 167.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.36 -0.838 . . . . 0.0 109.738 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.942 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.2 OUTLIER -86.79 170.52 11.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.086 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.942 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -147.6 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.284 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.674 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.69 112.4 24.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -38.74 166.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.878 0.847 . . . . 0.0 112.42 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.561 -0.712 . . . . 0.0 110.286 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.051 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -130.32 167.46 25.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.449 -1.3 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -125.89 134.7 51.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 53.1 t -111.78 122.59 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.524 -0.735 . . . . 0.0 110.537 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.557 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.083 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.699 HG21 ' HD2' ' A' ' 214' ' ' PRO . 46.6 p . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.93 49.06 1.51 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.549 1.5 . . . . 0.0 112.533 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -37.2 -66.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.0 -1.063 . . . . 0.0 111.63 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.57 -41.98 22.72 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.849 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 10.1 mttt -74.13 -28.4 61.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.46 -54.93 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.1 mpp_? -53.1 -37.44 61.72 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.7 mm-40 -62.97 -36.26 82.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.65 -71.46 0.64 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.544 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.634 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.2 m-85 -57.03 -51.43 69.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.424 -0.911 . . . . 0.0 108.71 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.776 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.25 -20.72 29.99 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.42 57.63 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.914 ' CD1' HD11 ' A' ' 239' ' ' ILE . 75.3 m-85 -56.15 -36.32 68.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -1.193 . . . . 0.0 108.911 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.58 139.21 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -41.43 141.57 0.71 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -1.15 . . . . 0.0 109.808 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.776 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.7 t -100.43 151.29 5.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.51 -0.743 . . . . 0.0 110.482 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 231' ' ' LYS . 20.5 tp10 -87.59 -54.46 4.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -153.47 173.66 15.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.818 HD13 ' CD2' ' A' ' 213' ' ' LEU . 2.4 pp -123.93 -172.02 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 120.556 -1.34 . . . . 0.0 109.554 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.599 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.9 tp10 -150.4 122.36 8.2 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 108.882 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.818 ' CD2' HD13 ' A' ' 211' ' ' ILE . 1.2 mm? -102.54 173.05 3.77 Favored Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 120.324 -1.485 . . . . 0.0 111.16 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.699 ' HD2' HG21 ' A' ' 193' ' ' THR . 3.1 Cg_exo . . . . . 0 C--N 1.306 -1.661 0 O-C-N 124.075 1.566 . . . . 0.0 110.871 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 121.976 0.894 . . . . 0.0 111.71 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.682 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.4 p -128.64 118.31 22.69 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -94.37 -166.53 1.5 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.487 -1.383 . . . . 0.0 110.394 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 0.9 OUTLIER -168.0 138.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.9 t -115.04 142.74 46.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 119.933 -1.729 . . . . 0.0 110.471 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 39.6 m-85 -104.17 -157.6 0.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HD2' ' OE1' ' A' ' 209' ' ' GLU . 4.9 tttm -106.9 -59.97 1.73 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.191 -0.943 . . . . 0.0 111.65 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 11.1 mt-10 -91.61 -70.98 0.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.048 -1.032 . . . . 0.0 111.421 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 165.45 -28.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.163 0.982 . . . . 0.0 109.426 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.72 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 16.9 tt0 -54.88 -44.58 99.54 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.72 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.9 Cg_exo -51.74 -33.76 51.27 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 122.774 0.881 . . . . 0.0 110.972 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.051 HG22 HG23 ' A' ' 184' ' ' ILE . 61.3 t -78.59 -32.67 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.791 -1.193 . . . . 0.0 108.864 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -47.86 -50.78 25.31 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.017 178.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 1.0 OUTLIER -69.29 -58.53 3.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.045 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.914 HD11 ' CD1' ' A' ' 205' ' ' PHE . 23.0 mm -48.57 -64.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.756 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -44.69 -32.47 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.707 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 9.9 tp10 -71.94 2.66 5.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.553 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 3.8 tptt -132.57 51.24 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 108.941 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -25.0 -40.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -117.56 102.36 9.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.523 -1.361 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.75 ' HD1' HD13 ' A' ' 254' ' ' ILE . 33.7 m80 -89.64 -159.6 0.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -0.94 . . . . 0.0 110.92 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 250' ' ' SER . 1.6 t30 -141.33 125.25 17.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 246' ' ' ASN . 77.0 t -148.13 126.04 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.45 66.52 2.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.5 mt 46.35 38.69 5.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -1.148 . . . . 0.0 110.504 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 246' ' ' ASN . 1.4 t -146.28 -173.49 4.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.694 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -149.86 51.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.448 179.046 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.581 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.6 m -34.86 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.835 -0.541 . . . . 0.0 109.737 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.933 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -86.9 170.78 11.34 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.521 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.933 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.8 mp -149.76 101.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 118.401 -1.32 . . . . 0.0 112.798 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.8 OUTLIER -110.06 111.9 23.56 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -36.65 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.068 0.937 . . . . 0.0 112.805 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.657 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.252 0 O-C-N 121.582 -0.698 . . . . 0.0 110.171 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.688 ' HD3' ' CA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.836 ' CG2' HG22 ' A' ' 236' ' ' VAL . 2.2 pp -127.09 169.46 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.235 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.34 133.22 46.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 110.016 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 254' ' ' ILE . 39.6 t -109.2 125.8 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.391 -0.818 . . . . 0.0 110.484 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.559 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.529 HG21 ' HD2' ' A' ' 214' ' ' PRO . 29.1 p . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.13 46.87 1.2 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.604 1.536 . . . . 0.0 112.359 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.1 mt-10 -36.15 -66.46 0.21 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 0.0 110.977 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 5.4 tt0 -47.49 -41.83 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.874 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 17.8 mttt -75.32 -27.44 59.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.89 -53.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.35 -39.27 60.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 37.2 mm-40 -58.53 -39.77 81.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.487 -0.758 . . . . 0.0 110.032 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.3 t80 -91.3 -72.03 0.6 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.42 -1.712 . . . . 0.0 109.712 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.623 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.6 m-85 -54.42 -54.67 37.66 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.409 -0.916 . . . . 0.0 108.691 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.96 -22.98 29.61 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -66.73 -46.37 75.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.872 ' CD1' HD11 ' A' ' 239' ' ' ILE . 65.9 m-85 -53.55 -37.69 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -1.203 . . . . 0.0 108.451 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.22 143.69 6.36 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 3.0 pm0 -41.74 141.71 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -1.176 . . . . 0.0 110.009 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.851 HG23 ' HA2' ' A' ' 203' ' ' GLY . 14.7 t -102.1 154.67 5.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.483 -0.761 . . . . 0.0 110.52 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 231' ' ' LYS . 1.8 tt0 -87.84 -59.28 2.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.619 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.38 169.91 21.96 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 8.6 pt -119.16 -170.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.389 -1.324 . . . . 0.0 109.763 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.583 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.6 tp10 -150.6 124.08 9.02 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.669 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.1 mm? -101.64 174.18 3.08 Favored Pre-proline 0 C--N 1.293 -1.88 0 O-C-N 120.465 -1.397 . . . . 0.0 110.74 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.306 -1.703 0 O-C-N 123.707 1.372 . . . . 0.0 110.863 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.641 0.734 . . . . 0.0 110.995 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.616 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.3 116.45 19.13 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.26 -170.06 2.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.408 -1.433 . . . . 0.0 110.394 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.61 134.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.688 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.4 t -110.42 139.99 45.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.206 -1.559 . . . . 0.0 109.594 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 69.9 m-85 -101.36 -165.65 1.22 Allowed 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 19.2 tttt -92.21 -65.22 1.02 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -101.56 166.68 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -20.22 65.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 35.2 tt0 -54.81 -53.61 58.85 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.8 Cg_exo -44.42 -38.72 11.96 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 120.477 0.785 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.836 HG22 ' CG2' ' A' ' 184' ' ' ILE . 55.5 t -74.87 -34.06 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.734 -1.228 . . . . 0.0 109.25 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -46.31 -46.33 18.03 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.333 1.064 . . . . 0.0 108.22 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -62.7 1.29 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.949 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.872 HD11 ' CD1' ' A' ' 205' ' ' PHE . 25.2 mm -46.64 -65.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.485 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 239' ' ' ILE . 12.0 tpt -43.63 -33.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 110.052 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -67.54 -2.84 7.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.116 -0.99 . . . . 0.0 110.828 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.729 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.12 50.7 2.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 109.099 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -25.42 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.7 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.6 t80 -114.52 93.71 4.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.463 -1.398 . . . . 0.0 109.454 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.729 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 10.6 m80 -91.19 -157.97 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 111.301 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 12.1 t-20 -141.07 139.8 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.797 -0.564 . . . . 0.0 109.621 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.41 113.32 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.003 -1.061 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 62.66 -87.08 0.05 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 2.2 mt -137.55 27.1 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.187 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.48 170.25 17.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.427 -0.796 . . . . 0.0 109.421 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.7 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -132.95 64.28 1.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.791 -1.193 . . . . 0.0 111.289 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.633 ' HB3' HG12 ' A' ' 186' ' ' VAL . 67.7 m -39.24 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.968 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -86.51 171.35 11.14 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.048 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -150.54 97.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.938 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.0 tttt -103.94 116.17 31.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.38 167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.168 0.985 . . . . 0.0 112.572 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.231 0 O-C-N 121.634 -0.667 . . . . 0.0 110.207 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.06 HG23 HG22 ' A' ' 236' ' ' VAL . 2.8 pt -131.58 172.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -133.23 132.71 41.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.955 -1.09 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 254' ' ' ILE . 26.2 t -105.95 127.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.424 -0.797 . . . . 0.0 110.395 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.538 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.079 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.617 HG21 ' HD2' ' A' ' 214' ' ' PRO . 9.5 p . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.738 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -73.47 113.75 3.86 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.513 1.475 . . . . 0.0 111.646 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.525 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -97.73 -70.56 0.72 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.01 0.909 . . . . 0.0 109.556 177.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -50.79 -47.5 59.79 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -63.82 -26.95 68.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -68.06 -60.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.4 tmm_? -50.34 -31.87 15.7 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -63.26 -41.05 98.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.708 178.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' GLY . 0.9 OUTLIER -90.89 -70.4 0.68 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.813 179.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.665 ' CD1' HD11 ' A' ' 184' ' ' ILE . 70.8 m-85 -54.07 -55.61 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.726 -0.79 . . . . 0.0 108.947 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.783 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.08 -22.64 29.27 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -67.33 -46.74 68.19 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 82.6 m-85 -56.3 -31.04 63.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.031 -1.276 . . . . 0.0 108.494 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.68 142.73 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.4 pm0 -42.87 143.81 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.048 -1.266 . . . . 0.0 109.824 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.817 HG22 ' CE2' ' A' ' 230' ' ' PHE . 11.8 t -105.12 154.26 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.396 -0.815 . . . . 0.0 110.874 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -88.33 -57.74 2.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 229' ' ' THR . 0.4 OUTLIER -153.4 170.24 21.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 42.6 pt -118.57 -169.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 118.549 -1.26 . . . . 0.0 110.021 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.0 tt0 -151.12 121.8 7.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.638 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -98.64 173.7 3.68 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.405 -1.434 . . . . 0.0 110.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.7 Cg_exo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.753 1.396 . . . . 0.0 110.746 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 121.467 0.651 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.659 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -131.57 118.19 19.77 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -96.21 -171.75 2.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.46 -1.4 . . . . 0.0 110.159 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.4 mt -163.91 137.52 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 210' ' ' SER . 7.0 t -113.17 146.3 39.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.079 -1.638 . . . . 0.0 110.253 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.817 ' CE2' HG22 ' A' ' 208' ' ' VAL . 44.0 m-85 -109.8 -164.86 0.96 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.583 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 232' ' ' GLU . 31.1 tttt -110.49 -65.78 1.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.477 0.656 . . . . 0.0 110.911 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 6.6 mt-10 -66.05 -67.68 0.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 110.842 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.9 OUTLIER 147.72 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-O 122.807 1.289 . . . . 0.0 107.666 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.689 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt-10 -54.74 -45.21 99.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -50.9 -21.5 8.61 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.496 0.735 . . . . 0.0 110.451 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.06 HG22 HG23 ' A' ' 184' ' ' ILE . 57.6 t -91.31 -35.33 6.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -48.21 -48.38 34.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -73.54 -61.58 1.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.962 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 184' ' ' ILE . 15.4 mm -43.56 -66.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.463 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.4 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -43.09 -44.49 4.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 110.386 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -59.17 -13.52 7.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.137 -0.977 . . . . 0.0 110.438 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.795 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -124.4 45.21 2.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' ILE . 4.6 ttmt -25.43 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -115.25 95.02 4.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.428 -1.42 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.795 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 1.6 m80 -102.36 -145.91 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.997 -1.065 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 3.6 m-20 -145.09 145.32 31.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.0 109.538 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.55 108.3 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 110.415 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 249' ' ' LEU . . . 65.62 -86.01 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 248' ' ' GLY . 0.8 OUTLIER -142.62 28.92 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.102 . . . . 0.0 110.008 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.52 132.7 23.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -90.2 46.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.608 -179.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.539 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 29.1 p -35.57 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.575 -0.703 . . . . 0.0 109.783 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.945 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -87.43 173.14 9.3 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.419 -1.312 . . . . 0.0 108.668 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.945 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.26 94.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.406 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 17.7 ttmt -100.08 113.0 25.3 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.3 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.071 0.939 . . . . 0.0 112.686 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.487 0.661 . . . . 0.0 110.04 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.819 HG23 HG22 ' A' ' 236' ' ' VAL . 1.6 pp -132.2 -178.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.731 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.86 148.4 50.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 110.041 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 253' ' ' GLU . 24.1 t -120.55 124.94 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.079 -1.013 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.535 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.495 2.574 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.593 ' HB ' ' CG ' ' A' ' 213' ' ' LEU . 4.4 m . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' HD13 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.05 76.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 194' ' ' PRO . 1.8 mt-10 -36.45 -40.5 0.24 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.482 -0.761 . . . . 0.0 110.128 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.1 -53.31 39.64 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 117.937 -1.505 . . . . 0.0 108.519 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 12.3 ttmt -69.78 -28.63 65.91 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 211' ' ' ILE . 1.1 tp -64.18 -51.2 71.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.63 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -54.38 -33.25 58.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -61.61 -40.51 95.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 245' ' ' HIS . 3.3 t80 -91.02 -68.8 0.77 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.529 -1.669 . . . . 0.0 109.449 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 198' ' ' ILE . 77.9 m-85 -58.33 -52.34 66.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.72 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -57.25 -25.63 54.74 Favored Glycine 0 N--CA 1.481 1.678 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -59.5 -44.82 96.41 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.662 ' CD2' HD11 ' A' ' 239' ' ' ILE . 78.9 m-85 -61.34 -40.08 92.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.167 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.46 140.22 6.15 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.7 OUTLIER -42.63 143.12 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.251 . . . . 0.0 110.122 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 230' ' ' PHE . 14.2 t -110.24 152.54 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 110.728 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 1.1 tp10 -88.32 -58.51 2.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 229' ' ' THR . 1.7 m -153.14 163.58 39.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 198' ' ' ILE . 2.2 pp -111.59 -171.27 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.176 -1.409 . . . . 0.0 110.351 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.875 ' N ' HD12 ' A' ' 211' ' ' ILE . 22.7 tt0 -152.69 139.65 19.13 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.452 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.671 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 4.0 mt -99.28 -177.93 0.64 Allowed Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.5 Cg_exo . . . . . 0 C--N 1.308 -1.588 0 O-C-N 122.627 0.804 . . . . 0.0 110.145 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.7 p90 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 10.3 p -138.19 129.62 27.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -95.62 -175.56 3.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.569 -1.332 . . . . 0.0 109.203 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 198' ' ' ILE . 1.7 mt -161.58 133.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 210' ' ' SER . 7.7 t -110.49 143.66 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.166 -1.584 . . . . 0.0 110.299 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.769 ' CE2' HG22 ' A' ' 208' ' ' VAL . 63.5 m-85 -104.68 -126.41 0.23 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.61 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.92 -56.09 0.55 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.654 -1.279 . . . . 0.0 111.182 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 2.1 tt0 -92.8 -69.75 0.73 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.018 -1.051 . . . . 0.0 110.145 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 2.0 pt-20 165.88 -31.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.238 1.018 . . . . 0.0 108.914 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.682 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -48.58 -48.91 67.41 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -51.03 -36.18 53.27 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 122.667 0.825 . . . . 0.0 110.522 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 184' ' ' ILE . 3.6 t -67.62 -41.96 86.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 108.333 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.58 -46.08 9.8 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.278 1.037 . . . . 0.0 108.741 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB3' ' CD1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -71.82 -63.33 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.916 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 205' ' ' PHE . 31.4 mm -44.23 -64.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.393 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -46.18 -34.15 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.958 . . . . 0.0 109.476 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 15.0 tt0 -80.05 10.17 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 110.522 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 244' ' ' TYR . 9.5 mmtt -131.28 49.03 2.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 108.987 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 242' ' ' LYS . 1.4 tmmm? -26.55 -39.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.686 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -123.56 104.59 9.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.624 -1.298 . . . . 0.0 109.616 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.61 ' CE1' HG21 ' A' ' 254' ' ' ILE . 53.6 m80 -89.6 -174.6 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.951 . . . . 0.0 110.663 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 250' ' ' SER . 3.8 m120 -133.92 119.19 18.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.523 -0.736 . . . . 0.0 109.494 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 250' ' ' SER . 54.5 t -145.59 131.56 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.997 -1.064 . . . . 0.0 110.57 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.04 65.3 2.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 249' ' ' LEU . 6.8 mp 48.24 28.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -1.159 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 69.8 m -136.3 171.57 14.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.048 -1.032 . . . . 0.0 109.762 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.686 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -150.47 53.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 111.313 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.56 ' HB2' HG12 ' A' ' 186' ' ' VAL . 24.0 p -39.05 161.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 109.405 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.869 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.52 168.57 13.59 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.043 -1.463 . . . . 0.0 108.01 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.869 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.26 109.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 117.942 -1.503 . . . . 0.0 113.548 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tttp -99.18 -154.67 0.47 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 7.0 p -122.64 168.41 15.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.309 -1.495 . . . . 0.0 110.448 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.878 . . . . 0.0 110.654 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.675 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.067 HG23 HG22 ' A' ' 236' ' ' VAL . 3.8 pt -130.22 176.99 7.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 118.317 -1.353 . . . . 0.0 110.48 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.72 117.82 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.775 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 22.3 t -89.62 119.08 36.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.541 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.417 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.761 ' CB ' HD12 ' A' ' 213' ' ' LEU . 94.8 m . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.6 Cg_endo -68.06 71.98 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.756 1.398 . . . . 0.0 112.158 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.72 -64.55 0.34 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.479 -0.763 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 1.8 tt0 -46.28 -43.67 15.88 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.083 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 2.5 tttt -74.64 -29.06 61.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.3 tp -62.24 -53.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.615 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.5 mtt180 -52.43 -37.48 56.89 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 2.4 mm-40 -59.59 -38.39 81.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.909 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.55 -70.86 0.67 Allowed 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.591 ' CD2' HG13 ' A' ' 198' ' ' ILE . 91.2 m-85 -56.6 -53.24 59.9 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.893 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.44 -21.5 27.53 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.46 70.73 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.927 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.8 m-85 -56.72 -40.84 76.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -1.209 . . . . 0.0 108.896 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.32 138.03 4.95 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 206' ' ' GLY . 1.1 pm0 -41.83 142.36 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -1.185 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.805 HG23 ' HA2' ' A' ' 203' ' ' GLY . 18.5 t -102.98 152.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.419 -0.8 . . . . 0.0 110.951 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.1 tt0 -88.12 -55.89 3.56 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.7 ' O ' HG22 ' A' ' 229' ' ' THR . 3.4 m -153.59 169.0 24.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 2.4 pt -118.63 -171.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.528 -1.357 . . . . 0.0 110.137 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 11.5 tp10 -151.51 130.82 12.83 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.106 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.849 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.4 mm? -101.87 176.99 1.61 Allowed Pre-proline 0 C--N 1.295 -1.762 0 O-C-N 120.528 -1.357 . . . . 0.0 109.829 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.849 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.327 1.172 . . . . 0.0 110.457 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.555 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.4 p90 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.616 0.722 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.553 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -165.07 117.37 1.19 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.82 . . . . 0.0 108.83 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.82 -174.8 3.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.476 -1.39 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.2 mt -164.03 133.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 210' ' ' SER . 6.0 t -106.18 141.97 36.65 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.221 -1.549 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.76 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.8 m-85 -100.65 -142.68 0.34 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.198 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -123.23 -58.56 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.837 -1.165 . . . . 0.0 111.674 -178.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 8.8 mt-10 -92.24 -70.08 0.71 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 110.725 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 163.76 -27.61 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.461 1.124 . . . . 0.0 108.895 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.705 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 tt0 -57.93 -42.6 96.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.705 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -52.74 -31.44 50.93 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.496 0.735 . . . . 0.0 110.304 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 184' ' ' ILE . 37.2 t -76.74 -36.82 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.741 -1.224 . . . . 0.0 108.121 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -44.5 -46.75 9.93 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.468 1.128 . . . . 0.0 108.25 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.84 -61.26 1.85 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.892 0.853 . . . . 0.0 109.869 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.927 HD11 ' CD1' ' A' ' 205' ' ' PHE . 15.4 mm -45.63 -65.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.482 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -48.21 -31.15 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.55 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 70.8 tt0 -66.41 -5.26 10.29 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.932 -1.105 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.739 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.26 52.88 1.45 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 0.0 109.355 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 33.6 ttpt -26.32 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -107.59 90.74 3.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.334 -1.479 . . . . 0.0 110.456 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.739 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 10.9 m80 -95.11 -164.09 1.12 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.254 -0.904 . . . . 0.0 110.703 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 13.2 m120 -137.1 143.99 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.639 -0.663 . . . . 0.0 109.629 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.45 99.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.07 . . . . 0.0 110.323 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 67.28 -83.61 0.13 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.17 24.41 2.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -1.145 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 4.1 m -143.95 134.52 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.79 56.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.063 . . . . 0.0 110.895 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 33.9 m -41.34 162.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.287 -0.883 . . . . 0.0 109.065 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.956 ' C ' HD12 ' A' ' 254' ' ' ILE . 2.2 pt-20 -88.1 175.7 7.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.575 -1.328 . . . . 0.0 108.293 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.956 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -149.2 108.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.426 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 1.2 tttt -114.6 110.56 19.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -37.55 167.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.114 0.959 . . . . 0.0 112.918 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.315 0 O-C-N 121.764 -0.585 . . . . 0.0 109.762 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.718 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 239' ' ' ILE . 1.1 pt -128.78 178.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 117.593 -1.643 . . . . 0.0 110.734 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.624 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -147.35 119.24 8.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.951 -1.093 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 254' ' ' ILE . 95.0 t -89.2 121.7 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.573 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . . . . . . 0 N--CA 1.497 2.732 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.949 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.657 HG21 ' HD2' ' A' ' 214' ' ' PRO . 44.9 p . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.653 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.89 47.18 1.19 Allowed 'Trans proline' 0 C--O 1.204 -1.224 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -37.33 -71.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.959 -1.088 . . . . 0.0 112.315 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -47.25 -40.49 16.67 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.299 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 13.2 mmtt -75.84 -26.58 57.29 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.781 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -67.37 -55.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 42.7 ttt-85 -56.94 -34.68 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.9 mm-40 -57.97 -46.78 84.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 110.182 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.45 -71.05 0.64 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 117.377 -1.729 . . . . 0.0 109.657 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.651 ' CD2' HG13 ' A' ' 198' ' ' ILE . 11.4 m-30 -51.29 -51.33 55.19 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.177 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.62 -21.18 27.49 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.24 -45.73 29.83 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 239' ' ' ILE . 73.6 m-85 -54.35 -28.1 40.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -1.187 . . . . 0.0 108.361 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.91 129.45 1.3 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.0 OUTLIER -39.84 141.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -1.098 . . . . 0.0 110.199 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 211' ' ' ILE . 2.6 t -91.17 140.46 15.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.587 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -87.53 -47.02 9.06 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 176.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.767 ' O ' HG22 ' A' ' 229' ' ' THR . 35.2 m -153.19 161.31 42.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 195' ' ' GLU . 4.4 pt -118.58 -166.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.037 -1.465 . . . . 0.0 110.638 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.96 130.52 12.24 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.972 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.68 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 3.0 mm? -111.78 172.7 3.34 Favored Pre-proline 0 C--N 1.292 -1.92 0 O-C-N 120.614 -1.304 . . . . 0.0 108.595 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.68 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.299 -2.039 0 O-C-N 123.366 1.193 . . . . 0.0 110.938 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 3.6 p90 . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.4 0.619 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.536 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 14.8 p -139.26 131.07 27.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.318 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.713 ' HB2' ' HB3' ' A' ' 212' ' ' GLU . 2.3 m-85 -97.25 -173.33 2.64 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.114 -1.616 . . . . 0.0 108.875 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.781 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -163.34 132.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 210' ' ' SER . 13.3 t -111.2 150.49 29.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.423 -1.423 . . . . 0.0 110.253 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.52 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 66.9 m-85 -118.93 -116.04 0.32 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.048 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -47.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.815 -1.178 . . . . 0.0 111.654 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -83.75 -101.18 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.916 -1.115 . . . . 0.0 111.366 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 176.05 -27.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 109.844 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.8 mt-10 -59.49 -49.56 91.69 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 112.6 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -53.25 -22.68 20.81 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 122.923 0.959 . . . . 0.0 111.563 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.435 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.1 t -79.37 -48.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.83 -41.29 10.92 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.191 0.996 . . . . 0.0 108.653 178.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 1.1 tttm -71.22 -64.62 0.88 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.856 0.836 . . . . 0.0 110.332 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -50.96 -62.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.825 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.658 ' N ' HG22 ' A' ' 239' ' ' ILE . 3.5 tmm? -44.3 -32.79 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 110.333 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -65.3 -5.89 8.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.019 -1.051 . . . . 0.0 110.599 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.587 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -137.69 51.7 1.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.134 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 254' ' ' ILE . 3.0 ttmt -25.02 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -106.75 91.94 3.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.478 -1.388 . . . . 0.0 109.567 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.831 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.4 m-70 -89.64 -159.61 0.6 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.07 -1.018 . . . . 0.0 110.83 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.459 ' C ' HG23 ' A' ' 247' ' ' VAL . 9.4 t-20 -136.59 128.57 29.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 250' ' ' SER . 44.4 t -146.36 136.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.925 -1.109 . . . . 0.0 110.634 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 42.55 70.93 0.43 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.3 OUTLIER 42.51 35.75 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -144.87 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -137.19 46.87 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.005 . . . . 0.0 110.583 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.62 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 63.6 m -40.07 157.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.887 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.9 pt-20 -87.92 165.51 15.19 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 117.618 -1.633 . . . . 0.0 107.568 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.37 110.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.168 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 8.5 tttt -100.98 113.82 27.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -40.6 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 111.912 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.658 -0.651 . . . . 0.0 109.848 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.89 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -138.22 169.53 18.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.035 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.634 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -115.39 155.33 27.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.931 -1.105 . . . . 0.0 109.573 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 61.7 t -134.82 136.35 52.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.198 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.434 ' HA3' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 213' ' ' LEU . 62.9 p . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -66.92 43.23 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.467 1.444 . . . . 0.0 113.255 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -37.94 -66.68 0.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.886 -1.134 . . . . 0.0 111.523 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.6 mm-40 -47.59 -43.44 25.58 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.182 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 5.7 mttt -73.97 -25.45 59.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 0.6 OUTLIER -65.76 -56.61 14.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -51.17 -37.33 45.84 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.4 mm-40 -60.53 -40.05 90.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.675 . . . . 0.0 109.905 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.21 -72.27 0.59 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.497 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 198' ' ' ILE . 79.4 m-85 -53.53 -53.37 52.61 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.472 -0.891 . . . . 0.0 108.982 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.726 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.68 -21.97 30.97 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -70.01 -45.7 55.49 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 239' ' ' ILE . 82.0 m-85 -57.06 -34.75 68.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -1.222 . . . . 0.0 108.886 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.83 139.41 4.63 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.5 OUTLIER -41.31 142.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -1.104 . . . . 0.0 109.983 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.726 HG23 ' HA2' ' A' ' 203' ' ' GLY . 7.6 t -101.76 148.52 7.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 44.1 tt0 -87.95 -53.27 4.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 229' ' ' THR . 3.7 m -153.54 168.67 25.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 12.0 pt -121.54 -170.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.538 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.7 tt0 -150.8 130.51 13.15 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.78 HD13 ' OG1' ' A' ' 193' ' ' THR . 13.4 mt -106.78 178.75 1.02 Allowed Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 120.786 -1.196 . . . . 0.0 109.591 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.766 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.0 Cg_exo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 123.212 1.112 . . . . 0.0 111.1 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.2 p -142.26 116.6 9.57 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 120.96 -1.087 . . . . 0.0 108.632 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.5 m-85 -92.79 -165.78 1.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.647 -1.283 . . . . 0.0 109.642 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -168.25 139.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 210' ' ' SER . 8.1 t -113.25 145.62 40.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.065 -1.647 . . . . 0.0 110.118 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.9 m-30 -109.56 -125.02 0.26 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.738 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 209' ' ' GLU . 7.5 tttt -174.7 -50.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.104 -0.997 . . . . 0.0 109.866 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.9 mt-10 -71.48 -26.44 62.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -0.801 . . . . 0.0 109.117 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 88.52 -27.12 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 122.843 1.306 . . . . 0.0 108.377 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 8.4 mt-10 -65.06 -39.32 35.86 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.767 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.1 Cg_exo -54.83 -24.83 40.23 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 N-CA-C 109.618 -0.955 . . . . 0.0 109.618 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.89 HG22 ' CG2' ' A' ' 184' ' ' ILE . 16.2 t -81.12 -41.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 236' ' ' VAL . 1.8 tptt -42.85 -45.77 5.03 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.423 1.106 . . . . 0.0 108.348 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.9 OUTLIER -72.31 -62.2 1.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.856 0.836 . . . . 0.0 109.722 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.495 HG23 HG21 ' A' ' 254' ' ' ILE . 8.2 mm -43.94 -65.44 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.329 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.2 OUTLIER -43.63 -37.85 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 5.2 tt0 -63.3 -8.95 9.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.129 -0.982 . . . . 0.0 110.644 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.726 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.22 51.52 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 10.1 ttmt -26.96 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.629 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.27 100.78 8.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.442 . . . . 0.0 110.015 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.726 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 3.4 m80 -102.35 -158.32 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.156 -0.965 . . . . 0.0 110.773 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -139.19 149.14 44.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.519 -0.738 . . . . 0.0 109.958 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 249' ' ' LEU . 37.9 t -143.67 123.15 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.41 -93.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -131.71 32.78 4.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 110.088 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.9 m -149.98 155.74 40.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.629 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.96 56.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 111.072 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 30.3 p -37.19 156.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.724 . . . . 0.0 109.835 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.0 pm0 -88.34 172.42 9.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.624 -1.231 . . . . 0.0 108.973 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -146.25 129.42 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.509 -1.276 . . . . 0.0 112.155 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HG2' ' CE1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -137.42 104.92 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.9 p -34.48 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.094 0.949 . . . . 0.0 113.171 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.676 -0.64 . . . . 0.0 109.651 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.692 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.865 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -133.35 179.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.92 130.46 35.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.987 -1.071 . . . . 0.0 110.236 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 59.3 t -102.62 122.23 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 110.304 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.594 ' HB ' HD22 ' A' ' 213' ' ' LEU . 43.8 p . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -71.73 103.65 1.49 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.411 1.407 . . . . 0.0 111.399 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.609 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -94.44 -66.72 0.9 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.882 0.849 . . . . 0.0 110.201 178.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 5.4 tm-20 -50.14 -46.03 53.63 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.657 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -67.49 -26.12 66.2 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -66.35 -58.94 4.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.719 ' N ' HG22 ' A' ' 198' ' ' ILE . 50.2 ttt180 -53.05 -34.64 57.39 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 15.2 mm-40 -59.88 -41.94 92.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.34 -69.96 0.71 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.43 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -54.47 -53.99 46.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.767 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.52 -21.59 28.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.92 -46.1 54.08 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 239' ' ' ILE . 80.8 m-85 -55.98 -38.01 69.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.951 -1.323 . . . . 0.0 108.847 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -173.31 142.04 6.43 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' OE2' ' CD ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -42.39 142.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -1.198 . . . . 0.0 110.095 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.767 HG23 ' HA2' ' A' ' 203' ' ' GLY . 13.3 t -103.06 151.9 6.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 110.689 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 29.2 tp10 -87.8 -61.05 1.8 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 4.0 m -153.72 161.1 42.41 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 16.6 pt -106.46 -168.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.236 -1.386 . . . . 0.0 109.714 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.2 tt0 -150.91 131.41 13.82 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.745 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.702 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 11.2 mt -102.7 177.53 1.44 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.309 1.163 . . . . 0.0 111.039 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.525 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 121.496 0.665 . . . . 0.0 110.815 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -127.61 119.74 26.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.651 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -91.78 -169.34 2.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 110.147 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 198' ' ' ILE . 1.5 mt -164.34 133.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 5.8 t -109.7 141.56 42.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 119.834 -1.791 . . . . 0.0 109.879 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.73 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.2 m-30 -98.28 -140.3 0.3 Allowed 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' CD ' ' OE2' ' A' ' 207' ' ' GLU . 74.4 tttt -126.83 -54.85 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.936 -1.103 . . . . 0.0 111.41 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.6 mt-10 -97.4 -68.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.013 -1.054 . . . . 0.0 110.481 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 162.35 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.173 0.987 . . . . 0.0 108.997 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.699 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -56.43 -43.5 99.33 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.65 -32.24 53.72 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 122.663 0.822 . . . . 0.0 110.649 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 184' ' ' ILE . 40.6 t -77.67 -34.5 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.262 . . . . 0.0 108.226 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -44.88 -48.15 11.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.281 1.038 . . . . 0.0 108.454 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -61.27 1.83 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.868 0.842 . . . . 0.0 109.731 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.7 mm -44.93 -66.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.464 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -41.23 -42.24 2.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.483 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -58.03 -14.0 5.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.095 -1.003 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.742 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -132.26 48.25 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.8 ttmt -26.95 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.614 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.4 t80 -112.13 96.58 6.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.533 -1.354 . . . . 0.0 110.081 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.742 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 1.5 m80 -103.34 -150.81 0.42 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.07 -1.019 . . . . 0.0 110.569 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -130.0 141.48 50.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.555 -0.716 . . . . 0.0 109.648 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 250' ' ' SER . 40.7 t -150.28 118.69 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 0.0 110.816 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 39.76 76.71 0.08 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 4.6 mt 44.95 24.0 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -1.206 . . . . 0.0 110.85 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 247' ' ' VAL . 17.4 m -143.6 122.17 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.101 -0.999 . . . . 0.0 109.216 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.614 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.4 pttt -89.61 52.47 2.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.089 -1.007 . . . . 0.0 110.958 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 22.0 p -38.81 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.2 pt-20 -87.59 168.78 12.73 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.847 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -142.74 95.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.025 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.33 110.14 22.77 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.1 p -39.85 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.879 -1.138 . . . . 0.0 112.045 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.602 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.554 -0.716 . . . . 0.0 110.441 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.745 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.687 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.4 pt -125.93 162.3 29.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.891 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.66 135.82 50.75 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.027 -1.045 . . . . 0.0 110.723 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 252' ' ' CYS . 17.6 t -109.44 137.81 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.575 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.019 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.82 HG21 ' CD1' ' A' ' 213' ' ' LEU . 98.1 m . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.62 64.41 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.335 1.357 . . . . 0.0 112.105 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.58 -69.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.444 -0.785 . . . . 0.0 112.002 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 25.4 tt0 -45.92 -41.25 11.28 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.281 -176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -75.71 -30.05 59.17 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -62.94 -51.8 67.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.613 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -56.28 -38.49 71.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -55.98 -40.08 72.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.88 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -70.59 0.68 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.563 -1.655 . . . . 0.0 110.006 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 184' ' ' ILE . 39.3 m-85 -57.19 -53.03 62.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.53 -0.731 . . . . 0.0 109.649 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.853 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.67 -23.02 12.9 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.56 55.89 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 239' ' ' ILE . 86.1 m-85 -57.02 -27.89 62.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.952 -1.323 . . . . 0.0 108.711 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 235' ' ' PRO . . . -179.13 133.7 2.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 15.1 pt-20 -40.98 142.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.911 HG22 ' CD1' ' A' ' 230' ' ' PHE . 10.7 t -97.32 145.53 9.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.449 -0.782 . . . . 0.0 110.847 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -87.81 -53.31 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.709 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.74 167.72 28.66 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 176.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 38.5 pt -112.38 -168.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 118.357 -1.337 . . . . 0.0 109.835 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -151.48 125.62 9.28 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 213' ' ' LEU . 2.5 mm? -108.32 174.53 2.41 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.343 -1.473 . . . . 0.0 110.348 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 2.9 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 O-C-N 123.675 1.355 . . . . 0.0 111.212 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 121.147 0.498 . . . . 0.0 110.206 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -126.18 119.25 27.02 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.9 m-85 -96.22 -165.36 1.27 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.497 -1.377 . . . . 0.0 110.757 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.602 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -169.71 134.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 210' ' ' SER . 6.5 t -112.31 143.64 43.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.849 -1.782 . . . . 0.0 109.627 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 208' ' ' VAL . 21.1 m-85 -108.9 -134.33 0.34 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.156 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 232' ' ' GLU . 2.7 tptt -128.2 -69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.06 -1.025 . . . . 0.0 113.276 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.9 mt-10 -73.82 -80.5 0.07 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.87 -1.144 . . . . 0.0 113.535 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.2 OUTLIER 161.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 122.111 0.958 . . . . 0.0 109.087 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 15.1 mm-40 -56.4 -55.99 36.53 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -51.62 -40.68 63.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.86 0.926 . . . . 0.0 110.682 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -55.21 -48.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.6 -1.313 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.87 -42.37 7.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -70.17 -62.68 1.29 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.868 0.842 . . . . 0.0 109.724 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.1 mm -45.6 -64.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.121 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -43.06 -37.17 1.87 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 110.191 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -9.02 11.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.114 -0.991 . . . . 0.0 110.658 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.748 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 9.1 mmtt -132.55 47.58 2.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.335 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 254' ' ' ILE . 12.0 ttmt -29.62 -32.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.632 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.6 t80 -117.57 86.99 2.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.27 -1.518 . . . . 0.0 110.39 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.763 ' CE1' HG21 ' A' ' 254' ' ' ILE . 2.6 m80 -93.03 -144.78 0.22 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.967 -1.083 . . . . 0.0 110.061 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.0 OUTLIER -143.04 135.37 27.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.761 . . . . 0.0 109.384 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.435 HG23 ' C ' ' A' ' 246' ' ' ASN . 60.1 t -147.53 133.32 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.908 -1.12 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 250' ' ' SER . . . 41.86 62.5 1.97 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.43 24.62 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -1.209 . . . . 0.0 110.546 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 248' ' ' GLY . 0.7 OUTLIER -137.26 128.43 27.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.1 -1.0 . . . . 0.0 109.594 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.632 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.26 44.42 1.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 0.0 110.552 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 186' ' ' VAL . 26.7 p -37.27 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.604 -0.685 . . . . 0.0 109.44 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.957 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.86 172.05 10.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.226 -1.389 . . . . 0.0 108.458 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.957 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -149.24 91.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.836 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.2 tttt -98.86 113.99 26.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -36.87 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.837 0.827 . . . . 0.0 112.122 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.141 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.709 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.682 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.8 pp -124.64 172.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.328 -1.349 . . . . 0.0 110.653 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.68 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.33 124.14 18.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.308 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 254' ' ' ILE . 17.3 t -96.84 108.3 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HD12 ' A' ' 213' ' ' LEU . 50.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.497 0.189 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -71.24 83.94 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.819 1.431 . . . . 0.0 111.237 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -36.55 -63.18 0.42 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.593 -0.692 . . . . 0.0 111.145 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -47.58 -44.11 26.01 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.108 -177.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 18.4 tttm -75.53 -27.16 58.59 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 211' ' ' ILE . 1.3 tp -64.56 -52.06 59.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.609 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.8 OUTLIER -54.13 -38.35 65.35 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.7 mt-10 -56.34 -41.34 75.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.95 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 3.7 t80 -90.94 -69.9 0.71 Allowed 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.479 -1.689 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.593 ' CD2' HG13 ' A' ' 198' ' ' ILE . 74.4 m-85 -57.74 -54.11 50.56 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.373 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.1 -24.9 16.34 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -63.23 -45.86 94.33 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 239' ' ' ILE . 70.3 m-85 -57.0 -33.51 67.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -1.135 . . . . 0.0 108.68 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.58 140.26 4.69 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 2.6 pt-20 -42.45 142.19 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -1.176 . . . . 0.0 110.091 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.853 HG22 ' CE1' ' A' ' 230' ' ' PHE . 8.3 t -99.92 146.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.519 -0.738 . . . . 0.0 111.131 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -88.71 -55.7 3.6 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.617 ' O ' HG22 ' A' ' 229' ' ' THR . 4.8 m -153.34 161.89 41.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 198' ' ' ILE . 4.8 pt -114.43 -170.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.209 -1.396 . . . . 0.0 110.253 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.6 tp10 -151.21 138.95 19.77 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.165 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.824 HD12 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -110.49 172.32 3.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.699 -1.251 . . . . 0.0 110.187 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.784 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.2 Cg_exo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.503 1.265 . . . . 0.0 111.103 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.624 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.709 0.766 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 3.1 p -146.45 127.44 14.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -99.01 -173.67 2.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.112 -1.617 . . . . 0.0 109.555 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 198' ' ' ILE . 1.4 mt -163.69 131.87 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.655 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.7 t -107.54 139.68 41.69 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 119.918 -1.739 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.853 ' CE1' HG22 ' A' ' 208' ' ' VAL . 23.8 m-85 -105.94 -131.48 0.3 Allowed 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.623 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 -64.71 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.846 -1.159 . . . . 0.0 112.874 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.42 -80.47 0.1 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.994 -1.066 . . . . 0.0 113.483 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 5.1 pt-20 162.97 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.948 0.88 . . . . 0.0 108.748 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 235' ' ' PRO . 1.3 mt-10 -55.47 -61.99 5.21 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 234' ' ' GLU . 5.2 Cg_exo -47.19 -39.9 26.89 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 122.988 0.994 . . . . 0.0 110.659 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -57.41 -48.25 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -45.51 -40.69 8.81 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.07 0.938 . . . . 0.0 108.536 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 8.6 tttt -72.23 -64.0 1.03 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.925 0.869 . . . . 0.0 109.55 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.652 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -45.16 -65.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.613 ' N ' HG22 ' A' ' 239' ' ' ILE . 4.2 tmm? -43.15 -39.16 2.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.192 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 39.3 tt0 -61.92 -15.67 44.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.617 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.53 47.33 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.708 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.3 mtpt -30.87 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -99.88 85.25 3.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.414 -1.429 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.731 ' CD2' HD13 ' A' ' 254' ' ' ILE . 7.5 m-70 -89.5 -148.72 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.975 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.564 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.9 OUTLIER -140.65 129.64 23.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.658 -0.651 . . . . 0.0 109.524 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 250' ' ' SER . 24.5 t -150.19 129.26 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.592 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 41.15 69.32 0.53 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 249' ' ' LEU . 0.9 OUTLIER 44.9 25.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 247' ' ' VAL . 18.9 m -139.11 118.96 13.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.546 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.609 ' HG2' ' CE1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.06 44.36 1.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.879 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.954 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.7 p -29.07 148.3 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.184 -0.322 . . . . 0.0 110.502 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.96 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -86.49 161.68 18.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.974 -1.49 . . . . 0.0 107.871 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.96 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -146.32 105.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.807 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 13.8 tttt -99.21 115.48 29.19 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 3.5 p -37.6 162.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.709 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.542 -0.723 . . . . 0.0 110.607 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.701 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.701 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.9 pp -127.27 165.74 25.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.433 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.76 139.27 52.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.861 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 253' ' ' GLU . 43.6 t -114.03 130.28 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 110.459 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.816 HG21 ' CD2' ' A' ' 213' ' ' LEU . 62.1 m . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.8 72.47 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.415 1.41 . . . . 0.0 112.293 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.8 -67.14 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.369 -0.832 . . . . 0.0 111.596 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.6 OUTLIER -47.03 -43.62 19.8 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.147 -177.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.0 OUTLIER -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.4 -54.28 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 5.9 mtp180 -51.78 -38.22 54.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 4.6 mm-40 -56.57 -40.52 75.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.394 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.36 -71.77 0.62 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.604 ' CD2' HG13 ' A' ' 198' ' ' ILE . 83.6 m-85 -54.3 -54.94 33.48 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.947 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.73 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.21 -22.8 23.01 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.269 -2.332 . . . . 0.0 107.269 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.1 -44.93 86.3 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.6 m-85 -57.97 -36.55 72.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -1.199 . . . . 0.0 108.93 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.14 141.99 6.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 206' ' ' GLY . 9.4 pt-20 -42.48 142.04 0.89 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -1.174 . . . . 0.0 109.86 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.73 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.6 t -104.36 150.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.518 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -88.01 -57.64 2.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.633 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.34 173.08 16.07 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pt -120.07 -170.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.895 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.606 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 3.0 tp10 -151.17 129.59 12.09 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.687 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 193' ' ' THR . 14.0 mt -105.82 175.12 2.24 Favored Pre-proline 0 C--N 1.295 -1.79 0 O-C-N 120.608 -1.308 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--N 1.303 -1.846 0 O-C-N 123.586 1.309 . . . . 0.0 110.984 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.505 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.151 0 CA-C-O 121.378 0.608 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.623 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.1 118.88 23.2 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.205 -0.935 . . . . 0.0 109.072 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.83 -171.44 2.35 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.275 -1.516 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -165.78 132.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.657 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.0 t -106.22 137.72 43.66 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.03 -1.669 . . . . 0.0 109.041 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 73.8 m-85 -96.79 -162.38 0.95 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.742 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -97.11 -46.26 6.23 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.478 -0.764 . . . . 0.0 109.197 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 42.2 mt-10 -121.79 167.22 13.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.559 -0.713 . . . . 0.0 109.371 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -15.79 63.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.985 -1.072 . . . . 0.0 109.341 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -57.39 -58.78 15.75 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.665 -0.647 . . . . 0.0 112.702 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -45.25 -24.91 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.226 1.119 . . . . 0.0 111.176 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 184' ' ' ILE . 6.5 t -83.34 -41.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.008 -1.058 . . . . 0.0 108.842 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -45.51 -44.84 12.91 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.136 0.97 . . . . 0.0 108.536 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -71.63 -63.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.982 0.896 . . . . 0.0 109.738 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.635 HG21 HG21 ' A' ' 184' ' ' ILE . 3.8 mm -44.54 -64.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.373 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 2.6 ttm -45.17 -36.19 3.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 1.5 tp10 -62.73 -9.55 9.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 0.0 110.483 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.624 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.03 52.26 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.156 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 254' ' ' ILE . 11.7 mtmt -31.86 -25.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.618 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -121.68 87.24 2.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.084 -1.635 . . . . 0.0 110.803 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 6.0 m-70 -89.61 -149.66 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.867 -1.146 . . . . 0.0 110.375 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 5.4 p-10 -145.19 145.19 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 249' ' ' LEU . 53.5 t -140.97 126.65 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.856 -1.152 . . . . 0.0 110.242 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 249' ' ' LEU . . . 46.13 -94.83 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 248' ' ' GLY . 19.2 mt -131.55 34.17 3.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 110.026 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.9 m -150.45 135.47 17.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.618 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.5 pttt -103.76 52.07 0.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.051 -1.03 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.6 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 84.5 m -36.77 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.774 -0.579 . . . . 0.0 109.818 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.861 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.8 pm0 -87.65 172.39 9.75 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.286 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.861 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.89 96.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 118.294 -1.362 . . . . 0.0 112.897 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 8.8 mttm -100.64 115.89 31.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -38.43 166.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.024 0.916 . . . . 0.0 112.546 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.627 -0.67 . . . . 0.0 110.04 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.703 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.703 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 29.3 pt -133.1 -176.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.531 -1.268 . . . . 0.0 111.018 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.38 141.23 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.247 -0.908 . . . . 0.0 110.506 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.581 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 46.3 t -110.39 128.69 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.539 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.769 ' CB ' HD12 ' A' ' 213' ' ' LEU . 55.4 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -64.58 60.88 0.27 Allowed 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 121.313 1.342 . . . . 0.0 112.474 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.671 ' OE2' HG21 ' A' ' 198' ' ' ILE . 2.5 mm-40 -37.98 -65.31 0.34 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 111.414 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 24.4 tt0 -47.59 -42.45 23.96 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.692 -1.203 . . . . 0.0 108.705 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.01 -28.13 62.18 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -65.99 -56.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.61 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.15 -36.96 32.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -61.09 -36.68 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.554 -0.716 . . . . 0.0 109.768 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.3 t80 -91.25 -72.04 0.6 Allowed 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 117.571 -1.652 . . . . 0.0 109.864 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.56 ' CD2' HG13 ' A' ' 198' ' ' ILE . 23.0 m-85 -58.64 -50.18 74.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.77 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.15 -20.75 29.41 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.51 -46.25 41.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 239' ' ' ILE . 74.1 m-85 -53.78 -37.75 63.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.049 -1.265 . . . . 0.0 108.633 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.13 132.44 2.51 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.4 OUTLIER -39.76 142.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -1.106 . . . . 0.0 109.905 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.77 HG23 ' HA2' ' A' ' 203' ' ' GLY . 6.4 t -97.48 146.18 8.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.549 -0.719 . . . . 0.0 110.653 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 7.1 tp10 -87.48 -47.61 8.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.31 169.88 22.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.652 HD13 ' OE2' ' A' ' 195' ' ' GLU . 2.2 pp -128.66 -173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.646 -1.284 . . . . 0.0 110.304 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.593 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 33.6 tp10 -152.14 135.6 16.04 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.327 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 193' ' ' THR . 1.3 mm? -106.02 172.2 4.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.484 -1.385 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.706 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.307 -1.618 0 O-C-N 123.806 1.424 . . . . 0.0 110.801 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 4.8 p90 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.54 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 8.2 p -170.35 125.44 0.75 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -99.46 -176.94 3.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.264 -1.522 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.685 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.1 mt -163.89 134.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 210' ' ' SER . 6.8 t -107.1 140.11 40.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.157 -1.589 . . . . 0.0 109.896 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 18.9 m-30 -100.13 -141.63 0.33 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -63.47 1.44 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.238 -0.914 . . . . 0.0 110.935 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 5.4 mt-10 -102.8 -69.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 0.0 111.037 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 7.0 pt-20 174.03 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.697 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.618 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -38.68 -55.29 2.72 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.2 Cg_exo -52.4 -37.6 72.33 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.093 1.049 . . . . 0.0 110.94 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.615 HG22 ' CG2' ' A' ' 184' ' ' ILE . 2.1 t -67.38 -43.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.04 . . . . 0.0 108.92 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.32 -47.01 13.22 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.175 0.988 . . . . 0.0 108.597 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -68.51 -58.5 4.22 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.528 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 205' ' ' PHE . 3.7 mm -48.62 -63.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.688 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 1.6 tmm? -44.45 -35.4 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.942 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -65.45 -7.63 15.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.175 -0.953 . . . . 0.0 110.497 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.757 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.97 49.61 2.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 35.1 mtpt -29.09 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.06 89.9 3.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.515 -1.366 . . . . 0.0 110.012 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.785 ' CE1' HG21 ' A' ' 254' ' ' ILE . 2.6 m80 -95.8 -149.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.135 -0.978 . . . . 0.0 110.786 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.48 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -133.46 137.61 45.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.698 -0.626 . . . . 0.0 109.534 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 250' ' ' SER . 11.6 t -146.65 125.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.017 -1.052 . . . . 0.0 110.211 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 47.19 75.2 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.1 OUTLIER 41.85 34.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -1.095 . . . . 0.0 110.529 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 247' ' ' VAL . 1.6 t -146.72 166.4 26.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 4.3 ptpp? -124.38 45.98 2.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.577 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 28.7 p -40.05 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 254' ' ' ILE . 0.1 OUTLIER -88.08 171.36 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.629 -1.228 . . . . 0.0 109.141 179.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -144.75 103.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.484 -178.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.35 107.65 19.05 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -43.97 167.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.21 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.934 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.703 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 239' ' ' ILE . 22.4 mt -131.72 177.62 6.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 C-N-CA 117.3 -1.76 . . . . 0.0 110.639 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.635 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.16 117.6 6.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.962 -1.086 . . . . 0.0 110.801 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 58.0 t -89.62 126.77 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.899 -1.126 . . . . 0.0 109.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.517 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.628 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.807 ' CB ' HD22 ' A' ' 213' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.7 Cg_endo -67.92 52.34 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.406 1.404 . . . . 0.0 112.525 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.551 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -36.66 -66.51 0.22 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.192 -0.943 . . . . 0.0 111.286 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -47.41 -40.65 18.36 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.814 -177.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 11.0 mttt -74.32 -28.66 61.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.958 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -66.36 -55.91 16.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.6 OUTLIER -52.2 -36.39 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.374 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -61.07 -39.19 88.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 110.376 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.437 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.16 -70.91 0.66 Allowed 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 117.361 -1.735 . . . . 0.0 109.421 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.602 ' CD2' HG13 ' A' ' 198' ' ' ILE . 22.4 m-85 -57.19 -51.81 67.85 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.137 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.42 -20.63 30.8 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.5 -45.22 60.78 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.819 ' CD1' HD11 ' A' ' 239' ' ' ILE . 81.2 m-85 -58.36 -33.23 69.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -1.232 . . . . 0.0 108.962 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.58 130.36 1.98 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' GLY . 12.2 pt-20 -41.6 141.79 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -1.216 . . . . 0.0 110.079 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.582 HG11 HG23 ' A' ' 211' ' ' ILE . 2.4 t -92.11 144.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.566 0.698 . . . . 0.0 111.222 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -88.12 -48.75 7.49 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.72 ' O ' HG22 ' A' ' 229' ' ' THR . 69.5 m -153.58 158.39 41.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.582 HG23 HG11 ' A' ' 208' ' ' VAL . 9.0 pt -114.93 -170.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.781 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.6 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 24.8 tp10 -151.3 137.26 18.18 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.321 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 193' ' ' THR . 5.3 mt -107.04 172.61 3.69 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 120.545 -1.347 . . . . 0.0 110.748 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.308 -1.598 0 O-C-N 124.098 1.578 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 1.8 p90 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.755 0.788 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.531 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 0.6 OUTLIER -170.73 129.11 0.8 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.635 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -101.55 -173.69 2.42 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.243 -1.536 . . . . 0.0 108.918 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.958 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.2 mt -164.91 136.32 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 210' ' ' SER . 14.3 t -113.8 149.6 34.71 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.237 -1.539 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 70.2 m-85 -117.82 -115.7 0.33 Allowed 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.472 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HE2' ' N ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER -163.77 -39.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.494 ' N ' ' HE2' ' A' ' 231' ' ' LYS . 53.7 tt0 -87.83 -96.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.796 -1.19 . . . . 0.0 111.302 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.4 OUTLIER 169.61 -24.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.199 -0.938 . . . . 0.0 109.912 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.609 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.1 tm-20 -63.44 -52.06 62.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.277 -0.889 . . . . 0.0 112.967 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.4 Cg_exo -52.38 -21.28 13.3 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 122.815 0.903 . . . . 0.0 111.349 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.478 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.0 t -80.74 -51.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 240' ' ' MET . 0.0 OUTLIER -41.76 -42.04 2.5 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.312 1.053 . . . . 0.0 108.886 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -59.15 3.26 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.412 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 205' ' ' PHE . 17.3 mm -51.69 -62.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.528 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.505 ' HG3' ' N ' ' A' ' 241' ' ' GLU . 1.4 ppp? -44.75 -33.2 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.493 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 240' ' ' MET . 1.8 tt0 -70.74 -8.48 52.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.741 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -131.19 47.66 2.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.978 -1.076 . . . . 0.0 109.107 179.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -28.12 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -111.76 83.14 1.73 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.508 -1.37 . . . . 0.0 110.34 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.741 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 3.4 m80 -92.79 -147.14 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.983 -1.073 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -144.1 120.24 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 249' ' ' LEU . 4.4 t -112.04 112.01 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.954 -1.091 . . . . 0.0 110.635 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 64.01 -68.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -154.24 23.08 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 110.482 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.2 t -145.45 148.0 32.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.033 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -102.06 50.54 0.84 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.755 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.0 m -43.84 169.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.549 -0.719 . . . . 0.0 109.376 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.982 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -87.14 165.0 16.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.496 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.982 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -142.36 98.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.266 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.4 108.17 20.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.0 p -43.62 166.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.917 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.406 -0.809 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.691 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.737 HG23 HG22 ' A' ' 236' ' ' VAL . 7.2 pt -130.14 175.33 11.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.429 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -137.35 135.44 37.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.189 -0.945 . . . . 0.0 110.213 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.675 HG12 ' HB3' ' A' ' 252' ' ' CYS . 55.4 t -111.55 128.38 68.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.902 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.494 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.703 ' CB ' HD12 ' A' ' 213' ' ' LEU . 18.8 m . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.4 Cg_endo -70.61 80.23 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.741 1.39 . . . . 0.0 112.072 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -37.03 -61.67 0.54 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.452 -0.78 . . . . 0.0 111.038 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.2 mt-10 -49.22 -45.34 44.33 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.031 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -74.62 -26.42 59.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.261 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -64.53 -50.11 77.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -57.01 -35.28 69.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.52 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.5 mt-10 -59.75 -38.82 82.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.46 -70.49 0.68 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.509 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -57.95 -52.19 66.54 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.77 27.95 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.44 -45.61 67.51 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.753 ' CD1' HD11 ' A' ' 239' ' ' ILE . 90.6 m-85 -59.52 -34.29 72.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -1.232 . . . . 0.0 109.207 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -172.42 135.09 3.22 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -41.51 141.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.978 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.676 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.7 t -104.2 145.91 12.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.541 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.0 -49.69 6.89 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 177.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.595 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.6 174.33 14.6 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 5.1 pt -127.54 -171.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.092 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.526 ' O ' ' O ' ' A' ' 227' ' ' PHE . 3.2 tt0 -150.82 128.5 11.57 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.917 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.703 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.5 mm? -104.88 171.38 5.02 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 120.578 -1.326 . . . . 0.0 111.004 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.4 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.15 1.605 . . . . 0.0 110.574 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -119.76 117.93 29.5 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -97.25 -169.45 1.86 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.503 -1.373 . . . . 0.0 109.986 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.54 138.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.607 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 8.1 t -111.79 144.4 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 119.816 -1.802 . . . . 0.0 110.413 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.666 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.2 m-30 -103.44 -136.01 0.34 Allowed 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.073 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -154.27 -48.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.488 -178.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 83.9 tt0 -79.26 -56.48 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.975 . . . . 0.0 109.236 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.634 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 131.06 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -57.01 -45.65 99.94 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.366 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 3.9 Cg_exo -54.58 -27.48 50.83 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 109.709 -0.92 . . . . 0.0 109.709 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 184' ' ' ILE . 2.3 t -74.16 -43.96 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.43 -48.28 9.92 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 108.836 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -61.28 1.84 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.015 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 205' ' ' PHE . 11.4 mm -44.79 -64.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.64 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.53 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.0 tmm? -46.65 -33.26 4.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.372 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 3.9 tt0 -73.08 2.45 7.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.78 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.92 51.01 1.72 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.014 -1.054 . . . . 0.0 109.444 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 4.1 ttmm -26.45 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -120.28 94.48 4.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.297 -1.502 . . . . 0.0 110.258 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.78 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 4.1 m80 -97.79 -148.88 0.33 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.009 -1.057 . . . . 0.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.57 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 7.6 m-80 -145.35 139.83 27.27 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 249' ' ' LEU . 25.8 t -133.29 120.43 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.99 -1.069 . . . . 0.0 110.174 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.22 -90.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -135.56 32.81 3.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -1.111 . . . . 0.0 109.824 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.58 145.39 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.63 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.0 pttt -113.41 54.91 0.72 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.97 -1.081 . . . . 0.0 110.934 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.675 ' HB3' HG12 ' A' ' 186' ' ' VAL . 62.1 m -40.47 162.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.38 -0.825 . . . . 0.0 108.94 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.902 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.1 pm0 -87.7 177.42 7.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.722 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 253' ' ' GLU . 0.9 OUTLIER -150.04 147.38 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.329 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 5.1 tttp -156.03 105.4 2.34 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.5 p -35.08 161.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.94 0.876 . . . . 0.0 112.94 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.685 -0.635 . . . . 0.0 110.164 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.727 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 239' ' ' ILE . 2.4 pp -132.47 171.36 18.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.09 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -132.37 135.65 46.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 110.412 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 252' ' ' CYS . 16.4 t -108.35 131.76 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.67 -0.644 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.878 HG21 ' CD2' ' A' ' 213' ' ' LEU . 3.6 m . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.27 55.31 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.238 1.292 . . . . 0.0 112.155 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.626 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.5 OUTLIER -37.46 -60.28 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.427 -0.796 . . . . 0.0 110.26 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 200' ' ' GLU . 10.6 tt0 -49.07 -45.17 42.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.471 -1.291 . . . . 0.0 108.854 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -74.39 -23.94 59.05 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 195' ' ' GLU . 0.2 OUTLIER -68.06 -51.59 47.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.586 ' N ' HG22 ' A' ' 198' ' ' ILE . 22.6 ttm180 -55.72 -36.05 66.78 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.533 ' CA ' ' OE1' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -57.48 -42.88 83.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.622 -0.674 . . . . 0.0 109.537 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -91.25 -73.69 0.53 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 117.582 -1.647 . . . . 0.0 110.05 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -51.09 -50.28 59.05 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.229 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.98 -21.21 23.22 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -75.39 -43.97 23.32 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.746 ' CD1' HD11 ' A' ' 239' ' ' ILE . 83.5 m-85 -58.01 -28.26 64.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -1.212 . . . . 0.0 108.941 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 179.72 132.73 1.85 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' GLY . 6.9 pt-20 -41.12 142.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.137 . . . . 0.0 110.263 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 230' ' ' PHE . 10.7 t -102.64 147.48 9.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -54.81 4.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 53.9 m -154.05 158.23 40.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pp -105.2 -168.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.305 -1.358 . . . . 0.0 109.418 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.576 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.8 tp10 -151.27 134.33 15.91 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.743 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 193' ' ' THR . 19.6 mt -109.52 178.13 1.09 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 120.794 -1.191 . . . . 0.0 109.7 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.0 Cg_exo . . . . . 0 C--N 1.302 -1.896 0 O-C-N 123.389 1.205 . . . . 0.0 110.754 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.411 0.624 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -130.68 120.79 24.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.115 -0.991 . . . . 0.0 109.015 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -98.27 -168.7 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.407 -1.433 . . . . 0.0 110.428 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.3 mt -164.81 134.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 10.5 t -116.15 146.47 42.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.072 -1.642 . . . . 0.0 110.225 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.872 ' CE2' HG22 ' A' ' 208' ' ' VAL . 58.0 m-85 -114.44 -127.83 0.29 Allowed 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -145.04 -44.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.673 -1.267 . . . . 0.0 113.377 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 7.5 mt-10 -82.74 -82.8 0.14 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.614 -1.304 . . . . 0.0 112.883 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.73 -28.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.659 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.6 tt0 -62.8 -53.29 57.44 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.315 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.3 Cg_exo -48.49 -32.71 21.42 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.992 0.996 . . . . 0.0 110.323 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 183' ' ' LYS . 2.1 t -68.71 -47.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.844 -1.16 . . . . 0.0 107.907 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.19 -43.66 7.3 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.215 1.007 . . . . 0.0 108.8 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -69.05 -60.43 2.36 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.539 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 184' ' ' ILE . 12.4 mm -49.08 -63.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.259 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.667 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -47.86 -28.37 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.637 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -77.13 7.02 5.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 111.059 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.741 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.98 54.42 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 109.047 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.3 OUTLIER -25.46 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.652 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.3 t80 -120.27 96.27 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.378 -1.451 . . . . 0.0 110.215 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.804 ' CE1' HG21 ' A' ' 254' ' ' ILE . 15.1 m80 -93.58 -165.34 1.31 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.086 -1.009 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 57.0 m-80 -135.92 133.74 37.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 250' ' ' SER . 55.7 t -149.48 131.68 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.111 -0.993 . . . . 0.0 110.477 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 42.74 62.96 2.08 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 1.9 tp 48.22 22.37 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.152 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 247' ' ' VAL . 50.3 m -132.34 118.06 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.2 pttt -97.94 53.74 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 110.693 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 186' ' ' VAL . 58.8 m -41.67 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.459 -0.776 . . . . 0.0 109.011 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.947 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.7 pm0 -86.94 173.88 9.07 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.388 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.947 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.43 129.28 3.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.015 -1.474 . . . . 0.0 112.873 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 9.1 mttm -134.46 107.57 7.64 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 240' ' ' MET . 2.7 p -37.1 163.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.026 0.917 . . . . 0.0 112.575 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.727 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.695 -0.628 . . . . 0.0 109.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.704 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.704 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.3 mt -138.82 174.74 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.095 -1.003 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.694 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.08 139.79 50.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.143 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.574 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 62.9 t -114.62 131.38 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.55 -0.719 . . . . 0.0 109.862 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.547 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 213' ' ' LEU . 76.5 p . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -69.25 45.17 0.39 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.436 1.424 . . . . 0.0 112.872 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.66 -69.41 0.11 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.048 -1.033 . . . . 0.0 111.679 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 3.8 tt0 -47.82 -39.88 19.61 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.577 -1.249 . . . . 0.0 109.034 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 194' ' ' PRO . 26.0 mmmt -75.7 -27.04 58.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -66.99 -54.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.627 ' N ' HG22 ' A' ' 198' ' ' ILE . 3.3 ttp85 -54.48 -38.28 66.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -59.32 -40.38 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.477 -0.765 . . . . 0.0 110.158 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 204' ' ' GLY . 2.0 t80 -91.02 -71.87 0.61 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.395 -1.722 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.621 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.0 m-85 -54.41 -54.06 45.72 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.564 -0.855 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.17 -22.1 27.83 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.93 -46.99 57.61 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 85.6 m-85 -56.13 -31.22 63.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.269 . . . . 0.0 108.698 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.39 138.82 4.04 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.1 OUTLIER -43.56 143.14 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.016 -1.285 . . . . 0.0 109.577 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.766 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.4 t -101.19 152.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.754 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 3.2 tt0 -87.83 -56.19 3.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.636 ' O ' HG22 ' A' ' 229' ' ' THR . 30.8 m -153.47 160.35 42.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 46.2 pt -110.66 -169.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.009 -1.476 . . . . 0.0 109.584 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 4.6 tp10 -152.11 129.36 11.24 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.77 ' N ' HD22 ' A' ' 213' ' ' LEU . 2.0 mm? -102.22 178.23 1.27 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.706 -1.246 . . . . 0.0 108.71 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.304 -1.806 0 O-C-N 123.101 1.053 . . . . 0.0 110.844 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.29 0 CA-C-O 121.488 0.661 . . . . 0.0 110.645 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -130.29 120.7 24.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.18 -173.8 3.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.451 -1.406 . . . . 0.0 109.984 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 2.0 mt -161.51 134.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 210' ' ' SER . 2.5 t -107.68 138.46 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.863 -1.773 . . . . 0.0 110.21 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CD2' ' CG ' ' A' ' 235' ' ' PRO . 35.1 m-85 -99.47 -112.75 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.298 -1.361 . . . . 0.0 111.922 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 28.6 tttp 175.32 -53.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.636 -1.29 . . . . 0.0 109.892 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.602 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 2.3 mt-10 -75.51 -22.98 56.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.144 -0.972 . . . . 0.0 108.682 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 2.2 pt-20 87.7 -21.35 0.17 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.361 1.077 . . . . 0.0 108.751 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.681 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.7 mt-10 -61.11 -45.65 96.02 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -54.06 -25.29 36.24 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 109.675 -0.933 . . . . 0.0 109.675 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.643 HG22 ' CG1' ' A' ' 184' ' ' ILE . 2.2 t -76.89 -47.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -44.16 -46.52 8.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.306 1.051 . . . . 0.0 108.895 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.61 -61.95 1.59 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.883 0.849 . . . . 0.0 109.751 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 205' ' ' PHE . 21.5 mm -43.12 -65.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 256' ' ' VAL . 0.4 OUTLIER -46.55 -34.08 4.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -61.14 -11.58 9.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 110.68 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.738 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.06 52.98 1.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.161 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.5 ttpp -27.87 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.1 t80 -115.43 92.85 4.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.325 -1.484 . . . . 0.0 110.061 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.738 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 2.6 m80 -97.96 -154.85 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 110.778 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 10.2 p30 -136.26 143.35 44.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.306 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 24.4 t -139.5 131.01 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.421 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.18 -93.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -133.19 34.22 3.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -1.181 . . . . 0.0 110.197 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.23 168.25 24.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.54 48.38 1.61 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 110.49 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.545 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 26.7 p -34.08 152.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.866 -0.522 . . . . 0.0 109.922 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.919 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.66 170.9 10.87 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.79 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.919 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.1 mp -145.26 113.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.293 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -119.71 106.82 12.51 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 18.4 t -38.32 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.14 -0.975 . . . . 0.0 112.404 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.653 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.959 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -130.01 -175.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 117.663 -1.615 . . . . 0.0 110.912 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.13 124.14 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 111.454 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 92.6 t -93.34 128.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 109.278 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.534 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.688 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.873 ' CB ' HD12 ' A' ' 213' ' ' LEU . 1.3 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.36 58.67 0.68 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.269 1.313 . . . . 0.0 111.915 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.601 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -36.98 -67.9 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.258 -0.901 . . . . 0.0 111.739 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -47.91 -38.3 16.16 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.864 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.3 OUTLIER -77.21 -27.97 53.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.716 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.2 tp -66.57 -55.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 4.8 mtt180 -56.29 -38.3 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -52.49 -49.02 65.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.65 -0.656 . . . . 0.0 110.464 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.6 -71.18 0.64 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 117.249 -1.78 . . . . 0.0 109.752 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.637 ' HD2' HD12 ' A' ' 228' ' ' ILE . 7.7 m-30 -50.4 -55.01 17.63 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.669 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.704 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.39 -22.06 21.97 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.18 -46.29 28.03 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -53.05 -36.0 60.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.318 . . . . 0.0 108.628 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.22 135.04 3.02 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.2 pt-20 -40.5 141.55 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.059 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.704 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.25 144.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 110.52 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 49.4 tp10 -87.65 -50.8 6.26 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 229' ' ' THR . 51.9 m -153.0 171.73 17.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.601 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 27.4 pt -125.17 -170.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.654 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.61 138.57 19.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.0 mm? -110.53 170.2 5.55 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 120.264 -1.523 . . . . 0.0 111.576 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.8 Cg_exo . . . . . 0 C--N 1.31 -1.485 0 O-C-N 124.051 1.553 . . . . 0.0 111.287 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 2.1 p90 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.511 0.672 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 0.5 OUTLIER -168.52 128.63 1.21 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.275 -0.891 . . . . 0.0 108.848 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.7 m-85 -101.01 -176.61 3.21 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.695 -1.253 . . . . 0.0 109.021 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.716 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -165.61 136.13 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.328 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 210' ' ' SER . 5.2 t -107.39 139.54 41.72 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.295 -1.503 . . . . 0.0 109.784 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.794 ' HD2' HG23 ' A' ' 236' ' ' VAL . 15.0 m-85 -97.1 -131.64 0.2 Allowed 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.811 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' HG3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -136.09 -52.67 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.761 -1.212 . . . . 0.0 110.92 -178.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 4.1 mt-10 -96.48 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.98 -26.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.227 1.013 . . . . 0.0 108.991 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -56.89 -43.58 99.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.93 -34.8 68.25 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 122.601 0.79 . . . . 0.0 110.803 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 184' ' ' ILE . 54.6 t -75.67 -34.93 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.768 -1.208 . . . . 0.0 108.455 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -45.64 -44.16 13.02 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.3 1.047 . . . . 0.0 108.34 178.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -62.93 1.29 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.829 0.823 . . . . 0.0 110.458 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.629 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -50.04 -60.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.693 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.582 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -50.48 -33.62 21.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.089 -1.007 . . . . 0.0 110.817 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.8 -6.69 8.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.855 -1.153 . . . . 0.0 110.973 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.712 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -133.89 53.1 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 108.743 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 5.5 mtpt -26.64 -34.86 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.628 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.7 OUTLIER -115.11 90.05 3.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.466 -1.396 . . . . 0.0 109.666 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.712 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 36.2 m80 -89.87 -157.61 0.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.125 -0.985 . . . . 0.0 111.371 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 6.1 t30 -144.67 120.01 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.2 122.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 57.44 53.95 40.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.18 22.78 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -1.082 . . . . 0.0 109.957 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 7.6 m -132.87 117.84 18.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.69 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -93.42 51.63 1.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 110.591 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.556 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 62.2 m -41.86 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.497 -0.752 . . . . 0.0 109.409 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.935 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -88.01 164.44 15.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.591 -1.318 . . . . 0.0 109.753 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.935 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -139.0 117.1 12.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.716 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.627 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tmtt? -126.64 112.34 15.36 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -39.72 166.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 112.132 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.642 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.575 -0.703 . . . . 0.0 110.423 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.683 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 236' ' ' VAL . 3.6 pt -129.24 -179.2 2.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.361 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -150.15 125.89 10.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 60.8 t -94.65 132.26 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.119 -0.988 . . . . 0.0 110.339 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.464 ' C ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.844 ' CB ' HD22 ' A' ' 213' ' ' LEU . 61.1 m . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -65.51 54.92 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.165 1.243 . . . . 0.0 112.133 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.01 -66.16 0.22 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.52 -0.737 . . . . 0.0 110.762 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.46 -37.85 12.54 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.85 -177.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -78.22 -28.82 48.04 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.656 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.42 -53.79 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.603 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -56.48 -36.08 68.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.265 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.6 mm-40 -60.12 -41.21 92.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.267 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.796 ' CD2' HG22 ' A' ' 247' ' ' VAL . 2.6 t80 -90.99 -70.99 0.65 Allowed 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.36 -1.736 . . . . 0.0 108.967 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.656 ' CD2' HG13 ' A' ' 198' ' ' ILE . 14.6 m-30 -53.81 -55.73 23.92 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.919 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.743 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -53.89 -22.91 20.85 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.92 -47.64 53.47 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 239' ' ' ILE . 67.4 m-85 -51.06 -33.94 27.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.059 -1.259 . . . . 0.0 108.352 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.75 136.93 3.2 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 206' ' ' GLY . 4.4 pt-20 -42.21 141.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -1.185 . . . . 0.0 109.809 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.743 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.06 150.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.522 -0.736 . . . . 0.0 110.654 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -87.65 -51.92 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -152.79 165.62 34.81 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.591 ' CG2' HG11 ' A' ' 208' ' ' VAL . 5.8 pt -126.29 -173.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 118.199 -1.4 . . . . 0.0 110.158 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.598 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.9 tp10 -151.3 132.11 14.11 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.845 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.844 HD22 ' CB ' ' A' ' 193' ' ' THR . 6.6 mt -104.37 169.9 6.69 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 120.338 -1.476 . . . . 0.0 110.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.3 Cg_exo . . . . . 0 C--N 1.304 -1.772 0 O-C-N 123.871 1.459 . . . . 0.0 110.772 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 4.2 p90 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.2 0.524 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.539 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 13.7 p -122.68 126.91 48.54 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -96.85 -177.28 3.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.281 -1.512 . . . . 0.0 109.275 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.635 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -164.77 134.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.621 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.5 t -109.07 138.47 45.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.14 -1.6 . . . . 0.0 109.193 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.535 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 37.1 m-85 -101.52 -166.91 1.35 Allowed 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.877 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -90.5 -49.73 6.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 3.0 mt-10 -119.09 174.44 6.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.02 -18.86 60.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 0.0 109.886 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.695 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 30.9 mt-10 -49.35 -53.15 42.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.6 Cg_exo -47.16 -43.39 25.61 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.727 0.951 . . . . 0.0 111.73 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 184' ' ' ILE . 76.9 t -72.21 -32.05 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.631 -1.293 . . . . 0.0 109.671 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -49.74 -45.59 49.56 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.645 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -64.54 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.161 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 240' ' ' MET . 0.8 OUTLIER -47.56 -64.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.976 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.623 ' N ' HG22 ' A' ' 239' ' ' ILE . 8.0 ttp -41.33 -40.17 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 110.695 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 2.1 tp10 -56.11 -16.18 4.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.582 ' O ' ' ND1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.3 50.96 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 34.4 ttpt -25.52 -37.84 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.66 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.8 t80 -103.23 91.04 3.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.363 -1.46 . . . . 0.0 108.658 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.76 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.0 m-70 -89.37 -166.42 1.59 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.043 -1.036 . . . . 0.0 110.884 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' A' ' 201' ' ' TYR . 4.1 m120 -137.71 115.36 11.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.796 HG22 ' CD2' ' A' ' 201' ' ' TYR . 38.2 t -130.23 124.73 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 0.0 110.543 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 249' ' ' LEU . . . 52.97 51.41 46.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 248' ' ' GLY . 0.5 OUTLIER 60.25 25.7 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 110.067 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 17.6 m -138.57 122.08 17.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.66 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.01 56.03 0.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.945 . . . . 0.0 111.181 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 60.2 m -45.43 169.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.957 . . . . 0.0 109.109 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -88.04 167.89 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.275 -1.37 . . . . 0.0 107.86 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.916 HD12 ' C ' ' A' ' 253' ' ' GLU . 3.5 mp -151.32 102.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.293 -1.363 . . . . 0.0 112.449 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -98.72 117.22 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -40.74 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 112.095 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.683 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.708 -0.62 . . . . 0.0 110.076 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 236' ' ' VAL . 4.1 pt -129.91 173.21 14.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.118 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -132.66 136.11 46.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.018 -1.051 . . . . 0.0 110.609 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 254' ' ' ILE . 98.3 t -109.12 136.81 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.698 -0.626 . . . . 0.0 110.621 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.975 HG21 ' CD ' ' A' ' 214' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.828 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.3 124.08 9.67 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.553 1.502 . . . . 0.0 111.904 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.55 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -95.63 -65.25 0.99 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -49.82 -50.91 43.39 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.534 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -62.61 -26.0 68.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.7 OUTLIER -68.81 -61.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -54.72 -31.44 58.24 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.645 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 197' ' ' LYS . 8.1 tp10 -61.28 -42.78 99.23 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.75 -69.89 0.72 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 117.653 -1.619 . . . . 0.0 109.369 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 184' ' ' ILE . 58.8 m-85 -54.93 -50.95 67.57 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.542 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.64 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.43 26.67 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.28 47.61 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CD1' HD11 ' A' ' 239' ' ' ILE . 76.7 m-85 -55.94 -31.1 62.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -1.2 . . . . 0.0 108.86 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.14 138.82 3.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 5.6 pt-20 -41.73 141.62 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.64 HG23 ' HA2' ' A' ' 203' ' ' GLY . 5.4 t -100.55 150.14 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.799 . . . . 0.0 110.55 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -87.8 -54.53 4.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.677 ' O ' HG22 ' A' ' 229' ' ' THR . 21.1 m -153.51 173.42 15.73 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 14.8 pt -124.23 -171.27 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.125 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 15.3 tt0 -150.97 128.7 11.57 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.167 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.687 HD22 ' HB ' ' A' ' 193' ' ' THR . 8.4 mt -103.49 174.46 2.78 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 120.591 -1.318 . . . . 0.0 110.0 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.975 ' CD ' HG21 ' A' ' 193' ' ' THR . 3.2 Cg_exo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 123.654 1.344 . . . . 0.0 111.117 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.164 0 CA-C-O 121.526 0.679 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.641 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -127.82 119.88 26.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 109.295 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -95.74 -170.36 2.12 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.38 -1.45 . . . . 0.0 110.058 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -165.27 137.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 210' ' ' SER . 7.5 t -110.39 144.38 39.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.121 -1.612 . . . . 0.0 110.096 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.796 ' CD2' HG23 ' A' ' 236' ' ' VAL . 23.0 m-30 -103.71 -149.89 0.41 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.328 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -69.12 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 111.88 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.8 mm-40 -86.09 -68.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 111.116 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 1.4 pt-20 164.24 -27.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.221 1.01 . . . . 0.0 109.152 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.69 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 mt-10 -55.32 -45.05 99.92 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -53.24 -28.77 43.84 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.689 0.836 . . . . 0.0 110.586 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 184' ' ' ILE . 34.2 t -80.99 -35.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.826 -1.171 . . . . 0.0 108.433 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.7 ttpt -45.2 -46.79 12.44 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.394 1.092 . . . . 0.0 108.287 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -61.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 205' ' ' PHE . 10.1 mm -43.5 -66.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.314 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -45.36 -37.38 4.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 110.013 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -59.58 -13.77 10.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.769 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -130.7 48.55 2.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -26.59 -33.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.656 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -116.37 91.2 3.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.338 -1.476 . . . . 0.0 110.274 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.769 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 2.3 m80 -98.5 -145.82 0.32 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 16.2 p30 -142.59 139.62 31.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 50.1 t -150.4 125.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.93 62.68 5.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 83.4 mt 50.09 23.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -1.175 . . . . 0.0 110.523 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.8 t -132.67 151.5 51.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.139 -0.975 . . . . 0.0 109.704 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.656 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 2.3 ptpt -107.41 44.55 1.07 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.866 -1.146 . . . . 0.0 110.505 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.8 p -35.98 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.808 -0.558 . . . . 0.0 109.719 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.62 171.09 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.418 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -147.66 91.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.983 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.562 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 25.0 mttt -100.08 114.92 28.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -38.3 166.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.03 0.919 . . . . 0.0 112.346 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.666 -0.646 . . . . 0.0 109.845 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.685 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.676 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.5 pp -131.39 171.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.674 ' CD2' ' HB3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -131.5 134.61 46.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.996 -1.065 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 252' ' ' CYS . 21.9 t -111.09 154.19 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.431 0.634 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.535 ' N ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.45 32.85 7.02 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 1.075 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -76.28 -35.68 42.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 26.74 40.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.672 0.749 . . . . 0.0 111.593 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 188' ' ' GLY . 0.5 OUTLIER -70.89 168.58 19.48 Favored Pre-proline 0 C--N 1.295 -1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.689 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -55.83 -28.97 70.17 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.61 1.321 . . . . 0.0 110.342 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 192' ' ' ASP . 25.2 p-10 -150.57 107.0 3.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.942 . . . . 0.0 110.294 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.769 ' CB ' HD22 ' A' ' 213' ' ' LEU . 7.8 m -54.78 110.97 2.48 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -61.85 58.22 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.52 1.274 . . . . 0.0 111.664 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -37.28 -66.79 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 111.662 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.4 OUTLIER -47.12 -41.46 17.49 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.014 -177.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -75.92 -27.93 57.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.94 -53.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.8 ttt-85 -53.96 -39.51 66.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 5.0 mm-40 -55.2 -41.13 71.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.726 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.469 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.8 t80 -91.67 -71.33 0.64 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.736 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.6 m-85 -53.38 -56.83 13.5 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.124 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.751 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -51.34 -24.1 9.9 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -66.45 -45.51 85.0 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 239' ' ' ILE . 76.6 m-85 -57.74 -29.71 65.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -1.212 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 177.89 141.64 4.27 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -42.71 141.64 1.02 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.261 . . . . 0.0 110.141 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.876 HG22 ' CE1' ' A' ' 230' ' ' PHE . 6.0 t -97.65 146.37 7.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.651 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -87.96 -56.89 3.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.63 163.35 40.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.617 ' CD1' HD21 ' A' ' 213' ' ' LEU . 1.8 pp -112.66 -171.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.47 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.614 ' O ' HD23 ' A' ' 213' ' ' LEU . 8.3 tp10 -151.48 138.62 19.21 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.031 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.769 HD22 ' CB ' ' A' ' 193' ' ' THR . 15.0 mt -112.39 -175.95 0.35 Allowed Pre-proline 0 C--N 1.295 -1.798 0 O-C-N 120.467 -1.396 . . . . 0.0 109.253 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -64.03 164.85 20.81 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.155 1.081 . . . . 0.0 110.836 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.02 178.96 2.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 218' ' ' LYS . 3.1 t70 -97.16 -155.18 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.389 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 4.3 m120 58.23 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.426 -0.797 . . . . 0.0 110.328 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.4 OUTLIER 66.67 51.19 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.81 51.62 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.2 -86.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.483 -0.761 . . . . 0.0 110.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 168.45 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 110.183 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -77.76 80.06 4.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 70.18 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.232 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 1.041 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -120.63 126.76 6.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.586 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -151.36 -162.41 1.53 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.304 -1.116 . . . . 0.0 108.478 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.509 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -146.07 120.08 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 120.803 -1.185 . . . . 0.0 108.662 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.2 m-85 -96.98 -169.56 1.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.39 -1.444 . . . . 0.0 110.379 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -165.96 134.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 210' ' ' SER . 7.9 t -109.88 143.9 39.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.187 -1.571 . . . . 0.0 109.62 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.876 ' CE1' HG22 ' A' ' 208' ' ' VAL . 22.4 m-85 -111.36 -139.14 0.38 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.121 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -67.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.065 -1.022 . . . . 0.0 112.957 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 1.2 tp10 -70.48 -85.17 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.026 -1.046 . . . . 0.0 113.586 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER 161.21 -27.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 122.192 0.996 . . . . 0.0 108.426 -178.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.607 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.7 OUTLIER -55.77 -53.21 65.4 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -53.16 -43.37 57.77 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.893 0.943 . . . . 0.0 110.561 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 184' ' ' ILE . 2.1 t -52.78 -46.29 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.1 tttt -47.61 -44.15 26.33 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.106 -1.038 . . . . 0.0 108.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -70.84 -64.22 0.95 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 110.035 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.657 HG21 HG21 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -44.36 -64.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.579 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -44.68 -35.6 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.136 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 7.9 tp10 -65.51 -6.71 11.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.121 -0.987 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.741 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -136.31 51.03 2.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 0.0 109.258 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.6 mtpt -29.21 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.616 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -116.44 82.81 1.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.406 -1.434 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.912 ' CE1' HG21 ' A' ' 254' ' ' ILE . 6.6 m80 -89.71 -151.82 0.24 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.0 -1.063 . . . . 0.0 110.096 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.469 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 16.2 t-20 -143.63 142.83 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.784 . . . . 0.0 109.677 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 249' ' ' LEU . 58.9 t -135.02 116.77 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.064 -1.023 . . . . 0.0 110.474 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 55.06 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.3 OUTLIER -133.51 30.64 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 3.7 m -150.19 153.18 35.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.95 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.616 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.8 OUTLIER -119.53 54.43 1.0 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.142 -0.974 . . . . 0.0 110.595 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 186' ' ' VAL . 61.3 m -42.01 167.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.36 -0.838 . . . . 0.0 109.738 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.942 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.2 OUTLIER -86.79 170.52 11.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.086 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.942 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -147.6 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.284 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.674 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.69 112.4 24.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -38.74 166.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.878 0.847 . . . . 0.0 112.42 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.561 -0.712 . . . . 0.0 110.286 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.051 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -130.32 167.46 25.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.449 -1.3 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -125.89 134.7 51.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 53.1 t -111.78 122.59 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.524 -0.735 . . . . 0.0 110.537 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.557 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -95.57 49.49 1.84 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 1.0 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -122.17 -14.58 4.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.0 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER 16.45 54.39 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -41.34 166.4 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -58.57 -19.43 44.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.547 1.288 . . . . 0.0 111.435 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.493 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 2.4 p30 -149.84 99.1 2.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.948 -1.095 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.699 HG21 ' HD2' ' A' ' 214' ' ' PRO . 46.6 p -39.28 96.08 0.11 Allowed Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.634 -0.666 . . . . 0.0 109.997 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.93 49.06 1.51 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.549 1.5 . . . . 0.0 112.533 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -37.2 -66.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.0 -1.063 . . . . 0.0 111.63 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.57 -41.98 22.72 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.849 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 10.1 mttt -74.13 -28.4 61.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.46 -54.93 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.1 mpp_? -53.1 -37.44 61.72 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.7 mm-40 -62.97 -36.26 82.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.65 -71.46 0.64 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.544 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.634 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.2 m-85 -57.03 -51.43 69.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.424 -0.911 . . . . 0.0 108.71 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.776 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.25 -20.72 29.99 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.42 57.63 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.914 ' CD1' HD11 ' A' ' 239' ' ' ILE . 75.3 m-85 -56.15 -36.32 68.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -1.193 . . . . 0.0 108.911 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.58 139.21 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -41.43 141.57 0.71 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -1.15 . . . . 0.0 109.808 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.776 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.7 t -100.43 151.29 5.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.51 -0.743 . . . . 0.0 110.482 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 231' ' ' LYS . 20.5 tp10 -87.59 -54.46 4.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -153.47 173.66 15.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.818 HD13 ' CD2' ' A' ' 213' ' ' LEU . 2.4 pp -123.93 -172.02 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 120.556 -1.34 . . . . 0.0 109.554 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.599 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.9 tp10 -150.4 122.36 8.2 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 108.882 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.818 ' CD2' HD13 ' A' ' 211' ' ' ILE . 1.2 mm? -102.54 173.05 3.77 Favored Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 120.324 -1.485 . . . . 0.0 111.16 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.699 ' HD2' HG21 ' A' ' 193' ' ' THR . 3.1 Cg_exo -70.82 57.54 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.075 1.566 . . . . 0.0 110.871 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 52.66 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.991 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.483 ' HA ' ' NZ ' ' A' ' 218' ' ' LYS . 36.3 t0 -83.7 -12.29 56.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.471 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.592 ' HB3' HG22 ' A' ' 219' ' ' THR . 3.6 m-20 -84.87 -43.27 14.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 216' ' ' ASP . 1.0 OUTLIER 63.4 45.52 4.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 110.226 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 217' ' ' ASN . 15.2 t -150.6 39.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.738 0.78 . . . . 0.0 109.996 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 22.5 p-10 -150.92 -42.3 0.12 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.692 . . . . 0.0 109.76 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -149.4 -170.34 3.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.572 -0.705 . . . . 0.0 109.825 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 223' ' ' ARG . 40.6 ttt180 -91.78 99.52 12.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -51.65 -174.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.944 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.914 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 165.52 -87.78 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.046 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -88.82 177.67 6.65 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.441 -1.035 . . . . 0.0 111.71 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.682 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.4 p -128.64 118.31 22.69 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -94.37 -166.53 1.5 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.487 -1.383 . . . . 0.0 110.394 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 0.9 OUTLIER -168.0 138.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.9 t -115.04 142.74 46.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 119.933 -1.729 . . . . 0.0 110.471 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 39.6 m-85 -104.17 -157.6 0.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HD2' ' OE1' ' A' ' 209' ' ' GLU . 4.9 tttm -106.9 -59.97 1.73 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.191 -0.943 . . . . 0.0 111.65 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 11.1 mt-10 -91.61 -70.98 0.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.048 -1.032 . . . . 0.0 111.421 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 165.45 -28.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.163 0.982 . . . . 0.0 109.426 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.72 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 16.9 tt0 -54.88 -44.58 99.54 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.72 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.9 Cg_exo -51.74 -33.76 51.27 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 122.774 0.881 . . . . 0.0 110.972 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.051 HG22 HG23 ' A' ' 184' ' ' ILE . 61.3 t -78.59 -32.67 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.791 -1.193 . . . . 0.0 108.864 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -47.86 -50.78 25.31 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.017 178.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 1.0 OUTLIER -69.29 -58.53 3.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.045 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.914 HD11 ' CD1' ' A' ' 205' ' ' PHE . 23.0 mm -48.57 -64.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.756 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -44.69 -32.47 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.707 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 9.9 tp10 -71.94 2.66 5.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.553 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 3.8 tptt -132.57 51.24 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 108.941 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -25.0 -40.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -117.56 102.36 9.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.523 -1.361 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.75 ' HD1' HD13 ' A' ' 254' ' ' ILE . 33.7 m80 -89.64 -159.6 0.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -0.94 . . . . 0.0 110.92 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 250' ' ' SER . 1.6 t30 -141.33 125.25 17.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 246' ' ' ASN . 77.0 t -148.13 126.04 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.45 66.52 2.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.5 mt 46.35 38.69 5.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -1.148 . . . . 0.0 110.504 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 246' ' ' ASN . 1.4 t -146.28 -173.49 4.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.694 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -149.86 51.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.448 179.046 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.581 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.6 m -34.86 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.835 -0.541 . . . . 0.0 109.737 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.933 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -86.9 170.78 11.34 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.521 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.933 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.8 mp -149.76 101.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 118.401 -1.32 . . . . 0.0 112.798 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.8 OUTLIER -110.06 111.9 23.56 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -36.65 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.068 0.937 . . . . 0.0 112.805 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.657 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.252 0 O-C-N 121.582 -0.698 . . . . 0.0 110.171 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.688 ' HD3' ' CA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.836 ' CG2' HG22 ' A' ' 236' ' ' VAL . 2.2 pp -127.09 169.46 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.235 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.34 133.22 46.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 110.016 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 254' ' ' ILE . 39.6 t -109.2 125.8 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.391 -0.818 . . . . 0.0 110.484 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.559 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -98.83 45.99 1.54 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 1.043 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -131.17 2.67 5.5 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.043 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 0.02 68.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -41.0 165.94 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 110.24 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -55.75 -30.75 77.48 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.446 1.235 . . . . 0.0 111.199 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.512 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -140.0 104.44 4.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.086 -1.008 . . . . 0.0 110.356 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.529 HG21 ' HD2' ' A' ' 214' ' ' PRO . 29.1 p -38.88 95.38 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.13 46.87 1.2 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.604 1.536 . . . . 0.0 112.359 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.1 mt-10 -36.15 -66.46 0.21 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 0.0 110.977 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 5.4 tt0 -47.49 -41.83 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.874 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 17.8 mttt -75.32 -27.44 59.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.89 -53.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.35 -39.27 60.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 37.2 mm-40 -58.53 -39.77 81.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.487 -0.758 . . . . 0.0 110.032 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.3 t80 -91.3 -72.03 0.6 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.42 -1.712 . . . . 0.0 109.712 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.623 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.6 m-85 -54.42 -54.67 37.66 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.409 -0.916 . . . . 0.0 108.691 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.96 -22.98 29.61 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -66.73 -46.37 75.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.872 ' CD1' HD11 ' A' ' 239' ' ' ILE . 65.9 m-85 -53.55 -37.69 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -1.203 . . . . 0.0 108.451 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.22 143.69 6.36 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 3.0 pm0 -41.74 141.71 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -1.176 . . . . 0.0 110.009 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.851 HG23 ' HA2' ' A' ' 203' ' ' GLY . 14.7 t -102.1 154.67 5.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.483 -0.761 . . . . 0.0 110.52 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 231' ' ' LYS . 1.8 tt0 -87.84 -59.28 2.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.619 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.38 169.91 21.96 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 8.6 pt -119.16 -170.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.389 -1.324 . . . . 0.0 109.763 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.583 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.6 tp10 -150.6 124.08 9.02 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.669 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.1 mm? -101.64 174.18 3.08 Favored Pre-proline 0 C--N 1.293 -1.88 0 O-C-N 120.465 -1.397 . . . . 0.0 110.74 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -69.11 89.37 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.707 1.372 . . . . 0.0 110.863 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -161.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.487 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.519 ' HA ' ' NZ ' ' A' ' 218' ' ' LYS . 3.0 t70 -79.51 -138.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.415 ' C ' ' HG3' ' A' ' 218' ' ' LYS . 1.7 t-20 60.46 94.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.519 ' NZ ' ' HA ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -136.79 47.73 2.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.96 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -125.68 41.32 3.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.752 0.786 . . . . 0.0 109.964 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 8.8 p-10 -150.78 -41.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.621 -0.674 . . . . 0.0 110.094 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.402 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -147.83 -170.41 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.539 ' O ' ' CZ ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -55.5 162.26 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.012 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -130.89 140.29 50.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.324 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.546 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 118.68 50.93 0.31 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.539 ' CZ ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -151.71 177.41 10.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.243 . . . . 0.0 110.995 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.616 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.3 116.45 19.13 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.26 -170.06 2.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.408 -1.433 . . . . 0.0 110.394 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.61 134.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.688 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.4 t -110.42 139.99 45.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.206 -1.559 . . . . 0.0 109.594 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 69.9 m-85 -101.36 -165.65 1.22 Allowed 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 19.2 tttt -92.21 -65.22 1.02 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -101.56 166.68 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -20.22 65.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 35.2 tt0 -54.81 -53.61 58.85 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.8 Cg_exo -44.42 -38.72 11.96 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 120.477 0.785 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.836 HG22 ' CG2' ' A' ' 184' ' ' ILE . 55.5 t -74.87 -34.06 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.734 -1.228 . . . . 0.0 109.25 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -46.31 -46.33 18.03 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.333 1.064 . . . . 0.0 108.22 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -62.7 1.29 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.949 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.872 HD11 ' CD1' ' A' ' 205' ' ' PHE . 25.2 mm -46.64 -65.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.485 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 239' ' ' ILE . 12.0 tpt -43.63 -33.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 110.052 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -67.54 -2.84 7.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.116 -0.99 . . . . 0.0 110.828 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.729 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.12 50.7 2.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 109.099 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -25.42 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.7 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.6 t80 -114.52 93.71 4.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.463 -1.398 . . . . 0.0 109.454 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.729 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 10.6 m80 -91.19 -157.97 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 111.301 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 12.1 t-20 -141.07 139.8 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.797 -0.564 . . . . 0.0 109.621 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.41 113.32 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.003 -1.061 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 62.66 -87.08 0.05 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 2.2 mt -137.55 27.1 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.187 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.48 170.25 17.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.427 -0.796 . . . . 0.0 109.421 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.7 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -132.95 64.28 1.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.791 -1.193 . . . . 0.0 111.289 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.633 ' HB3' HG12 ' A' ' 186' ' ' VAL . 67.7 m -39.24 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.968 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -86.51 171.35 11.14 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.048 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -150.54 97.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.938 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.0 tttt -103.94 116.17 31.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.38 167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.168 0.985 . . . . 0.0 112.572 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.231 0 O-C-N 121.634 -0.667 . . . . 0.0 110.207 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.06 HG23 HG22 ' A' ' 236' ' ' VAL . 2.8 pt -131.58 172.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -133.23 132.71 41.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.955 -1.09 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 254' ' ' ILE . 26.2 t -105.95 127.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.424 -0.797 . . . . 0.0 110.395 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.538 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -102.5 48.88 1.02 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.954 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -125.66 -10.64 4.36 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.954 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 12.89 56.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -42.12 166.84 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.208 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -59.62 -13.65 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.653 1.343 . . . . 0.0 111.018 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 65.5 m-20 -142.92 92.09 2.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.617 HG21 ' HD2' ' A' ' 214' ' ' PRO . 9.5 p -38.92 95.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.727 -0.608 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.738 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -73.47 113.75 3.86 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.513 1.475 . . . . 0.0 111.646 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.525 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -97.73 -70.56 0.72 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.01 0.909 . . . . 0.0 109.556 177.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -50.79 -47.5 59.79 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -63.82 -26.95 68.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -68.06 -60.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.4 tmm_? -50.34 -31.87 15.7 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -63.26 -41.05 98.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.708 178.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' GLY . 0.9 OUTLIER -90.89 -70.4 0.68 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.813 179.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.665 ' CD1' HD11 ' A' ' 184' ' ' ILE . 70.8 m-85 -54.07 -55.61 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.726 -0.79 . . . . 0.0 108.947 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.783 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.08 -22.64 29.27 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -67.33 -46.74 68.19 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 82.6 m-85 -56.3 -31.04 63.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.031 -1.276 . . . . 0.0 108.494 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.68 142.73 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.4 pm0 -42.87 143.81 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.048 -1.266 . . . . 0.0 109.824 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.817 HG22 ' CE2' ' A' ' 230' ' ' PHE . 11.8 t -105.12 154.26 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.396 -0.815 . . . . 0.0 110.874 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -88.33 -57.74 2.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 229' ' ' THR . 0.4 OUTLIER -153.4 170.24 21.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 42.6 pt -118.57 -169.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 118.549 -1.26 . . . . 0.0 110.021 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.0 tt0 -151.12 121.8 7.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.638 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -98.64 173.7 3.68 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.405 -1.434 . . . . 0.0 110.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.7 Cg_exo -66.41 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.753 1.396 . . . . 0.0 110.746 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.402 ' O ' ' HE2' ' A' ' 218' ' ' LYS . 23.6 mtt -100.9 176.23 5.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.421 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 218' ' ' LYS . 25.3 t0 -89.29 160.42 16.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 21.6 m-20 64.18 -69.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER 65.84 50.98 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 0.0 109.769 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.0 t -144.59 50.06 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.225 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -150.2 -38.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 0.0 109.97 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 -173.41 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.444 -0.785 . . . . 0.0 110.145 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 223' ' ' ARG . 2.8 mtp85 -45.78 163.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.2 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -47.46 177.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.931 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -121.87 125.51 6.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -90.76 -179.53 5.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.454 -1.027 . . . . 0.0 110.389 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.659 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -131.57 118.19 19.77 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -96.21 -171.75 2.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.46 -1.4 . . . . 0.0 110.159 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.4 mt -163.91 137.52 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 210' ' ' SER . 7.0 t -113.17 146.3 39.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.079 -1.638 . . . . 0.0 110.253 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.817 ' CE2' HG22 ' A' ' 208' ' ' VAL . 44.0 m-85 -109.8 -164.86 0.96 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.583 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 232' ' ' GLU . 31.1 tttt -110.49 -65.78 1.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.477 0.656 . . . . 0.0 110.911 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 6.6 mt-10 -66.05 -67.68 0.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 110.842 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.9 OUTLIER 147.72 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-O 122.807 1.289 . . . . 0.0 107.666 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.689 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt-10 -54.74 -45.21 99.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -50.9 -21.5 8.61 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.496 0.735 . . . . 0.0 110.451 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.06 HG22 HG23 ' A' ' 184' ' ' ILE . 57.6 t -91.31 -35.33 6.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -48.21 -48.38 34.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -73.54 -61.58 1.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.962 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 184' ' ' ILE . 15.4 mm -43.56 -66.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.463 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.4 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -43.09 -44.49 4.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 110.386 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -59.17 -13.52 7.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.137 -0.977 . . . . 0.0 110.438 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.795 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -124.4 45.21 2.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' ILE . 4.6 ttmt -25.43 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -115.25 95.02 4.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.428 -1.42 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.795 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 1.6 m80 -102.36 -145.91 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.997 -1.065 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 3.6 m-20 -145.09 145.32 31.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.0 109.538 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.55 108.3 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 110.415 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 249' ' ' LEU . . . 65.62 -86.01 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 248' ' ' GLY . 0.8 OUTLIER -142.62 28.92 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.102 . . . . 0.0 110.008 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.52 132.7 23.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -90.2 46.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.608 -179.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.556 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 29.1 p -35.57 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.575 -0.703 . . . . 0.0 109.783 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.945 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -87.43 173.14 9.3 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.419 -1.312 . . . . 0.0 108.668 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.945 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.26 94.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.406 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 17.7 ttmt -100.08 113.0 25.3 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.3 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.071 0.939 . . . . 0.0 112.686 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.487 0.661 . . . . 0.0 110.04 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.819 HG23 HG22 ' A' ' 236' ' ' VAL . 1.6 pp -132.2 -178.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.731 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.86 148.4 50.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 110.041 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 253' ' ' GLU . 24.1 t -120.55 124.94 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.079 -1.013 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.535 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -97.69 32.69 6.52 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -156.01 16.77 0.45 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.744 ' C ' HD22 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -34.41 156.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.775 -0.838 . . . . 0.0 111.983 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.564 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.8 p -89.03 -175.25 0.53 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -66.07 -25.16 51.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.293 1.154 . . . . 0.0 110.486 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 1.8 t70 -148.75 83.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.324 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.593 ' HB ' ' CG ' ' A' ' 213' ' ' LEU . 4.4 m -38.64 95.02 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.691 -0.631 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' HD13 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.05 76.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 194' ' ' PRO . 1.8 mt-10 -36.45 -40.5 0.24 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.482 -0.761 . . . . 0.0 110.128 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.1 -53.31 39.64 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 117.937 -1.505 . . . . 0.0 108.519 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 12.3 ttmt -69.78 -28.63 65.91 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 211' ' ' ILE . 1.1 tp -64.18 -51.2 71.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.63 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -54.38 -33.25 58.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -61.61 -40.51 95.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 245' ' ' HIS . 3.3 t80 -91.02 -68.8 0.77 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.529 -1.669 . . . . 0.0 109.449 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 198' ' ' ILE . 77.9 m-85 -58.33 -52.34 66.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.72 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -57.25 -25.63 54.74 Favored Glycine 0 N--CA 1.481 1.678 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -59.5 -44.82 96.41 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.662 ' CD2' HD11 ' A' ' 239' ' ' ILE . 78.9 m-85 -61.34 -40.08 92.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.167 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.46 140.22 6.15 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.7 OUTLIER -42.63 143.12 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.251 . . . . 0.0 110.122 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 230' ' ' PHE . 14.2 t -110.24 152.54 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 110.728 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 1.1 tp10 -88.32 -58.51 2.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 229' ' ' THR . 1.7 m -153.14 163.58 39.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 198' ' ' ILE . 2.2 pp -111.59 -171.27 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.176 -1.409 . . . . 0.0 110.351 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.875 ' N ' HD12 ' A' ' 211' ' ' ILE . 22.7 tt0 -152.69 139.65 19.13 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.452 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.671 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 4.0 mt -99.28 -177.93 0.64 Allowed Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.5 Cg_exo -58.8 -78.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 122.627 0.804 . . . . 0.0 110.145 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 216' ' ' ASP . 0.1 OUTLIER 40.45 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.621 -0.675 . . . . 0.0 111.458 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 214' ' ' PRO . 11.6 t70 -40.96 166.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 110.75 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 1.3 m-20 67.82 83.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.294 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.35 45.72 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.3 52.29 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 110.198 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.47 -99.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -144.65 -169.43 3.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.97 -1.081 . . . . 0.0 110.276 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 221' ' ' LYS . 30.3 ttt-85 -40.94 118.3 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.727 . . . . 0.0 110.195 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.83 177.02 4.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.981 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 163.02 68.47 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.7 p90 -147.07 165.52 29.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.226 -1.161 . . . . 0.0 110.433 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 10.3 p -138.19 129.62 27.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -95.62 -175.56 3.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.569 -1.332 . . . . 0.0 109.203 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 198' ' ' ILE . 1.7 mt -161.58 133.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 210' ' ' SER . 7.7 t -110.49 143.66 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.166 -1.584 . . . . 0.0 110.299 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.769 ' CE2' HG22 ' A' ' 208' ' ' VAL . 63.5 m-85 -104.68 -126.41 0.23 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.61 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.92 -56.09 0.55 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.654 -1.279 . . . . 0.0 111.182 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 2.1 tt0 -92.8 -69.75 0.73 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.018 -1.051 . . . . 0.0 110.145 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 2.0 pt-20 165.88 -31.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.238 1.018 . . . . 0.0 108.914 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.682 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -48.58 -48.91 67.41 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -51.03 -36.18 53.27 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 122.667 0.825 . . . . 0.0 110.522 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 184' ' ' ILE . 3.6 t -67.62 -41.96 86.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 108.333 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.58 -46.08 9.8 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.278 1.037 . . . . 0.0 108.741 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB3' ' CD1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -71.82 -63.33 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.916 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 205' ' ' PHE . 31.4 mm -44.23 -64.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.393 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -46.18 -34.15 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.958 . . . . 0.0 109.476 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 15.0 tt0 -80.05 10.17 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 110.522 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 244' ' ' TYR . 9.5 mmtt -131.28 49.03 2.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 108.987 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 242' ' ' LYS . 1.4 tmmm? -26.55 -39.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.686 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -123.56 104.59 9.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.624 -1.298 . . . . 0.0 109.616 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.61 ' CE1' HG21 ' A' ' 254' ' ' ILE . 53.6 m80 -89.6 -174.6 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.951 . . . . 0.0 110.663 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 250' ' ' SER . 3.8 m120 -133.92 119.19 18.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.523 -0.736 . . . . 0.0 109.494 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 250' ' ' SER . 54.5 t -145.59 131.56 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.997 -1.064 . . . . 0.0 110.57 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.04 65.3 2.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 249' ' ' LEU . 6.8 mp 48.24 28.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -1.159 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 69.8 m -136.3 171.57 14.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.048 -1.032 . . . . 0.0 109.762 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.686 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -150.47 53.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 111.313 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.56 ' HB2' HG12 ' A' ' 186' ' ' VAL . 24.0 p -39.05 161.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 109.405 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.869 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.52 168.57 13.59 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.043 -1.463 . . . . 0.0 108.01 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.869 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.26 109.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 117.942 -1.503 . . . . 0.0 113.548 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tttp -99.18 -154.67 0.47 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 7.0 p -122.64 168.41 15.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.309 -1.495 . . . . 0.0 110.448 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.878 . . . . 0.0 110.654 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.675 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.067 HG23 HG22 ' A' ' 236' ' ' VAL . 3.8 pt -130.22 176.99 7.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 118.317 -1.353 . . . . 0.0 110.48 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.72 117.82 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.775 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 22.3 t -89.62 119.08 36.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.541 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -95.55 41.02 2.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' C ' HD13 ' A' ' 189' ' ' LEU . . . -147.62 13.09 1.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -24.83 145.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.145 0.974 . . . . 0.0 112.826 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.575 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.4 p -92.21 -174.47 0.42 Allowed Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -62.31 -25.01 76.28 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 122.924 0.96 . . . . 0.0 109.833 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 193' ' ' THR . 2.7 m-20 -150.91 85.76 1.36 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.009 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.761 ' CB ' HD12 ' A' ' 213' ' ' LEU . 94.8 m -40.41 99.92 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.306 -0.871 . . . . 0.0 110.361 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.6 Cg_endo -68.06 71.98 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.756 1.398 . . . . 0.0 112.158 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.72 -64.55 0.34 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.479 -0.763 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 1.8 tt0 -46.28 -43.67 15.88 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.083 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 2.5 tttt -74.64 -29.06 61.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.3 tp -62.24 -53.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.615 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.5 mtt180 -52.43 -37.48 56.89 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 2.4 mm-40 -59.59 -38.39 81.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.909 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.55 -70.86 0.67 Allowed 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.591 ' CD2' HG13 ' A' ' 198' ' ' ILE . 91.2 m-85 -56.6 -53.24 59.9 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.893 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.44 -21.5 27.53 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.46 70.73 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.927 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.8 m-85 -56.72 -40.84 76.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -1.209 . . . . 0.0 108.896 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.32 138.03 4.95 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 206' ' ' GLY . 1.1 pm0 -41.83 142.36 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -1.185 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.805 HG23 ' HA2' ' A' ' 203' ' ' GLY . 18.5 t -102.98 152.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.419 -0.8 . . . . 0.0 110.951 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.1 tt0 -88.12 -55.89 3.56 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.7 ' O ' HG22 ' A' ' 229' ' ' THR . 3.4 m -153.59 169.0 24.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 2.4 pt -118.63 -171.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.528 -1.357 . . . . 0.0 110.137 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 11.5 tp10 -151.51 130.82 12.83 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.106 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.849 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.4 mm? -101.87 176.99 1.61 Allowed Pre-proline 0 C--N 1.295 -1.762 0 O-C-N 120.528 -1.357 . . . . 0.0 109.829 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.849 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo -59.92 105.87 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.327 1.172 . . . . 0.0 110.457 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.459 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -121.45 -158.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.468 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 215' ' ' MET . 19.9 t0 66.18 26.26 10.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 217' ' ' ASN . 3.4 p-10 -96.72 44.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.995 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.596 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -146.86 48.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.834 . . . . 0.0 109.729 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.423 HG23 ' C ' ' A' ' 218' ' ' LYS . 45.1 p -148.65 -81.64 0.12 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.611 1.196 . . . . 0.0 110.21 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' OG1' ' A' ' 219' ' ' THR . 1.5 p-10 -144.3 -33.33 0.4 Allowed 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.391 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.49 -172.71 3.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 110.301 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.38 -169.64 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -112.57 130.64 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.17 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -156.17 24.89 0.54 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.555 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.4 p90 -150.51 -166.87 2.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -1.187 . . . . 0.0 110.648 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.553 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -165.07 117.37 1.19 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.82 . . . . 0.0 108.83 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.82 -174.8 3.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.476 -1.39 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.2 mt -164.03 133.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 210' ' ' SER . 6.0 t -106.18 141.97 36.65 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.221 -1.549 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.76 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.8 m-85 -100.65 -142.68 0.34 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.198 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -123.23 -58.56 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.837 -1.165 . . . . 0.0 111.674 -178.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 8.8 mt-10 -92.24 -70.08 0.71 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 110.725 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 163.76 -27.61 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.461 1.124 . . . . 0.0 108.895 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.705 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 tt0 -57.93 -42.6 96.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.705 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -52.74 -31.44 50.93 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.496 0.735 . . . . 0.0 110.304 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 184' ' ' ILE . 37.2 t -76.74 -36.82 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.741 -1.224 . . . . 0.0 108.121 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -44.5 -46.75 9.93 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.468 1.128 . . . . 0.0 108.25 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.84 -61.26 1.85 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.892 0.853 . . . . 0.0 109.869 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.927 HD11 ' CD1' ' A' ' 205' ' ' PHE . 15.4 mm -45.63 -65.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.482 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -48.21 -31.15 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.55 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 70.8 tt0 -66.41 -5.26 10.29 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.932 -1.105 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.739 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.26 52.88 1.45 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 0.0 109.355 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 33.6 ttpt -26.32 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -107.59 90.74 3.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.334 -1.479 . . . . 0.0 110.456 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.739 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 10.9 m80 -95.11 -164.09 1.12 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.254 -0.904 . . . . 0.0 110.703 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 13.2 m120 -137.1 143.99 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.639 -0.663 . . . . 0.0 109.629 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.45 99.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.07 . . . . 0.0 110.323 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 67.28 -83.61 0.13 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.17 24.41 2.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -1.145 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 4.1 m -143.95 134.52 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.79 56.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.063 . . . . 0.0 110.895 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 33.9 m -41.34 162.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.287 -0.883 . . . . 0.0 109.065 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.956 ' C ' HD12 ' A' ' 254' ' ' ILE . 2.2 pt-20 -88.1 175.7 7.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.575 -1.328 . . . . 0.0 108.293 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.956 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -149.2 108.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.426 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 1.2 tttt -114.6 110.56 19.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -37.55 167.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.114 0.959 . . . . 0.0 112.918 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.315 0 O-C-N 121.764 -0.585 . . . . 0.0 109.762 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.718 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 239' ' ' ILE . 1.1 pt -128.78 178.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 117.593 -1.643 . . . . 0.0 110.734 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.624 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -147.35 119.24 8.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.951 -1.093 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 254' ' ' ILE . 95.0 t -89.2 121.7 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.573 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -77.0 -59.31 3.19 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.949 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 189' ' ' LEU . . . -72.52 -59.35 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 226' ' ' CYS . 0.4 OUTLIER 69.43 151.66 0.09 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.71 -0.877 . . . . 0.0 110.811 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.56 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 2.7 p -72.29 -174.35 0.3 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 109.231 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.0 Cg_exo -66.67 -15.92 48.93 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.352 1.185 . . . . 0.0 111.208 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 3.9 p30 -150.04 123.44 9.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.973 -1.079 . . . . 0.0 110.771 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.657 HG21 ' HD2' ' A' ' 214' ' ' PRO . 44.9 p -39.59 96.62 0.12 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.653 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.89 47.18 1.19 Allowed 'Trans proline' 0 C--O 1.204 -1.224 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -37.33 -71.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.959 -1.088 . . . . 0.0 112.315 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -47.25 -40.49 16.67 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.299 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 13.2 mmtt -75.84 -26.58 57.29 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.781 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -67.37 -55.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 42.7 ttt-85 -56.94 -34.68 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.9 mm-40 -57.97 -46.78 84.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 110.182 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.45 -71.05 0.64 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 117.377 -1.729 . . . . 0.0 109.657 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.651 ' CD2' HG13 ' A' ' 198' ' ' ILE . 11.4 m-30 -51.29 -51.33 55.19 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.177 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.62 -21.18 27.49 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.24 -45.73 29.83 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 239' ' ' ILE . 73.6 m-85 -54.35 -28.1 40.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -1.187 . . . . 0.0 108.361 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.91 129.45 1.3 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.0 OUTLIER -39.84 141.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -1.098 . . . . 0.0 110.199 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 211' ' ' ILE . 2.6 t -91.17 140.46 15.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.587 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -87.53 -47.02 9.06 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 176.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.767 ' O ' HG22 ' A' ' 229' ' ' THR . 35.2 m -153.19 161.31 42.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 195' ' ' GLU . 4.4 pt -118.58 -166.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.037 -1.465 . . . . 0.0 110.638 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.96 130.52 12.24 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.972 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.68 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 3.0 mm? -111.78 172.7 3.34 Favored Pre-proline 0 C--N 1.292 -1.92 0 O-C-N 120.614 -1.304 . . . . 0.0 108.595 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.68 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -61.2 101.86 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.366 1.193 . . . . 0.0 110.938 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 8.5 ttt -132.81 -80.77 0.49 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.324 -0.86 . . . . 0.0 110.533 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 217' ' ' ASN . 2.4 t70 -98.8 -160.87 0.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.673 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.489 ' C ' ' HD3' ' A' ' 218' ' ' LYS . 1.6 t-20 70.96 83.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 217' ' ' ASN . 1.3 mmtt -118.63 40.77 3.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.88 47.75 1.92 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.486 0.66 . . . . 0.0 110.153 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.42 ' ND2' ' OD1' ' A' ' 217' ' ' ASN . 1.5 p30 -150.24 -73.78 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 110.258 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.42 -176.65 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.15 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -175.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -94.28 116.13 28.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.184 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 189' ' ' LEU . . . 148.82 46.18 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.109 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 3.6 p90 -127.06 162.01 27.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.059 -1.26 . . . . 0.0 110.256 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.982 ' HB3' HD11 ' A' ' 189' ' ' LEU . 14.8 p -139.26 131.07 27.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.318 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.713 ' HB2' ' HB3' ' A' ' 212' ' ' GLU . 2.3 m-85 -97.25 -173.33 2.64 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.114 -1.616 . . . . 0.0 108.875 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.781 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -163.34 132.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 210' ' ' SER . 13.3 t -111.2 150.49 29.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.423 -1.423 . . . . 0.0 110.253 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.52 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 66.9 m-85 -118.93 -116.04 0.32 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.048 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -47.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.815 -1.178 . . . . 0.0 111.654 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -83.75 -101.18 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.916 -1.115 . . . . 0.0 111.366 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 176.05 -27.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 109.844 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.8 mt-10 -59.49 -49.56 91.69 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 112.6 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -53.25 -22.68 20.81 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 122.923 0.959 . . . . 0.0 111.563 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.435 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.1 t -79.37 -48.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.83 -41.29 10.92 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.191 0.996 . . . . 0.0 108.653 178.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 1.1 tttm -71.22 -64.62 0.88 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.856 0.836 . . . . 0.0 110.332 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -50.96 -62.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.825 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.658 ' N ' HG22 ' A' ' 239' ' ' ILE . 3.5 tmm? -44.3 -32.79 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 110.333 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -65.3 -5.89 8.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.019 -1.051 . . . . 0.0 110.599 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.587 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -137.69 51.7 1.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.134 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 254' ' ' ILE . 3.0 ttmt -25.02 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -106.75 91.94 3.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.478 -1.388 . . . . 0.0 109.567 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.831 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.4 m-70 -89.64 -159.61 0.6 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.07 -1.018 . . . . 0.0 110.83 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.459 ' C ' HG23 ' A' ' 247' ' ' VAL . 9.4 t-20 -136.59 128.57 29.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 250' ' ' SER . 44.4 t -146.36 136.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.925 -1.109 . . . . 0.0 110.634 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 42.55 70.93 0.43 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.3 OUTLIER 42.51 35.75 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -144.87 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -137.19 46.87 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.005 . . . . 0.0 110.583 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.62 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 63.6 m -40.07 157.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.887 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.9 pt-20 -87.92 165.51 15.19 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 117.618 -1.633 . . . . 0.0 107.568 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.37 110.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.168 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 8.5 tttt -100.98 113.82 27.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -40.6 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 111.912 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.658 -0.651 . . . . 0.0 109.848 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.89 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -138.22 169.53 18.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.035 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.634 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -115.39 155.33 27.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.931 -1.105 . . . . 0.0 109.573 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 61.7 t -134.82 136.35 52.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.198 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.434 ' HA3' ' HG2' ' A' ' 253' ' ' GLU . . . -97.83 39.04 2.88 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 1.099 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -84.89 -38.07 9.68 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.099 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER 24.25 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 188' ' ' GLY . 0.8 OUTLIER -67.87 169.02 10.57 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 110.267 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -60.79 -23.09 75.71 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.612 1.322 . . . . 0.0 110.676 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 193' ' ' THR . 12.5 t0 -141.22 95.77 2.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.791 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 213' ' ' LEU . 62.9 p -41.58 103.92 0.32 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.848 . . . . 0.0 109.633 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -66.92 43.23 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.467 1.444 . . . . 0.0 113.255 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -37.94 -66.68 0.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.886 -1.134 . . . . 0.0 111.523 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.6 mm-40 -47.59 -43.44 25.58 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.182 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 5.7 mttt -73.97 -25.45 59.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 0.6 OUTLIER -65.76 -56.61 14.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -51.17 -37.33 45.84 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.4 mm-40 -60.53 -40.05 90.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.675 . . . . 0.0 109.905 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.21 -72.27 0.59 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.497 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 198' ' ' ILE . 79.4 m-85 -53.53 -53.37 52.61 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.472 -0.891 . . . . 0.0 108.982 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.726 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.68 -21.97 30.97 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -70.01 -45.7 55.49 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 239' ' ' ILE . 82.0 m-85 -57.06 -34.75 68.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -1.222 . . . . 0.0 108.886 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.83 139.41 4.63 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.5 OUTLIER -41.31 142.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -1.104 . . . . 0.0 109.983 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.726 HG23 ' HA2' ' A' ' 203' ' ' GLY . 7.6 t -101.76 148.52 7.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 44.1 tt0 -87.95 -53.27 4.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 229' ' ' THR . 3.7 m -153.54 168.67 25.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 12.0 pt -121.54 -170.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.538 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.7 tt0 -150.8 130.51 13.15 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.78 HD13 ' OG1' ' A' ' 193' ' ' THR . 13.4 mt -106.78 178.75 1.02 Allowed Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 120.786 -1.196 . . . . 0.0 109.591 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.766 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.0 Cg_exo -64.75 -174.57 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.212 1.112 . . . . 0.0 111.1 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.42 163.79 12.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 110.534 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.606 ' O ' ' ND2' ' A' ' 217' ' ' ASN . 3.6 t0 -72.07 -163.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.616 ' O ' ' ND2' ' A' ' 217' ' ' ASN . 0.7 OUTLIER 36.61 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.737 -0.602 . . . . 0.0 110.629 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -164.48 55.9 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 110.268 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 38.8 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 5.5 p30 -151.26 -45.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.696 0.76 . . . . 0.0 109.763 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -105.74 -161.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.744 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 221' ' ' LYS . 0.8 OUTLIER -48.76 -179.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.54 -0.725 . . . . 0.0 110.284 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.746 ' HD2' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -117.62 48.77 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 110.771 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 1.059 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 35.69 -143.21 0.11 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -150.97 -165.61 2.31 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.663 -0.904 . . . . 0.0 108.941 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.2 p -142.26 116.6 9.57 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 120.96 -1.087 . . . . 0.0 108.632 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.5 m-85 -92.79 -165.78 1.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.647 -1.283 . . . . 0.0 109.642 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -168.25 139.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 210' ' ' SER . 8.1 t -113.25 145.62 40.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.065 -1.647 . . . . 0.0 110.118 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.9 m-30 -109.56 -125.02 0.26 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.738 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 209' ' ' GLU . 7.5 tttt -174.7 -50.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.104 -0.997 . . . . 0.0 109.866 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.9 mt-10 -71.48 -26.44 62.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -0.801 . . . . 0.0 109.117 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 88.52 -27.12 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 122.843 1.306 . . . . 0.0 108.377 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 8.4 mt-10 -65.06 -39.32 35.86 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.767 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.1 Cg_exo -54.83 -24.83 40.23 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 N-CA-C 109.618 -0.955 . . . . 0.0 109.618 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.89 HG22 ' CG2' ' A' ' 184' ' ' ILE . 16.2 t -81.12 -41.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 236' ' ' VAL . 1.8 tptt -42.85 -45.77 5.03 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.423 1.106 . . . . 0.0 108.348 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.9 OUTLIER -72.31 -62.2 1.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.856 0.836 . . . . 0.0 109.722 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.495 HG23 HG21 ' A' ' 254' ' ' ILE . 8.2 mm -43.94 -65.44 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.329 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.2 OUTLIER -43.63 -37.85 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 5.2 tt0 -63.3 -8.95 9.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.129 -0.982 . . . . 0.0 110.644 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.726 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.22 51.52 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 10.1 ttmt -26.96 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.629 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.27 100.78 8.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.442 . . . . 0.0 110.015 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.726 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 3.4 m80 -102.35 -158.32 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.156 -0.965 . . . . 0.0 110.773 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -139.19 149.14 44.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.519 -0.738 . . . . 0.0 109.958 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 249' ' ' LEU . 37.9 t -143.67 123.15 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.41 -93.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -131.71 32.78 4.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 110.088 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.9 m -149.98 155.74 40.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.629 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.96 56.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 111.072 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 30.3 p -37.19 156.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.724 . . . . 0.0 109.835 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.0 pm0 -88.34 172.42 9.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.624 -1.231 . . . . 0.0 108.973 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -146.25 129.42 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.509 -1.276 . . . . 0.0 112.155 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HG2' ' CE1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -137.42 104.92 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.9 p -34.48 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.094 0.949 . . . . 0.0 113.171 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.676 -0.64 . . . . 0.0 109.651 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.692 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.865 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -133.35 179.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.92 130.46 35.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.987 -1.071 . . . . 0.0 110.236 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 59.3 t -102.62 122.23 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 110.304 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -96.11 41.46 2.42 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 190' ' ' SER . . . -119.46 -16.3 5.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.953 HD13 ' N ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER 1.46 56.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.2 p -44.8 170.97 0.05 OUTLIER Pre-proline 0 C--N 1.277 -2.571 0 O-C-N 121.869 -0.519 . . . . 0.0 109.845 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -60.73 -10.74 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.537 1.283 . . . . 0.0 110.877 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 5.1 t70 -138.5 91.96 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.509 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.594 ' HB ' HD22 ' A' ' 213' ' ' LEU . 43.8 p -39.09 97.05 0.12 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.65 -0.657 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -71.73 103.65 1.49 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.411 1.407 . . . . 0.0 111.399 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.609 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -94.44 -66.72 0.9 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.882 0.849 . . . . 0.0 110.201 178.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 5.4 tm-20 -50.14 -46.03 53.63 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.657 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -67.49 -26.12 66.2 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -66.35 -58.94 4.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.719 ' N ' HG22 ' A' ' 198' ' ' ILE . 50.2 ttt180 -53.05 -34.64 57.39 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 15.2 mm-40 -59.88 -41.94 92.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.34 -69.96 0.71 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.43 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -54.47 -53.99 46.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.767 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.52 -21.59 28.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.92 -46.1 54.08 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 239' ' ' ILE . 80.8 m-85 -55.98 -38.01 69.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.951 -1.323 . . . . 0.0 108.847 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -173.31 142.04 6.43 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' OE2' ' CD ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -42.39 142.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -1.198 . . . . 0.0 110.095 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.767 HG23 ' HA2' ' A' ' 203' ' ' GLY . 13.3 t -103.06 151.9 6.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 110.689 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 29.2 tp10 -87.8 -61.05 1.8 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 4.0 m -153.72 161.1 42.41 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 16.6 pt -106.46 -168.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.236 -1.386 . . . . 0.0 109.714 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.2 tt0 -150.91 131.41 13.82 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.745 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.702 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 11.2 mt -102.7 177.53 1.44 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo -67.66 166.76 23.02 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.309 1.163 . . . . 0.0 111.039 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 215' ' ' MET . 7.1 ttp -92.03 25.39 2.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.913 . . . . 0.0 110.361 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 217' ' ' ASN . 9.0 t0 44.2 -145.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 109.9 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 216' ' ' ASP . 6.2 t-20 41.47 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 0.0 110.113 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 44.34 2.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.303 -0.873 . . . . 0.0 109.931 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.7 p -121.16 40.16 3.64 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.81 0.814 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -150.23 -41.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.383 0.611 . . . . 0.0 110.121 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.83 -175.06 4.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 110.146 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -90.0 100.19 13.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.74 131.74 4.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 189' ' ' LEU . . . 176.36 36.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.594 ' HA ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -88.68 174.86 7.79 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.471 -1.017 . . . . 0.0 110.815 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -127.61 119.74 26.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.651 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -91.78 -169.34 2.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 110.147 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 198' ' ' ILE . 1.5 mt -164.34 133.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 5.8 t -109.7 141.56 42.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 119.834 -1.791 . . . . 0.0 109.879 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.73 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.2 m-30 -98.28 -140.3 0.3 Allowed 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' CD ' ' OE2' ' A' ' 207' ' ' GLU . 74.4 tttt -126.83 -54.85 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.936 -1.103 . . . . 0.0 111.41 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.6 mt-10 -97.4 -68.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.013 -1.054 . . . . 0.0 110.481 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 162.35 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.173 0.987 . . . . 0.0 108.997 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.699 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -56.43 -43.5 99.33 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.65 -32.24 53.72 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 122.663 0.822 . . . . 0.0 110.649 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 184' ' ' ILE . 40.6 t -77.67 -34.5 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.262 . . . . 0.0 108.226 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -44.88 -48.15 11.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.281 1.038 . . . . 0.0 108.454 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -61.27 1.83 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.868 0.842 . . . . 0.0 109.731 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.7 mm -44.93 -66.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.464 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -41.23 -42.24 2.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.483 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -58.03 -14.0 5.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.095 -1.003 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.742 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -132.26 48.25 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.8 ttmt -26.95 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.614 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.4 t80 -112.13 96.58 6.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.533 -1.354 . . . . 0.0 110.081 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.742 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 1.5 m80 -103.34 -150.81 0.42 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.07 -1.019 . . . . 0.0 110.569 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -130.0 141.48 50.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.555 -0.716 . . . . 0.0 109.648 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 250' ' ' SER . 40.7 t -150.28 118.69 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 0.0 110.816 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 39.76 76.71 0.08 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 4.6 mt 44.95 24.0 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -1.206 . . . . 0.0 110.85 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 247' ' ' VAL . 17.4 m -143.6 122.17 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.101 -0.999 . . . . 0.0 109.216 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.614 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.4 pttt -89.61 52.47 2.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.089 -1.007 . . . . 0.0 110.958 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 22.0 p -38.81 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.2 pt-20 -87.59 168.78 12.73 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.847 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -142.74 95.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.025 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.33 110.14 22.77 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.1 p -39.85 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.879 -1.138 . . . . 0.0 112.045 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.602 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.554 -0.716 . . . . 0.0 110.441 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.745 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.687 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.4 pt -125.93 162.3 29.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.891 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.66 135.82 50.75 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.027 -1.045 . . . . 0.0 110.723 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 252' ' ' CYS . 17.6 t -109.44 137.81 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.575 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -106.96 46.18 1.2 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.962 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -112.82 -17.11 8.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.962 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.1 OUTLIER 22.4 43.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 121.476 0.655 . . . . 0.0 112.268 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.8 p -47.42 175.64 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -58.16 -36.05 98.19 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.198 1.104 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 30.1 t0 -150.8 99.64 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.421 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.82 HG21 ' CD1' ' A' ' 213' ' ' LEU . 98.1 m -42.69 101.9 0.26 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.602 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.62 64.41 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.335 1.357 . . . . 0.0 112.105 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.58 -69.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.444 -0.785 . . . . 0.0 112.002 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 25.4 tt0 -45.92 -41.25 11.28 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.281 -176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -75.71 -30.05 59.17 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -62.94 -51.8 67.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.613 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -56.28 -38.49 71.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -55.98 -40.08 72.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.88 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -70.59 0.68 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.563 -1.655 . . . . 0.0 110.006 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 184' ' ' ILE . 39.3 m-85 -57.19 -53.03 62.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.53 -0.731 . . . . 0.0 109.649 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.853 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.67 -23.02 12.9 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.56 55.89 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 239' ' ' ILE . 86.1 m-85 -57.02 -27.89 62.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.952 -1.323 . . . . 0.0 108.711 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 235' ' ' PRO . . . -179.13 133.7 2.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 15.1 pt-20 -40.98 142.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.911 HG22 ' CD1' ' A' ' 230' ' ' PHE . 10.7 t -97.32 145.53 9.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.449 -0.782 . . . . 0.0 110.847 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -87.81 -53.31 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.709 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.74 167.72 28.66 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 176.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 38.5 pt -112.38 -168.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 118.357 -1.337 . . . . 0.0 109.835 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -151.48 125.62 9.28 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 213' ' ' LEU . 2.5 mm? -108.32 174.53 2.41 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.343 -1.473 . . . . 0.0 110.348 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 2.9 Cg_endo -72.28 66.87 3.52 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.675 1.355 . . . . 0.0 111.212 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -138.06 28.44 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 59.5 t0 -152.98 36.3 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.847 . . . . 0.0 110.099 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 6.5 t-20 -83.3 -56.32 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.681 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 70.25 53.34 0.34 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.8 p -111.82 -83.59 0.58 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.492 1.139 . . . . 0.0 110.281 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.54 -105.85 0.1 Allowed 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 222' ' ' ARG . 1.5 mmtt -114.5 -175.6 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.841 -1.162 . . . . 0.0 110.239 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER 60.23 130.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.159 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.403 ' NH2' ' HA ' ' A' ' 191' ' ' PRO . 0.0 OUTLIER -48.33 171.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.867 . . . . 0.0 110.349 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.953 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -110.36 -131.13 5.96 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -109.04 -179.14 3.77 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.279 -1.13 . . . . 0.0 110.206 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -126.18 119.25 27.02 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.9 m-85 -96.22 -165.36 1.27 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.497 -1.377 . . . . 0.0 110.757 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.602 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -169.71 134.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 210' ' ' SER . 6.5 t -112.31 143.64 43.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.849 -1.782 . . . . 0.0 109.627 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 208' ' ' VAL . 21.1 m-85 -108.9 -134.33 0.34 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.156 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 232' ' ' GLU . 2.7 tptt -128.2 -69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.06 -1.025 . . . . 0.0 113.276 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.9 mt-10 -73.82 -80.5 0.07 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.87 -1.144 . . . . 0.0 113.535 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.2 OUTLIER 161.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 122.111 0.958 . . . . 0.0 109.087 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 15.1 mm-40 -56.4 -55.99 36.53 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -51.62 -40.68 63.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.86 0.926 . . . . 0.0 110.682 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -55.21 -48.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.6 -1.313 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.87 -42.37 7.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -70.17 -62.68 1.29 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.868 0.842 . . . . 0.0 109.724 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.1 mm -45.6 -64.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.121 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -43.06 -37.17 1.87 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 110.191 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -9.02 11.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.114 -0.991 . . . . 0.0 110.658 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.748 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 9.1 mmtt -132.55 47.58 2.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.335 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 254' ' ' ILE . 12.0 ttmt -29.62 -32.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.632 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.6 t80 -117.57 86.99 2.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.27 -1.518 . . . . 0.0 110.39 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.763 ' CE1' HG21 ' A' ' 254' ' ' ILE . 2.6 m80 -93.03 -144.78 0.22 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.967 -1.083 . . . . 0.0 110.061 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.0 OUTLIER -143.04 135.37 27.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.761 . . . . 0.0 109.384 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.435 HG23 ' C ' ' A' ' 246' ' ' ASN . 60.1 t -147.53 133.32 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.908 -1.12 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 250' ' ' SER . . . 41.86 62.5 1.97 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.43 24.62 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -1.209 . . . . 0.0 110.546 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 248' ' ' GLY . 0.7 OUTLIER -137.26 128.43 27.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.1 -1.0 . . . . 0.0 109.594 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.632 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.26 44.42 1.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 0.0 110.552 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 186' ' ' VAL . 26.7 p -37.27 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.604 -0.685 . . . . 0.0 109.44 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.957 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.86 172.05 10.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.226 -1.389 . . . . 0.0 108.458 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.957 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -149.24 91.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.836 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.2 tttt -98.86 113.99 26.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -36.87 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.837 0.827 . . . . 0.0 112.122 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.141 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.709 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.682 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.8 pp -124.64 172.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.328 -1.349 . . . . 0.0 110.653 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.68 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.33 124.14 18.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.308 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 254' ' ' ILE . 17.3 t -96.84 108.3 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -71.76 -32.38 64.08 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 189' ' ' LEU . . . -96.74 29.58 10.25 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.049 HD13 ' CA ' ' A' ' 225' ' ' PHE . 2.7 pt? -38.67 172.16 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.06 0.933 . . . . 0.0 111.507 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 4.8 p -93.09 168.35 12.39 Favored Pre-proline 0 C--N 1.296 -1.743 0 O-C-N 121.533 -0.729 . . . . 0.0 110.136 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.0 Cg_endo -62.7 -29.55 77.55 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.631 1.332 . . . . 0.0 108.831 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 3.6 t70 -146.9 76.99 1.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HD12 ' A' ' 213' ' ' LEU . 50.0 m -38.01 96.82 0.12 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.656 -0.652 . . . . 0.0 111.014 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -71.24 83.94 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.819 1.431 . . . . 0.0 111.237 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -36.55 -63.18 0.42 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.593 -0.692 . . . . 0.0 111.145 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -47.58 -44.11 26.01 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.108 -177.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 18.4 tttm -75.53 -27.16 58.59 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 211' ' ' ILE . 1.3 tp -64.56 -52.06 59.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.609 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.8 OUTLIER -54.13 -38.35 65.35 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.7 mt-10 -56.34 -41.34 75.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.95 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 3.7 t80 -90.94 -69.9 0.71 Allowed 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.479 -1.689 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.593 ' CD2' HG13 ' A' ' 198' ' ' ILE . 74.4 m-85 -57.74 -54.11 50.56 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.373 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.1 -24.9 16.34 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -63.23 -45.86 94.33 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 239' ' ' ILE . 70.3 m-85 -57.0 -33.51 67.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -1.135 . . . . 0.0 108.68 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.58 140.26 4.69 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 2.6 pt-20 -42.45 142.19 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -1.176 . . . . 0.0 110.091 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.853 HG22 ' CE1' ' A' ' 230' ' ' PHE . 8.3 t -99.92 146.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.519 -0.738 . . . . 0.0 111.131 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -88.71 -55.7 3.6 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.617 ' O ' HG22 ' A' ' 229' ' ' THR . 4.8 m -153.34 161.89 41.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 198' ' ' ILE . 4.8 pt -114.43 -170.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.209 -1.396 . . . . 0.0 110.253 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.6 tp10 -151.21 138.95 19.77 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.165 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.824 HD12 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -110.49 172.32 3.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.699 -1.251 . . . . 0.0 110.187 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.784 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.2 Cg_exo -50.06 -79.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.503 1.265 . . . . 0.0 111.103 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.57 -70.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.005 -1.06 . . . . 0.0 110.473 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 217' ' ' ASN . 4.1 t70 -177.93 168.84 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 0.9 OUTLIER 45.48 82.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.784 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.4 ' HG3' ' C ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -130.46 45.19 2.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.48 44.66 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.662 0.744 . . . . 0.0 109.853 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.43 -100.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 110.136 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -176.41 3.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.97 -1.081 . . . . 0.0 110.288 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 45.32 80.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -85.61 158.71 20.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.626 ' O ' HD22 ' A' ' 189' ' ' LEU . . . -114.77 -125.41 4.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 1.049 ' CA ' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -152.25 -166.32 2.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.385 -1.068 . . . . 0.0 110.584 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 3.1 p -146.45 127.44 14.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -99.01 -173.67 2.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.112 -1.617 . . . . 0.0 109.555 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 198' ' ' ILE . 1.4 mt -163.69 131.87 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.655 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.7 t -107.54 139.68 41.69 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 119.918 -1.739 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.853 ' CE1' HG22 ' A' ' 208' ' ' VAL . 23.8 m-85 -105.94 -131.48 0.3 Allowed 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.623 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 -64.71 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.846 -1.159 . . . . 0.0 112.874 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.42 -80.47 0.1 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.994 -1.066 . . . . 0.0 113.483 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 5.1 pt-20 162.97 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.948 0.88 . . . . 0.0 108.748 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 235' ' ' PRO . 1.3 mt-10 -55.47 -61.99 5.21 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 234' ' ' GLU . 5.2 Cg_exo -47.19 -39.9 26.89 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 122.988 0.994 . . . . 0.0 110.659 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -57.41 -48.25 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -45.51 -40.69 8.81 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.07 0.938 . . . . 0.0 108.536 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 8.6 tttt -72.23 -64.0 1.03 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.925 0.869 . . . . 0.0 109.55 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.652 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -45.16 -65.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.613 ' N ' HG22 ' A' ' 239' ' ' ILE . 4.2 tmm? -43.15 -39.16 2.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.192 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 39.3 tt0 -61.92 -15.67 44.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.617 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.53 47.33 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.708 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.3 mtpt -30.87 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -99.88 85.25 3.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.414 -1.429 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.731 ' CD2' HD13 ' A' ' 254' ' ' ILE . 7.5 m-70 -89.5 -148.72 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.975 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.564 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.9 OUTLIER -140.65 129.64 23.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.658 -0.651 . . . . 0.0 109.524 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 250' ' ' SER . 24.5 t -150.19 129.26 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.592 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 41.15 69.32 0.53 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 249' ' ' LEU . 0.9 OUTLIER 44.9 25.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 247' ' ' VAL . 18.9 m -139.11 118.96 13.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.546 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.609 ' HG2' ' CE1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.06 44.36 1.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.879 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.954 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.7 p -29.07 148.3 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.184 -0.322 . . . . 0.0 110.502 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.96 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -86.49 161.68 18.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.974 -1.49 . . . . 0.0 107.871 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.96 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -146.32 105.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.807 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 13.8 tttt -99.21 115.48 29.19 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 3.5 p -37.6 162.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.709 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.542 -0.723 . . . . 0.0 110.607 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.701 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.701 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.9 pp -127.27 165.74 25.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.433 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.76 139.27 52.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.861 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 253' ' ' GLU . 43.6 t -114.03 130.28 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 110.459 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -100.18 42.41 1.97 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.971 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -122.31 -7.95 7.38 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.971 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 13.61 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 26.5 p -42.42 164.51 0.11 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.213 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.7 Cg_exo -53.91 -31.38 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.271 1.143 . . . . 0.0 110.933 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 1.7 t70 -150.66 85.66 1.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.053 . . . . 0.0 110.488 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.816 HG21 ' CD2' ' A' ' 213' ' ' LEU . 62.1 m -40.21 99.03 0.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.844 . . . . 0.0 109.841 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.8 72.47 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.415 1.41 . . . . 0.0 112.293 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.8 -67.14 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.369 -0.832 . . . . 0.0 111.596 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.6 OUTLIER -47.03 -43.62 19.8 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.147 -177.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.0 OUTLIER -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.4 -54.28 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 5.9 mtp180 -51.78 -38.22 54.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 4.6 mm-40 -56.57 -40.52 75.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.394 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.36 -71.77 0.62 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.604 ' CD2' HG13 ' A' ' 198' ' ' ILE . 83.6 m-85 -54.3 -54.94 33.48 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.947 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.73 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.21 -22.8 23.01 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.269 -2.332 . . . . 0.0 107.269 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.1 -44.93 86.3 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.6 m-85 -57.97 -36.55 72.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -1.199 . . . . 0.0 108.93 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.14 141.99 6.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 206' ' ' GLY . 9.4 pt-20 -42.48 142.04 0.89 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -1.174 . . . . 0.0 109.86 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.73 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.6 t -104.36 150.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.518 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -88.01 -57.64 2.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.633 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.34 173.08 16.07 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pt -120.07 -170.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.895 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.606 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 3.0 tp10 -151.17 129.59 12.09 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.687 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 193' ' ' THR . 14.0 mt -105.82 175.12 2.24 Favored Pre-proline 0 C--N 1.295 -1.79 0 O-C-N 120.608 -1.308 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo -70.1 -152.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.586 1.309 . . . . 0.0 110.984 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -147.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.601 ' HA ' ' HD3' ' A' ' 218' ' ' LYS . 36.1 t70 -137.58 174.76 10.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 2.0 t-20 68.76 78.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.286 -0.884 . . . . 0.0 109.045 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.601 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -155.7 56.58 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.497 -0.752 . . . . 0.0 109.912 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.5 t -112.4 38.57 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -148.66 -43.39 0.15 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.486 0.66 . . . . 0.0 110.053 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -133.62 -175.36 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 110.051 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 223' ' ' ARG . 3.5 mtt180 -109.65 129.37 55.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.287 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 222' ' ' ARG . 4.7 ptm180 175.51 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.172 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.833 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -163.64 89.49 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.505 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -89.81 -178.92 5.62 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.513 -0.992 . . . . 0.0 110.708 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.623 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.1 118.88 23.2 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.205 -0.935 . . . . 0.0 109.072 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.83 -171.44 2.35 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.275 -1.516 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -165.78 132.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.657 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.0 t -106.22 137.72 43.66 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.03 -1.669 . . . . 0.0 109.041 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 73.8 m-85 -96.79 -162.38 0.95 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.742 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -97.11 -46.26 6.23 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.478 -0.764 . . . . 0.0 109.197 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 42.2 mt-10 -121.79 167.22 13.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.559 -0.713 . . . . 0.0 109.371 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -15.79 63.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.985 -1.072 . . . . 0.0 109.341 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -57.39 -58.78 15.75 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.665 -0.647 . . . . 0.0 112.702 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -45.25 -24.91 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.226 1.119 . . . . 0.0 111.176 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 184' ' ' ILE . 6.5 t -83.34 -41.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.008 -1.058 . . . . 0.0 108.842 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -45.51 -44.84 12.91 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.136 0.97 . . . . 0.0 108.536 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -71.63 -63.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.982 0.896 . . . . 0.0 109.738 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.635 HG21 HG21 ' A' ' 184' ' ' ILE . 3.8 mm -44.54 -64.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.373 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 2.6 ttm -45.17 -36.19 3.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 1.5 tp10 -62.73 -9.55 9.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 0.0 110.483 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.624 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.03 52.26 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.156 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 254' ' ' ILE . 11.7 mtmt -31.86 -25.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.618 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -121.68 87.24 2.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.084 -1.635 . . . . 0.0 110.803 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 6.0 m-70 -89.61 -149.66 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.867 -1.146 . . . . 0.0 110.375 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 5.4 p-10 -145.19 145.19 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 249' ' ' LEU . 53.5 t -140.97 126.65 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.856 -1.152 . . . . 0.0 110.242 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 249' ' ' LEU . . . 46.13 -94.83 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 248' ' ' GLY . 19.2 mt -131.55 34.17 3.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 110.026 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.9 m -150.45 135.47 17.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.618 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.5 pttt -103.76 52.07 0.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.051 -1.03 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.6 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 84.5 m -36.77 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.774 -0.579 . . . . 0.0 109.818 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.861 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.8 pm0 -87.65 172.39 9.75 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.286 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.861 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.89 96.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 118.294 -1.362 . . . . 0.0 112.897 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 8.8 mttm -100.64 115.89 31.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -38.43 166.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.024 0.916 . . . . 0.0 112.546 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.627 -0.67 . . . . 0.0 110.04 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.703 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.703 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 29.3 pt -133.1 -176.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.531 -1.268 . . . . 0.0 111.018 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.38 141.23 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.247 -0.908 . . . . 0.0 110.506 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.581 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 46.3 t -110.39 128.69 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.539 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.35 59.18 0.44 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 179.22 69.23 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.827 HD12 ' OG1' ' A' ' 193' ' ' THR . 2.5 mm? -106.96 153.83 21.99 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.487 -1.008 . . . . 0.0 111.562 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.611 ' CB ' ' HD2' ' A' ' 191' ' ' PRO . 2.9 p -88.91 -166.52 0.11 Allowed Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 3.5 Cg_exo -62.84 -11.46 24.32 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 122.762 0.875 . . . . 0.0 110.266 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 62.7 t0 -150.74 133.29 15.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.167 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.827 ' OG1' HD12 ' A' ' 189' ' ' LEU . 55.4 m -87.73 113.78 56.03 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.048 -1.032 . . . . 0.0 110.032 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -64.58 60.88 0.27 Allowed 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 121.313 1.342 . . . . 0.0 112.474 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.671 ' OE2' HG21 ' A' ' 198' ' ' ILE . 2.5 mm-40 -37.98 -65.31 0.34 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 111.414 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 24.4 tt0 -47.59 -42.45 23.96 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.692 -1.203 . . . . 0.0 108.705 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.01 -28.13 62.18 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -65.99 -56.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.61 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.15 -36.96 32.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -61.09 -36.68 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.554 -0.716 . . . . 0.0 109.768 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.3 t80 -91.25 -72.04 0.6 Allowed 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 117.571 -1.652 . . . . 0.0 109.864 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.56 ' CD2' HG13 ' A' ' 198' ' ' ILE . 23.0 m-85 -58.64 -50.18 74.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.77 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.15 -20.75 29.41 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.51 -46.25 41.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 239' ' ' ILE . 74.1 m-85 -53.78 -37.75 63.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.049 -1.265 . . . . 0.0 108.633 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.13 132.44 2.51 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.4 OUTLIER -39.76 142.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -1.106 . . . . 0.0 109.905 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.77 HG23 ' HA2' ' A' ' 203' ' ' GLY . 6.4 t -97.48 146.18 8.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.549 -0.719 . . . . 0.0 110.653 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 7.1 tp10 -87.48 -47.61 8.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.31 169.88 22.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.652 HD13 ' OE2' ' A' ' 195' ' ' GLU . 2.2 pp -128.66 -173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.646 -1.284 . . . . 0.0 110.304 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.593 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 33.6 tp10 -152.14 135.6 16.04 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.327 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 193' ' ' THR . 1.3 mm? -106.02 172.2 4.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.484 -1.385 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.706 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -52.05 -37.03 67.64 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.806 1.424 . . . . 0.0 110.801 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.25 -163.22 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.603 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.491 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 35.8 t70 -98.14 16.06 22.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 30.0 t30 -83.24 102.59 12.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 176.52 67.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.275 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.6 p -136.25 46.44 2.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.882 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.457 ' OD1' ' HG3' ' A' ' 221' ' ' LYS . 2.1 p30 -150.62 -43.19 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.579 -0.7 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -149.62 -167.78 2.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 110.015 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 221' ' ' LYS . 22.8 ttt180 -41.44 157.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.387 -0.82 . . . . 0.0 110.167 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.87 -167.82 2.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.598 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.45 77.58 1.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 4.8 p90 -149.88 -166.4 2.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -1.218 . . . . 0.0 110.959 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.54 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 8.2 p -170.35 125.44 0.75 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -99.46 -176.94 3.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.264 -1.522 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.685 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.1 mt -163.89 134.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 210' ' ' SER . 6.8 t -107.1 140.11 40.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.157 -1.589 . . . . 0.0 109.896 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 18.9 m-30 -100.13 -141.63 0.33 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -63.47 1.44 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.238 -0.914 . . . . 0.0 110.935 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 5.4 mt-10 -102.8 -69.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 0.0 111.037 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 7.0 pt-20 174.03 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.697 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.618 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -38.68 -55.29 2.72 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.2 Cg_exo -52.4 -37.6 72.33 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.093 1.049 . . . . 0.0 110.94 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.615 HG22 ' CG2' ' A' ' 184' ' ' ILE . 2.1 t -67.38 -43.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.04 . . . . 0.0 108.92 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.32 -47.01 13.22 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.175 0.988 . . . . 0.0 108.597 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -68.51 -58.5 4.22 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.528 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 205' ' ' PHE . 3.7 mm -48.62 -63.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.688 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 1.6 tmm? -44.45 -35.4 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.942 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -65.45 -7.63 15.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.175 -0.953 . . . . 0.0 110.497 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.757 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.97 49.61 2.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 35.1 mtpt -29.09 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.06 89.9 3.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.515 -1.366 . . . . 0.0 110.012 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.785 ' CE1' HG21 ' A' ' 254' ' ' ILE . 2.6 m80 -95.8 -149.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.135 -0.978 . . . . 0.0 110.786 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.48 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -133.46 137.61 45.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.698 -0.626 . . . . 0.0 109.534 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 250' ' ' SER . 11.6 t -146.65 125.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.017 -1.052 . . . . 0.0 110.211 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 47.19 75.2 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.1 OUTLIER 41.85 34.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -1.095 . . . . 0.0 110.529 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 247' ' ' VAL . 1.6 t -146.72 166.4 26.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 4.3 ptpp? -124.38 45.98 2.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.577 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 28.7 p -40.05 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 254' ' ' ILE . 0.1 OUTLIER -88.08 171.36 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.629 -1.228 . . . . 0.0 109.141 179.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -144.75 103.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.484 -178.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.35 107.65 19.05 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -43.97 167.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.21 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.934 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.703 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 239' ' ' ILE . 22.4 mt -131.72 177.62 6.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 C-N-CA 117.3 -1.76 . . . . 0.0 110.639 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.635 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.16 117.6 6.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.962 -1.086 . . . . 0.0 110.801 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.848 ' HB ' HD11 ' A' ' 189' ' ' LEU . 58.0 t -89.62 126.77 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.899 -1.126 . . . . 0.0 109.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -103.44 59.21 0.51 Allowed Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -178.93 62.84 0.08 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.848 HD11 ' HB ' ' A' ' 186' ' ' VAL . 67.3 mt -135.55 162.45 32.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -1.205 . . . . 0.0 111.573 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.567 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 0.4 OUTLIER -90.01 172.4 7.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.8 Cg_exo -53.23 -17.23 8.13 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.331 1.174 . . . . 0.0 110.541 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -109.97 101.6 10.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.807 ' CB ' HD22 ' A' ' 213' ' ' LEU . 2.6 m -86.56 129.32 53.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.165 -0.96 . . . . 0.0 110.399 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.7 Cg_endo -67.92 52.34 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.406 1.404 . . . . 0.0 112.525 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.551 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -36.66 -66.51 0.22 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.192 -0.943 . . . . 0.0 111.286 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -47.41 -40.65 18.36 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.814 -177.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 11.0 mttt -74.32 -28.66 61.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.958 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -66.36 -55.91 16.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.6 OUTLIER -52.2 -36.39 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -61.07 -39.19 88.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 110.376 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.437 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.16 -70.91 0.66 Allowed 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 117.361 -1.735 . . . . 0.0 109.421 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.602 ' CD2' HG13 ' A' ' 198' ' ' ILE . 22.4 m-85 -57.19 -51.81 67.85 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.137 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.42 -20.63 30.8 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.5 -45.22 60.78 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.819 ' CD1' HD11 ' A' ' 239' ' ' ILE . 81.2 m-85 -58.36 -33.23 69.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -1.232 . . . . 0.0 108.962 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.58 130.36 1.98 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' GLY . 12.2 pt-20 -41.6 141.79 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -1.216 . . . . 0.0 110.079 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.582 HG11 HG23 ' A' ' 211' ' ' ILE . 2.4 t -92.11 144.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.566 0.698 . . . . 0.0 111.222 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -88.12 -48.75 7.49 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.72 ' O ' HG22 ' A' ' 229' ' ' THR . 69.5 m -153.58 158.39 41.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.582 HG23 HG11 ' A' ' 208' ' ' VAL . 9.0 pt -114.93 -170.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.781 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.6 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 24.8 tp10 -151.3 137.26 18.18 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.321 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 193' ' ' THR . 5.3 mt -107.04 172.61 3.69 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 120.545 -1.347 . . . . 0.0 110.748 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -50.57 83.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.098 1.578 . . . . 0.0 111.168 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 213' ' ' LEU . 1.4 mtt 37.49 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.619 -0.676 . . . . 0.0 110.682 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 214' ' ' PRO . 4.5 t70 -175.39 -178.51 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.04 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 1.7 m-20 62.36 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.079 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER 63.83 50.87 2.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 109.754 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.0 t -142.71 49.94 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 110.132 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 5.3 p-10 -142.1 -39.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.409 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -133.35 -169.59 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.499 ' C ' ' HG2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -114.44 -176.46 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.477 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 223' ' ' ARG . 20.0 ptp180 30.68 61.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.414 0.625 . . . . 0.0 111.376 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 189' ' ' LEU . . . -63.97 -146.45 0.03 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 1.8 p90 -148.4 -166.86 2.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -1.111 . . . . 0.0 110.704 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.543 ' SG ' ' CD1' ' A' ' 189' ' ' LEU . 0.6 OUTLIER -170.73 129.11 0.8 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.635 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -101.55 -173.69 2.42 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.243 -1.536 . . . . 0.0 108.918 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.958 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.2 mt -164.91 136.32 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 210' ' ' SER . 14.3 t -113.8 149.6 34.71 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.237 -1.539 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 70.2 m-85 -117.82 -115.7 0.33 Allowed 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.472 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HE2' ' N ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER -163.77 -39.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.494 ' N ' ' HE2' ' A' ' 231' ' ' LYS . 53.7 tt0 -87.83 -96.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.796 -1.19 . . . . 0.0 111.302 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.4 OUTLIER 169.61 -24.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.199 -0.938 . . . . 0.0 109.912 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.609 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.1 tm-20 -63.44 -52.06 62.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.277 -0.889 . . . . 0.0 112.967 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.4 Cg_exo -52.38 -21.28 13.3 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 122.815 0.903 . . . . 0.0 111.349 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.478 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.0 t -80.74 -51.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 240' ' ' MET . 0.0 OUTLIER -41.76 -42.04 2.5 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.312 1.053 . . . . 0.0 108.886 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -59.15 3.26 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.412 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 205' ' ' PHE . 17.3 mm -51.69 -62.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.528 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.505 ' HG3' ' N ' ' A' ' 241' ' ' GLU . 1.4 ppp? -44.75 -33.2 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.493 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 240' ' ' MET . 1.8 tt0 -70.74 -8.48 52.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.741 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -131.19 47.66 2.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.978 -1.076 . . . . 0.0 109.107 179.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -28.12 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -111.76 83.14 1.73 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.508 -1.37 . . . . 0.0 110.34 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.741 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 3.4 m80 -92.79 -147.14 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.983 -1.073 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -144.1 120.24 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 249' ' ' LEU . 4.4 t -112.04 112.01 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.954 -1.091 . . . . 0.0 110.635 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 64.01 -68.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -154.24 23.08 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 110.482 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.2 t -145.45 148.0 32.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.033 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -102.06 50.54 0.84 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.755 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.0 m -43.84 169.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.549 -0.719 . . . . 0.0 109.376 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.982 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -87.14 165.0 16.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.496 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.982 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -142.36 98.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.266 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.4 108.17 20.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.0 p -43.62 166.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.917 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.406 -0.809 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.691 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.737 HG23 HG22 ' A' ' 236' ' ' VAL . 7.2 pt -130.14 175.33 11.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.429 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -137.35 135.44 37.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.189 -0.945 . . . . 0.0 110.213 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.675 HG12 ' HB3' ' A' ' 252' ' ' CYS . 55.4 t -111.55 128.38 68.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.902 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.494 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -99.71 44.5 1.64 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 1.047 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -132.2 2.94 5.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.047 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 3.56 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 178.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.2 p -43.75 170.07 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.551 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.6 Cg_exo -55.54 -35.11 91.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.275 1.145 . . . . 0.0 111.374 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 4.7 p-10 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.865 -1.147 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.703 ' CB ' HD12 ' A' ' 213' ' ' LEU . 18.8 m -39.69 97.09 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.585 -0.697 . . . . 0.0 109.958 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.4 Cg_endo -70.61 80.23 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.741 1.39 . . . . 0.0 112.072 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -37.03 -61.67 0.54 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.452 -0.78 . . . . 0.0 111.038 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.2 mt-10 -49.22 -45.34 44.33 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.031 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -74.62 -26.42 59.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -64.53 -50.11 77.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -57.01 -35.28 69.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.52 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.5 mt-10 -59.75 -38.82 82.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.46 -70.49 0.68 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.509 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -57.95 -52.19 66.54 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.77 27.95 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.44 -45.61 67.51 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.753 ' CD1' HD11 ' A' ' 239' ' ' ILE . 90.6 m-85 -59.52 -34.29 72.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -1.232 . . . . 0.0 109.207 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -172.42 135.09 3.22 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -41.51 141.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.978 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.676 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.7 t -104.2 145.91 12.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.541 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.0 -49.69 6.89 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 177.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.595 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.6 174.33 14.6 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 5.1 pt -127.54 -171.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.092 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.526 ' O ' ' O ' ' A' ' 227' ' ' PHE . 3.2 tt0 -150.82 128.5 11.57 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.917 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.703 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.5 mm? -104.88 171.38 5.02 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 120.578 -1.326 . . . . 0.0 111.004 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.4 Cg_endo -75.5 0.17 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.15 1.605 . . . . 0.0 110.574 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 1.1 tpt 71.36 -162.61 0.13 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 22.7 t70 -155.83 26.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.522 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 0.9 OUTLIER -88.83 -52.18 5.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.693 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 64.48 50.29 2.25 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.256 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.47 50.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 110.207 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 19.6 p-10 -149.92 -48.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -150.75 -171.68 3.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.432 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -58.92 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.258 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 222' ' ' ARG . 18.3 ptt180 -39.72 161.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.462 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.691 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -117.76 -162.37 12.4 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.181 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -151.9 173.97 14.17 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -1.025 . . . . 0.0 109.757 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -119.76 117.93 29.5 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -97.25 -169.45 1.86 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.503 -1.373 . . . . 0.0 109.986 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.54 138.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.607 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 8.1 t -111.79 144.4 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 119.816 -1.802 . . . . 0.0 110.413 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.666 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.2 m-30 -103.44 -136.01 0.34 Allowed 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.073 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -154.27 -48.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.488 -178.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 83.9 tt0 -79.26 -56.48 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.975 . . . . 0.0 109.236 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.634 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 131.06 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -57.01 -45.65 99.94 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.366 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 3.9 Cg_exo -54.58 -27.48 50.83 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 109.709 -0.92 . . . . 0.0 109.709 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 184' ' ' ILE . 2.3 t -74.16 -43.96 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.43 -48.28 9.92 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 108.836 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -61.28 1.84 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.015 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 205' ' ' PHE . 11.4 mm -44.79 -64.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.64 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.53 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.0 tmm? -46.65 -33.26 4.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.372 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 3.9 tt0 -73.08 2.45 7.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.78 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.92 51.01 1.72 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.014 -1.054 . . . . 0.0 109.444 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 4.1 ttmm -26.45 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -120.28 94.48 4.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.297 -1.502 . . . . 0.0 110.258 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.78 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 4.1 m80 -97.79 -148.88 0.33 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.009 -1.057 . . . . 0.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.57 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 7.6 m-80 -145.35 139.83 27.27 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 249' ' ' LEU . 25.8 t -133.29 120.43 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.99 -1.069 . . . . 0.0 110.174 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.22 -90.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -135.56 32.81 3.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -1.111 . . . . 0.0 109.824 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.58 145.39 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.63 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.0 pttt -113.41 54.91 0.72 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.97 -1.081 . . . . 0.0 110.934 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.675 ' HB3' HG12 ' A' ' 186' ' ' VAL . 62.1 m -40.47 162.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.38 -0.825 . . . . 0.0 108.94 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.902 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.1 pm0 -87.7 177.42 7.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.722 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 253' ' ' GLU . 0.9 OUTLIER -150.04 147.38 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.329 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 5.1 tttp -156.03 105.4 2.34 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.5 p -35.08 161.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.94 0.876 . . . . 0.0 112.94 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.685 -0.635 . . . . 0.0 110.164 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.727 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 239' ' ' ILE . 2.4 pp -132.47 171.36 18.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.09 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -132.37 135.65 46.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 110.412 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 252' ' ' CYS . 16.4 t -108.35 131.76 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.67 -0.644 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -95.64 47.98 1.87 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 1.121 ' O ' HD22 ' A' ' 189' ' ' LEU . . . -119.01 -29.83 1.73 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.121 HD22 ' O ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER 21.84 39.83 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.869 0.842 . . . . 0.0 112.805 179.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.623 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.3 p -41.39 167.12 0.06 OUTLIER Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -56.13 -18.71 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.409 1.215 . . . . 0.0 110.841 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 17.6 m-20 -150.49 87.31 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 110.501 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.878 HG21 ' CD2' ' A' ' 213' ' ' LEU . 3.6 m -48.25 106.31 0.59 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.526 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.27 55.31 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.238 1.292 . . . . 0.0 112.155 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.626 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.5 OUTLIER -37.46 -60.28 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.427 -0.796 . . . . 0.0 110.26 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 200' ' ' GLU . 10.6 tt0 -49.07 -45.17 42.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.471 -1.291 . . . . 0.0 108.854 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -74.39 -23.94 59.05 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 195' ' ' GLU . 0.2 OUTLIER -68.06 -51.59 47.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.586 ' N ' HG22 ' A' ' 198' ' ' ILE . 22.6 ttm180 -55.72 -36.05 66.78 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.533 ' CA ' ' OE1' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -57.48 -42.88 83.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.622 -0.674 . . . . 0.0 109.537 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -91.25 -73.69 0.53 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 117.582 -1.647 . . . . 0.0 110.05 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -51.09 -50.28 59.05 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.229 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.98 -21.21 23.22 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -75.39 -43.97 23.32 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.746 ' CD1' HD11 ' A' ' 239' ' ' ILE . 83.5 m-85 -58.01 -28.26 64.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -1.212 . . . . 0.0 108.941 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 179.72 132.73 1.85 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' GLY . 6.9 pt-20 -41.12 142.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.137 . . . . 0.0 110.263 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 230' ' ' PHE . 10.7 t -102.64 147.48 9.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -54.81 4.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 53.9 m -154.05 158.23 40.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pp -105.2 -168.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.305 -1.358 . . . . 0.0 109.418 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.576 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.8 tp10 -151.27 134.33 15.91 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.743 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 193' ' ' THR . 19.6 mt -109.52 178.13 1.09 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 120.794 -1.191 . . . . 0.0 109.7 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.0 Cg_exo -69.85 -172.36 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.389 1.205 . . . . 0.0 110.754 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -170.2 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.072 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 5.0 t70 -108.62 -7.53 15.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.253 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.472 ' C ' ' CD ' ' A' ' 218' ' ' LYS . 35.4 m-80 -77.23 111.03 12.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' A' ' 217' ' ' ASN . 0.3 OUTLIER -134.96 46.55 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.1 m -144.87 49.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.493 -0.755 . . . . 0.0 110.321 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 6.5 p-10 -150.45 -46.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.28 -174.41 4.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 109.962 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.22 53.16 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 110.115 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -117.02 166.35 12.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 109.994 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . 140.56 137.67 3.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.885 ' HA ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.87 -178.35 6.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -1.128 . . . . 0.0 110.265 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -130.68 120.79 24.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.115 -0.991 . . . . 0.0 109.015 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -98.27 -168.7 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.407 -1.433 . . . . 0.0 110.428 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.3 mt -164.81 134.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 10.5 t -116.15 146.47 42.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.072 -1.642 . . . . 0.0 110.225 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.872 ' CE2' HG22 ' A' ' 208' ' ' VAL . 58.0 m-85 -114.44 -127.83 0.29 Allowed 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -145.04 -44.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.673 -1.267 . . . . 0.0 113.377 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 7.5 mt-10 -82.74 -82.8 0.14 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.614 -1.304 . . . . 0.0 112.883 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.73 -28.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.659 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.6 tt0 -62.8 -53.29 57.44 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.315 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.3 Cg_exo -48.49 -32.71 21.42 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.992 0.996 . . . . 0.0 110.323 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 183' ' ' LYS . 2.1 t -68.71 -47.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.844 -1.16 . . . . 0.0 107.907 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.19 -43.66 7.3 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.215 1.007 . . . . 0.0 108.8 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -69.05 -60.43 2.36 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.539 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 184' ' ' ILE . 12.4 mm -49.08 -63.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.259 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.667 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -47.86 -28.37 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.637 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -77.13 7.02 5.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 111.059 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.741 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.98 54.42 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 109.047 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.3 OUTLIER -25.46 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.652 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.3 t80 -120.27 96.27 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.378 -1.451 . . . . 0.0 110.215 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.804 ' CE1' HG21 ' A' ' 254' ' ' ILE . 15.1 m80 -93.58 -165.34 1.31 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.086 -1.009 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 57.0 m-80 -135.92 133.74 37.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 250' ' ' SER . 55.7 t -149.48 131.68 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.111 -0.993 . . . . 0.0 110.477 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 42.74 62.96 2.08 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 1.9 tp 48.22 22.37 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.152 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 247' ' ' VAL . 50.3 m -132.34 118.06 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.2 pttt -97.94 53.74 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 110.693 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 186' ' ' VAL . 58.8 m -41.67 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.459 -0.776 . . . . 0.0 109.011 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.947 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.7 pm0 -86.94 173.88 9.07 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.388 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.947 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.43 129.28 3.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.015 -1.474 . . . . 0.0 112.873 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 9.1 mttm -134.46 107.57 7.64 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 240' ' ' MET . 2.7 p -37.1 163.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.026 0.917 . . . . 0.0 112.575 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.727 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.695 -0.628 . . . . 0.0 109.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.704 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.704 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.3 mt -138.82 174.74 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.095 -1.003 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.694 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.08 139.79 50.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.143 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 188' ' ' GLY . 62.9 t -114.62 131.38 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.55 -0.719 . . . . 0.0 109.862 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.547 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -104.97 43.6 1.64 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.981 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -117.38 -15.46 6.49 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.981 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 10.35 58.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 188' ' ' GLY . 1.3 p -44.77 168.49 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.244 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -58.04 -11.93 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.416 1.219 . . . . 0.0 110.914 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 8.4 t0 -150.24 105.26 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.965 -1.085 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 213' ' ' LEU . 76.5 p -40.21 98.99 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.373 -0.829 . . . . 0.0 109.822 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -69.25 45.17 0.39 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.436 1.424 . . . . 0.0 112.872 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.66 -69.41 0.11 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.048 -1.033 . . . . 0.0 111.679 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 3.8 tt0 -47.82 -39.88 19.61 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.577 -1.249 . . . . 0.0 109.034 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 194' ' ' PRO . 26.0 mmmt -75.7 -27.04 58.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -66.99 -54.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.627 ' N ' HG22 ' A' ' 198' ' ' ILE . 3.3 ttp85 -54.48 -38.28 66.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -59.32 -40.38 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.477 -0.765 . . . . 0.0 110.158 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 204' ' ' GLY . 2.0 t80 -91.02 -71.87 0.61 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.395 -1.722 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.621 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.0 m-85 -54.41 -54.06 45.72 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.564 -0.855 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.17 -22.1 27.83 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.93 -46.99 57.61 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 85.6 m-85 -56.13 -31.22 63.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.269 . . . . 0.0 108.698 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.39 138.82 4.04 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.1 OUTLIER -43.56 143.14 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.016 -1.285 . . . . 0.0 109.577 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.766 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.4 t -101.19 152.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.754 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 3.2 tt0 -87.83 -56.19 3.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.636 ' O ' HG22 ' A' ' 229' ' ' THR . 30.8 m -153.47 160.35 42.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 46.2 pt -110.66 -169.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.009 -1.476 . . . . 0.0 109.584 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 4.6 tp10 -152.11 129.36 11.24 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.77 ' N ' HD22 ' A' ' 213' ' ' LEU . 2.0 mm? -102.22 178.23 1.27 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.706 -1.246 . . . . 0.0 108.71 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -65.6 -165.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.101 1.053 . . . . 0.0 110.844 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.6 mtt -119.13 -176.25 3.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.1 -1.0 . . . . 0.0 110.563 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -77.56 -162.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.263 -0.898 . . . . 0.0 110.281 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 56.14 85.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.443 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -124.87 41.82 3.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.764 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.2 t -145.43 47.49 1.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.503 0.668 . . . . 0.0 109.827 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 220' ' ' ASN . 2.7 p-10 -150.51 -45.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.522 -0.736 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 -170.99 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 110.237 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.476 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -103.03 65.86 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -128.66 76.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.849 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -140.68 58.1 0.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -89.44 177.69 6.51 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.574 -0.956 . . . . 0.0 110.645 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -130.29 120.7 24.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.18 -173.8 3.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.451 -1.406 . . . . 0.0 109.984 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 2.0 mt -161.51 134.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 210' ' ' SER . 2.5 t -107.68 138.46 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.863 -1.773 . . . . 0.0 110.21 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CD2' ' CG ' ' A' ' 235' ' ' PRO . 35.1 m-85 -99.47 -112.75 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.298 -1.361 . . . . 0.0 111.922 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 28.6 tttp 175.32 -53.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.636 -1.29 . . . . 0.0 109.892 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.602 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 2.3 mt-10 -75.51 -22.98 56.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.144 -0.972 . . . . 0.0 108.682 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 2.2 pt-20 87.7 -21.35 0.17 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.361 1.077 . . . . 0.0 108.751 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.681 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.7 mt-10 -61.11 -45.65 96.02 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -54.06 -25.29 36.24 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 109.675 -0.933 . . . . 0.0 109.675 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.643 HG22 ' CG1' ' A' ' 184' ' ' ILE . 2.2 t -76.89 -47.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -44.16 -46.52 8.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.306 1.051 . . . . 0.0 108.895 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.61 -61.95 1.59 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.883 0.849 . . . . 0.0 109.751 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 205' ' ' PHE . 21.5 mm -43.12 -65.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 256' ' ' VAL . 0.4 OUTLIER -46.55 -34.08 4.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -61.14 -11.58 9.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 110.68 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.738 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.06 52.98 1.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.161 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.5 ttpp -27.87 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.1 t80 -115.43 92.85 4.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.325 -1.484 . . . . 0.0 110.061 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.738 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 2.6 m80 -97.96 -154.85 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 110.778 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 10.2 p30 -136.26 143.35 44.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.306 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 24.4 t -139.5 131.01 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.421 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.18 -93.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -133.19 34.22 3.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -1.181 . . . . 0.0 110.197 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.23 168.25 24.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.54 48.38 1.61 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 110.49 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.545 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 26.7 p -34.08 152.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.866 -0.522 . . . . 0.0 109.922 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.919 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.66 170.9 10.87 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.79 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.919 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.1 mp -145.26 113.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.293 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -119.71 106.82 12.51 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 18.4 t -38.32 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.14 -0.975 . . . . 0.0 112.404 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.653 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.959 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -130.01 -175.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 117.663 -1.615 . . . . 0.0 110.912 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.13 124.14 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 111.454 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.916 ' HB ' HD11 ' A' ' 189' ' ' LEU . 92.6 t -93.34 128.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 109.278 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -105.25 58.96 0.45 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.688 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.699 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 179.58 67.67 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.916 HD11 ' HB ' ' A' ' 186' ' ' VAL . 40.9 mt -139.87 163.52 32.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -1.192 . . . . 0.0 111.644 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.537 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -79.74 171.43 12.47 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.7 Cg_exo -55.25 -16.4 13.06 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.38 1.2 . . . . 0.0 110.555 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.57 117.49 31.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.873 ' CB ' HD12 ' A' ' 213' ' ' LEU . 1.3 m -84.09 125.54 72.31 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.36 58.67 0.68 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.269 1.313 . . . . 0.0 111.915 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.601 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -36.98 -67.9 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.258 -0.901 . . . . 0.0 111.739 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -47.91 -38.3 16.16 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.864 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.3 OUTLIER -77.21 -27.97 53.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.716 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.2 tp -66.57 -55.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 4.8 mtt180 -56.29 -38.3 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -52.49 -49.02 65.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.65 -0.656 . . . . 0.0 110.464 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.6 -71.18 0.64 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 117.249 -1.78 . . . . 0.0 109.752 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.637 ' HD2' HD12 ' A' ' 228' ' ' ILE . 7.7 m-30 -50.4 -55.01 17.63 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.669 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.704 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.39 -22.06 21.97 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.18 -46.29 28.03 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -53.05 -36.0 60.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.318 . . . . 0.0 108.628 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.22 135.04 3.02 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.2 pt-20 -40.5 141.55 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.059 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.704 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.25 144.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 110.52 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 49.4 tp10 -87.65 -50.8 6.26 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 229' ' ' THR . 51.9 m -153.0 171.73 17.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.601 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 27.4 pt -125.17 -170.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.654 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.61 138.57 19.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.0 mm? -110.53 170.2 5.55 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 120.264 -1.523 . . . . 0.0 111.576 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.8 Cg_exo -49.71 88.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 124.051 1.553 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER 41.75 -141.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.428 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 218' ' ' LYS . 15.5 t70 -120.38 167.67 12.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.872 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 216' ' ' ASP . 11.8 t-20 63.77 -67.78 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.479 -0.763 . . . . 0.0 110.206 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER 63.98 46.81 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.972 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.2 m -150.76 53.38 0.88 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.665 . . . . 0.0 109.898 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -131.68 -37.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.829 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -132.78 -171.66 2.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 110.789 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -55.36 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 110.72 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 189' ' ' LEU . 32.6 ptt180 -43.73 169.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.702 . . . . 0.0 110.165 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -134.11 -148.9 5.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 2.1 p90 -131.15 -163.73 1.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.398 -1.06 . . . . 0.0 110.215 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.551 ' SG ' ' CD1' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -168.52 128.63 1.21 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.275 -0.891 . . . . 0.0 108.848 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.7 m-85 -101.01 -176.61 3.21 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.695 -1.253 . . . . 0.0 109.021 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.716 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -165.61 136.13 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 210' ' ' SER . 5.2 t -107.39 139.54 41.72 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.295 -1.503 . . . . 0.0 109.784 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.794 ' HD2' HG23 ' A' ' 236' ' ' VAL . 15.0 m-85 -97.1 -131.64 0.2 Allowed 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.811 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.423 ' HG3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -136.09 -52.67 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.761 -1.212 . . . . 0.0 110.92 -178.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 4.1 mt-10 -96.48 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.98 -26.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.227 1.013 . . . . 0.0 108.991 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -56.89 -43.58 99.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.93 -34.8 68.25 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 122.601 0.79 . . . . 0.0 110.803 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 184' ' ' ILE . 54.6 t -75.67 -34.93 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.768 -1.208 . . . . 0.0 108.455 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -45.64 -44.16 13.02 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.3 1.047 . . . . 0.0 108.34 178.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -62.93 1.29 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.829 0.823 . . . . 0.0 110.458 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.629 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -50.04 -60.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.693 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.582 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -50.48 -33.62 21.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.089 -1.007 . . . . 0.0 110.817 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.8 -6.69 8.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.855 -1.153 . . . . 0.0 110.973 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.712 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -133.89 53.1 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 108.743 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 5.5 mtpt -26.64 -34.86 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.628 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.7 OUTLIER -115.11 90.05 3.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.466 -1.396 . . . . 0.0 109.666 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.712 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 36.2 m80 -89.87 -157.61 0.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.125 -0.985 . . . . 0.0 111.371 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 6.1 t30 -144.67 120.01 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.2 122.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 57.44 53.95 40.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.18 22.78 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -1.082 . . . . 0.0 109.957 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 7.6 m -132.87 117.84 18.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.69 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -93.42 51.63 1.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 110.591 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.562 ' SG ' HD23 ' A' ' 189' ' ' LEU . 62.2 m -41.86 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.497 -0.752 . . . . 0.0 109.409 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.935 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -88.01 164.44 15.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.591 -1.318 . . . . 0.0 109.753 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.935 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -139.0 117.1 12.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.716 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.627 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tmtt? -126.64 112.34 15.36 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -39.72 166.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 112.132 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.642 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.575 -0.703 . . . . 0.0 110.423 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.683 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 236' ' ' VAL . 3.6 pt -129.24 -179.2 2.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.361 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -150.15 125.89 10.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 60.8 t -94.65 132.26 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.119 -0.988 . . . . 0.0 110.339 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.464 ' C ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.56 56.82 0.51 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -178.64 64.56 0.08 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.599 HD21 ' HB ' ' A' ' 186' ' ' VAL . 2.0 mm? -105.23 152.26 23.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.508 -0.995 . . . . 0.0 111.484 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 3.0 p -90.12 -167.92 0.16 Allowed Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.3 Cg_exo -65.15 -6.52 13.25 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.047 1.025 . . . . 0.0 110.632 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.7 120.18 6.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.357 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.844 ' CB ' HD22 ' A' ' 213' ' ' LEU . 61.1 m -79.71 120.29 79.61 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.964 -1.085 . . . . 0.0 109.937 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -65.51 54.92 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.165 1.243 . . . . 0.0 112.133 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.01 -66.16 0.22 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.52 -0.737 . . . . 0.0 110.762 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.46 -37.85 12.54 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.85 -177.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -78.22 -28.82 48.04 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.656 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.42 -53.79 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.603 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -56.48 -36.08 68.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.265 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.6 mm-40 -60.12 -41.21 92.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.267 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.796 ' CD2' HG22 ' A' ' 247' ' ' VAL . 2.6 t80 -90.99 -70.99 0.65 Allowed 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.36 -1.736 . . . . 0.0 108.967 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.656 ' CD2' HG13 ' A' ' 198' ' ' ILE . 14.6 m-30 -53.81 -55.73 23.92 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.919 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.743 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -53.89 -22.91 20.85 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.92 -47.64 53.47 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 239' ' ' ILE . 67.4 m-85 -51.06 -33.94 27.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.059 -1.259 . . . . 0.0 108.352 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.75 136.93 3.2 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 206' ' ' GLY . 4.4 pt-20 -42.21 141.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -1.185 . . . . 0.0 109.809 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.743 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.06 150.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.522 -0.736 . . . . 0.0 110.654 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -87.65 -51.92 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -152.79 165.62 34.81 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.591 ' CG2' HG11 ' A' ' 208' ' ' VAL . 5.8 pt -126.29 -173.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 118.199 -1.4 . . . . 0.0 110.158 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.598 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.9 tp10 -151.3 132.11 14.11 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.845 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.844 HD22 ' CB ' ' A' ' 193' ' ' THR . 6.6 mt -104.37 169.9 6.69 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 120.338 -1.476 . . . . 0.0 110.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.3 Cg_exo -62.57 85.88 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.871 1.459 . . . . 0.0 110.772 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.2 ptp -165.88 146.86 6.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 110.361 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.524 ' O ' ' CE ' ' A' ' 218' ' ' LYS . 5.7 t0 -172.05 -65.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.713 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.696 ' HB3' HG22 ' A' ' 219' ' ' THR . 11.1 m-20 -67.53 -28.79 68.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.419 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 216' ' ' ASP . 8.8 mttt 59.58 40.56 20.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 217' ' ' ASN . 5.0 t -151.29 43.61 0.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.567 -0.708 . . . . 0.0 110.129 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -151.06 -98.43 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.462 -0.774 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -147.49 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 110.268 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 191' ' ' PRO . 45.4 mtm180 -98.77 68.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -165.98 169.09 15.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 131.18 -95.58 0.32 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 4.2 p90 -143.97 153.66 42.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.273 -1.134 . . . . 0.0 110.074 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.539 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 13.7 p -122.68 126.91 48.54 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -96.85 -177.28 3.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.281 -1.512 . . . . 0.0 109.275 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.635 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -164.77 134.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.621 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.5 t -109.07 138.47 45.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.14 -1.6 . . . . 0.0 109.193 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.535 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 37.1 m-85 -101.52 -166.91 1.35 Allowed 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.877 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -90.5 -49.73 6.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 3.0 mt-10 -119.09 174.44 6.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.02 -18.86 60.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 0.0 109.886 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.695 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 30.9 mt-10 -49.35 -53.15 42.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.6 Cg_exo -47.16 -43.39 25.61 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.727 0.951 . . . . 0.0 111.73 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 184' ' ' ILE . 76.9 t -72.21 -32.05 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.631 -1.293 . . . . 0.0 109.671 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -49.74 -45.59 49.56 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.645 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -64.54 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.161 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 240' ' ' MET . 0.8 OUTLIER -47.56 -64.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.976 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.623 ' N ' HG22 ' A' ' 239' ' ' ILE . 8.0 ttp -41.33 -40.17 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 110.695 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 2.1 tp10 -56.11 -16.18 4.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.582 ' O ' ' ND1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.3 50.96 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 34.4 ttpt -25.52 -37.84 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.66 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.8 t80 -103.23 91.04 3.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.363 -1.46 . . . . 0.0 108.658 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.76 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.0 m-70 -89.37 -166.42 1.59 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.043 -1.036 . . . . 0.0 110.884 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' A' ' 201' ' ' TYR . 4.1 m120 -137.71 115.36 11.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.796 HG22 ' CD2' ' A' ' 201' ' ' TYR . 38.2 t -130.23 124.73 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 0.0 110.543 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 249' ' ' LEU . . . 52.97 51.41 46.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 248' ' ' GLY . 0.5 OUTLIER 60.25 25.7 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 110.067 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 17.6 m -138.57 122.08 17.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.66 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.01 56.03 0.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.945 . . . . 0.0 111.181 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 60.2 m -45.43 169.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.957 . . . . 0.0 109.109 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -88.04 167.89 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.275 -1.37 . . . . 0.0 107.86 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.916 HD12 ' C ' ' A' ' 253' ' ' GLU . 3.5 mp -151.32 102.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.293 -1.363 . . . . 0.0 112.449 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -98.72 117.22 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -40.74 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 112.095 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.683 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.708 -0.62 . . . . 0.0 110.076 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 236' ' ' VAL . 4.1 pt -129.91 173.21 14.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.118 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -132.66 136.11 46.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.018 -1.051 . . . . 0.0 110.609 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 254' ' ' ILE . 98.3 t -109.12 136.81 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.698 -0.626 . . . . 0.0 110.621 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -110.34 47.79 1.01 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.968 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -120.0 -15.64 5.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.968 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 13.53 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.368 0.604 . . . . 0.0 112.57 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.0 p -45.03 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 109.92 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -59.47 -12.97 18.79 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.446 1.235 . . . . 0.0 110.977 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 1.8 t70 -150.08 87.25 1.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 110.253 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.975 HG21 ' CD ' ' A' ' 214' ' ' PRO . 0.6 OUTLIER -39.13 96.8 0.12 Allowed Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.613 -0.679 . . . . 0.0 110.362 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.828 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.3 124.08 9.67 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.553 1.502 . . . . 0.0 111.904 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.55 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -95.63 -65.25 0.99 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -49.82 -50.91 43.39 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.534 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -62.61 -26.0 68.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.7 OUTLIER -68.81 -61.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -54.72 -31.44 58.24 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 197' ' ' LYS . 8.1 tp10 -61.28 -42.78 99.23 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.75 -69.89 0.72 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 117.653 -1.619 . . . . 0.0 109.369 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 184' ' ' ILE . 58.8 m-85 -54.93 -50.95 67.57 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.542 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.64 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.43 26.67 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.28 47.61 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CD1' HD11 ' A' ' 239' ' ' ILE . 76.7 m-85 -55.94 -31.1 62.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -1.2 . . . . 0.0 108.86 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.14 138.82 3.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 5.6 pt-20 -41.73 141.62 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.64 HG23 ' HA2' ' A' ' 203' ' ' GLY . 5.4 t -100.55 150.14 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.799 . . . . 0.0 110.55 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -87.8 -54.53 4.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.677 ' O ' HG22 ' A' ' 229' ' ' THR . 21.1 m -153.51 173.42 15.73 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 14.8 pt -124.23 -171.27 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.125 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 15.3 tt0 -150.97 128.7 11.57 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.167 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.687 HD22 ' HB ' ' A' ' 193' ' ' THR . 8.4 mt -103.49 174.46 2.78 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 120.591 -1.318 . . . . 0.0 110.0 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.975 ' CD ' HG21 ' A' ' 193' ' ' THR . 3.2 Cg_exo -69.43 -4.92 14.78 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.654 1.344 . . . . 0.0 111.117 -178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.423 ' O ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -53.54 -177.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 110.156 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 215' ' ' MET . 5.2 t0 60.36 150.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.138 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.42 ' C ' ' HG3' ' A' ' 218' ' ' LYS . 1.0 OUTLIER 52.73 97.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.107 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 179.32 48.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.217 -0.927 . . . . 0.0 110.481 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 36.9 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.94 0.876 . . . . 0.0 109.472 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.43 -37.4 0.14 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.407 0.622 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.534 ' HD3' ' CG ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.44 -166.49 1.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 110.321 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -137.59 64.25 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 110.219 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.534 ' CG ' ' HD3' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 175.74 141.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.351 -0.843 . . . . 0.0 109.957 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.906 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -160.93 173.71 37.44 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.12 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -91.44 177.75 6.14 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.473 -1.016 . . . . 0.0 110.758 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.641 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -127.82 119.88 26.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 109.295 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -95.74 -170.36 2.12 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.38 -1.45 . . . . 0.0 110.058 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -165.27 137.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 210' ' ' SER . 7.5 t -110.39 144.38 39.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.121 -1.612 . . . . 0.0 110.096 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.796 ' CD2' HG23 ' A' ' 236' ' ' VAL . 23.0 m-30 -103.71 -149.89 0.41 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.328 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -69.12 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 111.88 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.8 mm-40 -86.09 -68.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 111.116 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 1.4 pt-20 164.24 -27.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.221 1.01 . . . . 0.0 109.152 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.69 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 mt-10 -55.32 -45.05 99.92 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -53.24 -28.77 43.84 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.689 0.836 . . . . 0.0 110.586 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 184' ' ' ILE . 34.2 t -80.99 -35.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.826 -1.171 . . . . 0.0 108.433 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.7 ttpt -45.2 -46.79 12.44 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.394 1.092 . . . . 0.0 108.287 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -61.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 205' ' ' PHE . 10.1 mm -43.5 -66.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.314 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -45.36 -37.38 4.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 110.013 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -59.58 -13.77 10.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.769 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -130.7 48.55 2.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -26.59 -33.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.656 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -116.37 91.2 3.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.338 -1.476 . . . . 0.0 110.274 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.769 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 2.3 m80 -98.5 -145.82 0.32 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 16.2 p30 -142.59 139.62 31.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 50.1 t -150.4 125.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.93 62.68 5.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 83.4 mt 50.09 23.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -1.175 . . . . 0.0 110.523 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.8 t -132.67 151.5 51.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.139 -0.975 . . . . 0.0 109.704 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.656 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 2.3 ptpt -107.41 44.55 1.07 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.866 -1.146 . . . . 0.0 110.505 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.8 p -35.98 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.808 -0.558 . . . . 0.0 109.719 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.62 171.09 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.418 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -147.66 91.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.983 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.562 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 25.0 mttt -100.08 114.92 28.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -38.3 166.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.03 0.919 . . . . 0.0 112.346 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.666 -0.646 . . . . 0.0 109.845 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.685 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.676 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.5 pp -131.39 171.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.674 ' CD2' ' HB3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -131.5 134.61 46.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.996 -1.065 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 252' ' ' CYS . 21.9 t -111.09 154.19 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.431 0.634 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.535 ' N ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.888 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.769 ' CB ' HD22 ' A' ' 213' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -61.85 58.22 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.52 1.274 . . . . 0.0 111.664 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -37.28 -66.79 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 111.662 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.4 OUTLIER -47.12 -41.46 17.49 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.014 -177.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -75.92 -27.93 57.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.94 -53.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.8 ttt-85 -53.96 -39.51 66.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 5.0 mm-40 -55.2 -41.13 71.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.726 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.469 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.8 t80 -91.67 -71.33 0.64 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.736 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.6 m-85 -53.38 -56.83 13.5 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.124 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.751 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -51.34 -24.1 9.9 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -66.45 -45.51 85.0 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 239' ' ' ILE . 76.6 m-85 -57.74 -29.71 65.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -1.212 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 177.89 141.64 4.27 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -42.71 141.64 1.02 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.261 . . . . 0.0 110.141 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.876 HG22 ' CE1' ' A' ' 230' ' ' PHE . 6.0 t -97.65 146.37 7.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.651 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -87.96 -56.89 3.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.63 163.35 40.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.617 ' CD1' HD21 ' A' ' 213' ' ' LEU . 1.8 pp -112.66 -171.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.47 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.614 ' O ' HD23 ' A' ' 213' ' ' LEU . 8.3 tp10 -151.48 138.62 19.21 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.031 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.769 HD22 ' CB ' ' A' ' 193' ' ' THR . 15.0 mt -112.39 -175.95 0.35 Allowed Pre-proline 0 C--N 1.295 -1.798 0 O-C-N 120.467 -1.396 . . . . 0.0 109.253 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.303 -1.817 0 O-C-N 123.155 1.081 . . . . 0.0 110.836 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.586 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.509 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -146.07 120.08 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 120.803 -1.185 . . . . 0.0 108.662 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.2 m-85 -96.98 -169.56 1.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.39 -1.444 . . . . 0.0 110.379 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -165.96 134.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 210' ' ' SER . 7.9 t -109.88 143.9 39.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.187 -1.571 . . . . 0.0 109.62 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.876 ' CE1' HG22 ' A' ' 208' ' ' VAL . 22.4 m-85 -111.36 -139.14 0.38 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.121 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -67.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.065 -1.022 . . . . 0.0 112.957 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 1.2 tp10 -70.48 -85.17 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.026 -1.046 . . . . 0.0 113.586 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER 161.21 -27.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 122.192 0.996 . . . . 0.0 108.426 -178.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.607 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.7 OUTLIER -55.77 -53.21 65.4 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -53.16 -43.37 57.77 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.893 0.943 . . . . 0.0 110.561 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 184' ' ' ILE . 2.1 t -52.78 -46.29 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.1 tttt -47.61 -44.15 26.33 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.106 -1.038 . . . . 0.0 108.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -70.84 -64.22 0.95 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 110.035 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.657 HG21 HG21 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -44.36 -64.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.579 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -44.68 -35.6 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.136 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 7.9 tp10 -65.51 -6.71 11.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.121 -0.987 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.618 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -136.31 51.03 2.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 0.0 109.258 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.6 mtpt -29.21 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.616 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -116.44 82.81 1.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.406 -1.434 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.712 ' NE2' HG21 ' A' ' 254' ' ' ILE . 7.4 m-70 -89.71 -151.82 0.24 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.0 -1.063 . . . . 0.0 110.096 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.469 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 1.7 t30 -143.63 142.83 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.784 . . . . 0.0 109.677 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 249' ' ' LEU . 58.9 t -135.02 116.77 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.064 -1.023 . . . . 0.0 110.474 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 55.06 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.3 OUTLIER -133.51 30.64 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 3.7 m -150.19 153.18 35.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.95 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.616 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.8 OUTLIER -119.53 54.43 1.0 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.142 -0.974 . . . . 0.0 110.595 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 186' ' ' VAL . 61.3 m -42.01 167.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.36 -0.838 . . . . 0.0 109.738 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.942 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.2 OUTLIER -86.79 170.52 11.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.086 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.942 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -147.6 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.284 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.674 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.69 112.4 24.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -38.74 166.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.878 0.847 . . . . 0.0 112.42 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.561 -0.712 . . . . 0.0 110.286 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.051 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -130.32 167.46 25.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.449 -1.3 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -125.89 134.7 51.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 53.1 t -111.78 122.59 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.524 -0.735 . . . . 0.0 110.537 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.557 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.083 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.699 HG21 ' HD2' ' A' ' 214' ' ' PRO . 46.6 p . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.93 49.06 1.51 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.549 1.5 . . . . 0.0 112.533 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -37.2 -66.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.0 -1.063 . . . . 0.0 111.63 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.57 -41.98 22.72 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.849 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 10.1 mttt -74.13 -28.4 61.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.46 -54.93 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.1 mpp_? -53.1 -37.44 61.72 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.7 mm-40 -62.97 -36.26 82.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.65 -71.46 0.64 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.544 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.634 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.2 m-85 -57.03 -51.43 69.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.424 -0.911 . . . . 0.0 108.71 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.776 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.25 -20.72 29.99 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.42 57.63 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.914 ' CD1' HD11 ' A' ' 239' ' ' ILE . 75.3 m-85 -56.15 -36.32 68.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -1.193 . . . . 0.0 108.911 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.58 139.21 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -41.43 141.57 0.71 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -1.15 . . . . 0.0 109.808 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.776 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.7 t -100.43 151.29 5.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.51 -0.743 . . . . 0.0 110.482 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 231' ' ' LYS . 20.5 tp10 -87.59 -54.46 4.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -153.47 173.66 15.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.818 HD13 ' CD2' ' A' ' 213' ' ' LEU . 2.4 pp -123.93 -172.02 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 120.556 -1.34 . . . . 0.0 109.554 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.599 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.9 tp10 -150.4 122.36 8.2 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 108.882 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.818 ' CD2' HD13 ' A' ' 211' ' ' ILE . 1.2 mm? -102.54 173.05 3.77 Favored Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 120.324 -1.485 . . . . 0.0 111.16 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.699 ' HD2' HG21 ' A' ' 193' ' ' THR . 3.1 Cg_exo . . . . . 0 C--N 1.306 -1.661 0 O-C-N 124.075 1.566 . . . . 0.0 110.871 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 121.976 0.894 . . . . 0.0 111.71 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.682 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.4 p -128.64 118.31 22.69 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -94.37 -166.53 1.5 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.487 -1.383 . . . . 0.0 110.394 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 0.9 OUTLIER -168.0 138.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.9 t -115.04 142.74 46.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 119.933 -1.729 . . . . 0.0 110.471 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 39.6 m-85 -104.17 -157.6 0.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HD2' ' OE1' ' A' ' 209' ' ' GLU . 4.9 tttm -106.9 -59.97 1.73 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.191 -0.943 . . . . 0.0 111.65 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 11.1 mt-10 -91.61 -70.98 0.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.048 -1.032 . . . . 0.0 111.421 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 165.45 -28.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.163 0.982 . . . . 0.0 109.426 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.72 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 16.9 tt0 -54.88 -44.58 99.54 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.72 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.9 Cg_exo -51.74 -33.76 51.27 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 122.774 0.881 . . . . 0.0 110.972 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.051 HG22 HG23 ' A' ' 184' ' ' ILE . 61.3 t -78.59 -32.67 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.791 -1.193 . . . . 0.0 108.864 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -47.86 -50.78 25.31 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.017 178.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 1.0 OUTLIER -69.29 -58.53 3.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.045 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.914 HD11 ' CD1' ' A' ' 205' ' ' PHE . 23.0 mm -48.57 -64.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.756 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -44.69 -32.47 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.707 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 9.9 tp10 -71.94 2.66 5.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 3.8 tptt -132.57 51.24 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 108.941 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -25.0 -40.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -117.56 102.36 9.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.523 -1.361 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.812 ' CD2' HD13 ' A' ' 254' ' ' ILE . 25.3 m-70 -89.64 -159.6 0.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -0.94 . . . . 0.0 110.92 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 250' ' ' SER . 1.6 t30 -141.33 125.25 17.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 246' ' ' ASN . 77.0 t -148.13 126.04 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.45 66.52 2.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.5 mt 46.35 38.69 5.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -1.148 . . . . 0.0 110.504 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 246' ' ' ASN . 1.4 t -146.28 -173.49 4.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.694 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -149.86 51.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.448 179.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.581 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.6 m -34.86 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.835 -0.541 . . . . 0.0 109.737 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.933 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -86.9 170.78 11.34 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.521 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.933 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.8 mp -149.76 101.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 118.401 -1.32 . . . . 0.0 112.798 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.8 OUTLIER -110.06 111.9 23.56 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -36.65 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.068 0.937 . . . . 0.0 112.805 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.657 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.252 0 O-C-N 121.582 -0.698 . . . . 0.0 110.171 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.688 ' HD3' ' CA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.836 ' CG2' HG22 ' A' ' 236' ' ' VAL . 2.2 pp -127.09 169.46 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.235 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.34 133.22 46.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 110.016 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 254' ' ' ILE . 39.6 t -109.2 125.8 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.391 -0.818 . . . . 0.0 110.484 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.559 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.529 HG21 ' HD2' ' A' ' 214' ' ' PRO . 29.1 p . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.13 46.87 1.2 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.604 1.536 . . . . 0.0 112.359 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.1 mt-10 -36.15 -66.46 0.21 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 0.0 110.977 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 5.4 tt0 -47.49 -41.83 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.874 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 17.8 mttt -75.32 -27.44 59.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.89 -53.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.35 -39.27 60.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 37.2 mm-40 -58.53 -39.77 81.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.487 -0.758 . . . . 0.0 110.032 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.3 t80 -91.3 -72.03 0.6 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.42 -1.712 . . . . 0.0 109.712 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.623 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.6 m-85 -54.42 -54.67 37.66 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.409 -0.916 . . . . 0.0 108.691 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.96 -22.98 29.61 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -66.73 -46.37 75.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.872 ' CD1' HD11 ' A' ' 239' ' ' ILE . 65.9 m-85 -53.55 -37.69 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -1.203 . . . . 0.0 108.451 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.22 143.69 6.36 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 3.0 pm0 -41.74 141.71 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -1.176 . . . . 0.0 110.009 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.851 HG23 ' HA2' ' A' ' 203' ' ' GLY . 14.7 t -102.1 154.67 5.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.483 -0.761 . . . . 0.0 110.52 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 231' ' ' LYS . 1.8 tt0 -87.84 -59.28 2.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.619 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.38 169.91 21.96 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 8.6 pt -119.16 -170.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.389 -1.324 . . . . 0.0 109.763 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.583 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.6 tp10 -150.6 124.08 9.02 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.669 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.1 mm? -101.64 174.18 3.08 Favored Pre-proline 0 C--N 1.293 -1.88 0 O-C-N 120.465 -1.397 . . . . 0.0 110.74 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.306 -1.703 0 O-C-N 123.707 1.372 . . . . 0.0 110.863 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.641 0.734 . . . . 0.0 110.995 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.616 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.3 116.45 19.13 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.26 -170.06 2.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.408 -1.433 . . . . 0.0 110.394 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.61 134.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.688 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.4 t -110.42 139.99 45.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.206 -1.559 . . . . 0.0 109.594 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 69.9 m-85 -101.36 -165.65 1.22 Allowed 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 19.2 tttt -92.21 -65.22 1.02 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -101.56 166.68 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -20.22 65.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 35.2 tt0 -54.81 -53.61 58.85 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.8 Cg_exo -44.42 -38.72 11.96 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 120.477 0.785 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.836 HG22 ' CG2' ' A' ' 184' ' ' ILE . 55.5 t -74.87 -34.06 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.734 -1.228 . . . . 0.0 109.25 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -46.31 -46.33 18.03 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.333 1.064 . . . . 0.0 108.22 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -62.7 1.29 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.949 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.872 HD11 ' CD1' ' A' ' 205' ' ' PHE . 25.2 mm -46.64 -65.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.485 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 239' ' ' ILE . 12.0 tpt -43.63 -33.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 110.052 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -67.54 -2.84 7.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.116 -0.99 . . . . 0.0 110.828 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.12 50.7 2.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 109.099 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -25.42 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.7 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.6 t80 -114.52 93.71 4.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.463 -1.398 . . . . 0.0 109.454 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.734 ' HD2' HD13 ' A' ' 254' ' ' ILE . 11.3 m-70 -91.19 -157.97 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 111.301 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 12.1 t-20 -141.07 139.8 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.797 -0.564 . . . . 0.0 109.621 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.41 113.32 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.003 -1.061 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 62.66 -87.08 0.05 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 2.2 mt -137.55 27.1 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.187 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.48 170.25 17.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.427 -0.796 . . . . 0.0 109.421 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.7 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -132.95 64.28 1.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.791 -1.193 . . . . 0.0 111.289 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.633 ' HB3' HG12 ' A' ' 186' ' ' VAL . 67.7 m -39.24 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.968 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -86.51 171.35 11.14 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.048 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -150.54 97.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.938 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.0 tttt -103.94 116.17 31.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.38 167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.168 0.985 . . . . 0.0 112.572 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.231 0 O-C-N 121.634 -0.667 . . . . 0.0 110.207 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.06 HG23 HG22 ' A' ' 236' ' ' VAL . 2.8 pt -131.58 172.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -133.23 132.71 41.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.955 -1.09 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 254' ' ' ILE . 26.2 t -105.95 127.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.424 -0.797 . . . . 0.0 110.395 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.538 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.079 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.617 HG21 ' HD2' ' A' ' 214' ' ' PRO . 9.5 p . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.738 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -73.47 113.75 3.86 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.513 1.475 . . . . 0.0 111.646 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.525 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -97.73 -70.56 0.72 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.01 0.909 . . . . 0.0 109.556 177.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -50.79 -47.5 59.79 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -63.82 -26.95 68.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -68.06 -60.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.4 tmm_? -50.34 -31.87 15.7 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -63.26 -41.05 98.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.708 178.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' GLY . 0.9 OUTLIER -90.89 -70.4 0.68 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.813 179.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.665 ' CD1' HD11 ' A' ' 184' ' ' ILE . 70.8 m-85 -54.07 -55.61 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.726 -0.79 . . . . 0.0 108.947 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.783 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.08 -22.64 29.27 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -67.33 -46.74 68.19 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 82.6 m-85 -56.3 -31.04 63.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.031 -1.276 . . . . 0.0 108.494 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.68 142.73 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.4 pm0 -42.87 143.81 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.048 -1.266 . . . . 0.0 109.824 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.817 HG22 ' CE2' ' A' ' 230' ' ' PHE . 11.8 t -105.12 154.26 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.396 -0.815 . . . . 0.0 110.874 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -88.33 -57.74 2.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 229' ' ' THR . 0.4 OUTLIER -153.4 170.24 21.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 42.6 pt -118.57 -169.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 118.549 -1.26 . . . . 0.0 110.021 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.0 tt0 -151.12 121.8 7.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.638 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -98.64 173.7 3.68 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.405 -1.434 . . . . 0.0 110.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.7 Cg_exo . . . . . 0 C--N 1.305 -1.721 0 O-C-N 123.753 1.396 . . . . 0.0 110.746 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 121.467 0.651 . . . . 0.0 110.389 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.659 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -131.57 118.19 19.77 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -96.21 -171.75 2.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.46 -1.4 . . . . 0.0 110.159 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.4 mt -163.91 137.52 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 210' ' ' SER . 7.0 t -113.17 146.3 39.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.079 -1.638 . . . . 0.0 110.253 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.817 ' CE2' HG22 ' A' ' 208' ' ' VAL . 44.0 m-85 -109.8 -164.86 0.96 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.583 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 232' ' ' GLU . 31.1 tttt -110.49 -65.78 1.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.477 0.656 . . . . 0.0 110.911 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 6.6 mt-10 -66.05 -67.68 0.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 110.842 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.9 OUTLIER 147.72 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-O 122.807 1.289 . . . . 0.0 107.666 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.689 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt-10 -54.74 -45.21 99.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -50.9 -21.5 8.61 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.496 0.735 . . . . 0.0 110.451 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.06 HG22 HG23 ' A' ' 184' ' ' ILE . 57.6 t -91.31 -35.33 6.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -48.21 -48.38 34.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -73.54 -61.58 1.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.962 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 184' ' ' ILE . 15.4 mm -43.56 -66.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.463 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.4 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -43.09 -44.49 4.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 110.386 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -59.17 -13.52 7.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.137 -0.977 . . . . 0.0 110.438 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -124.4 45.21 2.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' ILE . 4.6 ttmt -25.43 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -115.25 95.02 4.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.428 -1.42 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.771 ' HD2' HD13 ' A' ' 254' ' ' ILE . 1.6 m-70 -102.36 -145.91 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.997 -1.065 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 3.6 m-20 -145.09 145.32 31.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.0 109.538 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.55 108.3 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 110.415 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 249' ' ' LEU . . . 65.62 -86.01 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 248' ' ' GLY . 0.8 OUTLIER -142.62 28.92 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.102 . . . . 0.0 110.008 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.52 132.7 23.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -90.2 46.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.608 -179.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.539 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 29.1 p -35.57 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.575 -0.703 . . . . 0.0 109.783 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.945 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -87.43 173.14 9.3 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.419 -1.312 . . . . 0.0 108.668 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.945 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.26 94.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.406 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 17.7 ttmt -100.08 113.0 25.3 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.3 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.071 0.939 . . . . 0.0 112.686 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.487 0.661 . . . . 0.0 110.04 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.819 HG23 HG22 ' A' ' 236' ' ' VAL . 1.6 pp -132.2 -178.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.731 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.86 148.4 50.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 110.041 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 253' ' ' GLU . 24.1 t -120.55 124.94 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.079 -1.013 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.535 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.495 2.574 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.593 ' HB ' ' CG ' ' A' ' 213' ' ' LEU . 4.4 m . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' HD13 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.05 76.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 194' ' ' PRO . 1.8 mt-10 -36.45 -40.5 0.24 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.482 -0.761 . . . . 0.0 110.128 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.1 -53.31 39.64 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 117.937 -1.505 . . . . 0.0 108.519 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 12.3 ttmt -69.78 -28.63 65.91 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 211' ' ' ILE . 1.1 tp -64.18 -51.2 71.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.63 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -54.38 -33.25 58.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -61.61 -40.51 95.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 245' ' ' HIS . 3.3 t80 -91.02 -68.8 0.77 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.529 -1.669 . . . . 0.0 109.449 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 198' ' ' ILE . 77.9 m-85 -58.33 -52.34 66.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.72 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -57.25 -25.63 54.74 Favored Glycine 0 N--CA 1.481 1.678 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -59.5 -44.82 96.41 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.662 ' CD2' HD11 ' A' ' 239' ' ' ILE . 78.9 m-85 -61.34 -40.08 92.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.167 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.46 140.22 6.15 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.7 OUTLIER -42.63 143.12 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.251 . . . . 0.0 110.122 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 230' ' ' PHE . 14.2 t -110.24 152.54 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 110.728 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 1.1 tp10 -88.32 -58.51 2.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 229' ' ' THR . 1.7 m -153.14 163.58 39.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 198' ' ' ILE . 2.2 pp -111.59 -171.27 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.176 -1.409 . . . . 0.0 110.351 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.875 ' N ' HD12 ' A' ' 211' ' ' ILE . 22.7 tt0 -152.69 139.65 19.13 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.452 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.671 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 4.0 mt -99.28 -177.93 0.64 Allowed Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.5 Cg_exo . . . . . 0 C--N 1.308 -1.588 0 O-C-N 122.627 0.804 . . . . 0.0 110.145 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.7 p90 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 10.3 p -138.19 129.62 27.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -95.62 -175.56 3.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.569 -1.332 . . . . 0.0 109.203 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 198' ' ' ILE . 1.7 mt -161.58 133.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 210' ' ' SER . 7.7 t -110.49 143.66 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.166 -1.584 . . . . 0.0 110.299 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.769 ' CE2' HG22 ' A' ' 208' ' ' VAL . 63.5 m-85 -104.68 -126.41 0.23 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.61 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.92 -56.09 0.55 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.654 -1.279 . . . . 0.0 111.182 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 2.1 tt0 -92.8 -69.75 0.73 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.018 -1.051 . . . . 0.0 110.145 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 2.0 pt-20 165.88 -31.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.238 1.018 . . . . 0.0 108.914 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.682 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -48.58 -48.91 67.41 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -51.03 -36.18 53.27 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 122.667 0.825 . . . . 0.0 110.522 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 184' ' ' ILE . 3.6 t -67.62 -41.96 86.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 108.333 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.58 -46.08 9.8 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.278 1.037 . . . . 0.0 108.741 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB3' ' CD1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -71.82 -63.33 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.916 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 205' ' ' PHE . 31.4 mm -44.23 -64.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.393 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -46.18 -34.15 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.958 . . . . 0.0 109.476 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 15.0 tt0 -80.05 10.17 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 110.522 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.584 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.5 mmtt -131.28 49.03 2.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 108.987 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 242' ' ' LYS . 1.4 tmmm? -26.55 -39.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.686 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -123.56 104.59 9.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.624 -1.298 . . . . 0.0 109.616 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.744 ' CD2' HD13 ' A' ' 254' ' ' ILE . 36.5 m-70 -89.6 -174.6 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.951 . . . . 0.0 110.663 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 250' ' ' SER . 3.8 m120 -133.92 119.19 18.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.523 -0.736 . . . . 0.0 109.494 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 250' ' ' SER . 54.5 t -145.59 131.56 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.997 -1.064 . . . . 0.0 110.57 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.04 65.3 2.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 249' ' ' LEU . 6.8 mp 48.24 28.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -1.159 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 69.8 m -136.3 171.57 14.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.048 -1.032 . . . . 0.0 109.762 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.686 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -150.47 53.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 111.313 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.56 ' HB2' HG12 ' A' ' 186' ' ' VAL . 24.0 p -39.05 161.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 109.405 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.869 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.52 168.57 13.59 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.043 -1.463 . . . . 0.0 108.01 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.869 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.26 109.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 117.942 -1.503 . . . . 0.0 113.548 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tttp -99.18 -154.67 0.47 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 7.0 p -122.64 168.41 15.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.309 -1.495 . . . . 0.0 110.448 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.878 . . . . 0.0 110.654 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.675 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.067 HG23 HG22 ' A' ' 236' ' ' VAL . 3.8 pt -130.22 176.99 7.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 118.317 -1.353 . . . . 0.0 110.48 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.72 117.82 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.775 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 22.3 t -89.62 119.08 36.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.541 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.417 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.761 ' CB ' HD12 ' A' ' 213' ' ' LEU . 94.8 m . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.6 Cg_endo -68.06 71.98 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.756 1.398 . . . . 0.0 112.158 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.72 -64.55 0.34 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.479 -0.763 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 1.8 tt0 -46.28 -43.67 15.88 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.083 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 2.5 tttt -74.64 -29.06 61.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.3 tp -62.24 -53.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.615 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.5 mtt180 -52.43 -37.48 56.89 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 2.4 mm-40 -59.59 -38.39 81.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.909 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.55 -70.86 0.67 Allowed 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.591 ' CD2' HG13 ' A' ' 198' ' ' ILE . 91.2 m-85 -56.6 -53.24 59.9 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.893 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.44 -21.5 27.53 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.46 70.73 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.927 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.8 m-85 -56.72 -40.84 76.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -1.209 . . . . 0.0 108.896 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.32 138.03 4.95 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 206' ' ' GLY . 1.1 pm0 -41.83 142.36 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -1.185 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.805 HG23 ' HA2' ' A' ' 203' ' ' GLY . 18.5 t -102.98 152.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.419 -0.8 . . . . 0.0 110.951 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.1 tt0 -88.12 -55.89 3.56 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.7 ' O ' HG22 ' A' ' 229' ' ' THR . 3.4 m -153.59 169.0 24.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 2.4 pt -118.63 -171.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.528 -1.357 . . . . 0.0 110.137 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 11.5 tp10 -151.51 130.82 12.83 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.106 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.849 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.4 mm? -101.87 176.99 1.61 Allowed Pre-proline 0 C--N 1.295 -1.762 0 O-C-N 120.528 -1.357 . . . . 0.0 109.829 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.849 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.327 1.172 . . . . 0.0 110.457 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.555 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.4 p90 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.616 0.722 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.553 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -165.07 117.37 1.19 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.82 . . . . 0.0 108.83 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.82 -174.8 3.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.476 -1.39 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.2 mt -164.03 133.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 210' ' ' SER . 6.0 t -106.18 141.97 36.65 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.221 -1.549 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.76 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.8 m-85 -100.65 -142.68 0.34 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.198 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -123.23 -58.56 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.837 -1.165 . . . . 0.0 111.674 -178.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 8.8 mt-10 -92.24 -70.08 0.71 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 110.725 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 163.76 -27.61 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.461 1.124 . . . . 0.0 108.895 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.705 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 tt0 -57.93 -42.6 96.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.705 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -52.74 -31.44 50.93 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.496 0.735 . . . . 0.0 110.304 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 184' ' ' ILE . 37.2 t -76.74 -36.82 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.741 -1.224 . . . . 0.0 108.121 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -44.5 -46.75 9.93 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.468 1.128 . . . . 0.0 108.25 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.84 -61.26 1.85 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.892 0.853 . . . . 0.0 109.869 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.927 HD11 ' CD1' ' A' ' 205' ' ' PHE . 15.4 mm -45.63 -65.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.482 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -48.21 -31.15 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.55 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 70.8 tt0 -66.41 -5.26 10.29 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.932 -1.105 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.26 52.88 1.45 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 0.0 109.355 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 33.6 ttpt -26.32 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -107.59 90.74 3.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.334 -1.479 . . . . 0.0 110.456 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.773 ' HD2' HD13 ' A' ' 254' ' ' ILE . 11.9 m-70 -95.11 -164.09 1.12 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.254 -0.904 . . . . 0.0 110.703 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 13.2 m120 -137.1 143.99 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.639 -0.663 . . . . 0.0 109.629 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.45 99.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.07 . . . . 0.0 110.323 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 67.28 -83.61 0.13 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.17 24.41 2.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -1.145 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 4.1 m -143.95 134.52 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.79 56.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.063 . . . . 0.0 110.895 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 33.9 m -41.34 162.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.287 -0.883 . . . . 0.0 109.065 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.956 ' C ' HD12 ' A' ' 254' ' ' ILE . 2.2 pt-20 -88.1 175.7 7.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.575 -1.328 . . . . 0.0 108.293 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.956 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -149.2 108.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.426 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 1.2 tttt -114.6 110.56 19.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -37.55 167.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.114 0.959 . . . . 0.0 112.918 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.315 0 O-C-N 121.764 -0.585 . . . . 0.0 109.762 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.718 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 239' ' ' ILE . 1.1 pt -128.78 178.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 117.593 -1.643 . . . . 0.0 110.734 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.624 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -147.35 119.24 8.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.951 -1.093 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 254' ' ' ILE . 95.0 t -89.2 121.7 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.573 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . . . . . . 0 N--CA 1.497 2.732 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.949 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.657 HG21 ' HD2' ' A' ' 214' ' ' PRO . 44.9 p . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.653 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.89 47.18 1.19 Allowed 'Trans proline' 0 C--O 1.204 -1.224 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -37.33 -71.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.959 -1.088 . . . . 0.0 112.315 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -47.25 -40.49 16.67 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.299 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 13.2 mmtt -75.84 -26.58 57.29 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.781 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -67.37 -55.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 42.7 ttt-85 -56.94 -34.68 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.9 mm-40 -57.97 -46.78 84.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 110.182 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.45 -71.05 0.64 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 117.377 -1.729 . . . . 0.0 109.657 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.651 ' CD2' HG13 ' A' ' 198' ' ' ILE . 11.4 m-30 -51.29 -51.33 55.19 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.177 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.62 -21.18 27.49 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.24 -45.73 29.83 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 239' ' ' ILE . 73.6 m-85 -54.35 -28.1 40.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -1.187 . . . . 0.0 108.361 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.91 129.45 1.3 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.0 OUTLIER -39.84 141.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -1.098 . . . . 0.0 110.199 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 211' ' ' ILE . 2.6 t -91.17 140.46 15.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.587 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -87.53 -47.02 9.06 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 176.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.767 ' O ' HG22 ' A' ' 229' ' ' THR . 35.2 m -153.19 161.31 42.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 195' ' ' GLU . 4.4 pt -118.58 -166.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.037 -1.465 . . . . 0.0 110.638 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.96 130.52 12.24 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.972 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.68 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 3.0 mm? -111.78 172.7 3.34 Favored Pre-proline 0 C--N 1.292 -1.92 0 O-C-N 120.614 -1.304 . . . . 0.0 108.595 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.68 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.299 -2.039 0 O-C-N 123.366 1.193 . . . . 0.0 110.938 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 3.6 p90 . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.4 0.619 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.536 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 14.8 p -139.26 131.07 27.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.318 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.713 ' HB2' ' HB3' ' A' ' 212' ' ' GLU . 2.3 m-85 -97.25 -173.33 2.64 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.114 -1.616 . . . . 0.0 108.875 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.781 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -163.34 132.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 210' ' ' SER . 13.3 t -111.2 150.49 29.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.423 -1.423 . . . . 0.0 110.253 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.52 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 66.9 m-85 -118.93 -116.04 0.32 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.048 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -47.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.815 -1.178 . . . . 0.0 111.654 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -83.75 -101.18 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.916 -1.115 . . . . 0.0 111.366 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 176.05 -27.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 109.844 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.8 mt-10 -59.49 -49.56 91.69 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 112.6 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -53.25 -22.68 20.81 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 122.923 0.959 . . . . 0.0 111.563 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.435 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.1 t -79.37 -48.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.83 -41.29 10.92 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.191 0.996 . . . . 0.0 108.653 178.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 1.1 tttm -71.22 -64.62 0.88 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.856 0.836 . . . . 0.0 110.332 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -50.96 -62.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.825 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.658 ' N ' HG22 ' A' ' 239' ' ' ILE . 3.5 tmm? -44.3 -32.79 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 110.333 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -65.3 -5.89 8.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.019 -1.051 . . . . 0.0 110.599 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.587 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -137.69 51.7 1.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.134 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 254' ' ' ILE . 3.0 ttmt -25.02 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -106.75 91.94 3.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.478 -1.388 . . . . 0.0 109.567 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.831 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.4 m-70 -89.64 -159.61 0.6 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.07 -1.018 . . . . 0.0 110.83 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.459 ' C ' HG23 ' A' ' 247' ' ' VAL . 9.4 t-20 -136.59 128.57 29.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 250' ' ' SER . 44.4 t -146.36 136.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.925 -1.109 . . . . 0.0 110.634 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 42.55 70.93 0.43 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.3 OUTLIER 42.51 35.75 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -144.87 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -137.19 46.87 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.005 . . . . 0.0 110.583 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.62 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 63.6 m -40.07 157.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.887 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.9 pt-20 -87.92 165.51 15.19 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 117.618 -1.633 . . . . 0.0 107.568 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.37 110.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.168 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 8.5 tttt -100.98 113.82 27.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -40.6 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 111.912 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.658 -0.651 . . . . 0.0 109.848 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.89 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -138.22 169.53 18.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.035 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.634 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -115.39 155.33 27.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.931 -1.105 . . . . 0.0 109.573 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 61.7 t -134.82 136.35 52.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.198 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.434 ' HA3' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 213' ' ' LEU . 62.9 p . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -66.92 43.23 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.467 1.444 . . . . 0.0 113.255 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -37.94 -66.68 0.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.886 -1.134 . . . . 0.0 111.523 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.6 mm-40 -47.59 -43.44 25.58 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.182 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 5.7 mttt -73.97 -25.45 59.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 0.6 OUTLIER -65.76 -56.61 14.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -51.17 -37.33 45.84 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.4 mm-40 -60.53 -40.05 90.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.675 . . . . 0.0 109.905 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.21 -72.27 0.59 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.497 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 198' ' ' ILE . 79.4 m-85 -53.53 -53.37 52.61 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.472 -0.891 . . . . 0.0 108.982 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.726 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.68 -21.97 30.97 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -70.01 -45.7 55.49 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 239' ' ' ILE . 82.0 m-85 -57.06 -34.75 68.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -1.222 . . . . 0.0 108.886 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.83 139.41 4.63 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.5 OUTLIER -41.31 142.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -1.104 . . . . 0.0 109.983 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.726 HG23 ' HA2' ' A' ' 203' ' ' GLY . 7.6 t -101.76 148.52 7.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 44.1 tt0 -87.95 -53.27 4.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 229' ' ' THR . 3.7 m -153.54 168.67 25.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 12.0 pt -121.54 -170.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.538 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.7 tt0 -150.8 130.51 13.15 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.78 HD13 ' OG1' ' A' ' 193' ' ' THR . 13.4 mt -106.78 178.75 1.02 Allowed Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 120.786 -1.196 . . . . 0.0 109.591 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.766 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.0 Cg_exo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 123.212 1.112 . . . . 0.0 111.1 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.2 p -142.26 116.6 9.57 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 120.96 -1.087 . . . . 0.0 108.632 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.5 m-85 -92.79 -165.78 1.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.647 -1.283 . . . . 0.0 109.642 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -168.25 139.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 210' ' ' SER . 8.1 t -113.25 145.62 40.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.065 -1.647 . . . . 0.0 110.118 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.9 m-30 -109.56 -125.02 0.26 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.738 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 209' ' ' GLU . 7.5 tttt -174.7 -50.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.104 -0.997 . . . . 0.0 109.866 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.9 mt-10 -71.48 -26.44 62.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -0.801 . . . . 0.0 109.117 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 88.52 -27.12 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 122.843 1.306 . . . . 0.0 108.377 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 8.4 mt-10 -65.06 -39.32 35.86 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.767 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.1 Cg_exo -54.83 -24.83 40.23 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 N-CA-C 109.618 -0.955 . . . . 0.0 109.618 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.89 HG22 ' CG2' ' A' ' 184' ' ' ILE . 16.2 t -81.12 -41.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 236' ' ' VAL . 1.8 tptt -42.85 -45.77 5.03 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.423 1.106 . . . . 0.0 108.348 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.9 OUTLIER -72.31 -62.2 1.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.856 0.836 . . . . 0.0 109.722 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.495 HG23 HG21 ' A' ' 254' ' ' ILE . 8.2 mm -43.94 -65.44 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.329 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.2 OUTLIER -43.63 -37.85 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 5.2 tt0 -63.3 -8.95 9.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.129 -0.982 . . . . 0.0 110.644 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.609 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.22 51.52 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 10.1 ttmt -26.96 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.629 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.27 100.78 8.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.442 . . . . 0.0 110.015 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.776 ' HD2' HD13 ' A' ' 254' ' ' ILE . 4.2 m-70 -102.35 -158.32 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.156 -0.965 . . . . 0.0 110.773 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -139.19 149.14 44.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.519 -0.738 . . . . 0.0 109.958 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 249' ' ' LEU . 37.9 t -143.67 123.15 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.41 -93.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -131.71 32.78 4.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 110.088 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.9 m -149.98 155.74 40.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.629 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.96 56.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 111.072 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 30.3 p -37.19 156.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.724 . . . . 0.0 109.835 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.0 pm0 -88.34 172.42 9.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.624 -1.231 . . . . 0.0 108.973 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -146.25 129.42 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.509 -1.276 . . . . 0.0 112.155 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HG2' ' CE1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -137.42 104.92 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.9 p -34.48 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.094 0.949 . . . . 0.0 113.171 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.676 -0.64 . . . . 0.0 109.651 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.692 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.865 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -133.35 179.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.92 130.46 35.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.987 -1.071 . . . . 0.0 110.236 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 59.3 t -102.62 122.23 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 110.304 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.057 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.594 ' HB ' HD22 ' A' ' 213' ' ' LEU . 43.8 p . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -71.73 103.65 1.49 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.411 1.407 . . . . 0.0 111.399 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.609 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -94.44 -66.72 0.9 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.882 0.849 . . . . 0.0 110.201 178.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 5.4 tm-20 -50.14 -46.03 53.63 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.657 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -67.49 -26.12 66.2 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -66.35 -58.94 4.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.719 ' N ' HG22 ' A' ' 198' ' ' ILE . 50.2 ttt180 -53.05 -34.64 57.39 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 15.2 mm-40 -59.88 -41.94 92.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.34 -69.96 0.71 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.43 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -54.47 -53.99 46.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.767 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.52 -21.59 28.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.92 -46.1 54.08 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 239' ' ' ILE . 80.8 m-85 -55.98 -38.01 69.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.951 -1.323 . . . . 0.0 108.847 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -173.31 142.04 6.43 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' OE2' ' CD ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -42.39 142.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -1.198 . . . . 0.0 110.095 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.767 HG23 ' HA2' ' A' ' 203' ' ' GLY . 13.3 t -103.06 151.9 6.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 110.689 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 29.2 tp10 -87.8 -61.05 1.8 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 4.0 m -153.72 161.1 42.41 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 16.6 pt -106.46 -168.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.236 -1.386 . . . . 0.0 109.714 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.2 tt0 -150.91 131.41 13.82 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.745 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.702 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 11.2 mt -102.7 177.53 1.44 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.309 1.163 . . . . 0.0 111.039 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.525 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 121.496 0.665 . . . . 0.0 110.815 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -127.61 119.74 26.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.651 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -91.78 -169.34 2.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 110.147 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 198' ' ' ILE . 1.5 mt -164.34 133.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 5.8 t -109.7 141.56 42.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 119.834 -1.791 . . . . 0.0 109.879 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.73 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.2 m-30 -98.28 -140.3 0.3 Allowed 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' CD ' ' OE2' ' A' ' 207' ' ' GLU . 74.4 tttt -126.83 -54.85 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.936 -1.103 . . . . 0.0 111.41 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.6 mt-10 -97.4 -68.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.013 -1.054 . . . . 0.0 110.481 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 162.35 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.173 0.987 . . . . 0.0 108.997 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.699 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -56.43 -43.5 99.33 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.65 -32.24 53.72 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 122.663 0.822 . . . . 0.0 110.649 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 184' ' ' ILE . 40.6 t -77.67 -34.5 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.262 . . . . 0.0 108.226 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -44.88 -48.15 11.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.281 1.038 . . . . 0.0 108.454 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -61.27 1.83 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.868 0.842 . . . . 0.0 109.731 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.7 mm -44.93 -66.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.464 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -41.23 -42.24 2.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.483 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -58.03 -14.0 5.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.095 -1.003 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.591 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -132.26 48.25 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.8 ttmt -26.95 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.614 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.4 t80 -112.13 96.58 6.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.533 -1.354 . . . . 0.0 110.081 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.796 ' HD2' HD13 ' A' ' 254' ' ' ILE . 1.6 m-70 -103.34 -150.81 0.42 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.07 -1.019 . . . . 0.0 110.569 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -130.0 141.48 50.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.555 -0.716 . . . . 0.0 109.648 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 250' ' ' SER . 40.7 t -150.28 118.69 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 0.0 110.816 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 39.76 76.71 0.08 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 4.6 mt 44.95 24.0 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -1.206 . . . . 0.0 110.85 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 247' ' ' VAL . 17.4 m -143.6 122.17 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.101 -0.999 . . . . 0.0 109.216 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.614 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.4 pttt -89.61 52.47 2.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.089 -1.007 . . . . 0.0 110.958 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 22.0 p -38.81 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.2 pt-20 -87.59 168.78 12.73 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.847 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -142.74 95.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.025 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.33 110.14 22.77 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.1 p -39.85 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.879 -1.138 . . . . 0.0 112.045 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.602 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.554 -0.716 . . . . 0.0 110.441 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.745 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.687 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.4 pt -125.93 162.3 29.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.891 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.66 135.82 50.75 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.027 -1.045 . . . . 0.0 110.723 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 252' ' ' CYS . 17.6 t -109.44 137.81 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.575 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.486 2.019 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.82 HG21 ' CD1' ' A' ' 213' ' ' LEU . 98.1 m . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.62 64.41 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.335 1.357 . . . . 0.0 112.105 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.58 -69.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.444 -0.785 . . . . 0.0 112.002 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 25.4 tt0 -45.92 -41.25 11.28 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.281 -176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -75.71 -30.05 59.17 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -62.94 -51.8 67.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.613 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -56.28 -38.49 71.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -55.98 -40.08 72.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.88 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -70.59 0.68 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.563 -1.655 . . . . 0.0 110.006 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 184' ' ' ILE . 39.3 m-85 -57.19 -53.03 62.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.53 -0.731 . . . . 0.0 109.649 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.853 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.67 -23.02 12.9 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.56 55.89 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 239' ' ' ILE . 86.1 m-85 -57.02 -27.89 62.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.952 -1.323 . . . . 0.0 108.711 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 235' ' ' PRO . . . -179.13 133.7 2.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 15.1 pt-20 -40.98 142.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.911 HG22 ' CD1' ' A' ' 230' ' ' PHE . 10.7 t -97.32 145.53 9.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.449 -0.782 . . . . 0.0 110.847 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -87.81 -53.31 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.709 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.74 167.72 28.66 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 176.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 38.5 pt -112.38 -168.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 118.357 -1.337 . . . . 0.0 109.835 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -151.48 125.62 9.28 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 213' ' ' LEU . 2.5 mm? -108.32 174.53 2.41 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.343 -1.473 . . . . 0.0 110.348 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 2.9 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 O-C-N 123.675 1.355 . . . . 0.0 111.212 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 121.147 0.498 . . . . 0.0 110.206 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -126.18 119.25 27.02 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.9 m-85 -96.22 -165.36 1.27 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.497 -1.377 . . . . 0.0 110.757 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.602 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -169.71 134.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 210' ' ' SER . 6.5 t -112.31 143.64 43.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.849 -1.782 . . . . 0.0 109.627 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 208' ' ' VAL . 21.1 m-85 -108.9 -134.33 0.34 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.156 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 232' ' ' GLU . 2.7 tptt -128.2 -69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.06 -1.025 . . . . 0.0 113.276 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.9 mt-10 -73.82 -80.5 0.07 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.87 -1.144 . . . . 0.0 113.535 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.2 OUTLIER 161.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 122.111 0.958 . . . . 0.0 109.087 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 15.1 mm-40 -56.4 -55.99 36.53 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -51.62 -40.68 63.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.86 0.926 . . . . 0.0 110.682 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -55.21 -48.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.6 -1.313 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.87 -42.37 7.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -70.17 -62.68 1.29 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.868 0.842 . . . . 0.0 109.724 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.1 mm -45.6 -64.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.121 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -43.06 -37.17 1.87 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 110.191 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -9.02 11.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.114 -0.991 . . . . 0.0 110.658 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.1 mmtt -132.55 47.58 2.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.335 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 254' ' ' ILE . 12.0 ttmt -29.62 -32.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.632 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.6 t80 -117.57 86.99 2.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.27 -1.518 . . . . 0.0 110.39 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.702 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.6 m-70 -93.03 -144.78 0.22 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.967 -1.083 . . . . 0.0 110.061 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.0 OUTLIER -143.04 135.37 27.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.761 . . . . 0.0 109.384 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.435 HG23 ' C ' ' A' ' 246' ' ' ASN . 60.1 t -147.53 133.32 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.908 -1.12 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 250' ' ' SER . . . 41.86 62.5 1.97 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.43 24.62 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -1.209 . . . . 0.0 110.546 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 248' ' ' GLY . 0.7 OUTLIER -137.26 128.43 27.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.1 -1.0 . . . . 0.0 109.594 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.632 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.26 44.42 1.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 0.0 110.552 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 186' ' ' VAL . 26.7 p -37.27 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.604 -0.685 . . . . 0.0 109.44 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.957 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.86 172.05 10.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.226 -1.389 . . . . 0.0 108.458 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.957 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -149.24 91.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.836 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.2 tttt -98.86 113.99 26.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -36.87 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.837 0.827 . . . . 0.0 112.122 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.141 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.709 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.682 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.8 pp -124.64 172.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.328 -1.349 . . . . 0.0 110.653 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.68 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.33 124.14 18.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.308 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 254' ' ' ILE . 17.3 t -96.84 108.3 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HD12 ' A' ' 213' ' ' LEU . 50.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.497 0.189 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -71.24 83.94 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.819 1.431 . . . . 0.0 111.237 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -36.55 -63.18 0.42 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.593 -0.692 . . . . 0.0 111.145 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -47.58 -44.11 26.01 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.108 -177.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 18.4 tttm -75.53 -27.16 58.59 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 211' ' ' ILE . 1.3 tp -64.56 -52.06 59.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.609 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.8 OUTLIER -54.13 -38.35 65.35 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.7 mt-10 -56.34 -41.34 75.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.95 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 3.7 t80 -90.94 -69.9 0.71 Allowed 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.479 -1.689 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.593 ' CD2' HG13 ' A' ' 198' ' ' ILE . 74.4 m-85 -57.74 -54.11 50.56 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.373 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.1 -24.9 16.34 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -63.23 -45.86 94.33 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 239' ' ' ILE . 70.3 m-85 -57.0 -33.51 67.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -1.135 . . . . 0.0 108.68 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.58 140.26 4.69 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 2.6 pt-20 -42.45 142.19 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -1.176 . . . . 0.0 110.091 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.853 HG22 ' CE1' ' A' ' 230' ' ' PHE . 8.3 t -99.92 146.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.519 -0.738 . . . . 0.0 111.131 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -88.71 -55.7 3.6 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.617 ' O ' HG22 ' A' ' 229' ' ' THR . 4.8 m -153.34 161.89 41.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 198' ' ' ILE . 4.8 pt -114.43 -170.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.209 -1.396 . . . . 0.0 110.253 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.6 tp10 -151.21 138.95 19.77 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.165 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.824 HD12 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -110.49 172.32 3.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.699 -1.251 . . . . 0.0 110.187 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.784 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.2 Cg_exo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.503 1.265 . . . . 0.0 111.103 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.624 ' HB3' ' HA2' ' A' ' 187' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.709 0.766 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 3.1 p -146.45 127.44 14.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -99.01 -173.67 2.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.112 -1.617 . . . . 0.0 109.555 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 198' ' ' ILE . 1.4 mt -163.69 131.87 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.655 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.7 t -107.54 139.68 41.69 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 119.918 -1.739 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.853 ' CE1' HG22 ' A' ' 208' ' ' VAL . 23.8 m-85 -105.94 -131.48 0.3 Allowed 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.623 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 -64.71 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.846 -1.159 . . . . 0.0 112.874 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.42 -80.47 0.1 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.994 -1.066 . . . . 0.0 113.483 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 5.1 pt-20 162.97 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.948 0.88 . . . . 0.0 108.748 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 235' ' ' PRO . 1.3 mt-10 -55.47 -61.99 5.21 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 234' ' ' GLU . 5.2 Cg_exo -47.19 -39.9 26.89 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 122.988 0.994 . . . . 0.0 110.659 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -57.41 -48.25 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -45.51 -40.69 8.81 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.07 0.938 . . . . 0.0 108.536 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 8.6 tttt -72.23 -64.0 1.03 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.925 0.869 . . . . 0.0 109.55 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.652 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -45.16 -65.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.613 ' N ' HG22 ' A' ' 239' ' ' ILE . 4.2 tmm? -43.15 -39.16 2.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.192 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 39.3 tt0 -61.92 -15.67 44.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.617 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.53 47.33 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.708 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.3 mtpt -30.87 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -99.88 85.25 3.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.414 -1.429 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.731 ' CD2' HD13 ' A' ' 254' ' ' ILE . 7.5 m-70 -89.5 -148.72 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.975 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.564 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.9 OUTLIER -140.65 129.64 23.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.658 -0.651 . . . . 0.0 109.524 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 250' ' ' SER . 24.5 t -150.19 129.26 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.592 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 41.15 69.32 0.53 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.662 ' O ' HD23 ' A' ' 249' ' ' LEU . 0.9 OUTLIER 44.9 25.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 247' ' ' VAL . 18.9 m -139.11 118.96 13.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.546 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.609 ' HG2' ' CE1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.06 44.36 1.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.879 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.954 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.7 p -29.07 148.3 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.184 -0.322 . . . . 0.0 110.502 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.96 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -86.49 161.68 18.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.974 -1.49 . . . . 0.0 107.871 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.96 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -146.32 105.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.807 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 13.8 tttt -99.21 115.48 29.19 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 3.5 p -37.6 162.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.709 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.542 -0.723 . . . . 0.0 110.607 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.701 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.701 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.9 pp -127.27 165.74 25.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.433 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.76 139.27 52.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.861 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 253' ' ' GLU . 43.6 t -114.03 130.28 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 110.459 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.816 HG21 ' CD2' ' A' ' 213' ' ' LEU . 62.1 m . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.8 72.47 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.415 1.41 . . . . 0.0 112.293 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.8 -67.14 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.369 -0.832 . . . . 0.0 111.596 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.6 OUTLIER -47.03 -43.62 19.8 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.147 -177.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.0 OUTLIER -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.4 -54.28 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 5.9 mtp180 -51.78 -38.22 54.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 4.6 mm-40 -56.57 -40.52 75.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.394 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.36 -71.77 0.62 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.604 ' CD2' HG13 ' A' ' 198' ' ' ILE . 83.6 m-85 -54.3 -54.94 33.48 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.947 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.73 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.21 -22.8 23.01 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.269 -2.332 . . . . 0.0 107.269 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.1 -44.93 86.3 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.6 m-85 -57.97 -36.55 72.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -1.199 . . . . 0.0 108.93 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.14 141.99 6.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 206' ' ' GLY . 9.4 pt-20 -42.48 142.04 0.89 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -1.174 . . . . 0.0 109.86 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.73 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.6 t -104.36 150.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.518 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -88.01 -57.64 2.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.633 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.34 173.08 16.07 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pt -120.07 -170.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.895 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.606 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 3.0 tp10 -151.17 129.59 12.09 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.687 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 193' ' ' THR . 14.0 mt -105.82 175.12 2.24 Favored Pre-proline 0 C--N 1.295 -1.79 0 O-C-N 120.608 -1.308 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--N 1.303 -1.846 0 O-C-N 123.586 1.309 . . . . 0.0 110.984 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.505 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.151 0 CA-C-O 121.378 0.608 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.623 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.1 118.88 23.2 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.205 -0.935 . . . . 0.0 109.072 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.83 -171.44 2.35 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.275 -1.516 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -165.78 132.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.657 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.0 t -106.22 137.72 43.66 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.03 -1.669 . . . . 0.0 109.041 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 73.8 m-85 -96.79 -162.38 0.95 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.742 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -97.11 -46.26 6.23 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.478 -0.764 . . . . 0.0 109.197 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 42.2 mt-10 -121.79 167.22 13.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.559 -0.713 . . . . 0.0 109.371 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -15.79 63.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.985 -1.072 . . . . 0.0 109.341 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -57.39 -58.78 15.75 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.665 -0.647 . . . . 0.0 112.702 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -45.25 -24.91 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.226 1.119 . . . . 0.0 111.176 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 184' ' ' ILE . 6.5 t -83.34 -41.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.008 -1.058 . . . . 0.0 108.842 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -45.51 -44.84 12.91 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.136 0.97 . . . . 0.0 108.536 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -71.63 -63.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.982 0.896 . . . . 0.0 109.738 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.635 HG21 HG21 ' A' ' 184' ' ' ILE . 3.8 mm -44.54 -64.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.373 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 2.6 ttm -45.17 -36.19 3.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 1.5 tp10 -62.73 -9.55 9.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 0.0 110.483 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.624 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.03 52.26 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.156 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 254' ' ' ILE . 11.7 mtmt -31.86 -25.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.618 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -121.68 87.24 2.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.084 -1.635 . . . . 0.0 110.803 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 6.0 m-70 -89.61 -149.66 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.867 -1.146 . . . . 0.0 110.375 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 5.4 p-10 -145.19 145.19 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 249' ' ' LEU . 53.5 t -140.97 126.65 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.856 -1.152 . . . . 0.0 110.242 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 249' ' ' LEU . . . 46.13 -94.83 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 248' ' ' GLY . 19.2 mt -131.55 34.17 3.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 110.026 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.9 m -150.45 135.47 17.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.618 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.5 pttt -103.76 52.07 0.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.051 -1.03 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.6 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 84.5 m -36.77 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.774 -0.579 . . . . 0.0 109.818 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.861 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.8 pm0 -87.65 172.39 9.75 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.286 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.861 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.89 96.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 118.294 -1.362 . . . . 0.0 112.897 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 8.8 mttm -100.64 115.89 31.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -38.43 166.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.024 0.916 . . . . 0.0 112.546 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.627 -0.67 . . . . 0.0 110.04 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.703 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.703 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 29.3 pt -133.1 -176.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.531 -1.268 . . . . 0.0 111.018 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.38 141.23 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.247 -0.908 . . . . 0.0 110.506 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.581 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 46.3 t -110.39 128.69 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.539 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.769 ' CB ' HD12 ' A' ' 213' ' ' LEU . 55.4 m . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -64.58 60.88 0.27 Allowed 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 121.313 1.342 . . . . 0.0 112.474 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.671 ' OE2' HG21 ' A' ' 198' ' ' ILE . 2.5 mm-40 -37.98 -65.31 0.34 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 111.414 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 24.4 tt0 -47.59 -42.45 23.96 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.692 -1.203 . . . . 0.0 108.705 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.01 -28.13 62.18 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -65.99 -56.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.61 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.15 -36.96 32.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -61.09 -36.68 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.554 -0.716 . . . . 0.0 109.768 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.3 t80 -91.25 -72.04 0.6 Allowed 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 117.571 -1.652 . . . . 0.0 109.864 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.56 ' CD2' HG13 ' A' ' 198' ' ' ILE . 23.0 m-85 -58.64 -50.18 74.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.77 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.15 -20.75 29.41 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.51 -46.25 41.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 239' ' ' ILE . 74.1 m-85 -53.78 -37.75 63.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.049 -1.265 . . . . 0.0 108.633 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.13 132.44 2.51 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.4 OUTLIER -39.76 142.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -1.106 . . . . 0.0 109.905 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.77 HG23 ' HA2' ' A' ' 203' ' ' GLY . 6.4 t -97.48 146.18 8.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.549 -0.719 . . . . 0.0 110.653 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 7.1 tp10 -87.48 -47.61 8.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.31 169.88 22.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.652 HD13 ' OE2' ' A' ' 195' ' ' GLU . 2.2 pp -128.66 -173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.646 -1.284 . . . . 0.0 110.304 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.593 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 33.6 tp10 -152.14 135.6 16.04 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.327 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 193' ' ' THR . 1.3 mm? -106.02 172.2 4.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.484 -1.385 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.706 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.307 -1.618 0 O-C-N 123.806 1.424 . . . . 0.0 110.801 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 4.8 p90 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.761 0.791 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.54 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 8.2 p -170.35 125.44 0.75 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -99.46 -176.94 3.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.264 -1.522 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.685 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.1 mt -163.89 134.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 210' ' ' SER . 6.8 t -107.1 140.11 40.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.157 -1.589 . . . . 0.0 109.896 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 18.9 m-30 -100.13 -141.63 0.33 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -63.47 1.44 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.238 -0.914 . . . . 0.0 110.935 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 5.4 mt-10 -102.8 -69.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 0.0 111.037 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 7.0 pt-20 174.03 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.697 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.618 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -38.68 -55.29 2.72 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.2 Cg_exo -52.4 -37.6 72.33 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.093 1.049 . . . . 0.0 110.94 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.615 HG22 ' CG2' ' A' ' 184' ' ' ILE . 2.1 t -67.38 -43.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.04 . . . . 0.0 108.92 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.32 -47.01 13.22 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.175 0.988 . . . . 0.0 108.597 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -68.51 -58.5 4.22 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.528 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 205' ' ' PHE . 3.7 mm -48.62 -63.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.688 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 1.6 tmm? -44.45 -35.4 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.942 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -65.45 -7.63 15.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.175 -0.953 . . . . 0.0 110.497 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -136.97 49.61 2.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 35.1 mtpt -29.09 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.06 89.9 3.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.515 -1.366 . . . . 0.0 110.012 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.67 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.9 m-70 -95.8 -149.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.135 -0.978 . . . . 0.0 110.786 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.48 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -133.46 137.61 45.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.698 -0.626 . . . . 0.0 109.534 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 250' ' ' SER . 11.6 t -146.65 125.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.017 -1.052 . . . . 0.0 110.211 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 47.19 75.2 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.1 OUTLIER 41.85 34.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -1.095 . . . . 0.0 110.529 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 247' ' ' VAL . 1.6 t -146.72 166.4 26.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 4.3 ptpp? -124.38 45.98 2.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.577 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 28.7 p -40.05 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 254' ' ' ILE . 0.1 OUTLIER -88.08 171.36 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.629 -1.228 . . . . 0.0 109.141 179.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -144.75 103.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.484 -178.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.35 107.65 19.05 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -43.97 167.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.21 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.934 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.703 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 239' ' ' ILE . 22.4 mt -131.72 177.62 6.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 C-N-CA 117.3 -1.76 . . . . 0.0 110.639 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.635 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.16 117.6 6.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.962 -1.086 . . . . 0.0 110.801 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 58.0 t -89.62 126.77 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.899 -1.126 . . . . 0.0 109.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.517 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.628 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.807 ' CB ' HD22 ' A' ' 213' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.7 Cg_endo -67.92 52.34 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.406 1.404 . . . . 0.0 112.525 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.551 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -36.66 -66.51 0.22 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.192 -0.943 . . . . 0.0 111.286 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -47.41 -40.65 18.36 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.814 -177.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 11.0 mttt -74.32 -28.66 61.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.958 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -66.36 -55.91 16.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.6 OUTLIER -52.2 -36.39 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -61.07 -39.19 88.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 110.376 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.437 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.16 -70.91 0.66 Allowed 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 117.361 -1.735 . . . . 0.0 109.421 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.602 ' CD2' HG13 ' A' ' 198' ' ' ILE . 22.4 m-85 -57.19 -51.81 67.85 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.137 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.42 -20.63 30.8 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.5 -45.22 60.78 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.819 ' CD1' HD11 ' A' ' 239' ' ' ILE . 81.2 m-85 -58.36 -33.23 69.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -1.232 . . . . 0.0 108.962 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.58 130.36 1.98 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' GLY . 12.2 pt-20 -41.6 141.79 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -1.216 . . . . 0.0 110.079 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.582 HG11 HG23 ' A' ' 211' ' ' ILE . 2.4 t -92.11 144.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.566 0.698 . . . . 0.0 111.222 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -88.12 -48.75 7.49 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.72 ' O ' HG22 ' A' ' 229' ' ' THR . 69.5 m -153.58 158.39 41.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.582 HG23 HG11 ' A' ' 208' ' ' VAL . 9.0 pt -114.93 -170.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.781 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.6 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 24.8 tp10 -151.3 137.26 18.18 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.321 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 193' ' ' THR . 5.3 mt -107.04 172.61 3.69 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 120.545 -1.347 . . . . 0.0 110.748 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo . . . . . 0 C--N 1.308 -1.598 0 O-C-N 124.098 1.578 . . . . 0.0 111.168 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 1.8 p90 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.755 0.788 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.531 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 0.6 OUTLIER -170.73 129.11 0.8 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.635 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -101.55 -173.69 2.42 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.243 -1.536 . . . . 0.0 108.918 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.958 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.2 mt -164.91 136.32 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 210' ' ' SER . 14.3 t -113.8 149.6 34.71 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.237 -1.539 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 70.2 m-85 -117.82 -115.7 0.33 Allowed 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.472 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HE2' ' N ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER -163.77 -39.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.494 ' N ' ' HE2' ' A' ' 231' ' ' LYS . 53.7 tt0 -87.83 -96.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.796 -1.19 . . . . 0.0 111.302 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.4 OUTLIER 169.61 -24.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.199 -0.938 . . . . 0.0 109.912 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.609 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.1 tm-20 -63.44 -52.06 62.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.277 -0.889 . . . . 0.0 112.967 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.4 Cg_exo -52.38 -21.28 13.3 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 122.815 0.903 . . . . 0.0 111.349 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.478 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.0 t -80.74 -51.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 240' ' ' MET . 0.0 OUTLIER -41.76 -42.04 2.5 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.312 1.053 . . . . 0.0 108.886 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -59.15 3.26 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.412 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 205' ' ' PHE . 17.3 mm -51.69 -62.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.528 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.505 ' HG3' ' N ' ' A' ' 241' ' ' GLU . 1.4 ppp? -44.75 -33.2 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.493 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 240' ' ' MET . 1.8 tt0 -70.74 -8.48 52.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.614 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -131.19 47.66 2.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.978 -1.076 . . . . 0.0 109.107 179.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -28.12 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -111.76 83.14 1.73 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.508 -1.37 . . . . 0.0 110.34 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.647 ' HD2' HD13 ' A' ' 254' ' ' ILE . 3.5 m-70 -92.79 -147.14 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.983 -1.073 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -144.1 120.24 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 249' ' ' LEU . 4.4 t -112.04 112.01 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.954 -1.091 . . . . 0.0 110.635 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 64.01 -68.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -154.24 23.08 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 110.482 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.2 t -145.45 148.0 32.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.033 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -102.06 50.54 0.84 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.755 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.0 m -43.84 169.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.549 -0.719 . . . . 0.0 109.376 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.982 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -87.14 165.0 16.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.496 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.982 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -142.36 98.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.266 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.4 108.17 20.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.0 p -43.62 166.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.917 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.406 -0.809 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.691 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.737 HG23 HG22 ' A' ' 236' ' ' VAL . 7.2 pt -130.14 175.33 11.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.429 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -137.35 135.44 37.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.189 -0.945 . . . . 0.0 110.213 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.675 HG12 ' HB3' ' A' ' 252' ' ' CYS . 55.4 t -111.55 128.38 68.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.902 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.494 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.703 ' CB ' HD12 ' A' ' 213' ' ' LEU . 18.8 m . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.4 Cg_endo -70.61 80.23 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.741 1.39 . . . . 0.0 112.072 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -37.03 -61.67 0.54 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.452 -0.78 . . . . 0.0 111.038 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.2 mt-10 -49.22 -45.34 44.33 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.031 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -74.62 -26.42 59.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -64.53 -50.11 77.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -57.01 -35.28 69.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.5 mt-10 -59.75 -38.82 82.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.46 -70.49 0.68 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.509 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -57.95 -52.19 66.54 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.77 27.95 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.44 -45.61 67.51 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.753 ' CD1' HD11 ' A' ' 239' ' ' ILE . 90.6 m-85 -59.52 -34.29 72.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -1.232 . . . . 0.0 109.207 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -172.42 135.09 3.22 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -41.51 141.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.978 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.676 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.7 t -104.2 145.91 12.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.541 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.0 -49.69 6.89 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 177.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.595 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.6 174.33 14.6 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 5.1 pt -127.54 -171.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.092 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.526 ' O ' ' O ' ' A' ' 227' ' ' PHE . 3.2 tt0 -150.82 128.5 11.57 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.917 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.703 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.5 mm? -104.88 171.38 5.02 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 120.578 -1.326 . . . . 0.0 111.004 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.4 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.15 1.605 . . . . 0.0 110.574 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -119.76 117.93 29.5 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -97.25 -169.45 1.86 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.503 -1.373 . . . . 0.0 109.986 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.54 138.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.607 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 8.1 t -111.79 144.4 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 119.816 -1.802 . . . . 0.0 110.413 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.666 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.2 m-30 -103.44 -136.01 0.34 Allowed 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.073 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -154.27 -48.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.488 -178.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 83.9 tt0 -79.26 -56.48 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.975 . . . . 0.0 109.236 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.634 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 131.06 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -57.01 -45.65 99.94 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.366 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 3.9 Cg_exo -54.58 -27.48 50.83 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 109.709 -0.92 . . . . 0.0 109.709 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 184' ' ' ILE . 2.3 t -74.16 -43.96 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.43 -48.28 9.92 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 108.836 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -61.28 1.84 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.015 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 205' ' ' PHE . 11.4 mm -44.79 -64.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.64 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.53 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.0 tmm? -46.65 -33.26 4.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.372 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 3.9 tt0 -73.08 2.45 7.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.92 51.01 1.72 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.014 -1.054 . . . . 0.0 109.444 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 4.1 ttmm -26.45 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -120.28 94.48 4.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.297 -1.502 . . . . 0.0 110.258 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.792 ' HD2' HD13 ' A' ' 254' ' ' ILE . 4.3 m-70 -97.79 -148.88 0.33 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.009 -1.057 . . . . 0.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.57 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 7.6 m-80 -145.35 139.83 27.27 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 249' ' ' LEU . 25.8 t -133.29 120.43 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.99 -1.069 . . . . 0.0 110.174 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.22 -90.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -135.56 32.81 3.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -1.111 . . . . 0.0 109.824 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.58 145.39 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.63 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.0 pttt -113.41 54.91 0.72 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.97 -1.081 . . . . 0.0 110.934 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.675 ' HB3' HG12 ' A' ' 186' ' ' VAL . 62.1 m -40.47 162.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.38 -0.825 . . . . 0.0 108.94 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.902 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.1 pm0 -87.7 177.42 7.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.722 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 253' ' ' GLU . 0.9 OUTLIER -150.04 147.38 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.329 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 5.1 tttp -156.03 105.4 2.34 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.5 p -35.08 161.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.94 0.876 . . . . 0.0 112.94 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.685 -0.635 . . . . 0.0 110.164 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.727 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 239' ' ' ILE . 2.4 pp -132.47 171.36 18.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.09 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.624 ' CD1' ' C ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -132.37 135.65 46.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 110.412 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 252' ' ' CYS . 16.4 t -108.35 131.76 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.67 -0.644 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.878 HG21 ' CD2' ' A' ' 213' ' ' LEU . 3.6 m . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.27 55.31 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.238 1.292 . . . . 0.0 112.155 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.626 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.5 OUTLIER -37.46 -60.28 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.427 -0.796 . . . . 0.0 110.26 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 200' ' ' GLU . 10.6 tt0 -49.07 -45.17 42.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.471 -1.291 . . . . 0.0 108.854 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -74.39 -23.94 59.05 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 195' ' ' GLU . 0.2 OUTLIER -68.06 -51.59 47.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.586 ' N ' HG22 ' A' ' 198' ' ' ILE . 22.6 ttm180 -55.72 -36.05 66.78 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.533 ' CA ' ' OE1' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -57.48 -42.88 83.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.622 -0.674 . . . . 0.0 109.537 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -91.25 -73.69 0.53 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 117.582 -1.647 . . . . 0.0 110.05 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -51.09 -50.28 59.05 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.229 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.98 -21.21 23.22 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -75.39 -43.97 23.32 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.746 ' CD1' HD11 ' A' ' 239' ' ' ILE . 83.5 m-85 -58.01 -28.26 64.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -1.212 . . . . 0.0 108.941 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 179.72 132.73 1.85 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' GLY . 6.9 pt-20 -41.12 142.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.137 . . . . 0.0 110.263 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 230' ' ' PHE . 10.7 t -102.64 147.48 9.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -54.81 4.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 53.9 m -154.05 158.23 40.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pp -105.2 -168.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.305 -1.358 . . . . 0.0 109.418 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.576 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.8 tp10 -151.27 134.33 15.91 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.743 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 193' ' ' THR . 19.6 mt -109.52 178.13 1.09 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 120.794 -1.191 . . . . 0.0 109.7 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.0 Cg_exo . . . . . 0 C--N 1.302 -1.896 0 O-C-N 123.389 1.205 . . . . 0.0 110.754 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.411 0.624 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -130.68 120.79 24.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.115 -0.991 . . . . 0.0 109.015 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -98.27 -168.7 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.407 -1.433 . . . . 0.0 110.428 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.3 mt -164.81 134.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 10.5 t -116.15 146.47 42.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.072 -1.642 . . . . 0.0 110.225 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.872 ' CE2' HG22 ' A' ' 208' ' ' VAL . 58.0 m-85 -114.44 -127.83 0.29 Allowed 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -145.04 -44.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.673 -1.267 . . . . 0.0 113.377 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 7.5 mt-10 -82.74 -82.8 0.14 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.614 -1.304 . . . . 0.0 112.883 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.73 -28.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.659 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.6 tt0 -62.8 -53.29 57.44 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.315 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.3 Cg_exo -48.49 -32.71 21.42 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.992 0.996 . . . . 0.0 110.323 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 183' ' ' LYS . 2.1 t -68.71 -47.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.844 -1.16 . . . . 0.0 107.907 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.19 -43.66 7.3 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.215 1.007 . . . . 0.0 108.8 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -69.05 -60.43 2.36 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.539 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 184' ' ' ILE . 12.4 mm -49.08 -63.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.259 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.667 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -47.86 -28.37 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.637 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -77.13 7.02 5.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 111.059 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.617 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.98 54.42 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 109.047 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.3 OUTLIER -25.46 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.652 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.3 t80 -120.27 96.27 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.378 -1.451 . . . . 0.0 110.215 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.667 ' HD2' HD13 ' A' ' 254' ' ' ILE . 15.0 m-70 -93.58 -165.34 1.31 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.086 -1.009 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 57.0 m-80 -135.92 133.74 37.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 250' ' ' SER . 55.7 t -149.48 131.68 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.111 -0.993 . . . . 0.0 110.477 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 42.74 62.96 2.08 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 1.9 tp 48.22 22.37 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.152 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 247' ' ' VAL . 50.3 m -132.34 118.06 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.2 pttt -97.94 53.74 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 110.693 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 186' ' ' VAL . 58.8 m -41.67 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.459 -0.776 . . . . 0.0 109.011 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.947 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.7 pm0 -86.94 173.88 9.07 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.388 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.947 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.43 129.28 3.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.015 -1.474 . . . . 0.0 112.873 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 9.1 mttm -134.46 107.57 7.64 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 240' ' ' MET . 2.7 p -37.1 163.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.026 0.917 . . . . 0.0 112.575 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.727 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.695 -0.628 . . . . 0.0 109.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.704 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.704 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.3 mt -138.82 174.74 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.095 -1.003 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.694 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.08 139.79 50.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.143 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.574 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 62.9 t -114.62 131.38 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.55 -0.719 . . . . 0.0 109.862 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.547 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 213' ' ' LEU . 76.5 p . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -69.25 45.17 0.39 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.436 1.424 . . . . 0.0 112.872 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.66 -69.41 0.11 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.048 -1.033 . . . . 0.0 111.679 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 3.8 tt0 -47.82 -39.88 19.61 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.577 -1.249 . . . . 0.0 109.034 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 194' ' ' PRO . 26.0 mmmt -75.7 -27.04 58.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -66.99 -54.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.627 ' N ' HG22 ' A' ' 198' ' ' ILE . 3.3 ttp85 -54.48 -38.28 66.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -59.32 -40.38 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.477 -0.765 . . . . 0.0 110.158 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 204' ' ' GLY . 2.0 t80 -91.02 -71.87 0.61 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.395 -1.722 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.621 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.0 m-85 -54.41 -54.06 45.72 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.564 -0.855 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.17 -22.1 27.83 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.93 -46.99 57.61 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 85.6 m-85 -56.13 -31.22 63.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.269 . . . . 0.0 108.698 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.39 138.82 4.04 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.1 OUTLIER -43.56 143.14 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.016 -1.285 . . . . 0.0 109.577 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.766 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.4 t -101.19 152.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.754 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 3.2 tt0 -87.83 -56.19 3.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.636 ' O ' HG22 ' A' ' 229' ' ' THR . 30.8 m -153.47 160.35 42.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 46.2 pt -110.66 -169.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.009 -1.476 . . . . 0.0 109.584 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 4.6 tp10 -152.11 129.36 11.24 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 213' ' ' LEU . 2.0 mm? -102.22 178.23 1.27 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.706 -1.246 . . . . 0.0 108.71 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo . . . . . 0 C--N 1.304 -1.806 0 O-C-N 123.101 1.053 . . . . 0.0 110.844 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.505 2.29 0 CA-C-O 121.488 0.661 . . . . 0.0 110.645 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -130.29 120.7 24.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.18 -173.8 3.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.451 -1.406 . . . . 0.0 109.984 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 2.0 mt -161.51 134.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 210' ' ' SER . 2.5 t -107.68 138.46 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.863 -1.773 . . . . 0.0 110.21 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CD2' ' CG ' ' A' ' 235' ' ' PRO . 35.1 m-85 -99.47 -112.75 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.298 -1.361 . . . . 0.0 111.922 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 28.6 tttp 175.32 -53.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.636 -1.29 . . . . 0.0 109.892 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.602 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 2.3 mt-10 -75.51 -22.98 56.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.144 -0.972 . . . . 0.0 108.682 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 2.2 pt-20 87.7 -21.35 0.17 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.361 1.077 . . . . 0.0 108.751 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.681 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.7 mt-10 -61.11 -45.65 96.02 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -54.06 -25.29 36.24 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 109.675 -0.933 . . . . 0.0 109.675 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.643 HG22 ' CG1' ' A' ' 184' ' ' ILE . 2.2 t -76.89 -47.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -44.16 -46.52 8.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.306 1.051 . . . . 0.0 108.895 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.61 -61.95 1.59 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.883 0.849 . . . . 0.0 109.751 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 205' ' ' PHE . 21.5 mm -43.12 -65.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 256' ' ' VAL . 0.4 OUTLIER -46.55 -34.08 4.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -61.14 -11.58 9.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 110.68 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.627 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.06 52.98 1.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.161 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.5 ttpp -27.87 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.1 t80 -115.43 92.85 4.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.325 -1.484 . . . . 0.0 110.061 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.773 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.7 m-70 -97.96 -154.85 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 110.778 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 10.2 p30 -136.26 143.35 44.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.306 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 24.4 t -139.5 131.01 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.421 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.18 -93.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -133.19 34.22 3.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -1.181 . . . . 0.0 110.197 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.23 168.25 24.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.54 48.38 1.61 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 110.49 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.545 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 26.7 p -34.08 152.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.866 -0.522 . . . . 0.0 109.922 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.919 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.66 170.9 10.87 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.79 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.919 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.1 mp -145.26 113.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.293 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -119.71 106.82 12.51 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 18.4 t -38.32 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.14 -0.975 . . . . 0.0 112.404 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.653 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.959 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -130.01 -175.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 117.663 -1.615 . . . . 0.0 110.912 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.13 124.14 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 111.454 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 253' ' ' GLU . 92.6 t -93.34 128.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 109.278 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.534 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.688 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.873 ' CB ' HD12 ' A' ' 213' ' ' LEU . 1.3 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.36 58.67 0.68 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.269 1.313 . . . . 0.0 111.915 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.601 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -36.98 -67.9 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.258 -0.901 . . . . 0.0 111.739 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -47.91 -38.3 16.16 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.864 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.3 OUTLIER -77.21 -27.97 53.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.716 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.2 tp -66.57 -55.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 4.8 mtt180 -56.29 -38.3 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -52.49 -49.02 65.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.65 -0.656 . . . . 0.0 110.464 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.6 -71.18 0.64 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 117.249 -1.78 . . . . 0.0 109.752 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.637 ' HD2' HD12 ' A' ' 228' ' ' ILE . 7.7 m-30 -50.4 -55.01 17.63 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.669 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.704 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.39 -22.06 21.97 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.18 -46.29 28.03 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -53.05 -36.0 60.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.318 . . . . 0.0 108.628 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.22 135.04 3.02 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.2 pt-20 -40.5 141.55 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.059 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.704 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.25 144.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 110.52 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 49.4 tp10 -87.65 -50.8 6.26 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 229' ' ' THR . 51.9 m -153.0 171.73 17.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.601 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 27.4 pt -125.17 -170.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.654 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.61 138.57 19.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.0 mm? -110.53 170.2 5.55 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 120.264 -1.523 . . . . 0.0 111.576 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.8 Cg_exo . . . . . 0 C--N 1.31 -1.485 0 O-C-N 124.051 1.553 . . . . 0.0 111.287 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 2.1 p90 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.511 0.672 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 0.5 OUTLIER -168.52 128.63 1.21 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.275 -0.891 . . . . 0.0 108.848 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.7 m-85 -101.01 -176.61 3.21 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.695 -1.253 . . . . 0.0 109.021 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.716 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -165.61 136.13 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 210' ' ' SER . 5.2 t -107.39 139.54 41.72 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.295 -1.503 . . . . 0.0 109.784 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.794 ' HD2' HG23 ' A' ' 236' ' ' VAL . 15.0 m-85 -97.1 -131.64 0.2 Allowed 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.811 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' HG3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -136.09 -52.67 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.761 -1.212 . . . . 0.0 110.92 -178.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 4.1 mt-10 -96.48 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.98 -26.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.227 1.013 . . . . 0.0 108.991 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -56.89 -43.58 99.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.93 -34.8 68.25 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 122.601 0.79 . . . . 0.0 110.803 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 184' ' ' ILE . 54.6 t -75.67 -34.93 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.768 -1.208 . . . . 0.0 108.455 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -45.64 -44.16 13.02 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.3 1.047 . . . . 0.0 108.34 178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -62.93 1.29 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.829 0.823 . . . . 0.0 110.458 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.629 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -50.04 -60.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.693 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.582 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -50.48 -33.62 21.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.089 -1.007 . . . . 0.0 110.817 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.8 -6.69 8.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.855 -1.153 . . . . 0.0 110.973 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -133.89 53.1 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 108.743 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 5.5 mtpt -26.64 -34.86 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.628 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.7 OUTLIER -115.11 90.05 3.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.466 -1.396 . . . . 0.0 109.666 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 36.2 m-70 -89.87 -157.61 0.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.125 -0.985 . . . . 0.0 111.371 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 6.1 t30 -144.67 120.01 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.2 122.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 57.44 53.95 40.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.18 22.78 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -1.082 . . . . 0.0 109.957 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 7.6 m -132.87 117.84 18.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.69 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -93.42 51.63 1.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 110.591 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.556 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 62.2 m -41.86 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.497 -0.752 . . . . 0.0 109.409 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.935 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -88.01 164.44 15.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.591 -1.318 . . . . 0.0 109.753 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.935 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -139.0 117.1 12.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.716 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.627 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tmtt? -126.64 112.34 15.36 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -39.72 166.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 112.132 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.642 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.575 -0.703 . . . . 0.0 110.423 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.683 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 236' ' ' VAL . 3.6 pt -129.24 -179.2 2.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.361 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -150.15 125.89 10.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 60.8 t -94.65 132.26 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.119 -0.988 . . . . 0.0 110.339 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.464 ' C ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.844 ' CB ' HD22 ' A' ' 213' ' ' LEU . 61.1 m . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -65.51 54.92 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.165 1.243 . . . . 0.0 112.133 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.01 -66.16 0.22 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.52 -0.737 . . . . 0.0 110.762 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.46 -37.85 12.54 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.85 -177.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -78.22 -28.82 48.04 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.656 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.42 -53.79 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.603 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -56.48 -36.08 68.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.6 mm-40 -60.12 -41.21 92.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.267 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.796 ' CD2' HG22 ' A' ' 247' ' ' VAL . 2.6 t80 -90.99 -70.99 0.65 Allowed 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.36 -1.736 . . . . 0.0 108.967 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.656 ' CD2' HG13 ' A' ' 198' ' ' ILE . 14.6 m-30 -53.81 -55.73 23.92 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.919 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.743 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -53.89 -22.91 20.85 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.92 -47.64 53.47 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 239' ' ' ILE . 67.4 m-85 -51.06 -33.94 27.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.059 -1.259 . . . . 0.0 108.352 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.75 136.93 3.2 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 206' ' ' GLY . 4.4 pt-20 -42.21 141.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -1.185 . . . . 0.0 109.809 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.743 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.06 150.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.522 -0.736 . . . . 0.0 110.654 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -87.65 -51.92 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -152.79 165.62 34.81 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.591 ' CG2' HG11 ' A' ' 208' ' ' VAL . 5.8 pt -126.29 -173.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 118.199 -1.4 . . . . 0.0 110.158 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.598 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.9 tp10 -151.3 132.11 14.11 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.845 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.844 HD22 ' CB ' ' A' ' 193' ' ' THR . 6.6 mt -104.37 169.9 6.69 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 120.338 -1.476 . . . . 0.0 110.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.3 Cg_exo . . . . . 0 C--N 1.304 -1.772 0 O-C-N 123.871 1.459 . . . . 0.0 110.772 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 4.2 p90 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.2 0.524 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.539 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 13.7 p -122.68 126.91 48.54 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -96.85 -177.28 3.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.281 -1.512 . . . . 0.0 109.275 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.635 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -164.77 134.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.621 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.5 t -109.07 138.47 45.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.14 -1.6 . . . . 0.0 109.193 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.535 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 37.1 m-85 -101.52 -166.91 1.35 Allowed 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.877 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -90.5 -49.73 6.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 3.0 mt-10 -119.09 174.44 6.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.02 -18.86 60.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 0.0 109.886 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.695 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 30.9 mt-10 -49.35 -53.15 42.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.6 Cg_exo -47.16 -43.39 25.61 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.727 0.951 . . . . 0.0 111.73 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 184' ' ' ILE . 76.9 t -72.21 -32.05 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.631 -1.293 . . . . 0.0 109.671 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -49.74 -45.59 49.56 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.645 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -64.54 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.161 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 240' ' ' MET . 0.8 OUTLIER -47.56 -64.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.976 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.623 ' N ' HG22 ' A' ' 239' ' ' ILE . 8.0 ttp -41.33 -40.17 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 110.695 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 2.1 tp10 -56.11 -16.18 4.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.582 ' O ' ' ND1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.3 50.96 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 34.4 ttpt -25.52 -37.84 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.66 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.8 t80 -103.23 91.04 3.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.363 -1.46 . . . . 0.0 108.658 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.76 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.0 m-70 -89.37 -166.42 1.59 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.043 -1.036 . . . . 0.0 110.884 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' A' ' 201' ' ' TYR . 4.1 m120 -137.71 115.36 11.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.796 HG22 ' CD2' ' A' ' 201' ' ' TYR . 38.2 t -130.23 124.73 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 0.0 110.543 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 249' ' ' LEU . . . 52.97 51.41 46.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 248' ' ' GLY . 0.5 OUTLIER 60.25 25.7 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 110.067 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 17.6 m -138.57 122.08 17.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.66 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.01 56.03 0.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.945 . . . . 0.0 111.181 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 60.2 m -45.43 169.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.957 . . . . 0.0 109.109 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -88.04 167.89 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.275 -1.37 . . . . 0.0 107.86 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.916 HD12 ' C ' ' A' ' 253' ' ' GLU . 3.5 mp -151.32 102.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.293 -1.363 . . . . 0.0 112.449 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -98.72 117.22 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -40.74 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 112.095 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.683 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.708 -0.62 . . . . 0.0 110.076 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 236' ' ' VAL . 4.1 pt -129.91 173.21 14.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.118 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -132.66 136.11 46.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.018 -1.051 . . . . 0.0 110.609 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 254' ' ' ILE . 98.3 t -109.12 136.81 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.698 -0.626 . . . . 0.0 110.621 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . . . . . . 0 N--CA 1.487 2.077 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.975 HG21 ' CD ' ' A' ' 214' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.828 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.3 124.08 9.67 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.553 1.502 . . . . 0.0 111.904 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.55 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -95.63 -65.25 0.99 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -49.82 -50.91 43.39 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.534 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -62.61 -26.0 68.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.7 OUTLIER -68.81 -61.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -54.72 -31.44 58.24 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 197' ' ' LYS . 8.1 tp10 -61.28 -42.78 99.23 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.75 -69.89 0.72 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 117.653 -1.619 . . . . 0.0 109.369 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 184' ' ' ILE . 58.8 m-85 -54.93 -50.95 67.57 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.542 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.64 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.43 26.67 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.28 47.61 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CD1' HD11 ' A' ' 239' ' ' ILE . 76.7 m-85 -55.94 -31.1 62.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -1.2 . . . . 0.0 108.86 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.14 138.82 3.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 5.6 pt-20 -41.73 141.62 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.64 HG23 ' HA2' ' A' ' 203' ' ' GLY . 5.4 t -100.55 150.14 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.799 . . . . 0.0 110.55 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -87.8 -54.53 4.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.677 ' O ' HG22 ' A' ' 229' ' ' THR . 21.1 m -153.51 173.42 15.73 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 14.8 pt -124.23 -171.27 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.125 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 15.3 tt0 -150.97 128.7 11.57 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.167 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.687 HD22 ' HB ' ' A' ' 193' ' ' THR . 8.4 mt -103.49 174.46 2.78 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 120.591 -1.318 . . . . 0.0 110.0 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.975 ' CD ' HG21 ' A' ' 193' ' ' THR . 3.2 Cg_exo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 123.654 1.344 . . . . 0.0 111.117 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.164 0 CA-C-O 121.526 0.679 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.641 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -127.82 119.88 26.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 109.295 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -95.74 -170.36 2.12 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.38 -1.45 . . . . 0.0 110.058 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -165.27 137.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 210' ' ' SER . 7.5 t -110.39 144.38 39.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.121 -1.612 . . . . 0.0 110.096 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.796 ' CD2' HG23 ' A' ' 236' ' ' VAL . 23.0 m-30 -103.71 -149.89 0.41 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.328 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -69.12 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 111.88 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.8 mm-40 -86.09 -68.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 111.116 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 1.4 pt-20 164.24 -27.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.221 1.01 . . . . 0.0 109.152 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.69 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 mt-10 -55.32 -45.05 99.92 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -53.24 -28.77 43.84 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.689 0.836 . . . . 0.0 110.586 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 184' ' ' ILE . 34.2 t -80.99 -35.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.826 -1.171 . . . . 0.0 108.433 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.7 ttpt -45.2 -46.79 12.44 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.394 1.092 . . . . 0.0 108.287 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -61.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 205' ' ' PHE . 10.1 mm -43.5 -66.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.314 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -45.36 -37.38 4.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 110.013 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -59.58 -13.77 10.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -130.7 48.55 2.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -26.59 -33.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.656 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -116.37 91.2 3.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.338 -1.476 . . . . 0.0 110.274 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.712 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.3 m-70 -98.5 -145.82 0.32 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 16.2 p30 -142.59 139.62 31.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 50.1 t -150.4 125.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.93 62.68 5.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 83.4 mt 50.09 23.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -1.175 . . . . 0.0 110.523 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.8 t -132.67 151.5 51.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.139 -0.975 . . . . 0.0 109.704 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.656 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 2.3 ptpt -107.41 44.55 1.07 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.866 -1.146 . . . . 0.0 110.505 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.8 p -35.98 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.808 -0.558 . . . . 0.0 109.719 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.62 171.09 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.418 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -147.66 91.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.983 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.562 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 25.0 mttt -100.08 114.92 28.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -38.3 166.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.03 0.919 . . . . 0.0 112.346 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.666 -0.646 . . . . 0.0 109.845 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.685 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.676 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 2.5 pp -131.39 171.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.674 ' CD2' ' HB3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -131.5 134.61 46.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.996 -1.065 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 252' ' ' CYS . 21.9 t -111.09 154.19 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.431 0.634 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.535 ' N ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.45 32.85 7.02 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 1.075 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -76.28 -35.68 42.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 26.74 40.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.672 0.749 . . . . 0.0 111.593 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 188' ' ' GLY . 0.5 OUTLIER -70.89 168.58 19.48 Favored Pre-proline 0 C--N 1.295 -1.78 0 O-C-N 121.664 -0.648 . . . . 0.0 109.689 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -55.83 -28.97 70.17 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.61 1.321 . . . . 0.0 110.342 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 25.2 p-10 -150.57 107.0 3.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.942 . . . . 0.0 110.294 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.769 ' CB ' HD22 ' A' ' 213' ' ' LEU . 7.8 m -54.78 110.97 2.48 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.604 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -61.85 58.22 0.12 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.52 1.274 . . . . 0.0 111.664 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -37.28 -66.79 0.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -0.847 . . . . 0.0 111.662 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.4 OUTLIER -47.12 -41.46 17.49 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.014 -177.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -75.92 -27.93 57.81 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.94 -53.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.8 ttt-85 -53.96 -39.51 66.01 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 5.0 mm-40 -55.2 -41.13 71.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.366 -0.834 . . . . 0.0 109.726 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.469 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.8 t80 -91.67 -71.33 0.64 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.736 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.6 m-85 -53.38 -56.83 13.5 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.124 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.751 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -51.34 -24.1 9.9 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -66.45 -45.51 85.0 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 239' ' ' ILE . 76.6 m-85 -57.74 -29.71 65.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -1.212 . . . . 0.0 108.661 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 177.89 141.64 4.27 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -42.71 141.64 1.02 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.261 . . . . 0.0 110.141 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.876 HG22 ' CE1' ' A' ' 230' ' ' PHE . 6.0 t -97.65 146.37 7.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.501 -0.749 . . . . 0.0 110.651 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -87.96 -56.89 3.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.63 163.35 40.14 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.617 ' CD1' HD21 ' A' ' 213' ' ' LEU . 1.8 pp -112.66 -171.08 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 118.208 -1.397 . . . . 0.0 110.47 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.614 ' O ' HD23 ' A' ' 213' ' ' LEU . 8.3 tp10 -151.48 138.62 19.21 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.031 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.769 HD22 ' CB ' ' A' ' 193' ' ' THR . 15.0 mt -112.39 -175.95 0.35 Allowed Pre-proline 0 C--N 1.295 -1.798 0 O-C-N 120.467 -1.396 . . . . 0.0 109.253 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -64.03 164.85 20.81 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.155 1.081 . . . . 0.0 110.836 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.02 178.96 2.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 218' ' ' LYS . 3.1 t70 -97.16 -155.18 0.48 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.389 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 4.3 m120 58.23 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.426 -0.797 . . . . 0.0 110.328 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.4 OUTLIER 66.67 51.19 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 109.878 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.81 51.62 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.942 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.2 -86.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.483 -0.761 . . . . 0.0 110.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 168.45 10.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 110.183 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -77.76 80.06 4.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 70.18 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.232 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 1.041 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -120.63 126.76 6.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.586 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -151.36 -162.41 1.53 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.304 -1.116 . . . . 0.0 108.478 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.509 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -146.07 120.08 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 120.803 -1.185 . . . . 0.0 108.662 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.2 m-85 -96.98 -169.56 1.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.39 -1.444 . . . . 0.0 110.379 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.4 mt -165.96 134.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 210' ' ' SER . 7.9 t -109.88 143.9 39.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.187 -1.571 . . . . 0.0 109.62 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.876 ' CE1' HG22 ' A' ' 208' ' ' VAL . 22.4 m-85 -111.36 -139.14 0.38 Allowed 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.121 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -67.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.065 -1.022 . . . . 0.0 112.957 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 1.2 tp10 -70.48 -85.17 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.026 -1.046 . . . . 0.0 113.586 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER 161.21 -27.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 122.192 0.996 . . . . 0.0 108.426 -178.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.607 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.7 OUTLIER -55.77 -53.21 65.4 Favored Pre-proline 0 N--CA 1.495 1.815 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -53.16 -43.37 57.77 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.893 0.943 . . . . 0.0 110.561 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.452 HG22 HG22 ' A' ' 184' ' ' ILE . 2.1 t -52.78 -46.29 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.1 tttt -47.61 -44.15 26.33 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.106 -1.038 . . . . 0.0 108.564 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -70.84 -64.22 0.95 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 110.035 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.657 HG21 HG21 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -44.36 -64.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.579 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.0 OUTLIER -44.68 -35.6 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.136 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 7.9 tp10 -65.51 -6.71 11.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.121 -0.987 . . . . 0.0 110.869 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.618 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -136.31 51.03 2.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 0.0 109.258 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.6 mtpt -29.21 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.616 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -116.44 82.81 1.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.406 -1.434 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.712 ' NE2' HG21 ' A' ' 254' ' ' ILE . 7.4 m-70 -89.71 -151.82 0.24 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.0 -1.063 . . . . 0.0 110.096 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.469 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 1.7 t30 -143.63 142.83 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.784 . . . . 0.0 109.677 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 249' ' ' LEU . 58.9 t -135.02 116.77 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.064 -1.023 . . . . 0.0 110.474 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 55.06 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.3 OUTLIER -133.51 30.64 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 3.7 m -150.19 153.18 35.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.95 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.616 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.8 OUTLIER -119.53 54.43 1.0 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.142 -0.974 . . . . 0.0 110.595 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.702 ' HB3' HG12 ' A' ' 186' ' ' VAL . 61.3 m -42.01 167.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.36 -0.838 . . . . 0.0 109.738 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.942 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.2 OUTLIER -86.79 170.52 11.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.086 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.942 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -147.6 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 C-N-CA 118.613 -1.235 . . . . 0.0 112.284 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.674 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.69 112.4 24.97 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -38.74 166.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.878 0.847 . . . . 0.0 112.42 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.561 -0.712 . . . . 0.0 110.286 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.051 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -130.32 167.46 25.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.449 -1.3 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -125.89 134.7 51.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 252' ' ' CYS . 53.1 t -111.78 122.59 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.524 -0.735 . . . . 0.0 110.537 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.557 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -95.57 49.49 1.84 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 1.0 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -122.17 -14.58 4.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.0 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER 16.45 54.39 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -41.34 166.4 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.557 -0.714 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -58.57 -19.43 44.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.547 1.288 . . . . 0.0 111.435 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.493 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 2.4 p30 -149.84 99.1 2.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.948 -1.095 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.699 HG21 ' HD2' ' A' ' 214' ' ' PRO . 46.6 p -39.28 96.08 0.11 Allowed Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.634 -0.666 . . . . 0.0 109.997 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.93 49.06 1.51 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.549 1.5 . . . . 0.0 112.533 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -37.2 -66.88 0.21 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.0 -1.063 . . . . 0.0 111.63 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.57 -41.98 22.72 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.849 -177.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 10.1 mttt -74.13 -28.4 61.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.46 -54.93 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.1 mpp_? -53.1 -37.44 61.72 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.7 mm-40 -62.97 -36.26 82.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.65 -71.46 0.64 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 117.442 -1.703 . . . . 0.0 109.544 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.634 ' CD2' HG13 ' A' ' 198' ' ' ILE . 78.2 m-85 -57.03 -51.43 69.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.424 -0.911 . . . . 0.0 108.71 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.776 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.25 -20.72 29.99 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.42 57.63 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.914 ' CD1' HD11 ' A' ' 239' ' ' ILE . 75.3 m-85 -56.15 -36.32 68.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -1.193 . . . . 0.0 108.911 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.58 139.21 4.77 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.3 OUTLIER -41.43 141.57 0.71 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -1.15 . . . . 0.0 109.808 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.776 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.7 t -100.43 151.29 5.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 O-C-N 121.51 -0.743 . . . . 0.0 110.482 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 231' ' ' LYS . 20.5 tp10 -87.59 -54.46 4.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -153.47 173.66 15.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.818 HD13 ' CD2' ' A' ' 213' ' ' LEU . 2.4 pp -123.93 -172.02 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 120.556 -1.34 . . . . 0.0 109.554 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.599 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.9 tp10 -150.4 122.36 8.2 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 108.882 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.818 ' CD2' HD13 ' A' ' 211' ' ' ILE . 1.2 mm? -102.54 173.05 3.77 Favored Pre-proline 0 C--N 1.295 -1.788 0 O-C-N 120.324 -1.485 . . . . 0.0 111.16 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.699 ' HD2' HG21 ' A' ' 193' ' ' THR . 3.1 Cg_exo -70.82 57.54 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.075 1.566 . . . . 0.0 110.871 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 52.66 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.991 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.483 ' HA ' ' NZ ' ' A' ' 218' ' ' LYS . 36.3 t0 -83.7 -12.29 56.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.246 -0.909 . . . . 0.0 110.471 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.592 ' HB3' HG22 ' A' ' 219' ' ' THR . 3.6 m-20 -84.87 -43.27 14.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 216' ' ' ASP . 1.0 OUTLIER 63.4 45.52 4.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 110.226 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 217' ' ' ASN . 15.2 t -150.6 39.04 0.71 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.738 0.78 . . . . 0.0 109.996 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 22.5 p-10 -150.92 -42.3 0.12 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.692 . . . . 0.0 109.76 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -149.4 -170.34 3.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.572 -0.705 . . . . 0.0 109.825 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 223' ' ' ARG . 40.6 ttt180 -91.78 99.52 12.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.262 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -51.65 -174.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.944 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.914 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 165.52 -87.78 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.046 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -88.82 177.67 6.65 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.441 -1.035 . . . . 0.0 111.71 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.682 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.4 p -128.64 118.31 22.69 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -94.37 -166.53 1.5 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.487 -1.383 . . . . 0.0 110.394 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 0.9 OUTLIER -168.0 138.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.617 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.9 t -115.04 142.74 46.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 119.933 -1.729 . . . . 0.0 110.471 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 39.6 m-85 -104.17 -157.6 0.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.463 ' HD2' ' OE1' ' A' ' 209' ' ' GLU . 4.9 tttm -106.9 -59.97 1.73 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.191 -0.943 . . . . 0.0 111.65 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 11.1 mt-10 -91.61 -70.98 0.66 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.048 -1.032 . . . . 0.0 111.421 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 165.45 -28.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.163 0.982 . . . . 0.0 109.426 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.72 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 16.9 tt0 -54.88 -44.58 99.54 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.72 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.9 Cg_exo -51.74 -33.76 51.27 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 O-C-N 122.774 0.881 . . . . 0.0 110.972 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.051 HG22 HG23 ' A' ' 184' ' ' ILE . 61.3 t -78.59 -32.67 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.791 -1.193 . . . . 0.0 108.864 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -47.86 -50.78 25.31 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.017 178.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 1.0 OUTLIER -69.29 -58.53 3.91 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.045 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.914 HD11 ' CD1' ' A' ' 205' ' ' PHE . 23.0 mm -48.57 -64.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.756 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -44.69 -32.47 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.707 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 9.9 tp10 -71.94 2.66 5.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.257 -0.902 . . . . 0.0 110.554 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.595 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 3.8 tptt -132.57 51.24 2.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 108.941 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -25.0 -40.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -117.56 102.36 9.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.523 -1.361 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.812 ' CD2' HD13 ' A' ' 254' ' ' ILE . 25.3 m-70 -89.64 -159.6 0.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -0.94 . . . . 0.0 110.92 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 250' ' ' SER . 1.6 t30 -141.33 125.25 17.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 246' ' ' ASN . 77.0 t -148.13 126.04 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 54.45 66.52 2.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.5 mt 46.35 38.69 5.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -1.148 . . . . 0.0 110.504 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 246' ' ' ASN . 1.4 t -146.28 -173.49 4.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.694 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -149.86 51.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 110.448 179.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.581 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.6 m -34.86 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.835 -0.541 . . . . 0.0 109.737 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.933 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -86.9 170.78 11.34 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.521 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.933 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.8 mp -149.76 101.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 118.401 -1.32 . . . . 0.0 112.798 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.8 OUTLIER -110.06 111.9 23.56 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -36.65 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.068 0.937 . . . . 0.0 112.805 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.657 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.252 0 O-C-N 121.582 -0.698 . . . . 0.0 110.171 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.688 ' HD3' ' CA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.836 ' CG2' HG22 ' A' ' 236' ' ' VAL . 2.2 pp -127.09 169.46 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.235 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.34 133.22 46.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.928 . . . . 0.0 110.016 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 254' ' ' ILE . 39.6 t -109.2 125.8 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.391 -0.818 . . . . 0.0 110.484 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.559 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -98.83 45.99 1.54 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 1.043 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -131.17 2.67 5.5 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.043 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 0.02 68.52 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -41.0 165.94 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.571 -0.706 . . . . 0.0 110.24 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -55.75 -30.75 77.48 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.446 1.235 . . . . 0.0 111.199 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.512 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -140.0 104.44 4.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.086 -1.008 . . . . 0.0 110.356 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.529 HG21 ' HD2' ' A' ' 214' ' ' PRO . 29.1 p -38.88 95.38 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.13 46.87 1.2 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.604 1.536 . . . . 0.0 112.359 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 1.1 mt-10 -36.15 -66.46 0.21 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.247 -0.908 . . . . 0.0 110.977 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 5.4 tt0 -47.49 -41.83 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.874 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 17.8 mttt -75.32 -27.44 59.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -64.89 -53.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -52.35 -39.27 60.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 37.2 mm-40 -58.53 -39.77 81.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.487 -0.758 . . . . 0.0 110.032 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.474 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 1.3 t80 -91.3 -72.03 0.6 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.42 -1.712 . . . . 0.0 109.712 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.623 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.6 m-85 -54.42 -54.67 37.66 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.409 -0.916 . . . . 0.0 108.691 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.851 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.96 -22.98 29.61 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -66.73 -46.37 75.9 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.872 ' CD1' HD11 ' A' ' 239' ' ' ILE . 65.9 m-85 -53.55 -37.69 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -1.203 . . . . 0.0 108.451 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.22 143.69 6.36 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.526 -2.229 . . . . 0.0 107.526 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 3.0 pm0 -41.74 141.71 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -1.176 . . . . 0.0 110.009 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.851 HG23 ' HA2' ' A' ' 203' ' ' GLY . 14.7 t -102.1 154.67 5.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 121.483 -0.761 . . . . 0.0 110.52 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 231' ' ' LYS . 1.8 tt0 -87.84 -59.28 2.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.619 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.38 169.91 21.96 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 8.6 pt -119.16 -170.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.389 -1.324 . . . . 0.0 109.763 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.583 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 7.6 tp10 -150.6 124.08 9.02 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.669 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.1 mm? -101.64 174.18 3.08 Favored Pre-proline 0 C--N 1.293 -1.88 0 O-C-N 120.465 -1.397 . . . . 0.0 110.74 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -69.11 89.37 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.707 1.372 . . . . 0.0 110.863 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -161.09 0.85 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.487 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.519 ' HA ' ' NZ ' ' A' ' 218' ' ' LYS . 3.0 t70 -79.51 -138.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.415 ' C ' ' HG3' ' A' ' 218' ' ' LYS . 1.7 t-20 60.46 94.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.519 ' NZ ' ' HA ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -136.79 47.73 2.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.96 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.4 m -125.68 41.32 3.54 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.752 0.786 . . . . 0.0 109.964 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 8.8 p-10 -150.78 -41.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.621 -0.674 . . . . 0.0 110.094 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.402 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -147.83 -170.41 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.539 ' O ' ' CZ ' ' A' ' 225' ' ' PHE . 0.6 OUTLIER -55.5 162.26 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.012 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -130.89 140.29 50.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 110.324 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.546 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 118.68 50.93 0.31 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.539 ' CZ ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -151.71 177.41 10.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.243 . . . . 0.0 110.995 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.616 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.3 116.45 19.13 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.26 -170.06 2.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.408 -1.433 . . . . 0.0 110.394 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.61 134.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.688 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 6.4 t -110.42 139.99 45.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.206 -1.559 . . . . 0.0 109.594 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 69.9 m-85 -101.36 -165.65 1.22 Allowed 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 19.2 tttt -92.21 -65.22 1.02 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -101.56 166.68 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -20.22 65.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 35.2 tt0 -54.81 -53.61 58.85 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.8 Cg_exo -44.42 -38.72 11.96 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 120.477 0.785 . . . . 0.0 111.398 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.836 HG22 ' CG2' ' A' ' 184' ' ' ILE . 55.5 t -74.87 -34.06 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.734 -1.228 . . . . 0.0 109.25 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -46.31 -46.33 18.03 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.333 1.064 . . . . 0.0 108.22 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -62.7 1.29 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.949 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.872 HD11 ' CD1' ' A' ' 205' ' ' PHE . 25.2 mm -46.64 -65.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.485 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 239' ' ' ILE . 12.0 tpt -43.63 -33.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 110.052 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -67.54 -2.84 7.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.116 -0.99 . . . . 0.0 110.828 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.12 50.7 2.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 109.099 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -25.42 -39.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.7 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.6 t80 -114.52 93.71 4.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.463 -1.398 . . . . 0.0 109.454 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.734 ' HD2' HD13 ' A' ' 254' ' ' ILE . 11.3 m-70 -91.19 -157.97 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.153 -0.967 . . . . 0.0 111.301 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 12.1 t-20 -141.07 139.8 34.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.797 -0.564 . . . . 0.0 109.621 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.41 113.32 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.003 -1.061 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 62.66 -87.08 0.05 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 2.2 mt -137.55 27.1 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.187 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.48 170.25 17.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.427 -0.796 . . . . 0.0 109.421 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.7 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -132.95 64.28 1.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.791 -1.193 . . . . 0.0 111.289 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.633 ' HB3' HG12 ' A' ' 186' ' ' VAL . 67.7 m -39.24 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.968 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -86.51 171.35 11.14 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.048 178.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.968 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -150.54 97.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 C-N-CA 118.094 -1.442 . . . . 0.0 112.938 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.0 tttt -103.94 116.17 31.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.38 167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.168 0.985 . . . . 0.0 112.572 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.231 0 O-C-N 121.634 -0.667 . . . . 0.0 110.207 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.698 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.06 HG23 HG22 ' A' ' 236' ' ' VAL . 2.8 pt -131.58 172.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -133.23 132.71 41.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.955 -1.09 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 254' ' ' ILE . 26.2 t -105.95 127.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.424 -0.797 . . . . 0.0 110.395 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.538 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -102.5 48.88 1.02 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.954 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -125.66 -10.64 4.36 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.954 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 12.89 56.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.4 p -42.12 166.84 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.208 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -59.62 -13.65 22.53 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.653 1.343 . . . . 0.0 111.018 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 65.5 m-20 -142.92 92.09 2.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.617 HG21 ' HD2' ' A' ' 214' ' ' PRO . 9.5 p -38.92 95.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.727 -0.608 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.738 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -73.47 113.75 3.86 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.513 1.475 . . . . 0.0 111.646 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.525 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -97.73 -70.56 0.72 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.01 0.909 . . . . 0.0 109.556 177.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -50.79 -47.5 59.79 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -63.82 -26.95 68.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -68.06 -60.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 198' ' ' ILE . 1.4 tmm_? -50.34 -31.87 15.7 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -63.26 -41.05 98.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.708 178.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' GLY . 0.9 OUTLIER -90.89 -70.4 0.68 Allowed 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.813 179.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.665 ' CD1' HD11 ' A' ' 184' ' ' ILE . 70.8 m-85 -54.07 -55.61 25.9 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.726 -0.79 . . . . 0.0 108.947 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.783 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.08 -22.64 29.27 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -67.33 -46.74 68.19 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 82.6 m-85 -56.3 -31.04 63.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.031 -1.276 . . . . 0.0 108.494 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.68 142.73 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.195 -1.962 . . . . 0.0 108.195 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.4 pm0 -42.87 143.81 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.048 -1.266 . . . . 0.0 109.824 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.817 HG22 ' CE2' ' A' ' 230' ' ' PHE . 11.8 t -105.12 154.26 6.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.396 -0.815 . . . . 0.0 110.874 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -88.33 -57.74 2.81 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 229' ' ' THR . 0.4 OUTLIER -153.4 170.24 21.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 42.6 pt -118.57 -169.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 118.549 -1.26 . . . . 0.0 110.021 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.0 tt0 -151.12 121.8 7.49 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.638 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 1.6 mm? -98.64 173.7 3.68 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.405 -1.434 . . . . 0.0 110.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 3.7 Cg_exo -66.41 -154.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.753 1.396 . . . . 0.0 110.746 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.402 ' O ' ' HE2' ' A' ' 218' ' ' LYS . 23.6 mtt -100.9 176.23 5.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.421 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 218' ' ' LYS . 25.3 t0 -89.29 160.42 16.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 21.6 m-20 64.18 -69.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER 65.84 50.98 1.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.385 -0.822 . . . . 0.0 109.769 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.0 t -144.59 50.06 1.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.225 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -150.2 -38.68 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 0.0 109.97 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 -173.41 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.444 -0.785 . . . . 0.0 110.145 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 223' ' ' ARG . 2.8 mtp85 -45.78 163.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.2 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -47.46 177.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.931 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -121.87 125.51 6.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -90.76 -179.53 5.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.454 -1.027 . . . . 0.0 110.389 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.659 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -131.57 118.19 19.77 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -96.21 -171.75 2.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.46 -1.4 . . . . 0.0 110.159 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.4 mt -163.91 137.52 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 210' ' ' SER . 7.0 t -113.17 146.3 39.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.079 -1.638 . . . . 0.0 110.253 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.817 ' CE2' HG22 ' A' ' 208' ' ' VAL . 44.0 m-85 -109.8 -164.86 0.96 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.583 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 232' ' ' GLU . 31.1 tttt -110.49 -65.78 1.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.477 0.656 . . . . 0.0 110.911 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 6.6 mt-10 -66.05 -67.68 0.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 110.842 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.583 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.9 OUTLIER 147.72 -29.41 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-O 122.807 1.289 . . . . 0.0 107.666 -179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.689 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt-10 -54.74 -45.21 99.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -50.9 -21.5 8.61 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 122.496 0.735 . . . . 0.0 110.451 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.06 HG22 HG23 ' A' ' 184' ' ' ILE . 57.6 t -91.31 -35.33 6.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -48.21 -48.38 34.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -73.54 -61.58 1.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.962 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 184' ' ' ILE . 15.4 mm -43.56 -66.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.463 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.4 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -43.09 -44.49 4.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 110.386 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -59.17 -13.52 7.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.137 -0.977 . . . . 0.0 110.438 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -124.4 45.21 2.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' ILE . 4.6 ttmt -25.43 -37.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -115.25 95.02 4.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.428 -1.42 . . . . 0.0 110.369 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.771 ' HD2' HD13 ' A' ' 254' ' ' ILE . 1.6 m-70 -102.36 -145.91 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.997 -1.065 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 3.6 m-20 -145.09 145.32 31.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.0 109.538 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.55 108.3 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 110.415 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 249' ' ' LEU . . . 65.62 -86.01 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 248' ' ' GLY . 0.8 OUTLIER -142.62 28.92 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -1.102 . . . . 0.0 110.008 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.52 132.7 23.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -90.2 46.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.608 -179.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.556 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 29.1 p -35.57 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.575 -0.703 . . . . 0.0 109.783 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.945 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.3 OUTLIER -87.43 173.14 9.3 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.419 -1.312 . . . . 0.0 108.668 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.945 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.26 94.12 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.406 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 17.7 ttmt -100.08 113.0 25.3 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -38.3 167.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 122.071 0.939 . . . . 0.0 112.686 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.698 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.487 0.661 . . . . 0.0 110.04 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.689 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.819 HG23 HG22 ' A' ' 236' ' ' VAL . 1.6 pp -132.2 -178.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.731 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.86 148.4 50.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 110.041 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 253' ' ' GLU . 24.1 t -120.55 124.94 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.079 -1.013 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.535 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -97.69 32.69 6.52 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -156.01 16.77 0.45 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.744 HD22 ' C ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -34.41 156.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.775 -0.838 . . . . 0.0 111.983 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.564 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.8 p -89.03 -175.25 0.53 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -66.07 -25.16 51.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.293 1.154 . . . . 0.0 110.486 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 1.8 t70 -148.75 83.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.324 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.593 ' HB ' ' CG ' ' A' ' 213' ' ' LEU . 4.4 m -38.64 95.02 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.691 -0.631 . . . . 0.0 110.074 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.53 ' HD2' HD13 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -73.05 76.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 194' ' ' PRO . 1.8 mt-10 -36.45 -40.5 0.24 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.482 -0.761 . . . . 0.0 110.128 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.1 -53.31 39.64 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 117.937 -1.505 . . . . 0.0 108.519 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 12.3 ttmt -69.78 -28.63 65.91 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 211' ' ' ILE . 1.1 tp -64.18 -51.2 71.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.63 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -54.38 -33.25 58.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -61.61 -40.51 95.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 245' ' ' HIS . 3.3 t80 -91.02 -68.8 0.77 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.529 -1.669 . . . . 0.0 109.449 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 198' ' ' ILE . 77.9 m-85 -58.33 -52.34 66.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.72 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -57.25 -25.63 54.74 Favored Glycine 0 N--CA 1.481 1.678 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -59.5 -44.82 96.41 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 108.059 -2.016 . . . . 0.0 108.059 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.662 ' CD2' HD11 ' A' ' 239' ' ' ILE . 78.9 m-85 -61.34 -40.08 92.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.167 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.46 140.22 6.15 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.7 OUTLIER -42.63 143.12 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.251 . . . . 0.0 110.122 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 230' ' ' PHE . 14.2 t -110.24 152.54 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 110.728 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 1.1 tp10 -88.32 -58.51 2.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 229' ' ' THR . 1.7 m -153.14 163.58 39.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 198' ' ' ILE . 2.2 pp -111.59 -171.27 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.176 -1.409 . . . . 0.0 110.351 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.875 ' N ' HD12 ' A' ' 211' ' ' ILE . 22.7 tt0 -152.69 139.65 19.13 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.452 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.671 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 4.0 mt -99.28 -177.93 0.64 Allowed Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.5 Cg_exo -58.8 -78.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 122.627 0.804 . . . . 0.0 110.145 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.485 ' O ' ' O ' ' A' ' 216' ' ' ASP . 0.1 OUTLIER 40.45 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.621 -0.675 . . . . 0.0 111.458 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 214' ' ' PRO . 11.6 t70 -40.96 166.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 110.75 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 1.3 m-20 67.82 83.24 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.294 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.35 45.72 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.3 52.29 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 110.198 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.47 -99.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -144.65 -169.43 3.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.97 -1.081 . . . . 0.0 110.276 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 221' ' ' LYS . 30.3 ttt-85 -40.94 118.3 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.727 . . . . 0.0 110.195 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.83 177.02 4.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.981 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 163.02 68.47 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.562 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.7 p90 -147.07 165.52 29.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.226 -1.161 . . . . 0.0 110.433 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 226' ' ' CYS . 10.3 p -138.19 129.62 27.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.671 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -95.62 -175.56 3.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.569 -1.332 . . . . 0.0 109.203 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 198' ' ' ILE . 1.7 mt -161.58 133.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 210' ' ' SER . 7.7 t -110.49 143.66 40.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.166 -1.584 . . . . 0.0 110.299 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.769 ' CE2' HG22 ' A' ' 208' ' ' VAL . 63.5 m-85 -104.68 -126.41 0.23 Allowed 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.61 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.92 -56.09 0.55 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.654 -1.279 . . . . 0.0 111.182 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 2.1 tt0 -92.8 -69.75 0.73 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.018 -1.051 . . . . 0.0 110.145 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 2.0 pt-20 165.88 -31.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.238 1.018 . . . . 0.0 108.914 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.682 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -48.58 -48.91 67.41 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -51.03 -36.18 53.27 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 122.667 0.825 . . . . 0.0 110.522 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.819 HG22 HG23 ' A' ' 184' ' ' ILE . 3.6 t -67.62 -41.96 86.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 120.971 -1.081 . . . . 0.0 108.333 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.58 -46.08 9.8 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.278 1.037 . . . . 0.0 108.741 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB3' ' CD1' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -71.82 -63.33 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.916 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 205' ' ' PHE . 31.4 mm -44.23 -64.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.393 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -46.18 -34.15 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -0.958 . . . . 0.0 109.476 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 15.0 tt0 -80.05 10.17 4.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 110.522 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.584 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.5 mmtt -131.28 49.03 2.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 108.987 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 242' ' ' LYS . 1.4 tmmm? -26.55 -39.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.686 ' CE2' ' CD ' ' A' ' 251' ' ' LYS . 1.7 t80 -123.56 104.59 9.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.624 -1.298 . . . . 0.0 109.616 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.744 ' CD2' HD13 ' A' ' 254' ' ' ILE . 36.5 m-70 -89.6 -174.6 4.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.951 . . . . 0.0 110.663 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 250' ' ' SER . 3.8 m120 -133.92 119.19 18.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.523 -0.736 . . . . 0.0 109.494 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 250' ' ' SER . 54.5 t -145.59 131.56 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.997 -1.064 . . . . 0.0 110.57 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.04 65.3 2.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 249' ' ' LEU . 6.8 mp 48.24 28.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -1.159 . . . . 0.0 110.937 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 69.8 m -136.3 171.57 14.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.048 -1.032 . . . . 0.0 109.762 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.686 ' CD ' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -150.47 53.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 111.313 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.56 ' HB2' HG12 ' A' ' 186' ' ' VAL . 24.0 p -39.05 161.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.469 -0.77 . . . . 0.0 109.405 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.869 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.52 168.57 13.59 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.043 -1.463 . . . . 0.0 108.01 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.869 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.26 109.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 117.942 -1.503 . . . . 0.0 113.548 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tttp -99.18 -154.67 0.47 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 7.0 p -122.64 168.41 15.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.309 -1.495 . . . . 0.0 110.448 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.689 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.878 . . . . 0.0 110.654 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.675 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.067 HG23 HG22 ' A' ' 236' ' ' VAL . 3.8 pt -130.22 176.99 7.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 118.317 -1.353 . . . . 0.0 110.48 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.72 117.82 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 110.775 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 22.3 t -89.62 119.08 36.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.541 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -95.55 41.02 2.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' C ' HD13 ' A' ' 189' ' ' LEU . . . -147.62 13.09 1.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -24.83 145.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.145 0.974 . . . . 0.0 112.826 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.575 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.4 p -92.21 -174.47 0.42 Allowed Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -62.31 -25.01 76.28 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 122.924 0.96 . . . . 0.0 109.833 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 193' ' ' THR . 2.7 m-20 -150.91 85.76 1.36 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.009 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.761 ' CB ' HD12 ' A' ' 213' ' ' LEU . 94.8 m -40.41 99.92 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.306 -0.871 . . . . 0.0 110.361 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.561 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.6 Cg_endo -68.06 71.98 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.756 1.398 . . . . 0.0 112.158 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.72 -64.55 0.34 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.479 -0.763 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 1.8 tt0 -46.28 -43.67 15.88 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.083 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 2.5 tttt -74.64 -29.06 61.14 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.3 tp -62.24 -53.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.615 ' N ' HG22 ' A' ' 198' ' ' ILE . 12.5 mtt180 -52.43 -37.48 56.89 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 2.4 mm-40 -59.59 -38.39 81.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.909 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.55 -70.86 0.67 Allowed 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.591 ' CD2' HG13 ' A' ' 198' ' ' ILE . 91.2 m-85 -56.6 -53.24 59.9 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.893 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.805 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.44 -21.5 27.53 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.2 -45.46 70.73 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.927 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.8 m-85 -56.72 -40.84 76.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -1.209 . . . . 0.0 108.896 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -167.32 138.03 4.95 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 206' ' ' GLY . 1.1 pm0 -41.83 142.36 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -1.185 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.805 HG23 ' HA2' ' A' ' 203' ' ' GLY . 18.5 t -102.98 152.47 5.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.419 -0.8 . . . . 0.0 110.951 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.1 tt0 -88.12 -55.89 3.56 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.7 ' O ' HG22 ' A' ' 229' ' ' THR . 3.4 m -153.59 169.0 24.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 2.4 pt -118.63 -171.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.528 -1.357 . . . . 0.0 110.137 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.586 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 11.5 tp10 -151.51 130.82 12.83 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.106 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.849 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 2.4 mm? -101.87 176.99 1.61 Allowed Pre-proline 0 C--N 1.295 -1.762 0 O-C-N 120.528 -1.357 . . . . 0.0 109.829 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.849 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo -59.92 105.87 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.327 1.172 . . . . 0.0 110.457 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.459 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -121.45 -158.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.468 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 215' ' ' MET . 19.9 t0 66.18 26.26 10.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 217' ' ' ASN . 3.4 p-10 -96.72 44.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.995 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.596 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -146.86 48.36 1.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.834 . . . . 0.0 109.729 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.423 HG23 ' C ' ' A' ' 218' ' ' LYS . 45.1 p -148.65 -81.64 0.12 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.611 1.196 . . . . 0.0 110.21 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' OG1' ' A' ' 219' ' ' THR . 1.5 p-10 -144.3 -33.33 0.4 Allowed 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.391 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.49 -172.71 3.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 110.301 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.38 -169.64 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 110.214 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -112.57 130.64 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.17 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -156.17 24.89 0.54 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.555 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 2.4 p90 -150.51 -166.87 2.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -1.187 . . . . 0.0 110.648 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.553 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -165.07 117.37 1.19 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.82 . . . . 0.0 108.83 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -93.82 -174.8 3.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.476 -1.39 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.2 mt -164.03 133.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 210' ' ' SER . 6.0 t -106.18 141.97 36.65 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.221 -1.549 . . . . 0.0 110.102 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.76 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.8 m-85 -100.65 -142.68 0.34 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.198 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -123.23 -58.56 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.837 -1.165 . . . . 0.0 111.674 -178.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 8.8 mt-10 -92.24 -70.08 0.71 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 110.725 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 163.76 -27.61 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.461 1.124 . . . . 0.0 108.895 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.705 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 tt0 -57.93 -42.6 96.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.705 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -52.74 -31.44 50.93 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.496 0.735 . . . . 0.0 110.304 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.067 HG22 HG23 ' A' ' 184' ' ' ILE . 37.2 t -76.74 -36.82 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.741 -1.224 . . . . 0.0 108.121 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -44.5 -46.75 9.93 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.468 1.128 . . . . 0.0 108.25 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.84 -61.26 1.85 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.892 0.853 . . . . 0.0 109.869 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.927 HD11 ' CD1' ' A' ' 205' ' ' PHE . 15.4 mm -45.63 -65.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.482 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -48.21 -31.15 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.55 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 70.8 tt0 -66.41 -5.26 10.29 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.932 -1.105 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.26 52.88 1.45 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 0.0 109.355 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 33.6 ttpt -26.32 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.645 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -107.59 90.74 3.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.334 -1.479 . . . . 0.0 110.456 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.773 ' HD2' HD13 ' A' ' 254' ' ' ILE . 11.9 m-70 -95.11 -164.09 1.12 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.254 -0.904 . . . . 0.0 110.703 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 13.2 m120 -137.1 143.99 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.639 -0.663 . . . . 0.0 109.629 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.45 99.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.07 . . . . 0.0 110.323 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 67.28 -83.61 0.13 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.17 24.41 2.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -1.145 . . . . 0.0 110.298 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 4.1 m -143.95 134.52 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.645 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.79 56.71 0.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.063 . . . . 0.0 110.895 -179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 33.9 m -41.34 162.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.287 -0.883 . . . . 0.0 109.065 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.956 ' C ' HD12 ' A' ' 254' ' ' ILE . 2.2 pt-20 -88.1 175.7 7.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.575 -1.328 . . . . 0.0 108.293 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.956 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -149.2 108.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.426 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 1.2 tttt -114.6 110.56 19.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -37.55 167.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.114 0.959 . . . . 0.0 112.918 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.315 0 O-C-N 121.764 -0.585 . . . . 0.0 109.762 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.718 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 239' ' ' ILE . 1.1 pt -128.78 178.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 C-N-CA 117.593 -1.643 . . . . 0.0 110.734 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.624 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -147.35 119.24 8.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.951 -1.093 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 254' ' ' ILE . 95.0 t -89.2 121.7 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.573 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -77.0 -59.31 3.19 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.949 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 189' ' ' LEU . . . -72.52 -59.35 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 226' ' ' CYS . 0.4 OUTLIER 69.43 151.66 0.09 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.71 -0.877 . . . . 0.0 110.811 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.56 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 2.7 p -72.29 -174.35 0.3 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 109.231 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.0 Cg_exo -66.67 -15.92 48.93 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.352 1.185 . . . . 0.0 111.208 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 3.9 p30 -150.04 123.44 9.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.973 -1.079 . . . . 0.0 110.771 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.657 HG21 ' HD2' ' A' ' 214' ' ' PRO . 44.9 p -39.59 96.62 0.12 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.495 -0.753 . . . . 0.0 109.948 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.653 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.89 47.18 1.19 Allowed 'Trans proline' 0 C--O 1.204 -1.224 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.729 ' HG3' HD12 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -37.33 -71.59 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.959 -1.088 . . . . 0.0 112.315 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -47.25 -40.49 16.67 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.299 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 13.2 mmtt -75.84 -26.58 57.29 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.781 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -67.37 -55.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 42.7 ttt-85 -56.94 -34.68 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.9 mm-40 -57.97 -46.78 84.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 110.182 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.45 -71.05 0.64 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 117.377 -1.729 . . . . 0.0 109.657 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.651 ' CD2' HG13 ' A' ' 198' ' ' ILE . 11.4 m-30 -51.29 -51.33 55.19 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.177 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.62 -21.18 27.49 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.24 -45.73 29.83 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.509 ' CD2' HG12 ' A' ' 239' ' ' ILE . 73.6 m-85 -54.35 -28.1 40.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -1.187 . . . . 0.0 108.361 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.91 129.45 1.3 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.0 OUTLIER -39.84 141.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -1.098 . . . . 0.0 110.199 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 211' ' ' ILE . 2.6 t -91.17 140.46 15.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.499 -0.751 . . . . 0.0 110.587 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.2 OUTLIER -87.53 -47.02 9.06 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 176.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.767 ' O ' HG22 ' A' ' 229' ' ' THR . 35.2 m -153.19 161.31 42.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 195' ' ' GLU . 4.4 pt -118.58 -166.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 118.037 -1.465 . . . . 0.0 110.638 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.96 130.52 12.24 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.972 -179.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.68 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 3.0 mm? -111.78 172.7 3.34 Favored Pre-proline 0 C--N 1.292 -1.92 0 O-C-N 120.614 -1.304 . . . . 0.0 108.595 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.68 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -61.2 101.86 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.366 1.193 . . . . 0.0 110.938 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 8.5 ttt -132.81 -80.77 0.49 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.324 -0.86 . . . . 0.0 110.533 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 217' ' ' ASN . 2.4 t70 -98.8 -160.87 0.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 110.673 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.489 ' C ' ' HD3' ' A' ' 218' ' ' LYS . 1.6 t-20 70.96 83.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.338 -0.851 . . . . 0.0 109.715 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 217' ' ' ASN . 1.3 mmtt -118.63 40.77 3.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.88 47.75 1.92 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.486 0.66 . . . . 0.0 110.153 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.42 ' ND2' ' OD1' ' A' ' 217' ' ' ASN . 1.5 p30 -150.24 -73.78 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 110.258 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.42 -176.65 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.915 . . . . 0.0 110.15 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -175.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -94.28 116.13 28.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.184 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 189' ' ' LEU . . . 148.82 46.18 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.109 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 3.6 p90 -127.06 162.01 27.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.059 -1.26 . . . . 0.0 110.256 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.982 ' HB3' HD11 ' A' ' 189' ' ' LEU . 14.8 p -139.26 131.07 27.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.318 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.713 ' HB2' ' HB3' ' A' ' 212' ' ' GLU . 2.3 m-85 -97.25 -173.33 2.64 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.114 -1.616 . . . . 0.0 108.875 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.781 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -163.34 132.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 210' ' ' SER . 13.3 t -111.2 150.49 29.46 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.423 -1.423 . . . . 0.0 110.253 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.52 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 66.9 m-85 -118.93 -116.04 0.32 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.048 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.64 -47.12 0.05 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.815 -1.178 . . . . 0.0 111.654 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -83.75 -101.18 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.916 -1.115 . . . . 0.0 111.366 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 176.05 -27.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 109.844 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.645 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.8 mt-10 -59.49 -49.56 91.69 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 112.6 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -53.25 -22.68 20.81 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 122.923 0.959 . . . . 0.0 111.563 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.435 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.1 t -79.37 -48.21 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.83 -41.29 10.92 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 122.191 0.996 . . . . 0.0 108.653 178.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 1.1 tttm -71.22 -64.62 0.88 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.856 0.836 . . . . 0.0 110.332 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -50.96 -62.1 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.825 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.658 ' N ' HG22 ' A' ' 239' ' ' ILE . 3.5 tmm? -44.3 -32.79 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 110.333 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -65.3 -5.89 8.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.019 -1.051 . . . . 0.0 110.599 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.587 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -137.69 51.7 1.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.144 -0.973 . . . . 0.0 109.134 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 254' ' ' ILE . 3.0 ttmt -25.02 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -106.75 91.94 3.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.478 -1.388 . . . . 0.0 109.567 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.831 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.4 m-70 -89.64 -159.61 0.6 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.07 -1.018 . . . . 0.0 110.83 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.459 ' C ' HG23 ' A' ' 247' ' ' VAL . 9.4 t-20 -136.59 128.57 29.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 250' ' ' SER . 44.4 t -146.36 136.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.925 -1.109 . . . . 0.0 110.634 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 42.55 70.93 0.43 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.3 OUTLIER 42.51 35.75 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -1.17 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -144.87 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.3 OUTLIER -137.19 46.87 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.092 -1.005 . . . . 0.0 110.583 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.62 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 63.6 m -40.07 157.04 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.887 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.9 pt-20 -87.92 165.51 15.19 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 117.618 -1.633 . . . . 0.0 107.568 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.887 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.37 110.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.168 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 8.5 tttt -100.98 113.82 27.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -40.6 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 111.912 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.658 -0.651 . . . . 0.0 109.848 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.89 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -138.22 169.53 18.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.035 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.634 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -115.39 155.33 27.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.931 -1.105 . . . . 0.0 109.573 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 61.7 t -134.82 136.35 52.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.198 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.434 ' HA3' ' HG2' ' A' ' 253' ' ' GLU . . . -97.83 39.04 2.88 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 1.099 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -84.89 -38.07 9.68 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.099 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.3 OUTLIER 24.25 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 188' ' ' GLY . 0.8 OUTLIER -67.87 169.02 10.57 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.641 -0.662 . . . . 0.0 110.267 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -60.79 -23.09 75.71 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.612 1.322 . . . . 0.0 110.676 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 193' ' ' THR . 12.5 t0 -141.22 95.77 2.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.791 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 213' ' ' LEU . 62.9 p -41.58 103.92 0.32 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.848 . . . . 0.0 109.633 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -66.92 43.23 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.467 1.444 . . . . 0.0 113.255 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.609 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.3 OUTLIER -37.94 -66.68 0.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.886 -1.134 . . . . 0.0 111.523 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.6 mm-40 -47.59 -43.44 25.58 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.182 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 5.7 mttt -73.97 -25.45 59.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 199' ' ' ARG . 0.6 OUTLIER -65.76 -56.61 14.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -51.17 -37.33 45.84 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.4 mm-40 -60.53 -40.05 90.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.675 . . . . 0.0 109.905 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.21 -72.27 0.59 Allowed 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.497 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.597 ' CD2' HG12 ' A' ' 198' ' ' ILE . 79.4 m-85 -53.53 -53.37 52.61 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.472 -0.891 . . . . 0.0 108.982 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.726 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.68 -21.97 30.97 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -70.01 -45.7 55.49 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 239' ' ' ILE . 82.0 m-85 -57.06 -34.75 68.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -1.222 . . . . 0.0 108.886 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.83 139.41 4.63 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.5 OUTLIER -41.31 142.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -1.104 . . . . 0.0 109.983 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.726 HG23 ' HA2' ' A' ' 203' ' ' GLY . 7.6 t -101.76 148.52 7.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 110.619 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 44.1 tt0 -87.95 -53.27 4.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 229' ' ' THR . 3.7 m -153.54 168.67 25.4 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 12.0 pt -121.54 -170.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.538 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.7 tt0 -150.8 130.51 13.15 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.78 HD13 ' OG1' ' A' ' 193' ' ' THR . 13.4 mt -106.78 178.75 1.02 Allowed Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 120.786 -1.196 . . . . 0.0 109.591 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.766 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.0 Cg_exo -64.75 -174.57 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.212 1.112 . . . . 0.0 111.1 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -96.42 163.79 12.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 110.534 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 217' ' ' ASN . 3.6 t0 -72.07 -163.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 217' ' ' ASN . 9.1 p30 36.61 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.737 -0.602 . . . . 0.0 110.629 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -164.48 55.9 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 110.268 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 38.8 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 5.5 p30 -151.26 -45.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.696 0.76 . . . . 0.0 109.763 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -105.74 -161.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.744 . . . . 0.0 110.063 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 221' ' ' LYS . 0.8 OUTLIER -48.76 -179.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.54 -0.725 . . . . 0.0 110.284 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.746 ' HD2' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -117.62 48.77 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.062 -1.024 . . . . 0.0 110.771 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 1.059 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 35.69 -143.21 0.11 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -150.97 -165.61 2.31 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.663 -0.904 . . . . 0.0 108.941 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 1.2 p -142.26 116.6 9.57 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 120.96 -1.087 . . . . 0.0 108.632 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.5 m-85 -92.79 -165.78 1.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.647 -1.283 . . . . 0.0 109.642 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -168.25 139.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 210' ' ' SER . 8.1 t -113.25 145.62 40.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.065 -1.647 . . . . 0.0 110.118 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.9 m-30 -109.56 -125.02 0.26 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.738 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 209' ' ' GLU . 7.5 tttt -174.7 -50.25 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.104 -0.997 . . . . 0.0 109.866 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.9 mt-10 -71.48 -26.44 62.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.418 -0.801 . . . . 0.0 109.117 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.7 OUTLIER 88.52 -27.12 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 122.843 1.306 . . . . 0.0 108.377 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.677 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 8.4 mt-10 -65.06 -39.32 35.86 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.767 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.1 Cg_exo -54.83 -24.83 40.23 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 N-CA-C 109.618 -0.955 . . . . 0.0 109.618 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.89 HG22 ' CG2' ' A' ' 184' ' ' ILE . 16.2 t -81.12 -41.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 236' ' ' VAL . 1.8 tptt -42.85 -45.77 5.03 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.423 1.106 . . . . 0.0 108.348 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.9 OUTLIER -72.31 -62.2 1.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.856 0.836 . . . . 0.0 109.722 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.495 HG23 HG21 ' A' ' 254' ' ' ILE . 8.2 mm -43.94 -65.44 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.329 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.2 OUTLIER -43.63 -37.85 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 5.2 tt0 -63.3 -8.95 9.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.129 -0.982 . . . . 0.0 110.644 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.609 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.22 51.52 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.047 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 10.1 ttmt -26.96 -36.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.629 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.27 100.78 8.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.392 -1.442 . . . . 0.0 110.015 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.776 ' HD2' HD13 ' A' ' 254' ' ' ILE . 4.2 m-70 -102.35 -158.32 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.156 -0.965 . . . . 0.0 110.773 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -139.19 149.14 44.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.519 -0.738 . . . . 0.0 109.958 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 249' ' ' LEU . 37.9 t -143.67 123.15 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.41 -93.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -131.71 32.78 4.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 110.088 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.9 m -149.98 155.74 40.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.629 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.96 56.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 111.072 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 30.3 p -37.19 156.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.542 -0.724 . . . . 0.0 109.835 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.965 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.0 pm0 -88.34 172.42 9.42 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.624 -1.231 . . . . 0.0 108.973 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -146.25 129.42 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.509 -1.276 . . . . 0.0 112.155 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HG2' ' CE1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -137.42 104.92 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.9 p -34.48 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.094 0.949 . . . . 0.0 113.171 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.676 -0.64 . . . . 0.0 109.651 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.692 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.865 HG23 HG22 ' A' ' 236' ' ' VAL . 1.2 pt -133.35 179.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.63 -1.228 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -134.92 130.46 35.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.987 -1.071 . . . . 0.0 110.236 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.592 HG13 ' SG ' ' A' ' 252' ' ' CYS . 59.3 t -102.62 122.23 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 110.304 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -96.11 41.46 2.42 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 190' ' ' SER . . . -119.46 -16.3 5.17 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.953 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.0 OUTLIER 1.46 56.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.2 p -44.8 170.97 0.05 OUTLIER Pre-proline 0 C--N 1.277 -2.571 0 O-C-N 121.869 -0.519 . . . . 0.0 109.845 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -60.73 -10.74 15.07 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.537 1.283 . . . . 0.0 110.877 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 5.1 t70 -138.5 91.96 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.509 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.594 ' HB ' HD22 ' A' ' 213' ' ' LEU . 43.8 p -39.09 97.05 0.12 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.65 -0.657 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.751 ' O ' HD12 ' A' ' 198' ' ' ILE . 2.5 Cg_endo -71.73 103.65 1.49 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.411 1.407 . . . . 0.0 111.399 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.609 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -94.44 -66.72 0.9 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.882 0.849 . . . . 0.0 110.201 178.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 5.4 tm-20 -50.14 -46.03 53.63 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.657 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -67.49 -26.12 66.2 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -66.35 -58.94 4.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.719 ' N ' HG22 ' A' ' 198' ' ' ILE . 50.2 ttt180 -53.05 -34.64 57.39 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 15.2 mm-40 -59.88 -41.94 92.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.34 -69.96 0.71 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 117.569 -1.652 . . . . 0.0 109.43 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -54.47 -53.99 46.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.767 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.52 -21.59 28.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.92 -46.1 54.08 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 239' ' ' ILE . 80.8 m-85 -55.98 -38.01 69.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.951 -1.323 . . . . 0.0 108.847 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -173.31 142.04 6.43 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' OE2' ' CD ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -42.39 142.91 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -1.198 . . . . 0.0 110.095 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.767 HG23 ' HA2' ' A' ' 203' ' ' GLY . 13.3 t -103.06 151.9 6.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 110.689 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 29.2 tp10 -87.8 -61.05 1.8 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 4.0 m -153.72 161.1 42.41 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 16.6 pt -106.46 -168.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.236 -1.386 . . . . 0.0 109.714 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 6.2 tt0 -150.91 131.41 13.82 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.745 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.702 ' HB3' ' HD2' ' A' ' 214' ' ' PRO . 11.2 mt -102.7 177.53 1.44 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.6 Cg_exo -67.66 166.76 23.02 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.309 1.163 . . . . 0.0 111.039 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 215' ' ' MET . 7.1 ttp -92.03 25.39 2.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.238 -0.913 . . . . 0.0 110.361 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 217' ' ' ASN . 9.0 t0 44.2 -145.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 109.9 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 216' ' ' ASP . 6.2 t-20 41.47 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 0.0 110.113 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 44.34 2.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.303 -0.873 . . . . 0.0 109.931 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.7 p -121.16 40.16 3.64 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.81 0.814 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -150.23 -41.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.383 0.611 . . . . 0.0 110.121 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.83 -175.06 4.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 110.146 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -90.0 100.19 13.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.74 131.74 4.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 189' ' ' LEU . . . 176.36 36.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.594 ' HA ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -88.68 174.86 7.79 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.471 -1.017 . . . . 0.0 110.815 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -127.61 119.74 26.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.651 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.8 m-85 -91.78 -169.34 2.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 110.147 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 198' ' ' ILE . 1.5 mt -164.34 133.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 5.8 t -109.7 141.56 42.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 119.834 -1.791 . . . . 0.0 109.879 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.73 ' HD2' HG23 ' A' ' 236' ' ' VAL . 20.2 m-30 -98.28 -140.3 0.3 Allowed 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' CD ' ' OE2' ' A' ' 207' ' ' GLU . 74.4 tttt -126.83 -54.85 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.936 -1.103 . . . . 0.0 111.41 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 5.6 mt-10 -97.4 -68.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.013 -1.054 . . . . 0.0 110.481 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 162.35 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.173 0.987 . . . . 0.0 108.997 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.699 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -56.43 -43.5 99.33 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.65 -32.24 53.72 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 122.663 0.822 . . . . 0.0 110.649 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 184' ' ' ILE . 40.6 t -77.67 -34.5 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.262 . . . . 0.0 108.226 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -44.88 -48.15 11.17 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.281 1.038 . . . . 0.0 108.454 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -61.27 1.83 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.868 0.842 . . . . 0.0 109.731 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.7 mm -44.93 -66.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.464 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -41.23 -42.24 2.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.483 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -58.03 -14.0 5.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.095 -1.003 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.591 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -132.26 48.25 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.8 ttmt -26.95 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.614 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.4 t80 -112.13 96.58 6.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.533 -1.354 . . . . 0.0 110.081 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.796 ' HD2' HD13 ' A' ' 254' ' ' ILE . 1.6 m-70 -103.34 -150.81 0.42 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.07 -1.019 . . . . 0.0 110.569 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -130.0 141.48 50.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.555 -0.716 . . . . 0.0 109.648 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 250' ' ' SER . 40.7 t -150.28 118.69 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 0.0 110.816 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 39.76 76.71 0.08 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 4.6 mt 44.95 24.0 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -1.206 . . . . 0.0 110.85 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 247' ' ' VAL . 17.4 m -143.6 122.17 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.101 -0.999 . . . . 0.0 109.216 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.614 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.4 pttt -89.61 52.47 2.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.089 -1.007 . . . . 0.0 110.958 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 186' ' ' VAL . 22.0 p -38.81 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.2 pt-20 -87.59 168.78 12.73 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.847 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -142.74 95.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.025 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.33 110.14 22.77 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.1 p -39.85 165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.879 -1.138 . . . . 0.0 112.045 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.602 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.554 -0.716 . . . . 0.0 110.441 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.745 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.687 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.4 pt -125.93 162.3 29.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.891 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.66 135.82 50.75 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.027 -1.045 . . . . 0.0 110.723 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 252' ' ' CYS . 17.6 t -109.44 137.81 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.575 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -106.96 46.18 1.2 Allowed Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.962 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -112.82 -17.11 8.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.962 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.1 OUTLIER 22.4 43.94 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 121.476 0.655 . . . . 0.0 112.268 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 2.8 p -47.42 175.64 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -58.16 -36.05 98.19 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.198 1.104 . . . . 0.0 110.857 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 30.1 t0 -150.8 99.64 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.421 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.82 HG21 ' CD1' ' A' ' 213' ' ' LEU . 98.1 m -42.69 101.9 0.26 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.602 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.62 64.41 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.335 1.357 . . . . 0.0 112.105 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.58 -69.59 0.11 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.444 -0.785 . . . . 0.0 112.002 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' GLU . 25.4 tt0 -45.92 -41.25 11.28 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.281 -176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -75.71 -30.05 59.17 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -62.94 -51.8 67.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.613 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -56.28 -38.49 71.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -55.98 -40.08 72.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.88 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -70.59 0.68 Allowed 'General case' 0 C--N 1.292 -1.921 0 C-N-CA 117.563 -1.655 . . . . 0.0 110.006 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 184' ' ' ILE . 39.3 m-85 -57.19 -53.03 62.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.53 -0.731 . . . . 0.0 109.649 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.853 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.67 -23.02 12.9 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.361 -2.296 . . . . 0.0 107.361 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.56 55.89 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 239' ' ' ILE . 86.1 m-85 -57.02 -27.89 62.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.952 -1.323 . . . . 0.0 108.711 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 235' ' ' PRO . . . -179.13 133.7 2.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 206' ' ' GLY . 15.1 pt-20 -40.98 142.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.911 HG22 ' CD1' ' A' ' 230' ' ' PHE . 10.7 t -97.32 145.53 9.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.449 -0.782 . . . . 0.0 110.847 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -87.81 -53.31 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.709 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.74 167.72 28.66 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 176.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 195' ' ' GLU . 38.5 pt -112.38 -168.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 118.357 -1.337 . . . . 0.0 109.835 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -151.48 125.62 9.28 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 213' ' ' LEU . 2.5 mm? -108.32 174.53 2.41 Favored Pre-proline 0 C--N 1.295 -1.785 0 O-C-N 120.343 -1.473 . . . . 0.0 110.348 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 2.9 Cg_endo -72.28 66.87 3.52 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.675 1.355 . . . . 0.0 111.212 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 10.3 ptt? -138.06 28.44 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 59.5 t0 -152.98 36.3 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.847 . . . . 0.0 110.099 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 6.5 t-20 -83.3 -56.32 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.681 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 70.25 53.34 0.34 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.481 -0.762 . . . . 0.0 109.714 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.8 p -111.82 -83.59 0.58 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.492 1.139 . . . . 0.0 110.281 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.54 -105.85 0.1 Allowed 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 222' ' ' ARG . 1.5 mmtt -114.5 -175.6 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.841 -1.162 . . . . 0.0 110.239 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 221' ' ' LYS . 0.1 OUTLIER 60.23 130.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.159 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.403 ' NH2' ' HA ' ' A' ' 191' ' ' PRO . 0.0 OUTLIER -48.33 171.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.312 -0.867 . . . . 0.0 110.349 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.953 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -110.36 -131.13 5.96 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -109.04 -179.14 3.77 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.279 -1.13 . . . . 0.0 110.206 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -126.18 119.25 27.02 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.9 m-85 -96.22 -165.36 1.27 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.497 -1.377 . . . . 0.0 110.757 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.602 HG22 ' CE1' ' A' ' 230' ' ' PHE . 1.1 mt -169.71 134.63 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 210' ' ' SER . 6.5 t -112.31 143.64 43.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.849 -1.782 . . . . 0.0 109.627 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 208' ' ' VAL . 21.1 m-85 -108.9 -134.33 0.34 Allowed 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.156 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 232' ' ' GLU . 2.7 tptt -128.2 -69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.06 -1.025 . . . . 0.0 113.276 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.9 mt-10 -73.82 -80.5 0.07 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.87 -1.144 . . . . 0.0 113.535 -177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.2 OUTLIER 161.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 122.111 0.958 . . . . 0.0 109.087 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 15.1 mm-40 -56.4 -55.99 36.53 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.1 Cg_exo -51.62 -40.68 63.89 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.86 0.926 . . . . 0.0 110.682 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -55.21 -48.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.6 -1.313 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -44.87 -42.37 7.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -70.17 -62.68 1.29 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.868 0.842 . . . . 0.0 109.724 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 205' ' ' PHE . 14.1 mm -45.6 -64.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.121 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -43.06 -37.17 1.87 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.483 -0.761 . . . . 0.0 110.191 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -9.02 11.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.114 -0.991 . . . . 0.0 110.658 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 9.1 mmtt -132.55 47.58 2.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 0.0 109.335 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 254' ' ' ILE . 12.0 ttmt -29.62 -32.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.632 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.6 t80 -117.57 86.99 2.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.27 -1.518 . . . . 0.0 110.39 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.702 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.6 m-70 -93.03 -144.78 0.22 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.967 -1.083 . . . . 0.0 110.061 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 1.0 OUTLIER -143.04 135.37 27.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.483 -0.761 . . . . 0.0 109.384 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.435 HG23 ' C ' ' A' ' 246' ' ' ASN . 60.1 t -147.53 133.32 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.908 -1.12 . . . . 0.0 110.885 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 250' ' ' SER . . . 41.86 62.5 1.97 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.43 24.62 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -1.209 . . . . 0.0 110.546 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 248' ' ' GLY . 0.7 OUTLIER -137.26 128.43 27.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.1 -1.0 . . . . 0.0 109.594 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.632 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.26 44.42 1.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 0.0 110.552 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 186' ' ' VAL . 26.7 p -37.27 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.604 -0.685 . . . . 0.0 109.44 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.957 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -86.86 172.05 10.38 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.226 -1.389 . . . . 0.0 108.458 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.957 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -149.24 91.82 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.836 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 20.2 tttt -98.86 113.99 26.37 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.7 p -36.87 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.837 0.827 . . . . 0.0 112.122 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.141 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.709 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.682 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.8 pp -124.64 172.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 C-N-CA 118.328 -1.349 . . . . 0.0 110.653 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.68 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -139.33 124.14 18.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 110.308 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 254' ' ' ILE . 17.3 t -96.84 108.3 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -71.76 -32.38 64.08 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 189' ' ' LEU . . . -96.74 29.58 10.25 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.049 HD13 ' CA ' ' A' ' 225' ' ' PHE . 2.7 pt? -38.67 172.16 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.06 0.933 . . . . 0.0 111.507 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 4.8 p -93.09 168.35 12.39 Favored Pre-proline 0 C--N 1.296 -1.743 0 O-C-N 121.533 -0.729 . . . . 0.0 110.136 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.0 Cg_endo -62.7 -29.55 77.55 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.631 1.332 . . . . 0.0 108.831 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 3.6 t70 -146.9 76.99 1.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HD12 ' A' ' 213' ' ' LEU . 50.0 m -38.01 96.82 0.12 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.656 -0.652 . . . . 0.0 111.014 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.4 Cg_endo -71.24 83.94 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.819 1.431 . . . . 0.0 111.237 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -36.55 -63.18 0.42 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.593 -0.692 . . . . 0.0 111.145 -179.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -47.58 -44.11 26.01 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.108 -177.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 18.4 tttm -75.53 -27.16 58.59 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 211' ' ' ILE . 1.3 tp -64.56 -52.06 59.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.609 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.8 OUTLIER -54.13 -38.35 65.35 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 17.7 mt-10 -56.34 -41.34 75.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.95 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 3.7 t80 -90.94 -69.9 0.71 Allowed 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.479 -1.689 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.593 ' CD2' HG13 ' A' ' 198' ' ' ILE . 74.4 m-85 -57.74 -54.11 50.56 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.373 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -52.1 -24.9 16.34 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 202' ' ' PHE . . . -63.23 -45.86 94.33 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.477 ' CD2' HG12 ' A' ' 239' ' ' ILE . 70.3 m-85 -57.0 -33.51 67.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -1.135 . . . . 0.0 108.68 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.58 140.26 4.69 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 206' ' ' GLY . 2.6 pt-20 -42.45 142.19 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -1.176 . . . . 0.0 110.091 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.853 HG22 ' CE1' ' A' ' 230' ' ' PHE . 8.3 t -99.92 146.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.519 -0.738 . . . . 0.0 111.131 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -88.71 -55.7 3.6 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.617 ' O ' HG22 ' A' ' 229' ' ' THR . 4.8 m -153.34 161.89 41.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.644 HG21 HG21 ' A' ' 198' ' ' ILE . 4.8 pt -114.43 -170.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.209 -1.396 . . . . 0.0 110.253 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.6 tp10 -151.21 138.95 19.77 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.165 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.824 HD12 ' HB ' ' A' ' 193' ' ' THR . 1.6 mm? -110.49 172.32 3.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 120.699 -1.251 . . . . 0.0 110.187 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.784 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 4.2 Cg_exo -50.06 -79.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.503 1.265 . . . . 0.0 111.103 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.57 -70.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.005 -1.06 . . . . 0.0 110.473 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 217' ' ' ASN . 4.1 t70 -177.93 168.84 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 0.9 OUTLIER 45.48 82.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.784 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.4 ' HG3' ' C ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -130.46 45.19 2.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.531 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.48 44.66 2.9 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.662 0.744 . . . . 0.0 109.853 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.43 -100.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 110.136 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -176.41 3.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.97 -1.081 . . . . 0.0 110.288 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 45.32 80.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -85.61 158.71 20.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.975 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.626 ' O ' HD22 ' A' ' 189' ' ' LEU . . . -114.77 -125.41 4.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 1.049 ' CA ' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -152.25 -166.32 2.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.385 -1.068 . . . . 0.0 110.584 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 3.1 p -146.45 127.44 14.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.3 m-85 -99.01 -173.67 2.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.112 -1.617 . . . . 0.0 109.555 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.64 HD11 ' CG1' ' A' ' 198' ' ' ILE . 1.4 mt -163.69 131.87 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.655 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.7 t -107.54 139.68 41.69 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 119.918 -1.739 . . . . 0.0 109.226 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.853 ' CE1' HG22 ' A' ' 208' ' ' VAL . 23.8 m-85 -105.94 -131.48 0.3 Allowed 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.623 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 -64.71 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.846 -1.159 . . . . 0.0 112.874 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 0.7 OUTLIER -77.42 -80.47 0.1 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.994 -1.066 . . . . 0.0 113.483 -177.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 5.1 pt-20 162.97 -26.13 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.948 0.88 . . . . 0.0 108.748 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 235' ' ' PRO . 1.3 mt-10 -55.47 -61.99 5.21 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 234' ' ' GLU . 5.2 Cg_exo -47.19 -39.9 26.89 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 122.988 0.994 . . . . 0.0 110.659 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' LYS . 2.1 t -57.41 -48.25 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -45.51 -40.69 8.81 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.07 0.938 . . . . 0.0 108.536 178.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 8.6 tttt -72.23 -64.0 1.03 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.925 0.869 . . . . 0.0 109.55 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.652 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.8 OUTLIER -45.16 -65.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.613 ' N ' HG22 ' A' ' 239' ' ' ILE . 4.2 tmm? -43.15 -39.16 2.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.192 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 238' ' ' LYS . 39.3 tt0 -61.92 -15.67 44.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.617 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.53 47.33 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.708 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 254' ' ' ILE . 26.3 mtpt -30.87 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 251' ' ' LYS . 0.2 OUTLIER -99.88 85.25 3.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.414 -1.429 . . . . 0.0 109.844 -178.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.731 ' CD2' HD13 ' A' ' 254' ' ' ILE . 7.5 m-70 -89.5 -148.72 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.975 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.564 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.9 OUTLIER -140.65 129.64 23.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.658 -0.651 . . . . 0.0 109.524 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 250' ' ' SER . 24.5 t -150.19 129.26 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.592 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 41.15 69.32 0.53 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.662 ' O ' HD23 ' A' ' 249' ' ' LEU . 0.9 OUTLIER 44.9 25.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 247' ' ' VAL . 18.9 m -139.11 118.96 13.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.546 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.609 ' HG2' ' CE1' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -90.06 44.36 1.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.879 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.954 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.7 p -29.07 148.3 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 O-C-N 122.184 -0.322 . . . . 0.0 110.502 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.96 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -86.49 161.68 18.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.974 -1.49 . . . . 0.0 107.871 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.96 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -146.32 105.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 118.208 -1.397 . . . . 0.0 112.807 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 13.8 tttt -99.21 115.48 29.19 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 3.5 p -37.6 162.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.709 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.542 -0.723 . . . . 0.0 110.607 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.701 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.701 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 1.9 pp -127.27 165.74 25.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.433 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -127.76 139.27 52.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.861 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 253' ' ' GLU . 43.6 t -114.03 130.28 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 110.459 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -100.18 42.41 1.97 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.971 ' O ' HD12 ' A' ' 189' ' ' LEU . . . -122.31 -7.95 7.38 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.971 HD12 ' O ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 13.61 57.15 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 178.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 26.5 p -42.42 164.51 0.11 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.213 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.7 Cg_exo -53.91 -31.38 62.66 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.271 1.143 . . . . 0.0 110.933 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 193' ' ' THR . 1.7 t70 -150.66 85.66 1.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.016 -1.053 . . . . 0.0 110.488 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.816 HG21 ' CD2' ' A' ' 213' ' ' LEU . 62.1 m -40.21 99.03 0.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.844 . . . . 0.0 109.841 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.8 72.47 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.415 1.41 . . . . 0.0 112.293 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.8 -67.14 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.369 -0.832 . . . . 0.0 111.596 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.6 OUTLIER -47.03 -43.62 19.8 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.147 -177.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.0 OUTLIER -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.638 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.1 tp -64.4 -54.28 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.638 ' N ' HG22 ' A' ' 198' ' ' ILE . 5.9 mtp180 -51.78 -38.22 54.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 4.6 mm-40 -56.57 -40.52 75.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.394 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.36 -71.77 0.62 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.63 -1.628 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.604 ' CD2' HG13 ' A' ' 198' ' ' ILE . 83.6 m-85 -54.3 -54.94 33.48 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.947 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.73 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.21 -22.8 23.01 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.269 -2.332 . . . . 0.0 107.269 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.1 -44.93 86.3 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 239' ' ' ILE . 77.6 m-85 -57.97 -36.55 72.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -1.199 . . . . 0.0 108.93 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -175.14 141.99 6.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 206' ' ' GLY . 9.4 pt-20 -42.48 142.04 0.89 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -1.174 . . . . 0.0 109.86 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.73 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.6 t -104.36 150.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.518 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -88.01 -57.64 2.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.633 ' O ' HG22 ' A' ' 229' ' ' THR . 7.2 m -153.34 173.08 16.07 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pt -120.07 -170.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.895 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.606 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 3.0 tp10 -151.17 129.59 12.09 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.687 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.816 ' CD2' HG21 ' A' ' 193' ' ' THR . 14.0 mt -105.82 175.12 2.24 Favored Pre-proline 0 C--N 1.295 -1.79 0 O-C-N 120.608 -1.308 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.2 Cg_exo -70.1 -152.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.586 1.309 . . . . 0.0 110.984 -177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -147.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.832 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.601 ' HA ' ' HD3' ' A' ' 218' ' ' LYS . 36.1 t70 -137.58 174.76 10.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 216' ' ' ASP . 2.0 t-20 68.76 78.05 0.22 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.286 -0.884 . . . . 0.0 109.045 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.601 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -155.7 56.58 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.497 -0.752 . . . . 0.0 109.912 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.5 t -112.4 38.57 2.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 4.5 p-10 -148.66 -43.39 0.15 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.486 0.66 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.404 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 1.9 mmtt -133.62 -175.36 3.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.408 -0.808 . . . . 0.0 110.051 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 223' ' ' ARG . 3.5 mtt180 -109.65 129.37 55.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.287 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 222' ' ' ARG . 4.7 ptm180 175.51 61.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.172 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.833 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -163.64 89.49 0.1 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.505 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -89.81 -178.92 5.62 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.513 -0.992 . . . . 0.0 110.708 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.623 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -129.1 118.88 23.2 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.205 -0.935 . . . . 0.0 109.072 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.83 -171.44 2.35 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.275 -1.516 . . . . 0.0 109.844 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.1 mt -165.78 132.8 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.657 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.0 t -106.22 137.72 43.66 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.03 -1.669 . . . . 0.0 109.041 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 73.8 m-85 -96.79 -162.38 0.95 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.742 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -97.11 -46.26 6.23 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.478 -0.764 . . . . 0.0 109.197 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 42.2 mt-10 -121.79 167.22 13.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.559 -0.713 . . . . 0.0 109.371 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.34 -15.79 63.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.985 -1.072 . . . . 0.0 109.341 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -57.39 -58.78 15.75 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.665 -0.647 . . . . 0.0 112.702 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.0 Cg_exo -45.25 -24.91 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.226 1.119 . . . . 0.0 111.176 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 184' ' ' ILE . 6.5 t -83.34 -41.39 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.008 -1.058 . . . . 0.0 108.842 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -45.51 -44.84 12.91 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.136 0.97 . . . . 0.0 108.536 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -71.63 -63.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.982 0.896 . . . . 0.0 109.738 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.635 HG21 HG21 ' A' ' 184' ' ' ILE . 3.8 mm -44.54 -64.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.373 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 2.6 ttm -45.17 -36.19 3.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 110.099 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 1.5 tp10 -62.73 -9.55 9.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 0.0 110.483 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.624 ' O ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.03 52.26 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.156 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 254' ' ' ILE . 11.7 mtmt -31.86 -25.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.618 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 2.0 t80 -121.68 87.24 2.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.084 -1.635 . . . . 0.0 110.803 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.624 ' CE1' ' O ' ' A' ' 242' ' ' LYS . 6.0 m-70 -89.61 -149.66 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.867 -1.146 . . . . 0.0 110.375 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 5.4 p-10 -145.19 145.19 31.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 249' ' ' LEU . 53.5 t -140.97 126.65 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.856 -1.152 . . . . 0.0 110.242 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 249' ' ' LEU . . . 46.13 -94.83 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 248' ' ' GLY . 19.2 mt -131.55 34.17 3.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 110.026 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.9 m -150.45 135.47 17.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.618 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.5 pttt -103.76 52.07 0.77 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.051 -1.03 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.6 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 84.5 m -36.77 157.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.774 -0.579 . . . . 0.0 109.818 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.861 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.8 pm0 -87.65 172.39 9.75 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.286 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.861 HD12 ' C ' ' A' ' 253' ' ' GLU . 2.5 mp -150.89 96.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 118.294 -1.362 . . . . 0.0 112.897 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 8.8 mttm -100.64 115.89 31.27 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -38.43 166.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.024 0.916 . . . . 0.0 112.546 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.627 -0.67 . . . . 0.0 110.04 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.703 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.703 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 29.3 pt -133.1 -176.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.531 -1.268 . . . . 0.0 111.018 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.38 141.23 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.247 -0.908 . . . . 0.0 110.506 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.581 ' N ' ' CD1' ' A' ' 185' ' ' PHE . 46.3 t -110.39 128.69 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.539 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.35 59.18 0.44 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 179.22 69.23 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.827 HD12 ' OG1' ' A' ' 193' ' ' THR . 2.5 mm? -106.96 153.83 21.99 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.487 -1.008 . . . . 0.0 111.562 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.611 ' CB ' ' HD2' ' A' ' 191' ' ' PRO . 2.9 p -88.91 -166.52 0.11 Allowed Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 190' ' ' SER . 3.5 Cg_exo -62.84 -11.46 24.32 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 122.762 0.875 . . . . 0.0 110.266 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 62.7 t0 -150.74 133.29 15.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.167 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.827 ' OG1' HD12 ' A' ' 189' ' ' LEU . 55.4 m -87.73 113.78 56.03 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.048 -1.032 . . . . 0.0 110.032 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -64.58 60.88 0.27 Allowed 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 121.313 1.342 . . . . 0.0 112.474 -178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.671 ' OE2' HG21 ' A' ' 198' ' ' ILE . 2.5 mm-40 -37.98 -65.31 0.34 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 111.414 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 195' ' ' GLU . 24.4 tt0 -47.59 -42.45 23.96 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.692 -1.203 . . . . 0.0 108.705 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -73.01 -28.13 62.18 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.1 tp -65.99 -56.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.61 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -50.15 -36.96 32.25 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -61.09 -36.68 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.554 -0.716 . . . . 0.0 109.768 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.3 t80 -91.25 -72.04 0.6 Allowed 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 117.571 -1.652 . . . . 0.0 109.864 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.56 ' CD2' HG13 ' A' ' 198' ' ' ILE . 23.0 m-85 -58.64 -50.18 74.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.77 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.15 -20.75 29.41 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 177.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.51 -46.25 41.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 239' ' ' ILE . 74.1 m-85 -53.78 -37.75 63.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.049 -1.265 . . . . 0.0 108.633 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.13 132.44 2.51 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.4 OUTLIER -39.76 142.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -1.106 . . . . 0.0 109.905 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.77 HG23 ' HA2' ' A' ' 203' ' ' GLY . 6.4 t -97.48 146.18 8.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.549 -0.719 . . . . 0.0 110.653 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 7.1 tp10 -87.48 -47.61 8.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 177.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 229' ' ' THR . 0.9 OUTLIER -153.31 169.88 22.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.652 HD13 ' OE2' ' A' ' 195' ' ' GLU . 2.2 pp -128.66 -173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.646 -1.284 . . . . 0.0 110.304 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.593 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 33.6 tp10 -152.14 135.6 16.04 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.327 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.769 HD12 ' CB ' ' A' ' 193' ' ' THR . 1.3 mm? -106.02 172.2 4.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.484 -1.385 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.706 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -52.05 -37.03 67.64 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.806 1.424 . . . . 0.0 110.801 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.25 -163.22 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.603 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.491 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 35.8 t70 -98.14 16.06 22.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 30.0 t30 -83.24 102.59 12.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 176.52 67.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.275 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.6 p -136.25 46.44 2.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.882 . . . . 0.0 109.985 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.457 ' OD1' ' HG3' ' A' ' 221' ' ' LYS . 2.1 p30 -150.62 -43.19 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.579 -0.7 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -149.62 -167.78 2.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.48 -0.762 . . . . 0.0 110.015 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 221' ' ' LYS . 22.8 ttt180 -41.44 157.12 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.387 -0.82 . . . . 0.0 110.167 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.87 -167.82 2.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.598 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.45 77.58 1.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 4.8 p90 -149.88 -166.4 2.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -1.218 . . . . 0.0 110.959 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.54 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 8.2 p -170.35 125.44 0.75 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -99.46 -176.94 3.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.264 -1.522 . . . . 0.0 109.329 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.685 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.1 mt -163.89 134.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 210' ' ' SER . 6.8 t -107.1 140.11 40.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.157 -1.589 . . . . 0.0 109.896 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 18.9 m-30 -100.13 -141.63 0.33 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 -63.47 1.44 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.238 -0.914 . . . . 0.0 110.935 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 233' ' ' GLU . 5.4 mt-10 -102.8 -69.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 0.0 111.037 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 7.0 pt-20 174.03 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.697 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.618 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -38.68 -55.29 2.72 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.2 Cg_exo -52.4 -37.6 72.33 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.093 1.049 . . . . 0.0 110.94 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.615 HG22 ' CG2' ' A' ' 184' ' ' ILE . 2.1 t -67.38 -43.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.04 . . . . 0.0 108.92 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -45.32 -47.01 13.22 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.175 0.988 . . . . 0.0 108.597 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -68.51 -58.5 4.22 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.528 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 205' ' ' PHE . 3.7 mm -48.62 -63.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.688 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 239' ' ' ILE . 1.6 tmm? -44.45 -35.4 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.942 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -65.45 -7.63 15.11 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.175 -0.953 . . . . 0.0 110.497 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -136.97 49.61 2.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 35.1 mtpt -29.09 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.646 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.2 t80 -116.06 89.9 3.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.515 -1.366 . . . . 0.0 110.012 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.67 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.9 m-70 -95.8 -149.79 0.31 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.135 -0.978 . . . . 0.0 110.786 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.48 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 0.6 OUTLIER -133.46 137.61 45.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.698 -0.626 . . . . 0.0 109.534 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 250' ' ' SER . 11.6 t -146.65 125.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.017 -1.052 . . . . 0.0 110.211 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 249' ' ' LEU . . . 47.19 75.2 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 248' ' ' GLY . 0.1 OUTLIER 41.85 34.63 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -1.095 . . . . 0.0 110.529 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 247' ' ' VAL . 1.6 t -146.72 166.4 26.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 4.3 ptpp? -124.38 45.98 2.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.577 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 28.7 p -40.05 161.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 254' ' ' ILE . 0.1 OUTLIER -88.08 171.36 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.629 -1.228 . . . . 0.0 109.141 179.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 253' ' ' GLU . 1.0 OUTLIER -144.75 103.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.746 -1.182 . . . . 0.0 112.484 -178.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -101.35 107.65 19.05 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.8 p -43.97 167.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.765 -1.21 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.934 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.703 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 239' ' ' ILE . 22.4 mt -131.72 177.62 6.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 C-N-CA 117.3 -1.76 . . . . 0.0 110.639 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.635 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -148.16 117.6 6.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.962 -1.086 . . . . 0.0 110.801 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.848 ' HB ' HD11 ' A' ' 189' ' ' LEU . 58.0 t -89.62 126.77 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.899 -1.126 . . . . 0.0 109.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.536 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -103.44 59.21 0.51 Allowed Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -178.93 62.84 0.08 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.848 HD11 ' HB ' ' A' ' 186' ' ' VAL . 67.3 mt -135.55 162.45 32.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -1.205 . . . . 0.0 111.573 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.567 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 0.4 OUTLIER -90.01 172.4 7.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.8 Cg_exo -53.23 -17.23 8.13 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.331 1.174 . . . . 0.0 110.541 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -109.97 101.6 10.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.695 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.807 ' CB ' HD22 ' A' ' 213' ' ' LEU . 2.6 m -86.56 129.32 53.41 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.165 -0.96 . . . . 0.0 110.399 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.7 Cg_endo -67.92 52.34 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.406 1.404 . . . . 0.0 112.525 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.551 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -36.66 -66.51 0.22 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.192 -0.943 . . . . 0.0 111.286 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -47.41 -40.65 18.36 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.814 -177.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 11.0 mttt -74.32 -28.66 61.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.958 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -66.36 -55.91 16.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.6 OUTLIER -52.2 -36.39 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -61.07 -39.19 88.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 110.376 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.437 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 0.8 OUTLIER -91.16 -70.91 0.66 Allowed 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 117.361 -1.735 . . . . 0.0 109.421 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.602 ' CD2' HG13 ' A' ' 198' ' ' ILE . 22.4 m-85 -57.19 -51.81 67.85 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.137 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -56.42 -20.63 30.8 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -69.5 -45.22 60.78 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.819 ' CD1' HD11 ' A' ' 239' ' ' ILE . 81.2 m-85 -58.36 -33.23 69.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.105 -1.232 . . . . 0.0 108.962 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -170.58 130.36 1.98 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 206' ' ' GLY . 12.2 pt-20 -41.6 141.79 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -1.216 . . . . 0.0 110.079 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.582 HG11 HG23 ' A' ' 211' ' ' ILE . 2.4 t -92.11 144.41 9.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.566 0.698 . . . . 0.0 111.222 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -88.12 -48.75 7.49 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.72 ' O ' HG22 ' A' ' 229' ' ' THR . 69.5 m -153.58 158.39 41.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.582 HG23 HG11 ' A' ' 208' ' ' VAL . 9.0 pt -114.93 -170.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.781 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.6 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 24.8 tp10 -151.3 137.26 18.18 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.321 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.807 HD22 ' CB ' ' A' ' 193' ' ' THR . 5.3 mt -107.04 172.61 3.69 Favored Pre-proline 0 C--N 1.297 -1.678 0 O-C-N 120.545 -1.347 . . . . 0.0 110.748 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.4 Cg_exo -50.57 83.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.098 1.578 . . . . 0.0 111.168 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 213' ' ' LEU . 1.4 mtt 37.49 -93.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.619 -0.676 . . . . 0.0 110.682 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 214' ' ' PRO . 4.5 t70 -175.39 -178.51 1.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.04 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 1.7 m-20 62.36 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.079 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER 63.83 50.87 2.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 109.754 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.0 t -142.71 49.94 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 110.132 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 221' ' ' LYS . 5.3 p-10 -142.1 -39.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.409 ' HB2' ' ND2' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -133.35 -169.59 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.499 ' C ' ' HG2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -114.44 -176.46 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.477 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 223' ' ' ARG . 20.0 ptp180 30.68 61.44 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.414 0.625 . . . . 0.0 111.376 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 189' ' ' LEU . . . -63.97 -146.45 0.03 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 1.8 p90 -148.4 -166.86 2.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -1.111 . . . . 0.0 110.704 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.543 ' SG ' ' CD1' ' A' ' 189' ' ' LEU . 0.6 OUTLIER -170.73 129.11 0.8 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.635 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -101.55 -173.69 2.42 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.243 -1.536 . . . . 0.0 108.918 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.958 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.2 mt -164.91 136.32 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 210' ' ' SER . 14.3 t -113.8 149.6 34.71 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.237 -1.539 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.565 ' CE1' ' CG2' ' A' ' 208' ' ' VAL . 70.2 m-85 -117.82 -115.7 0.33 Allowed 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.472 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HE2' ' N ' ' A' ' 232' ' ' GLU . 0.3 OUTLIER -163.77 -39.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.494 ' N ' ' HE2' ' A' ' 231' ' ' LYS . 53.7 tt0 -87.83 -96.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.796 -1.19 . . . . 0.0 111.302 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' GLU . 0.4 OUTLIER 169.61 -24.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.199 -0.938 . . . . 0.0 109.912 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.609 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.1 tm-20 -63.44 -52.06 62.98 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.277 -0.889 . . . . 0.0 112.967 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.4 Cg_exo -52.38 -21.28 13.3 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 122.815 0.903 . . . . 0.0 111.349 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.478 ' CG1' HG21 ' A' ' 256' ' ' VAL . 2.0 t -80.74 -51.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 240' ' ' MET . 0.0 OUTLIER -41.76 -42.04 2.5 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.312 1.053 . . . . 0.0 108.886 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -59.15 3.26 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.412 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 205' ' ' PHE . 17.3 mm -51.69 -62.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.528 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.505 ' HG3' ' N ' ' A' ' 241' ' ' GLU . 1.4 ppp? -44.75 -33.2 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.493 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 240' ' ' MET . 1.8 tt0 -70.74 -8.48 52.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.614 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.3 OUTLIER -131.19 47.66 2.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.978 -1.076 . . . . 0.0 109.107 179.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -28.12 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.637 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -111.76 83.14 1.73 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.508 -1.37 . . . . 0.0 110.34 -178.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.647 ' HD2' HD13 ' A' ' 254' ' ' ILE . 3.5 m-70 -92.79 -147.14 0.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.983 -1.073 . . . . 0.0 110.834 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -144.1 120.24 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 249' ' ' LEU . 4.4 t -112.04 112.01 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.954 -1.091 . . . . 0.0 110.635 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 64.01 -68.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -154.24 23.08 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 110.482 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.2 t -145.45 148.0 32.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.033 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.637 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER -102.06 50.54 0.84 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.755 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.559 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 61.0 m -43.84 169.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.549 -0.719 . . . . 0.0 109.376 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.982 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.4 OUTLIER -87.14 165.0 16.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.496 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.982 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -142.36 98.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.266 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -98.4 108.17 20.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.0 p -43.62 166.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.917 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.703 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.406 -0.809 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.691 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.737 HG23 HG22 ' A' ' 236' ' ' VAL . 7.2 pt -130.14 175.33 11.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.429 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.664 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -137.35 135.44 37.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.189 -0.945 . . . . 0.0 110.213 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.675 HG12 ' HB3' ' A' ' 252' ' ' CYS . 55.4 t -111.55 128.38 68.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.902 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.494 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -99.71 44.5 1.64 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 1.047 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -132.2 2.94 5.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.047 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 3.56 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 178.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.2 p -43.75 170.07 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.551 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.6 Cg_exo -55.54 -35.11 91.85 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.275 1.145 . . . . 0.0 111.374 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 4.7 p-10 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.865 -1.147 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.703 ' CB ' HD12 ' A' ' 213' ' ' LEU . 18.8 m -39.69 97.09 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.585 -0.697 . . . . 0.0 109.958 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 197' ' ' LYS . 2.4 Cg_endo -70.61 80.23 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.741 1.39 . . . . 0.0 112.072 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.579 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -37.03 -61.67 0.54 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.452 -0.78 . . . . 0.0 111.038 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 195' ' ' GLU . 2.2 mt-10 -49.22 -45.34 44.33 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.031 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -74.62 -26.42 59.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.0 OUTLIER -64.53 -50.11 77.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -57.01 -35.28 69.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.5 mt-10 -59.75 -38.82 82.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 246' ' ' ASN . 2.2 t80 -91.46 -70.49 0.68 Allowed 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.509 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -57.95 -52.19 66.54 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.676 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.77 27.95 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -68.44 -45.61 67.51 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.753 ' CD1' HD11 ' A' ' 239' ' ' ILE . 90.6 m-85 -59.52 -34.29 72.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -1.232 . . . . 0.0 109.207 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -172.42 135.09 3.22 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.6 pt-20 -41.51 141.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.978 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.676 HG23 ' HA2' ' A' ' 203' ' ' GLY . 12.7 t -104.2 145.91 12.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.541 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.0 -49.69 6.89 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 177.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.595 ' O ' HG22 ' A' ' 229' ' ' THR . 0.7 OUTLIER -153.6 174.33 14.6 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 5.1 pt -127.54 -171.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.092 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.526 ' O ' ' O ' ' A' ' 227' ' ' PHE . 3.2 tt0 -150.82 128.5 11.57 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.917 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.703 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.5 mm? -104.88 171.38 5.02 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 120.578 -1.326 . . . . 0.0 111.004 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 226' ' ' CYS . 2.4 Cg_endo -75.5 0.17 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.15 1.605 . . . . 0.0 110.574 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 1.1 tpt 71.36 -162.61 0.13 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' HA ' ' HE2' ' A' ' 218' ' ' LYS . 22.7 t70 -155.83 26.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.522 ' N ' ' HD3' ' A' ' 218' ' ' LYS . 0.9 OUTLIER -88.83 -52.18 5.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.693 ' N ' ' CD ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 64.48 50.29 2.25 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.256 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.47 50.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 110.207 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 221' ' ' LYS . 19.6 p-10 -149.92 -48.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.451 -0.781 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 0.0 OUTLIER -150.75 -171.68 3.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 110.432 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -58.92 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.258 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 222' ' ' ARG . 18.3 ptt180 -39.72 161.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.542 -0.724 . . . . 0.0 110.462 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.691 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -117.76 -162.37 12.4 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.181 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -151.9 173.97 14.17 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -1.025 . . . . 0.0 109.757 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.715 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.8 OUTLIER -119.76 117.93 29.5 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -97.25 -169.45 1.86 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.503 -1.373 . . . . 0.0 109.986 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -166.54 138.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.607 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 8.1 t -111.79 144.4 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 119.816 -1.802 . . . . 0.0 110.413 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.666 ' CD2' HG23 ' A' ' 236' ' ' VAL . 22.2 m-30 -103.44 -136.01 0.34 Allowed 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.073 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER -154.27 -48.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.488 -178.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 83.9 tt0 -79.26 -56.48 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.141 -0.975 . . . . 0.0 109.236 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.634 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.0 OUTLIER 131.06 -27.42 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.665 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -57.01 -45.65 99.94 Favored Pre-proline 0 N--CA 1.495 1.78 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.366 -178.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 3.9 Cg_exo -54.58 -27.48 50.83 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 109.709 -0.92 . . . . 0.0 109.709 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 184' ' ' ILE . 2.3 t -74.16 -43.96 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.43 -48.28 9.92 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 108.836 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -61.28 1.84 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.015 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.753 HD11 ' CD1' ' A' ' 205' ' ' PHE . 11.4 mm -44.79 -64.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.64 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.53 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 4.0 tmm? -46.65 -33.26 4.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.372 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 3.9 tt0 -73.08 2.45 7.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.057 -1.027 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.92 51.01 1.72 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.014 -1.054 . . . . 0.0 109.444 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 4.1 ttmm -26.45 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.7 t80 -120.28 94.48 4.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.297 -1.502 . . . . 0.0 110.258 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.792 ' HD2' HD13 ' A' ' 254' ' ' ILE . 4.3 m-70 -97.79 -148.88 0.33 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.009 -1.057 . . . . 0.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.57 ' O ' ' CE2' ' A' ' 201' ' ' TYR . 7.6 m-80 -145.35 139.83 27.27 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 249' ' ' LEU . 25.8 t -133.29 120.43 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.99 -1.069 . . . . 0.0 110.174 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 52.22 -90.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.5 OUTLIER -135.56 32.81 3.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -1.111 . . . . 0.0 109.824 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.58 145.39 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.63 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 5.0 pttt -113.41 54.91 0.72 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.97 -1.081 . . . . 0.0 110.934 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.675 ' HB3' HG12 ' A' ' 186' ' ' VAL . 62.1 m -40.47 162.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.38 -0.825 . . . . 0.0 108.94 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.902 ' O ' HD12 ' A' ' 254' ' ' ILE . 2.1 pm0 -87.7 177.42 7.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.722 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.902 HD12 ' O ' ' A' ' 253' ' ' GLU . 0.9 OUTLIER -150.04 147.38 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.329 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 5.1 tttp -156.03 105.4 2.34 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.5 p -35.08 161.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.94 0.876 . . . . 0.0 112.94 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.691 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.685 -0.635 . . . . 0.0 110.164 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.727 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 239' ' ' ILE . 2.4 pp -132.47 171.36 18.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.09 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.624 ' CD1' ' C ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -132.37 135.65 46.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 110.412 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 252' ' ' CYS . 16.4 t -108.35 131.76 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.67 -0.644 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' CA ' ' HG2' ' A' ' 253' ' ' GLU . . . -95.64 47.98 1.87 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 1.121 ' O ' HD22 ' A' ' 189' ' ' LEU . . . -119.01 -29.83 1.73 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.664 -1.775 . . . . 0.0 108.664 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.121 HD22 ' O ' ' A' ' 188' ' ' GLY . 0.0 OUTLIER 21.84 39.83 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.869 0.842 . . . . 0.0 112.805 179.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.623 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.3 p -41.39 167.12 0.06 OUTLIER Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.2 Cg_exo -56.13 -18.71 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.409 1.215 . . . . 0.0 110.841 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 17.6 m-20 -150.49 87.31 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 110.501 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.878 HG21 ' CD2' ' A' ' 213' ' ' LEU . 3.6 m -48.25 106.31 0.59 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.526 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.9 Cg_endo -63.27 55.31 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.238 1.292 . . . . 0.0 112.155 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.626 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.5 OUTLIER -37.46 -60.28 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.427 -0.796 . . . . 0.0 110.26 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 200' ' ' GLU . 10.6 tt0 -49.07 -45.17 42.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.471 -1.291 . . . . 0.0 108.854 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 200' ' ' GLU . 0.3 OUTLIER -74.39 -23.94 59.05 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 195' ' ' GLU . 0.2 OUTLIER -68.06 -51.59 47.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.586 ' N ' HG22 ' A' ' 198' ' ' ILE . 22.6 ttm180 -55.72 -36.05 66.78 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.533 ' CA ' ' OE1' ' A' ' 200' ' ' GLU . 0.1 OUTLIER -57.48 -42.88 83.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.622 -0.674 . . . . 0.0 109.537 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -91.25 -73.69 0.53 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 117.582 -1.647 . . . . 0.0 110.05 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -51.09 -50.28 59.05 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.229 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.98 -21.21 23.22 Favored Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -75.39 -43.97 23.32 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.746 ' CD1' HD11 ' A' ' 239' ' ' ILE . 83.5 m-85 -58.01 -28.26 64.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -1.212 . . . . 0.0 108.941 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 179.72 132.73 1.85 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' GLY . 6.9 pt-20 -41.12 142.45 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -1.137 . . . . 0.0 110.263 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 230' ' ' PHE . 10.7 t -102.64 147.48 9.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 111.093 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -54.81 4.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 229' ' ' THR . 53.9 m -154.05 158.23 40.2 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 1.1 pp -105.2 -168.43 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.305 -1.358 . . . . 0.0 109.418 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.576 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 8.8 tp10 -151.27 134.33 15.91 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.743 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.878 ' CD2' HG21 ' A' ' 193' ' ' THR . 19.6 mt -109.52 178.13 1.09 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 120.794 -1.191 . . . . 0.0 109.7 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.0 Cg_exo -69.85 -172.36 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.389 1.205 . . . . 0.0 110.754 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -170.2 2.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.072 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 5.0 t70 -108.62 -7.53 15.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.253 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.472 ' C ' ' CD ' ' A' ' 218' ' ' LYS . 35.4 m-80 -77.23 111.03 12.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' A' ' 217' ' ' ASN . 0.3 OUTLIER -134.96 46.55 2.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.1 m -144.87 49.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.493 -0.755 . . . . 0.0 110.321 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 220' ' ' ASN . 6.5 p-10 -150.45 -46.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.28 -174.41 4.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.775 . . . . 0.0 109.962 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.22 53.16 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 110.115 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -117.02 166.35 12.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 109.994 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 189' ' ' LEU . . . 140.56 137.67 3.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.885 ' HA ' HD12 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.87 -178.35 6.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -1.128 . . . . 0.0 110.265 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.579 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -130.68 120.79 24.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.115 -0.991 . . . . 0.0 109.015 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.622 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -98.27 -168.7 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.407 -1.433 . . . . 0.0 110.428 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.3 mt -164.81 134.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 210' ' ' SER . 10.5 t -116.15 146.47 42.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.072 -1.642 . . . . 0.0 110.225 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.872 ' CE2' HG22 ' A' ' 208' ' ' VAL . 58.0 m-85 -114.44 -127.83 0.29 Allowed 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.368 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -145.04 -44.67 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.673 -1.267 . . . . 0.0 113.377 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 7.5 mt-10 -82.74 -82.8 0.14 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.614 -1.304 . . . . 0.0 112.883 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.73 -28.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.659 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.6 tt0 -62.8 -53.29 57.44 Favored Pre-proline 0 N--CA 1.494 1.729 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.315 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 5.3 Cg_exo -48.49 -32.71 21.42 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.992 0.996 . . . . 0.0 110.323 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 183' ' ' LYS . 2.1 t -68.71 -47.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.844 -1.16 . . . . 0.0 107.907 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -44.19 -43.66 7.3 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 122.215 1.007 . . . . 0.0 108.8 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -69.05 -60.43 2.36 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.539 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 184' ' ' ILE . 12.4 mm -49.08 -63.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.259 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.667 ' HG3' HG11 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -47.86 -28.37 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.637 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -77.13 7.02 5.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.057 -1.027 . . . . 0.0 111.059 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.617 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.98 54.42 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.105 -0.997 . . . . 0.0 109.047 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 0.3 OUTLIER -25.46 -38.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.652 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.3 t80 -120.27 96.27 5.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.378 -1.451 . . . . 0.0 110.215 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.667 ' HD2' HD13 ' A' ' 254' ' ' ILE . 15.0 m-70 -93.58 -165.34 1.31 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.086 -1.009 . . . . 0.0 110.732 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 57.0 m-80 -135.92 133.74 37.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 250' ' ' SER . 55.7 t -149.48 131.68 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.111 -0.993 . . . . 0.0 110.477 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 42.74 62.96 2.08 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 1.9 tp 48.22 22.37 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.152 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 247' ' ' VAL . 50.3 m -132.34 118.06 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.652 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 1.2 pttt -97.94 53.74 1.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.989 . . . . 0.0 110.693 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 186' ' ' VAL . 58.8 m -41.67 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.459 -0.776 . . . . 0.0 109.011 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.947 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.7 pm0 -86.94 173.88 9.07 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.377 -1.329 . . . . 0.0 108.388 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.947 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.2 mp -150.43 129.28 3.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.015 -1.474 . . . . 0.0 112.873 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 9.1 mttm -134.46 107.57 7.64 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 240' ' ' MET . 2.7 p -37.1 163.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.026 0.917 . . . . 0.0 112.575 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.727 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.344 0 O-C-N 121.695 -0.628 . . . . 0.0 109.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.704 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.704 ' N ' ' HG3' ' A' ' 183' ' ' LYS . 3.3 mt -138.82 174.74 9.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.095 -1.003 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.694 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -130.08 139.79 50.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 110.143 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 188' ' ' GLY . 62.9 t -114.62 131.38 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.55 -0.719 . . . . 0.0 109.862 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.547 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -104.97 43.6 1.64 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.981 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -117.38 -15.46 6.49 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.981 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 10.35 58.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 188' ' ' GLY . 1.3 p -44.77 168.49 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.244 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.3 Cg_exo -58.04 -11.93 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.416 1.219 . . . . 0.0 110.914 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 194' ' ' PRO . 8.4 t0 -150.24 105.26 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.965 -1.085 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.486 ' HB ' HD12 ' A' ' 213' ' ' LEU . 76.5 p -40.21 98.99 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.373 -0.829 . . . . 0.0 109.822 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.5 Cg_endo -69.25 45.17 0.39 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.436 1.424 . . . . 0.0 112.872 -178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.66 -69.41 0.11 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.048 -1.033 . . . . 0.0 111.679 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 195' ' ' GLU . 3.8 tt0 -47.82 -39.88 19.61 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.577 -1.249 . . . . 0.0 109.034 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 194' ' ' PRO . 26.0 mmmt -75.7 -27.04 58.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 199' ' ' ARG . 1.2 tp -66.99 -54.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.627 ' N ' HG22 ' A' ' 198' ' ' ILE . 3.3 ttp85 -54.48 -38.28 66.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -59.32 -40.38 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.477 -0.765 . . . . 0.0 110.158 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 204' ' ' GLY . 2.0 t80 -91.02 -71.87 0.61 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.395 -1.722 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.621 ' CD2' HG13 ' A' ' 198' ' ' ILE . 81.0 m-85 -54.41 -54.06 45.72 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.564 -0.855 . . . . 0.0 108.982 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.766 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.17 -22.1 27.83 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.93 -46.99 57.61 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.745 ' CD1' HD11 ' A' ' 239' ' ' ILE . 85.6 m-85 -56.13 -31.22 63.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.269 . . . . 0.0 108.698 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.39 138.82 4.04 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 206' ' ' GLY . 0.1 OUTLIER -43.56 143.14 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.016 -1.285 . . . . 0.0 109.577 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.766 HG23 ' HA2' ' A' ' 203' ' ' GLY . 10.4 t -101.19 152.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.754 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 3.2 tt0 -87.83 -56.19 3.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.636 ' O ' HG22 ' A' ' 229' ' ' THR . 30.8 m -153.47 160.35 42.53 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 46.2 pt -110.66 -169.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.009 -1.476 . . . . 0.0 109.584 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.565 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 4.6 tp10 -152.11 129.36 11.24 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 213' ' ' LEU . 2.0 mm? -102.22 178.23 1.27 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.706 -1.246 . . . . 0.0 108.71 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.7 Cg_exo -65.6 -165.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.101 1.053 . . . . 0.0 110.844 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 4.6 mtt -119.13 -176.25 3.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.1 -1.0 . . . . 0.0 110.563 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -77.56 -162.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.263 -0.898 . . . . 0.0 110.281 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 56.14 85.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.443 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 0.0 OUTLIER -124.87 41.82 3.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.764 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.2 t -145.43 47.49 1.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.503 0.668 . . . . 0.0 109.827 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 220' ' ' ASN . 2.7 p-10 -150.51 -45.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.522 -0.736 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 -170.99 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 110.237 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.476 ' CG ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -103.03 65.86 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -128.66 76.84 1.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.849 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -140.68 58.1 0.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -89.44 177.69 6.51 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.574 -0.956 . . . . 0.0 110.645 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -130.29 120.7 24.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.7 m-85 -95.18 -173.8 3.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.451 -1.406 . . . . 0.0 109.984 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 2.0 mt -161.51 134.11 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 210' ' ' SER . 2.5 t -107.68 138.46 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.863 -1.773 . . . . 0.0 110.21 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CD2' ' CG ' ' A' ' 235' ' ' PRO . 35.1 m-85 -99.47 -112.75 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.298 -1.361 . . . . 0.0 111.922 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 230' ' ' PHE . 28.6 tttp 175.32 -53.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.636 -1.29 . . . . 0.0 109.892 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.602 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 2.3 mt-10 -75.51 -22.98 56.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.144 -0.972 . . . . 0.0 108.682 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 2.2 pt-20 87.7 -21.35 0.17 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.361 1.077 . . . . 0.0 108.751 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.681 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 1.7 mt-10 -61.11 -45.65 96.02 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.7 Cg_exo -54.06 -25.29 36.24 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 N-CA-C 109.675 -0.933 . . . . 0.0 109.675 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.643 HG22 ' CG1' ' A' ' 184' ' ' ILE . 2.2 t -76.89 -47.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' VAL . 0.0 OUTLIER -44.16 -46.52 8.83 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 122.306 1.051 . . . . 0.0 108.895 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -71.61 -61.95 1.59 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.883 0.849 . . . . 0.0 109.751 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 205' ' ' PHE . 21.5 mm -43.12 -65.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 109.282 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.443 ' HB2' ' CG2' ' A' ' 256' ' ' VAL . 0.4 OUTLIER -46.55 -34.08 4.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 238' ' ' LYS . 0.7 OUTLIER -61.14 -11.58 9.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 110.68 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.627 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.06 52.98 1.67 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.161 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 2.5 ttpp -27.87 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 1.1 t80 -115.43 92.85 4.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.325 -1.484 . . . . 0.0 110.061 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.773 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.7 m-70 -97.96 -154.85 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 110.778 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 10.2 p30 -136.26 143.35 44.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.647 -0.658 . . . . 0.0 109.306 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 24.4 t -139.5 131.01 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.421 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.18 -93.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.2 OUTLIER -133.19 34.22 3.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -1.181 . . . . 0.0 110.197 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.23 168.25 24.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.788 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -120.54 48.38 1.61 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 110.49 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.545 ' CB ' ' HA3' ' A' ' 188' ' ' GLY . 26.7 p -34.08 152.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.866 -0.522 . . . . 0.0 109.922 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.919 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.66 170.9 10.87 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.79 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.919 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.1 mp -145.26 113.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.293 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -119.71 106.82 12.51 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 18.4 t -38.32 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.14 -0.975 . . . . 0.0 112.404 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.653 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.281 -0.887 . . . . 0.0 110.407 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.959 ' CG2' HG22 ' A' ' 236' ' ' VAL . 1.2 pp -130.01 -175.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 117.663 -1.615 . . . . 0.0 110.912 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.13 124.14 8.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 111.454 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.916 ' HB ' HD11 ' A' ' 189' ' ' LEU . 92.6 t -93.34 128.26 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.02 -1.05 . . . . 0.0 109.278 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 253' ' ' GLU . . . -105.25 58.96 0.45 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.688 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.699 ' O ' HD23 ' A' ' 189' ' ' LEU . . . 179.58 67.67 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.916 HD11 ' HB ' ' A' ' 186' ' ' VAL . 40.9 mt -139.87 163.52 32.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -1.192 . . . . 0.0 111.644 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.537 ' HB2' ' HD2' ' A' ' 191' ' ' PRO . 0.5 OUTLIER -79.74 171.43 12.47 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.7 Cg_exo -55.25 -16.4 13.06 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.38 1.2 . . . . 0.0 110.555 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.57 117.49 31.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.873 ' CB ' HD12 ' A' ' 213' ' ' LEU . 1.3 m -84.09 125.54 72.31 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.6 Cg_endo -67.36 58.67 0.68 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.269 1.313 . . . . 0.0 111.915 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.601 ' CG ' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -36.98 -67.9 0.16 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.258 -0.901 . . . . 0.0 111.739 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -47.91 -38.3 16.16 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.742 -1.183 . . . . 0.0 108.864 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.496 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.3 OUTLIER -77.21 -27.97 53.68 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.716 ' CG2' HD11 ' A' ' 228' ' ' ILE . 1.2 tp -66.57 -55.2 19.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.639 ' N ' HG22 ' A' ' 198' ' ' ILE . 4.8 mtt180 -56.29 -38.3 71.03 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -52.49 -49.02 65.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.65 -0.656 . . . . 0.0 110.464 179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 204' ' ' GLY . 1.1 t80 -90.6 -71.18 0.64 Allowed 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 117.249 -1.78 . . . . 0.0 109.752 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.637 ' HD2' HD12 ' A' ' 228' ' ' ILE . 7.7 m-30 -50.4 -55.01 17.63 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.669 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.704 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -54.39 -22.06 21.97 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -73.18 -46.29 28.03 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -53.05 -36.0 60.11 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.318 . . . . 0.0 108.628 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -174.22 135.04 3.02 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 206' ' ' GLY . 10.2 pt-20 -40.5 141.55 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.059 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.704 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.25 144.93 8.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 110.52 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 230' ' ' PHE . 49.4 tp10 -87.65 -50.8 6.26 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 229' ' ' THR . 51.9 m -153.0 171.73 17.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.601 ' CD1' ' CG ' ' A' ' 195' ' ' GLU . 27.4 pt -125.17 -170.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.654 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -151.61 138.57 19.05 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 193' ' ' THR . 2.0 mm? -110.53 170.2 5.55 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 120.264 -1.523 . . . . 0.0 111.576 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.8 Cg_exo -49.71 88.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 124.051 1.553 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER 41.75 -141.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.428 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 218' ' ' LYS . 15.5 t70 -120.38 167.67 12.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.872 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 216' ' ' ASP . 11.8 t-20 63.77 -67.78 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.479 -0.763 . . . . 0.0 110.206 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER 63.98 46.81 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.972 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.2 m -150.76 53.38 0.88 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.665 . . . . 0.0 109.898 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -131.68 -37.31 1.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.829 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -132.78 -171.66 2.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 110.789 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -55.36 -163.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.0 110.72 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 189' ' ' LEU . 32.6 ptt180 -43.73 169.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.702 . . . . 0.0 110.165 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -134.11 -148.9 5.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 2.1 p90 -131.15 -163.73 1.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.398 -1.06 . . . . 0.0 110.215 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.551 ' SG ' ' CD1' ' A' ' 189' ' ' LEU . 0.5 OUTLIER -168.52 128.63 1.21 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.275 -0.891 . . . . 0.0 108.848 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 185' ' ' PHE . 2.7 m-85 -101.01 -176.61 3.21 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.695 -1.253 . . . . 0.0 109.021 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.716 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.9 OUTLIER -165.61 136.13 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 210' ' ' SER . 5.2 t -107.39 139.54 41.72 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.295 -1.503 . . . . 0.0 109.784 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.794 ' HD2' HG23 ' A' ' 236' ' ' VAL . 15.0 m-85 -97.1 -131.64 0.2 Allowed 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.811 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.423 ' HG3' ' OE1' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -136.09 -52.67 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.761 -1.212 . . . . 0.0 110.92 -178.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 4.1 mt-10 -96.48 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 0.1 OUTLIER 161.98 -26.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.227 1.013 . . . . 0.0 108.991 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.697 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 0.2 OUTLIER -56.89 -43.58 99.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.697 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.5 Cg_exo -52.93 -34.8 68.25 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 122.601 0.79 . . . . 0.0 110.803 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 184' ' ' ILE . 54.6 t -75.67 -34.93 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.768 -1.208 . . . . 0.0 108.455 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -45.64 -44.16 13.02 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.3 1.047 . . . . 0.0 108.34 178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -62.93 1.29 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.829 0.823 . . . . 0.0 110.458 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.629 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.6 OUTLIER -50.04 -60.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.693 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.582 ' N ' HG22 ' A' ' 239' ' ' ILE . 0.2 OUTLIER -50.48 -33.62 21.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.089 -1.007 . . . . 0.0 110.817 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.8 -6.69 8.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.855 -1.153 . . . . 0.0 110.973 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -133.89 53.1 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 108.743 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 5.5 mtpt -26.64 -34.86 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.628 ' CZ ' ' HG3' ' A' ' 251' ' ' LYS . 0.7 OUTLIER -115.11 90.05 3.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.466 -1.396 . . . . 0.0 109.666 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 242' ' ' LYS . 36.2 m-70 -89.87 -157.61 0.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.125 -0.985 . . . . 0.0 111.371 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 6.1 t30 -144.67 120.01 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.2 122.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 57.44 53.95 40.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.18 22.78 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -1.082 . . . . 0.0 109.957 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 7.6 m -132.87 117.84 18.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.69 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' CZ ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -93.42 51.63 1.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 110.591 -179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.562 ' SG ' HD23 ' A' ' 189' ' ' LEU . 62.2 m -41.86 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.497 -0.752 . . . . 0.0 109.409 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.935 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -88.01 164.44 15.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.591 -1.318 . . . . 0.0 109.753 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.935 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.4 mp -139.0 117.1 12.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.716 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.627 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 2.0 tmtt? -126.64 112.34 15.36 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -39.72 166.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 112.132 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.642 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.575 -0.703 . . . . 0.0 110.423 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.683 ' CG ' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 236' ' ' VAL . 3.6 pt -129.24 -179.2 2.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 117.942 -1.503 . . . . 0.0 111.361 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -150.15 125.89 10.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG22 HG13 ' A' ' 254' ' ' ILE . 60.8 t -94.65 132.26 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.119 -0.988 . . . . 0.0 110.339 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.464 ' C ' ' HG3' ' A' ' 253' ' ' GLU . . . -105.56 56.82 0.51 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -178.64 64.56 0.08 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.599 HD21 ' HB ' ' A' ' 186' ' ' VAL . 2.0 mm? -105.23 152.26 23.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.508 -0.995 . . . . 0.0 111.484 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 191' ' ' PRO . 3.0 p -90.12 -167.92 0.16 Allowed Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 190' ' ' SER . 3.3 Cg_exo -65.15 -6.52 13.25 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.047 1.025 . . . . 0.0 110.632 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.7 120.18 6.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.357 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.844 ' CB ' HD22 ' A' ' 213' ' ' LEU . 61.1 m -79.71 120.29 79.61 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.964 -1.085 . . . . 0.0 109.937 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 198' ' ' ILE . 2.8 Cg_endo -65.51 54.92 0.31 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.165 1.243 . . . . 0.0 112.133 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.588 ' HA ' ' HB ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -36.01 -66.16 0.22 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.52 -0.737 . . . . 0.0 110.762 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -47.46 -37.85 12.54 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.85 -177.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -78.22 -28.82 48.04 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.656 HG13 ' CD2' ' A' ' 202' ' ' PHE . 1.1 tp -64.42 -53.79 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.603 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -56.48 -36.08 68.71 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 197' ' ' LYS . 1.6 mm-40 -60.12 -41.21 92.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.267 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.796 ' CD2' HG22 ' A' ' 247' ' ' VAL . 2.6 t80 -90.99 -70.99 0.65 Allowed 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.36 -1.736 . . . . 0.0 108.967 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.656 ' CD2' HG13 ' A' ' 198' ' ' ILE . 14.6 m-30 -53.81 -55.73 23.92 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.919 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.743 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -53.89 -22.91 20.85 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 201' ' ' TYR . . . -68.92 -47.64 53.47 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.739 -1.745 . . . . 0.0 108.739 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 239' ' ' ILE . 67.4 m-85 -51.06 -33.94 27.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.059 -1.259 . . . . 0.0 108.352 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . -177.75 136.93 3.2 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 206' ' ' GLY . 4.4 pt-20 -42.21 141.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.186 -1.185 . . . . 0.0 109.809 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.743 HG23 ' HA2' ' A' ' 203' ' ' GLY . 4.8 t -95.06 150.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 121.522 -0.736 . . . . 0.0 110.654 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -87.65 -51.92 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 229' ' ' THR . 0.0 OUTLIER -152.79 165.62 34.81 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.591 ' CG2' HG11 ' A' ' 208' ' ' VAL . 5.8 pt -126.29 -173.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 118.199 -1.4 . . . . 0.0 110.158 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.598 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 20.9 tp10 -151.3 132.11 14.11 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.845 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.844 HD22 ' CB ' ' A' ' 193' ' ' THR . 6.6 mt -104.37 169.9 6.69 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 120.338 -1.476 . . . . 0.0 110.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 213' ' ' LEU . 3.3 Cg_exo -62.57 85.88 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.871 1.459 . . . . 0.0 110.772 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.2 ptp -165.88 146.86 6.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.871 . . . . 0.0 110.361 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.524 ' O ' ' CE ' ' A' ' 218' ' ' LYS . 5.7 t0 -172.05 -65.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.713 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.696 ' HB3' HG22 ' A' ' 219' ' ' THR . 11.1 m-20 -67.53 -28.79 68.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.419 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 216' ' ' ASP . 8.8 mttt 59.58 40.56 20.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 217' ' ' ASN . 5.0 t -151.29 43.61 0.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.567 -0.708 . . . . 0.0 110.129 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -151.06 -98.43 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.462 -0.774 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -147.49 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.002 -1.061 . . . . 0.0 110.268 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 191' ' ' PRO . 45.4 mtm180 -98.77 68.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -165.98 169.09 15.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 110.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 131.18 -95.58 0.32 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 214' ' ' PRO . 4.2 p90 -143.97 153.66 42.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.273 -1.134 . . . . 0.0 110.074 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.539 ' CB ' ' HD3' ' A' ' 214' ' ' PRO . 13.7 p -122.68 126.91 48.54 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.6 m-85 -96.85 -177.28 3.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.281 -1.512 . . . . 0.0 109.275 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.635 HD11 ' CG2' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -164.77 134.06 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.621 ' CA ' ' HD3' ' A' ' 183' ' ' LYS . 5.5 t -109.07 138.47 45.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.14 -1.6 . . . . 0.0 109.193 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.535 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 37.1 m-85 -101.52 -166.91 1.35 Allowed 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.877 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -90.5 -49.73 6.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 235' ' ' PRO . 3.0 mt-10 -119.09 174.44 6.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.02 -18.86 60.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 0.0 109.886 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.695 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 30.9 mt-10 -49.35 -53.15 42.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.6 Cg_exo -47.16 -43.39 25.61 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.727 0.951 . . . . 0.0 111.73 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 184' ' ' ILE . 76.9 t -72.21 -32.05 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.631 -1.293 . . . . 0.0 109.671 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 241' ' ' GLU . 0.0 OUTLIER -49.74 -45.59 49.56 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.645 179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -64.54 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.161 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 240' ' ' MET . 0.8 OUTLIER -47.56 -64.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.976 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.623 ' N ' HG22 ' A' ' 239' ' ' ILE . 8.0 ttp -41.33 -40.17 1.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 110.695 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 2.1 tp10 -56.11 -16.18 4.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.582 ' O ' ' ND1' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -135.3 50.96 2.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 254' ' ' ILE . 34.4 ttpt -25.52 -37.84 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.66 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 1.8 t80 -103.23 91.04 3.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.363 -1.46 . . . . 0.0 108.658 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.76 ' CD2' HD13 ' A' ' 254' ' ' ILE . 3.0 m-70 -89.37 -166.42 1.59 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.043 -1.036 . . . . 0.0 110.884 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' A' ' 201' ' ' TYR . 4.1 m120 -137.71 115.36 11.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.796 HG22 ' CD2' ' A' ' 201' ' ' TYR . 38.2 t -130.23 124.73 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 0.0 110.543 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 249' ' ' LEU . . . 52.97 51.41 46.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 248' ' ' GLY . 0.5 OUTLIER 60.25 25.7 15.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 110.067 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 17.6 m -138.57 122.08 17.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.66 ' HD3' ' CE2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.01 56.03 0.65 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.945 . . . . 0.0 111.181 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 186' ' ' VAL . 60.2 m -45.43 169.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.957 . . . . 0.0 109.109 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -88.04 167.89 13.29 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.275 -1.37 . . . . 0.0 107.86 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.916 HD12 ' C ' ' A' ' 253' ' ' GLU . 3.5 mp -151.32 102.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.293 -1.363 . . . . 0.0 112.449 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HB3' ' CD2' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -98.72 117.22 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -40.74 168.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 112.095 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.683 ' HB3' ' CG ' ' A' ' 183' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.708 -0.62 . . . . 0.0 110.076 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.735 ' HG3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 236' ' ' VAL . 4.1 pt -129.91 173.21 14.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.118 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -132.66 136.11 46.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.018 -1.051 . . . . 0.0 110.609 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 254' ' ' ILE . 98.3 t -109.12 136.81 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.698 -0.626 . . . . 0.0 110.621 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' ' HG3' ' A' ' 253' ' ' GLU . . . -110.34 47.79 1.01 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.968 ' C ' HD12 ' A' ' 189' ' ' LEU . . . -120.0 -15.64 5.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.968 HD12 ' C ' ' A' ' 188' ' ' GLY . 0.2 OUTLIER 13.53 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.368 0.604 . . . . 0.0 112.57 179.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 188' ' ' GLY . 3.0 p -45.03 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 109.92 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 190' ' ' SER . 3.1 Cg_exo -59.47 -12.97 18.79 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.446 1.235 . . . . 0.0 110.977 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 194' ' ' PRO . 1.8 t70 -150.08 87.25 1.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.154 -0.966 . . . . 0.0 110.253 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.975 HG21 ' CD ' ' A' ' 214' ' ' PRO . 0.6 OUTLIER -39.13 96.8 0.12 Allowed Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.613 -0.679 . . . . 0.0 110.362 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.828 ' O ' HD13 ' A' ' 198' ' ' ILE . 2.4 Cg_endo -72.3 124.08 9.67 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.553 1.502 . . . . 0.0 111.904 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.55 ' CA ' ' HB ' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -95.63 -65.25 0.99 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 177.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -49.82 -50.91 43.39 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.534 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -62.61 -26.0 68.38 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 194' ' ' PRO . 0.7 OUTLIER -68.81 -61.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -54.72 -31.44 58.24 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 197' ' ' LYS . 8.1 tp10 -61.28 -42.78 99.23 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.75 -69.89 0.72 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 117.653 -1.619 . . . . 0.0 109.369 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 184' ' ' ILE . 58.8 m-85 -54.93 -50.95 67.57 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.542 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.64 ' HA2' HG23 ' A' ' 208' ' ' VAL . . . -55.36 -21.43 26.67 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.28 47.61 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CD1' HD11 ' A' ' 239' ' ' ILE . 76.7 m-85 -55.94 -31.1 62.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -1.2 . . . . 0.0 108.86 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 207' ' ' GLU . . . 178.14 138.82 3.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 206' ' ' GLY . 5.6 pt-20 -41.73 141.62 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.64 HG23 ' HA2' ' A' ' 203' ' ' GLY . 5.4 t -100.55 150.14 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.799 . . . . 0.0 110.55 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 230' ' ' PHE . 0.4 OUTLIER -87.8 -54.53 4.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.677 ' O ' HG22 ' A' ' 229' ' ' THR . 21.1 m -153.51 173.42 15.73 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 228' ' ' ILE . 14.8 pt -124.23 -171.27 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.125 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 227' ' ' PHE . 15.3 tt0 -150.97 128.7 11.57 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.167 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.687 HD22 ' HB ' ' A' ' 193' ' ' THR . 8.4 mt -103.49 174.46 2.78 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 120.591 -1.318 . . . . 0.0 110.0 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.975 ' CD ' HG21 ' A' ' 193' ' ' THR . 3.2 Cg_exo -69.43 -4.92 14.78 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.654 1.344 . . . . 0.0 111.117 -178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.423 ' O ' ' O ' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -53.54 -177.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 110.156 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 215' ' ' MET . 5.2 t0 60.36 150.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.138 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.42 ' C ' ' HG3' ' A' ' 218' ' ' LYS . 1.0 OUTLIER 52.73 97.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.107 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 179.32 48.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.217 -0.927 . . . . 0.0 110.481 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 36.9 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.94 0.876 . . . . 0.0 109.472 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.43 -37.4 0.14 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.407 0.622 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.534 ' HD3' ' CG ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.44 -166.49 1.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 110.321 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -137.59 64.25 1.52 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 110.219 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.534 ' CG ' ' HD3' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 175.74 141.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.351 -0.843 . . . . 0.0 109.957 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.906 ' O ' HD23 ' A' ' 189' ' ' LEU . . . -160.93 173.71 37.44 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.12 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -91.44 177.75 6.14 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.473 -1.016 . . . . 0.0 110.758 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.641 ' HB3' ' HD3' ' A' ' 214' ' ' PRO . 0.9 OUTLIER -127.82 119.88 26.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.173 -0.955 . . . . 0.0 109.295 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 185' ' ' PHE . 2.4 m-85 -95.74 -170.36 2.12 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.38 -1.45 . . . . 0.0 110.058 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 211' ' ' ILE . 1.0 OUTLIER -165.27 137.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 210' ' ' SER . 7.5 t -110.39 144.38 39.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.121 -1.612 . . . . 0.0 110.096 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.796 ' CD2' HG23 ' A' ' 236' ' ' VAL . 23.0 m-30 -103.71 -149.89 0.41 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.328 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -69.12 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 111.88 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 3.8 mm-40 -86.09 -68.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 111.116 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 232' ' ' GLU . 1.4 pt-20 164.24 -27.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.221 1.01 . . . . 0.0 109.152 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.69 ' N ' ' HD2' ' A' ' 235' ' ' PRO . 17.2 mt-10 -55.32 -45.05 99.92 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 234' ' ' GLU . 4.4 Cg_exo -53.24 -28.77 43.84 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 122.689 0.836 . . . . 0.0 110.586 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 184' ' ' ILE . 34.2 t -80.99 -35.31 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.826 -1.171 . . . . 0.0 108.433 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 234' ' ' GLU . 3.7 ttpt -45.2 -46.79 12.44 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.394 1.092 . . . . 0.0 108.287 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.85 -61.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.738 HD11 ' CD1' ' A' ' 205' ' ' PHE . 10.1 mm -43.5 -66.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.314 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.514 ' HG3' ' CG1' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -45.36 -37.38 4.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 110.013 179.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -59.58 -13.77 10.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -130.7 48.55 2.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 109.148 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -26.59 -33.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.656 ' CE2' ' HG3' ' A' ' 251' ' ' LYS . 1.5 t80 -116.37 91.2 3.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.338 -1.476 . . . . 0.0 110.274 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.712 ' HD2' HD13 ' A' ' 254' ' ' ILE . 2.3 m-70 -98.5 -145.82 0.32 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 251' ' ' LYS . 16.2 p30 -142.59 139.62 31.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 110.161 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 50.1 t -150.4 125.15 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.93 62.68 5.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 83.4 mt 50.09 23.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -1.175 . . . . 0.0 110.523 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 2.8 t -132.67 151.5 51.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.139 -0.975 . . . . 0.0 109.704 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.656 ' HG3' ' CE2' ' A' ' 244' ' ' TYR . 2.3 ptpt -107.41 44.55 1.07 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.866 -1.146 . . . . 0.0 110.505 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 254' ' ' ILE . 30.8 p -35.98 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.808 -0.558 . . . . 0.0 109.719 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.964 ' C ' HD12 ' A' ' 254' ' ' ILE . 1.4 pt-20 -87.62 171.09 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.418 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.964 HD12 ' C ' ' A' ' 253' ' ' GLU . 1.3 mp -147.66 91.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.983 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.562 ' HB2' ' CD2' ' A' ' 185' ' ' PHE . 25.0 mttt -100.08 114.92 28.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.636 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.3 p -38.3 166.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.03 0.919 . . . . 0.0 112.346 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.485 1.293 0 O-C-N 121.666 -0.646 . . . . 0.0 109.845 -179.693 . . . . . . . . 1 1 . 1 stop_ save_